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Abstract 
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Abstract 
BT is endemic in India, particularly in the South and BTV strains belonging to twelve 
BTV-serotypes (BTV-1, 2, 3, 4, 5, 9, 10, 12, 16, 21, 23 and 24) have been isolated since 
2001. A pentavalent inactivated BTV vaccine containing serotypes 1, 2, 10, 16 and 23, is 
currently being used in the South. This study focusses on the isolation and the typing of 
BTV strains from Southern India, 2014-15, then generation of full length sequence data, 
primarily for BTV genome Seg-2 to provide molecular epidemiology information 
concerning the strains circulating in the region.  
Suspected field outbreaks of BTV from Telangana, Andhra Pradesh, Karnataka and Tamil 
Nadu states in Southern India during 2014-2015 were attended to collect well documented 
blood and necropsy clinical samples from mixed population of small ruminants and cattle. 
Of the 447 field samples (EDTA blood, spleen, lymph node and saliva), 236 gave positive 
results for BTV RNA by serogroup-specific real-time RT-PCR targeting Seg-9 and Seg-10 
for 2014 and 2015 samples respectively. A total of 141 BTV virus isolations were made 
from 141 serogroup-specific qRT-PCR positive samples, by infecting KC and BHK cells.  
The isolated 63 BTVs were serotyped by qRT-PCR assay targeting Seg-2 of the BTV-1 to 
BTV-24, BTV-26, BTV-27 and BTV-29, confirming the current co-circulation of 7 BTV 
serotypes, including BTV-1, BTV-2, BTV-4, BTV-5, BTV-9, BTV-10 and BTV-12 in 62 
BTV isolates. Dual and triple BTV co-infections with these serotypes were detected in 22 
and 4 BTV isolates, respectively.  
None of the serotypes present in the pentavalent vaccine were identified in any of the 22 
BTV isolates from vaccinated animals, suggesting that the vaccine was indeed effective 
against the homologous serotype field strains.  
Among the 7 serotypes identified by Seg-2 based ORF sequence analysis of 46 BTV 
isolates (BTV-1, BTV-2, BTV-4, BTV-5, BTV-9, BTV-10 and BTV-12), 4 serotypes 
BTV-1, BTV-2, BTV-4 and BTV-9, belonged to eastern topotypes, whereas 3 serotypes, 
BTV-5, BTV-10 and BTV-12 were identified as western topotypes. For 4 BTV isolates, 
the serotype detected by qRT-PCR was different of that detected by NGS. The full genome 
sequencing and analyses is still ongoing in Glasgow. This data will assist in understand the 
epidemiology of the BT in India and implementation of effective BTV control to ensure 
the use of appropriate BTV serotype and strains in the available BT vaccine in India. 
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AGID Agar gel immuno-diffusion  
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bp Base pair 
BT  Bluetongue 
BTV Bluetongue virus  
cDNA Complementary DNA 
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q Quantitative 
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SMRT Single molecule real-time sequencing  
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SPAT Single primer amplification technique  
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 General Introduction Chapter 1:
1.1 Introduction 
Bluetongue (BT) is an arthropod-borne, non-contagious and economically important 
haemorrhagic viral disease of domestic and wild ruminants (Verwoerd and Erasmus, 2004, 
MacLachlan, 1994), causing  direct and indirect losses to livestock industries worldwide, 
estimated at 3 billion US$ per year (Tabachnick et al., 1996). BT disease is endemic in 
most tropical and subtropical countries of the world, causing mortality up to 70% in naïve 
populations of sheep (Elbers et al., 2008b). Bluetongue virus is the type species, of 22 virus 
species classified within the  genus Orbivirus, family Reoviridae, although several 
additional species have recently been proposed (Mertens et al., 2005).  
Most bluetongue virus (BTV) strains are transmitted by ‘vector competent’ species of 
biting midge, infecting ruminants, including most domestic and wild species and camelids.  
BTV can also infect several carnivorous feline and canine species via an oral route, 
although these are usually regarded as dead-end hosts (Jauniaux et al., 2008). Severe BT 
disease is usually only seen in naïve sheep populations, and may be more severe in certain 
breeds, primarily the European fine wool and mutton breeds, or some species of wild 
ruminants such as white tailed deer, or brocket deer (Erasmus, 1975, Taylor, 1986, 
Vosdingh et al., 1968). BT disease is characterized by various clinical signs, that range 
from acute to subacute, mild or inapparent depending on the virus strain as well as the 
species, breed, age and immune status of the infected host (Verwoerd and Erasmus, 2004, 
Elbers et al., 2008b). In sheep, BTV can infect the vascular endothelium and is 
characterized by haemorrhages, fever, nasal discharge, oral erosions and ulcers, lameness, 
coronitis, weakness, depression, torticollis, facial and pulmonary oedema (Spreull, 1905, 
Verwoerd and Erasmus, 2004, Maclachlan et al., 2009).  
The disease is transmitted primarily by adult females of certain species of biting midges 
belonging to the genus Culicoides, family Ceratopogonidae which blood-feed to obtain 
protein for the production of eggs (Mellor, 2000, Tabachnick, 2004). Other BTV 
transmission modes can include venereal transmission (e.g. through infected bull semen - 
(Bowen and Howard, 1984), oral transmission (Batten et al., 2014), transplacental infection 
(De Clercq et al., 2008, Menzies et al., 2008) and by mechanical vectors (Wilson and 
Mellor, 2008, Luedke et al., 1965, Bouwknegt et al., 2010). Due to its economic impact on 
international livestock trade, BT is a notifiable disease, formerly classified among the list 
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A diseases by the Office International des Epizooties (OIE) (OIE, 2017). Twenty four 
distinct serotypes of BTV have been known and identified for many years. However  BTV-
25 was recently identified in asymptomatic goats in Switzerland (Hofmann et al., 2008b, 
Chaignat et al., 2009), BTV-26 was identified in clinical samples from sheep in Kuwait 
(Maan et al., 2011b) and BTV 27 from asymptomatic goats on Corsica, France (Zientara et 
al., 2014, Schulz et al., 2016, Jenckel et al., 2015, Savini et al., 2017b). Several further 
putative types, including: BTV-28 from the Middle East, detected in a Sheep pox vaccine 
preparation (Bumbarov et al., 2016), BTV-29, isolated from an Alpaca in South Africa 
have also been identified (Wright, 2014), and BTV-30, 31 and 32 from ruminants in 
Mongolia (EPIZONE, 2017).  
1.2 Taxonomy 
 dsRNA viruses 1.2.1
There are eight families of dsRNA viruses which are recognised by the International 
Committee for the Taxonomy of Viruses (ICTV), including a diverse group of pathogens 
affecting a large variety of vertebrates, invertebrates, plants, fungi and bacteria, and are of 
medical, veterinary and agricultural significance (Mertens, 2004). Important examples 
include: rotavirus, causing neonate mortality; bluetongue virus, causing bluetongue disease 
in ruminants; plant viruses of wheat and rice; birnavirus in poultry; infectious pancreatic 
necrosis virus affecting fish; and cypoviruses causing losses in silk industry (Table 1.1). 
The Reoviridae is the largest of the eight  dsRNA virus families (Mertens, 2000).  
Table 1.1 The families of dsRNA viruses.  
Family Host 
Birnaviridae Vertebrate and invertebrate 
Chrysoviridae Fungi 
Cystoviridae Bacteria 
Endornaviridae Algae, fungi and plants 
Partitiviridae Fungi, protozoa and plants 
Picobirnaviridae Vertebrate 
Totiviridae Fungi and  protozoa 
Reoviridae Fungi, protozoa, vertebrate, invertebrate and plants 
Compiled from (ICTV, 2011) 
Chapter 1  General introduction 
3 
 
 The family Reoviridae  1.2.2
The family Reoviridae comprises two subfamilies, the Spinareovirinae containing  nine 
genera, and the Sedoreovirinae containing six genera, which are found in a broad range of 
econiches, collectively infecting a diverse group of hosts including vertebrates, 
invertebrates, plants and fungi (Mertens, 2004, Mertens et al., 2005, Attoui, 2012). Viruses 
of the subfamily Spinareovirinae have large surface projections or turrets present at the 12 
vertices of the icosahedral virus or core particle, whereas viruses in the subfamily 
Sedoreovirinae are non-turreted or smooth. The family Reoviridae (the reoviruses) 
includes 15 distinct genera that are currently recognized by ICTV, as well as several 
unassigned viruses that may include representatives of additional genera (Table 1.2). The 
reoviruses are usually considered to be non-enveloped, although some viruses (including 
BTV) can exit infected cells by budding and may acquire a temporary external membrane 
in the process.  The intact reovirus particles are 60-80nm in diameter and have icosahedral 
capsid consisted of one, two or three concentric proteins layers, surrounding a single copy 
of 9, 10, 11 or 12 linear dsRNA segments that compose the viral genome (Mertens, 2004, 
Attoui, 2012). The reoviruses show similarities in their replication strategies and structure. 
The phylogenetic relationships of their more conserved genome segments, suggest a 
common ancestry and a process or divergence involving coevolution and co-speciation 
with their respective hosts (Attoui et al., 2002). 
1.3 The genus Orbivirus 
According to the 9
th
 report of the International Committee on Taxonomy of Viruses 
(ICTV), twenty-two species of Orbivirus have been recognized and 10 tentative species are 
waiting to be incorporated in the genus (Mertens et al., 2005, Attoui, 2012). A number of 
additional putative species have recently been identified by whole genome sequencing of 
different orbivirus isolates (Belaganahalli et al., 2012, Belaganahalli et al., 2011, Cowled et 
al., 2009).  
The Orbiviruses are arthropod-borne viruses that are transmitted by arthropod vectors 
including mosquitoes, biting midges, sandflies and ticks (Belaganahalli et al., 2015). 
Closely related segmented RNA viruses that infect a single host cell can exchange genome 
segments during co-infection generating hybrid progeny virus strains by a process called as 
reassortment. This is considered as the primary determinant for different virus strains 
belonging to the same virus species (Calisher and Mertens, 1998, Batten et al., 2008). The 
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polythetic parameters recognized by ICTV (van Regenmortel and Mahy, 2004) that can be 
used (singly or in combination) to identify members of an Orbivirus virus species  include: 
reassortment (primary parameter), serological cross-reaction at high level, conserved 
genome segments showing high level similarity in RNA sequence and cross-hybridization, 
reverse transcription polymerase chain reaction (RT-PCR) assays against conserved 
genome segments, identifying the virus serotype, agarose gel electrophoresis (AGE) to 
analyze the viral RNA electropherotype, identification of conserved terminal regions on 
the genome segments, common vector or host species identification (Mertens et al., 2005, 
Mertens et al., 2009, Mertens, 2000, Attoui et al., 2001). African horse sickness virus 
(AHSV), Epizootic hemorrhagic disease virus (EHDV), Equine encephalosis virus (EEV) 
and Bluetongue virus (BTV) are considered to be the most economically important 
Orbiviruses affecting ruminants and equines. 
Table 1.2 The genera within Reoviridae family  
Genus 
Genome 
segments(numbers) 
Host Vector 
Aquareovirus 11 
Molluscs,fish, 
Crustacea 
- 
Cardoreovirus 12 Crustacea - 
Coltivirus 12 
Mammals (including 
humans) 
Ticks 
Cypovirus 10 Insects - 
Fijivirus 10 Plants Planthooper 
Dinovernavirus 9 Mosquitoes - 
Idnoreovirus 10 Insects - 
Mimoreovirus 11 Phytoplankton - 
Mycoreovirus 11 or 12 Fungi - 
Orbivirus 10 
Mammals (including 
humans), birds 
Culicoides (midges), 
mosquito, sandfly, 
ticks 
Orthoreovirus 10 
Mammals, birds and 
reptiles 
- 
Oryzavirus 10 Plants Planthooper 
Phytoreovirus 12 Plants Leafhopper 
Rotavirus 11 
Mammals (including 
humans) and birds 
- 
Seadornavirus 12 
Mammals (including 
humans) 
Mosquitoes 
Unassigned 
reoviruses 
10,11or 12 - - 
(Mertens et al., 2005) 
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1.4 The structure of the Bluetongue virus particle  
A combination of cryoelectron microscopy, X-ray crystallography and radiolabelling 
techniques have been used for high resolution structural studies of the bluetongue virus 
particle (Grimes et al., 1998, Nason et al., 2004). Bluetongue virus is usually regarded as a 
nonenveloped virus, it is icosahedral, 80 nm in diameter (Verwoerd et al., 1972, Mertens, 
1999) with three concentric protein layers, consisting of seven structural proteins, VP1 to 
VP7 (Grimes et al., 1998, Mertens, 2000), which encapsidate a 10-segmented double-
stranded (ds) RNA genome (Mertens et al., 1984, Roy et al., 1990b) (Figure 1.1). The 
outer-most capsid-layer consists of two major structural proteins, 60 trimers of VP2 (110 
kDa) and 120 trimers of VP5 (60 kDa) (Mertens et al., 1987, Mertens et al., 1984, Grimes 
et al., 1998, Roy, 1989). The larger of these two outer-capsid proteins, ‘VP2’ is the most 
variable of the BTV proteins and is responsible for cell attachment during initiation of 
infection (Hassan and Roy, 1999). VP2 also represents a target for the neutralising 
antibodies that are generated during infection of the vertebrate host. As a consequence 
variation in the amino acid sequence of VP2 determines the serotype of BTV as detected in 
serum neutralisation assays (Cowley and Gorman, 1989, Mertens et al., 1989b). The 
smaller of the two outer-capsid proteins, ‘VP5’, which is the second most variable of the 
BTV proteins, is responsible for membrane penetration during initiation of infection and is 
thought to play a secondary role in determining the specificity of interactions with 
neutralising antibodies, and therefore virus serotype (Mertens et al., 1989b, Cowley and 
Gorman, 1989, DeMaula et al., 2000).  
The inner transcriptionally-active BTV ‘core’ particle is composed of the remaining five 
highly conserved, structural proteins and the viral genome segments. The core consists of 
two concentric protein layers, the outermost of which (the ‘core surface’ layer) is 
composed of 780 copies of the 38kDa VP7 protein, arranged as 260 trimers.  The 
innermost, ‘sub-core’ capsid layer is composed of 120 copies of the 100 kDa VP3 
‘scaffolding’ protein, arranged as 12 dish shaped decamers (Grimes et al., 1998).  The 
BTV sub-core layer, which determines the overall size and organisation of the BTV 
particle, surrounds the dsRNA genome segments and the transcriptase complexes (TCs), 
composed of the three minor structural proteins, namely: VP1(Pol), 149 kDa (RNA-
dependent RNA polymerase): VP4(CaP), 76 kDa (RNA capping enzyme): VP6(Hel), 36 
kDa (dsRNA helicase).  These TCs are situated on the inner-surface of the sub-core, at the 
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twelve fivefold axes of icosahedral symmetry of the particle (Verwoerd et al., 1972, 
Mertens, 1999, Mertens et al., 1987).  
 
 
During cell-entry, the outer-capsid of the virion is lost, with removal of VP2 and VP5 prior 
to the release of the core-particle from the early endosome into the host-cell cytoplasm 
(Martin and Zweerink, 1972, Forzan et al., 2007). Large electron-dense structures, called 
viral inclusion bodies (VIBs) are considered to be the primary sites for BTV genome 
replication and the assembly of progeny virions  (Brookes et al., 1993). Four BTV non-
structural proteins (NS1, NS2, NS3/NS3a and NS4) are synthesized in virus-infected cells, 
but are not detected in purified virus particles. These include: the tubule protein NS1(TuP); 
the viral inclusion body matrix protein, NS2(ViP), the virus release protein, NS3/NS3a 
(Mertens, 2004) and the recently discovered NS4 protein which has a role in virus 
replication and in modulating the host-cell response to infection (Belhouchet et al., 2011, 
Ratinier et al., 2011). A putative fifth non-structural protein, 50-59 residues length, 
encoded by an overlapping open reading frame (S10-ORF2) in segment 10 has recently 
been recognised, although further evidence for its expression in infected cells is required 
(Stewart et al., 2015). Two of the non-structural proteins, NS1and NS2, are highly 
conserved (Huismans et al., 1987, Huismans and Els, 1979, Owens et al., 2004) while the 
Figure 1.1 Diagram of the BTV virus particle  (Mertens et al., 2003) 
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smaller NS3 protein is more variable and in the closely related African horse sickness virus 
(AHSV), is the second most variable protein after VP2 (Huismans et al., 2004).  
1.5 The BTV genome 
The genome of BTV is 19.2 Kbp in size (Roy et al., 1990b) with genome segments ranging 
from 3954 to 822 bp for BTV-10 (Mertens, 2004). The BTV genome encodes seven 
structural proteins (VP1-VP7) and four (possibly five) non-structural proteins (NS1, NS2, 
NS3/NS3a, NS4 and NS5), which are synthesized during virus replication in infected cells 
(Mertens et al., 1984, Ratinier et al., 2011, Belhouchet et al., 2011). It was originally 
thought that the BTV genome was monocistronic, with a single viral protein encoded by 
each dsRNA segment (Mertens et al., 1984), until the identification and characterization of 
NS4, encoded by a second out of phase and overlapping open reading frame of genome-
segment 9 (Belhouchet et al., 2011, Ratinier et al., 2011, Firth, 2008). A putative fifth non-
structural protein, 50-59 residues length, has also recently been identified, encoded by an 
overlapping open reading frame on segment 10 (S10-ORF2), (Stewart et al., 2015).  
 The BTV genome segments are identified as segment 1 (Seg-1) to segment 10 (Seg-10) in 
order of decreasing size, which matches their characteristic pattern of migration during 
agarose gel electrophoresis (AGE) (Mertens et al., 2009). The genome-segment migration 
pattern by  polyacrylamide gel electrophoresis (PAGE) can vary with both polyacrylamide 
concentration, and virus strain (Pedley et al., 1988). The migration pattern of the genome 
segments, or viral RNA electropherotype, during polyacrylamide gel electrophoresis 
(PAGE) depends on the primary sequences of the RNAs (point mutations, insertions or 
deletions) and thus shows significant differences between different strains and serotypes of 
BTV, whereas the migration pattern of the viral dsRNA genome segments by agarose gel 
electrophoresis (AGE) reflects the difference in their molecular weights and thus show a 
more consistent electropherotype pattern, characteristic of BTV isolates, regardless of virus 
strain (Maan et al., 2007a, Mertens et al., 1989a, Mertens, 2000).  
Conserved terminal sequences are a common feature of the genome segments of members 
of the family Reoviridae (Mertens and Sangar, 1985, Mertens, 2004) and may provide 
important recognition signals for initiation of transcription and RNA packaging. The 
positive strand of the BTV genome segments has conserved hexanucleotides at the 
noncoding termini of both 5’ and 3’ ends , 5’-GUUAAA……….. ACUUAC-3’ (Mertens 
and Sangar, 1985).  
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Comparisons of Seg-2 sequences show that the terminal hexanucleotides are the longest 
regions that are fully conserved across reference strains of  the 24 types (Maan et al., 
2007a). The noncoding region (NCR) at 5’ varies from 8-34 bp in length whereas at 3’end, 
NCR ranges from 24-116 bp in length for BTV (Batten et al., 2008, Mertens et al., 2005). 
Recently conserved hexanucleotide regions have been identified on the +ve strands of at 
least some of the BTV genome segments, that are essential for successful rescue of ssRNA 
transcripts from cDNA copies, into viable virus particles.  These regions are therefore 
thought to play an essential role in the identification and packaging of the individual 
genome-segments during BTV genome replication and packaging (Boyce et al., 2016).  
1.6 BTV structural proteins  
 Outer capsid proteins (VP2 and VP5) 1.6.1
Both core proteins and the non-structural proteins (NS) are highly conserved among BTV 
serotypes with the exception of the outer capsid proteins VP2 and VP5 which are the most 
variable (least conserved) proteins encoded by Seg-2 and Seg-6 respectively (Roy, 1989, 
Mertens, 2004). Outer capsid proteins, VP2 and VP5 are primarily involved in attachment 
to the cellular receptor and membrane penetration respectively during the initiation of 
infection (Mertens et al., 1984, Roy, 1992, Hassan and Roy, 1999, Hassan et al., 2001). 
Variations in VP2 and VP5 proteins are probably regarded to reflect adaptive responses by 
the virus to the immunological defences by the host and vector and the virus’s need to 
attach host cells from different species (Huismans and Erasmus, 1981, Roy et al., 1994). 
Among all of the BTV genome segments, Seg-2 (encoding outer capsid protein VP2)  has 
the highest rate of sequence variation, showing 29% to 59% nucleotide variation between 
different BTV serotypes (Maan et al., 2004, Maan et al., 2007a, Batten et al., 2008).  VP2 
is the major serotype-determining antigen, based on the specificity of interactions between 
VP2 and the neutralizing antibodies generated during infection of the host (Mertens et al., 
1989b, Inumaru and Roy, 1987, Gould and Eaton, 1990, Cowley and Gorman, 1989). 
 Phylogenetic analyses of Seg-2 from multiple BTV isolates have established that Seg-2 
divides into 27 distinct groups, precisely reflecting virus serotype, with <33% variation in 
nucleotide sequence within each serotype, and 29–59% nucleotide sequence variation 
between types (Maan et al., 2007a, Maan et al., 2010, Schulz et al., 2016, Mertens et al., 
2007b). As the least conserved of the BTV genome segments, sequence variations in Seg-2 
represents a basis for molecular evolutionary and phylogenetic studies and can be used for 
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identification of virus serotype, the geographical origins of the virus lineage and the design 
of primers and probes for typing specific RT-PCR assays to identify serotype and 
topotypes of BTV (Mertens et al., 2007a). 
The second most variable of the BTV-genome segments is Seg-6, which encodes the 
smaller outer capsid protein VP5, which plays a minor role in determining the specificity  
of the neutralising antibody response, contributing to serotype determination (Maan et al., 
2008, Singh et al., 2004, Cowley and Gorman, 1989). 
 Major core proteins (VP3 and VP7) 1.6.2
The atomic structure of VP7 revealed by x-ray crystallography, presents two distinct 
domains within each VP7 molecule. The upper domain of VP7 interacts with the VP2 and 
VP5, while the lower domain interacts with VP3 (Basak et al., 1996, Basak et al., 1992, 
Grimes et al., 1998). The outer/upper domain of VP7 includes an exposed arginine-
glycine-aspartic acid (RGD) tripeptide motif (amino acids 168 to 170) which may mediate 
cell attachment and penetration of insect cells by BTV core particles (Tan et al., 2001, 
Basak et al., 1996, Xu et al., 1997, Darpel et al., 2009). 
BTV core particles are poorly infectious for BHK cells, but show high levels of infectivity 
(comparable to intact virus particles) for adult Culicoides midges or a Culicoides 
sonorensis cell line (KC cells)(Mertens et al., 1987). Infectious subviral particles (ISVPs) 
of BTV are generated by treatment of virus particles with a protease (e.g. chymotrypsin), 
resulting in modification of the outer-capsid layer, which includes cleavage products of the 
VP2 protein (Marchi et al., 1995, Mertens et al., 1987, Mellor, 1990, Mertens et al., 1996). 
ISVP show an enhanced infectivity for adult Culicoides midges or a KC cells, suggesting 
that VP2 cleavage may be an important early step during transmission of the virus and 
infection of the vector insect (Mertens et al., 1987).   
VP7 is the third least conserved of the BTV proteins and the most immuno-dominant of the 
serogroup specific BTV antigens, exhibiting serological cross-reactions at high level 
between any BTV strains but meagre or no cross-reaction with viruses belonging to other 
Orbivirus species (Maan et al., 2008, Huismans and Erasmus, 1981, Wilson et al., 2000, 
Anthony et al., 2007, Mecham et al., 2003).  
Sequence analyses of BTV Seg-3 encoding VP3 have demonstrated that nucleotide 
sequence variations reflect correlation with the geographical grouping of BTV isolates into 
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topotypes with distinct eastern or western geographic variants (Nomikou et al., 2009, Maan 
et al., 2011b, Gould and Pritchard, 1991, Gould, 1987, Pritchard et al., 1995, Sailleau et al., 
2017). 
The nucleotide sequences of Seg-7 branches into multiple distinct clades that give evidence 
for only a partial correlation with the geographical origins of the virus lineage (Wilson et 
al., 2000, Maan et al., 2008). These distinct clades suggest that VP7 functions in infection 
of insect cells and insect vectors from various geographic regions, have resulted in 
additional variations that reflect adaptations to different vector populations/species 
(Mertens et al., 1996). However, as a result of its immune-dominant and antigenically 
conserved properties, VP7 provides as an appropriate target for serogroup-specific 
serological assays (Afshar et al., 1992a, Lunt et al., 1988, Anderson, 1984) and RT PCR 
assays (for designing primers and probes) to identify BTV serogroup (Anthony et al., 2007, 
Mertens, 2000).  
 Minor enzymatic core proteins (VP1, VP4 and VP6) 1.6.3
The three minor core proteins VP1 (Pol) (a monomer), VP4 (CaP) (a dimer) and VP6 (Hel) 
(a hexamer) of transcriptionally active BTV core particles, together form the Transcriptase 
or replicase complexes (TCs) which are located at each of the 5 fold axes of VP3 sub-core 
layer (Gouet et al., 1999). These minor proteins play a vital role in viral genome 
transcription and replication (Roy, 2008b) during viral infection.  
VP1: VP1 is the viral polymerase VP1 (149.5 kDa, encoded by Seg-1) is the largest and 
most highly conserved BTV protein, (Huang et al., 1995, Roy et al., 1988). VP1 is located 
within the sub-viral capsid layer as 12 copies per core particle (Stuart et al., 1998) where it 
uses the BTV genome segments as templates for the transcription of the ten BTV mRNAs,  
protected from host cell cytoplasm and antiviral surveillance mechanisms (Grimes et al., 
1998, Mertens and Diprose, 2004, Urakawa et al., 1989). VP1(Pol) also has replicase 
activity that is responsible for the  synthesis of -ve sense RNA strands using the viral 
mRNAs as templates, reforming the  dsRNA genome segments during the assembly of 
progeny virus particles (Boyce et al., 2004, Matsuo and Roy, 2011).  
Seg-1 of BTV, which encodes VP1(Pol), is not only highly conserved across the BTV 
virus species but also shows significant conservation across all members of family 
Reoviridae (Huang et al., 1995). Seg-1 represents a potential target for serogroup-specific 
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RT-PCR assays (for design of primers and probes) to detect any BTV strains, and 
potentially to identify different geographic variant or topotypes of BTV (Shaw et al., 
2007). Distantly related reoviruses can also be compared and their species/genus identified 
by analysis of the conserved nucleotide sequence of their genome segment that encode the 
viral polymerase (Pol)  (Attoui et al., 2000a, Mertens et al., 2004, Attoui et al., 2005, 
Attoui et al., 2001, Belaganahalli et al., 2012, Belaganahalli et al., 2011, Belhouchet et al., 
2010, Maan et al., 2011b).  
VP4: VP4 is also a highly conserved BTV protein encoded by genome segment 4 (Seg-4). 
BTV mRNAs (+ve sense transcripts) that are synthesised at an early stage during infection 
of the host-cell, are modified by VP4 (Hel) within the parental core particles, which has 
four distinct enzyme functions: an RNA triphosphatase; guanyltransferase and two distinct 
methyltransferase  activities (Le Blois et al., 1992, Martinez-Costas et al., 1998, Ramadevi 
and Roy, 1998, Roy, 2008a). These mRNAs are subsequently translated into the viral 
proteins by the host cell ribosomes. The ‘Cap-structure’ is to stabilises the viral mRNA and 
promotes efficient translation of most eukaryotic mRNAs (Sutton et al., 2007). However 
BTV mRNAs do not have a poly ’A’ tail. 
VP6: VP6 is the smallest enzymatic core protein (35.7 kDa) and is encoded by the 
conserved genome segment 9 of BTV, along with the NS4 protein.  VP6 displays RNA-
dependent ATPase, an RNA binding site and helicase functions (Roy et al., 1990a, Stauber 
et al., 1997). It is thought to unwind the dsRNA BTV genome segments, facilitating 
transcription by VP1, helping in separation of the newly synthesised positive sense RNA 
(mRNA transcript) after transcription. There are two related forms of VP6 (VP6 and VP6a) 
that are translated from the separate in-frame initiation codon of same ORF on Seg-9 of 
BTV (Wade-Evans et al., 1992). 
Seg-1, Seg-4 and Seg-9 (encoding minor core protein) from different BTV strains can be 
separated into eastern and western geographically distinct variants / topotypes of BTV 
isolates by phylogenetic sequence comparison (Maan et al., 2011b, Maan et al., 2008, 
Maan et al., 2010 ). 
1.7 BTV non-structural proteins (NS1, NS2, NS3, NS4 and NS5) 
NS1 (64kDa viral protein, encoded by Seg-5): forms tubular structures within the cell 
cytoplasm, that are the characteristic morphological features of BTV infection (Hewat et 
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al., 1992, Urakawa and Roy, 1988). NS1 ‘tubules’ are formed by multimers of NS1 as 
helically coiled ribbons, 68 nm diameter and 1000 nm long (Huismans and Els, 1979). 
Tubules are also present in viral inclusion bodies (VIB) during early stage in infection 
(Brookes et al., 1993, Eaton et al., 1988). NS1 is also involved in regulating the egress of 
virus from the mammalian and Culicoides cells (Owens et al., 2004). Owens and 
colleagues demonstrated that high NS1: NS3 ratio correlates with virion egress by cell 
lysis in mammalian cells, whereas a lower NS1:NS3 ratio correlated with BTV egress via a 
budding (Owens et al., 2004). NS1 has been shown to increase the translation of specific 
viral proteins (Boyce et al., 2012). 
NS2: NS2 is expressed abundantly and is a major component of the viral inclusion bodies 
(VIBs) that form as perinuclear structures in infected cells (Brookes et al., 1993, Thomas et 
al., 1990, Butan and Tucker, 2010, Kar et al., 2007, Lymperopoulos et al., 2006). VIBs 
play a major role in BTV replication, viral protein synthesis and the assembly of core 
proteins, and viral RNAs to form progeny core particles. NS2 binds to viral ssRNA and 
interacts with VP3 to start BTV core formation (Kar et al., 2007). 
Phylogenetic sequence comparison of the highly conserved Seg-5 (encoding NS1) and 
Seg-8 (encoding NS2) from different BTV strains gives a clear split into geographically 
distinct eastern and western variants (topotypes) of BTV in a manner similar to the proteins 
of virus subcore (Maan et al., 2008).  
NS3: early in infection, Bluetongue virus is released from infected mammalian cells by 
budding through the plasma membrane.  Later in infection, larger numbers of progeny 
virus particles are released by cell lysis, while in insect cells, virus egress occurs without 
significant damage to the host cell or cytopathic effects, through the action of NS3 as a 
viroporin (Celma and Roy, 2009, Guirakhoo et al., 1995, Hyatt et al., 1989, Hyatt et al., 
1993). There are two related forms of NS3, a 229-amino acid NS3 protein and its truncated 
form NS3a which is a 216-amino acid protein. These proteins are translated from the two 
in-frame initiation codon of same ORF on the positive strand of Seg-10 of BTV. Seg-10 
also encodes the NS5 protein. NS3 helps in trafficking and release of viral particles from 
infected cells (Mertens et al., 2004, Beaton et al., 2002, Celma and Roy, 2009, Doceul et 
al., 2014, Vitour et al., 2014). It has also been proposed that NS3 hinders the host innate 
immune response and down regulates IFN-β promoter activation in reporter assays 
(Chauveau et al., 2013).  
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NS3 and its truncated form NS3a are the membrane glycoprotein (Wu et al., 1992) which 
acts as a viroporin, hydrophobic viral transmembrane proteins that enhance membrane 
permeability by forming pores (Han and Harty, 2004) thereby assisting in virus release by 
promoting membrane permeabilization. NS3/NS3a are synthesised in only very small 
amounts in mammalian cells but represent major translation products of the viral genome 
in insect cells, mediating non-lytic release of progeny virus (Noad and Roy, 2009).  
Seg-10 is the fourth least conserved of the BTV genome segments and phylogenetic 
sequence comparison give evidence for separation into multiple distinct clades, with some 
geographic bias (Billinis et al., 2001, Balasuriya et al., 2008, Bonneau et al., 1999, 
Nikolakaki et al., 2005, Nikolakaki et al., 2004, Maan et al., 2008). It has been suggested 
that (like Seg-7/VP7) in view of the significance of NS3 for release of BTV virions from 
infected insect cells that these clades reflect adaptation to different insect vector 
populations / species in different geographic regions. 
NS4: Bioinformatics analysis of Seg-9 encoding VP6 showed the presence of an 
overlapping +2 open reading frame (ORF), positioned at +1 position downstream to the 
VP6 ORF (Firth, 2008, Belhouchet et al., 2011, Ratinier et al., 2011). NS4, is a 77-79 
amino acid protein which localises in the nucleolus and is highly conserved among 
different BTV serotypes as well as in most other orbiviruses (Ratinier et al., 2011, 
Belhouchet et al., 2011, Firth, 2008). Although the role of NS4 has not been full 
determined, its association with cell membrane is thought to indicate a role in  virus cell-
exit (Belhouchet et al., 2011). Ratinier and colleagues found that BTV-8 NS4 counteracted 
antiviral responses of the host, and it may therefore associated with evasion of the host 
immune system (Ratinier et al., 2011).  
NS5: A putative fifth non-structural protein, 50-59 residues in length, encoded by an 
overlapping open reading frame (S10-ORF2) in segment 10, has recently been identified, 
although further evidence for its expression in infected cells is still required (Stewart et al., 
2015).  
1.8 The BTV replication cycle 
 Attachment and entry  1.8.1
Following attachment of virions to specific receptors on the host cell surface, BTV enters 
the cell by receptor mediated endocytosis into clathrin-coated vesicles (Forzan et al., 2007) 
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or alternatively by micropinocytosis (Gold et al., 2010). Outer capsid protein, VP2 is 
primarily involved in attachment to the cellular receptor, while VP5 is involved in cell-
membrane penetration during the initiation of infection  (Mertens et al., 1984, Roy, 1992, 
Hassan and Roy, 1999, Hassan et al., 2001).  
Cell attachment and penetration of insect cells by BTV core particles is mediated by VP7, 
and can be neutralised by VP7 specific antibodies, suggesting more than one mechanisms 
of BTV entry. This interaction may be mediated by the arginine-glycine-aspartate (RGD) 
motifs (integrin binding domains) that are displayed on the  outer/head domain of VP7 
(Mertens et al., 1987, Mertens et al., 1996, Hynes, 1992, Tan et al., 2001, Grimes et al., 
1998, Forzan et al., 2007).  
 Uncoating  1.8.2
The low pH of early endosome favours dissociation of VP2 from the core layer (Forzan et 
al., 2004, Zhang et al., 2010) and conformational changes in VP5 that can induce 
membrane fusion and release of the transcriptionally active core particle through the 
endosome membrane into the host cell cytoplasm (Forzan et al., 2004, Hassan et al., 2001, 
Hassan and Roy, 1999, Noad and Roy, 2009).  
 Transcription  1.8.3
For the family Reoviridae, transcription and replication of the viral genome take place 
within the cytoplasm of host cell. However, in order to protect the viral dsRNA from 
antiviral surveillance mechanisms of host cell cytoplasm, the viral genome stays contained 
within the core particle (Mertens and Diprose, 2004). The three minor core proteins VP1 
(Pol), VP4 (CaP) and VP6 (Hel) form the transcriptase / replicase complexes, located at 
each of the 5 fold axes of VP3 sub-core layer of the transcriptionally active BTV core 
particles. Together these proteins mediate viral genome transcription and replication during 
infection (Roy, 2008b, Gouet et al., 1999, Mertens and Diprose, 2004).  
The RNA-dependent RNA polymerase (transcriptase) activity of VP1 transcribes +ve 
strand ssRNAs (mRNA) from negative strand of each of ds RNA genome segment within 
the core particle (Boyce et al., 2004, Urakawa et al., 1989). The helicase function of VP6 
(Hel) unwinds the dsRNA genome segments to allow transcription by VP1 (Pol) and may 
help in separation of the newly synthesised mRNA after transcription (Roy et al., 1990a, 
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Stauber et al., 1997). The four distinct enzyme functions of VP4 (CaP) which include: an 
RNA triphosphatase; guanyltransferase and two methyltransferase activities, generate 
methylated cap structures (
7mGpppGm) at the 5’ termini of viral mRNAs synthesised early 
during infection (Le Blois et al., 1992, Martinez-Costas et al., 1998, Ramadevi et al., 1998, 
Roy, 2008b). The cap structures stabilise the viral mRNAs and promote their efficient 
translation (Sutton et al., 2007). The capped transcripts leave the core structure through 
channels at the 5 fold axes (Diprose et al., 2001, Gouet et al., 1999, Grimes et al., 1998, 
Mertens and Diprose, 2004, Verwoerd and Huismans, 1972). BTV mRNAs don’t possess a 
poly (A) tail at their 3 ̍ termini. Translation of BTV proteins utilizes the translational 
machinery of the host cell, competing with host cell mRNAs (Huismans, 1979). BTV 
infection results in shut-off of host-cell protein synthesis in mammalian cells, but has little 
overall effect on host-protein synthesis in insect-vector cells. NS1 facilitates up-regulation 
of specific BTV genes expression for the synthesis of viral proteins (Boyce et al., 2012). 
Viral inclusion bodies (VIBs) play a major role and represent a site for virus genome-
replication and assembly of progeny core particles, from viral proteins that are synthesised 
within the cytoplasm of infected cells (Brookes et al., 1993).  
 Replication  1.8.4
VP1 with its replicase activity synthesizes the negative strand RNA from positive strand 
RNA or early mRNAs within the nascent progeny subviral particles (Boyce et al., 2004).  
 Assembly and release  1.8.5
Viral transcripts are directed to the viral inclusion bodies (VIB), possibly by interactions 
with the phosphorylated form of NS2, where negative strand synthesis, nascent progeny 
core particle assembly and genome encapsidation take place. NS2 binds to viral single 
stranded RNA and interacts with VP3 to start BTV core formation (Kar et al., 2007). The 
progeny virions are surrounded by outer-capsid proteins at the periphery of VIBs, when 
virions exit the VIBs to enter the host cell cytoplasm (Kar et al., 2007, Brookes et al., 
1993). VP3 proteins can self-assemble to form the subcore-shell and act as a scaffold for 
attachment of the internal replicase complexes (Grimes et al., 1998) as well as the trimmers 
of outer-core protein VP7. Bluetongue virus is released from infected cells by lytic cycle 
(Schwartz-Cornil et al., 2008), cell membrane permeabilization (Fu, 1995), or  through the 
role of NS3 in trafficking and release of BTV particles by its viroporin activity in insect 
cells, predominantly without inducing cytopathic effect (Noad and Roy, 2009, Celma and 
Chapter 1  General introduction 
16 
 
Roy, 2009, Guirakhoo et al., 1995, Hyatt et al., 1989, Hyatt et al., 1993, Owens et al., 
2004). There is also evidence that orbiviruses can leave infected cells by incorporation of 
multiple particles into intracellular vacuoles, that can subsequently fuse with the host cell-
membrane releasing their contents (Maree and Huismans, 1997).   
 
 
(Adapted from Mertens and Diprose, 2004 – with permission). 
1.9 BTV pathogenesis 
 Clinical signs 1.9.1
Although BTV can infect most domestic and wild ungulates, camelids and even certain 
carnivores (via an oral route) severe disease is usually seen primarily in certain breeds of 
sheep particularly in naïve populations of European fine wool and mutton breeds as well as 
some species of wild ruminants such as white tailed or brocket deer (Erasmus, 1975, 
Taylor, 1986, Vosdingh et al., 1968, Fernandez-Pacheco et al., 2008, Meyer et al., 2009). 
In adult cattle and goats, BT disease is often asymptomatic or inapparent (Parsonson, 1990, 
Barratt-Boyes and MacLachlan, 1995, Verwoerd and Erasmus, 2004), although infection 
can cause reproductive failure, abortion and loss of milk yield. The symptoms of 
bluetongue in sheep have been well documented, and include fever, serous or blood stained 
nasal discharge, ocular discharge, excessive salivation, oral erosions and ulcers, wool 
Figure 1.2 Schematic representation of the BTV replication cycle  
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break, lameness, coronitis, weakness, depression, torticollis/ wryneck, respiratory distress, 
facial and pulmonary oedema (Spreull, 1905, Verwoerd and Erasmus, 2004, Moulton, 
1961, Maclachlan, 2011, MacLachlan et al., 2008, Maclachlan et al., 2009). The clinical 
course of disease is variable with symptoms ranging from acute to subacute, mild or 
inapparent depending on the virus strain as well as species, breed, age and immune status 
of infected host (Verwoerd and Erasmus, 2004, Elbers et al., 2008b, MacLachlan, 1994, 
Parsonson, 1990, Barratt-Boyes and MacLachlan, 1995). The clinical manifestations of BT 
in adult sheep are at least in part the result of vascular injury mediated by virus that causes 
increased vascular permeability, oedema, hyperaemic congestion and haemorrhagic 
infarction (Verwoerd and Erasmus, 2004, Moulton, 1961, Chiang et al., 2006, 
MacLachlan, 1994). Mortality generally varies from 2 to 30% but may be more in naïve 
and susceptible flocks (Cox, 1954, Conraths et al., 2009, Erasmus, 1975). Viraemia occurs 
in sheep around three to five days post infection, followed by congestion of oral mucosa as 
an early sign of disease (Foster et al., 1991). In contrast, goats and cattle usually remain 
asymptomatic and rarely show symptoms other than anorexia and viremia, typical in 
enzootic areas (Erasmus, 1975, Luedke and Anakwenze, 1972, Maclachlan et al., 2009, 
Caporale et al., 2014). The  BTV-8 strain outbreak in northern Europe during 2006-2009 
did cause some clinical signs in naïve cattle, although their mortality rate was <1%, 
compared to ~25% in sheep (Backx et al., 2007, Dal Pozzo et al., 2009a, Dal Pozzo et al., 
2009b, Elbers et al., 2008a, Barratt-Boyes and MacLachlan, 1995, MacLachlan et al., 
1990, Elbers et al., 2008b). It has been reported that cattle have inapparent BTV infection 
due to less susceptibility to BTV-induced lung microvascular injury (DeMaula et al., 2001, 
DeMaula et al., 2002a, McLaughlin et al., 2003, Russell et al., 1996). 
Clinical manifestation of BTV infections in cattle represent a mild form of disease, 
showing viremia, anorexia, oral and nasal mucosae congestion, serous or mucopurulant 
nasal discharge, excessive frothy salivation, tongue oedema, erosions, coronitis, dermatitis 
(Bekker et al., 1934), udder lesions and decrease in milk production as an additional 
clinical sign (Bekker et al., 1934, Dal Pozzo et al., 2009b, Thiry et al., 2006, Williamson et 
al., 2008). Recent studies have confirmed that BTV can cross the placenta in both pregnant 
cattle and sheep, resulting in teratogenic effects in the foetus (dummy calf syndrome).  
There is also evidence for reduced reproductive success (and productivity) during BTV 
outbreaks that may result from failed implantation of the embryo, again causing loss of 
milk yield. 
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BTV antibodies have been detected by serological assays, in both large and small 
carnivorous species from Africa suggesting of BTV infection (Alexander et al., 1994, 
Coetzee et al., 2012a). There is a recorded sero-prevalence of BTV specific antibodies of 
~60% of elephants in India, indicating infection (K.P. Singh personal communication), 
suggesting that BT may be a factor in the survival of endangered mammalian wildlife 
species. In addition, there is evidence of BTV infection in dogs through the use of 
contaminated canine vaccine or in lynx by feeding on infected meat (Akita et al., 1994, 
Alexander et al., 1994, Fernandez-Pacheco et al., 2008, Jauniaux et al., 2008, Levings et 
al., 1996, Wilbur et al., 1994, Evermann, 2013, Brown et al., 1996).  
 Pathogenesis 1.9.2
Adult Culicoides can transmit BTV by intradermal inoculation during feeding on 
susceptible hosts. The protease activity of saliva in competent Culicoides can cleave BTV 
outer capsid protein, VP2 generating infectious subviral particles [ISVP] thereby 
promoting infectivity of BTV particles for the vector insects (Darpel et al., 2011). Saliva of 
Culicoides can also enhance BTV infectivity by modulating the host’s immune reaction, 
recruiting leucocytes (inflammatory cells), which can become infected, facilitating the 
initial replication of BTV and spread from the initial bite-site (Darpel et al., 2011, Pages et 
al., 2014). After primary replication of BTV in regional lymph nodes involving dendritic 
cells, lymphocytes, mononuclear cells, and macrophages, virus dissemination occurs, 
allowing virus replication in endothelial cells and mononuclear phagocytes of secondary 
sites like the lungs, spleen, heart, intestine and other tissues (Barratt-Boyes and 
MacLachlan, 1995, Barratt-Boyes and MacLachlan, 1994, Barratt-Boyes et al., 1995, 
MacLachlan et al., 1990, MacLachlan, 2004).  
BTV replication at primary sites occurs for 2–3 days, whereas secondary replication takes 
between 4 and 20 days, depending on the course of the disease (MacLachlan, 2004). BTV 
can spread through both the lymph (Barratt-Boyes and MacLachlan, 1994) and blood 
(Brodie et al., 1998) including mononuclear cells, erythrocytes, and thrombocytes.  
Diagnosis of BTV by detection of viral RNA using RT-PCR assays, does not by itself 
confirm that an animal is still infectious. Blood of infected animal had been found positive 
for BTV RNA by RT PCR for > 220 days post-infection, but virus could not be isolated in 
cell culture or inoculation of susceptible sheep from RT-PCR positive samples 
(MacLachlan, 1994, Bonneau et al., 2002). Ruminant blood detected positive by RT- PCR 
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many months post-infection was also found non-infectious to Culicoides by either intra 
thoracic inoculation or oral feeding (Bonneau et al., 2002, Tabachnick, 1996).  
BTV causes cell associated and prolonged viraemia in infected animals but there is little 
evidence of a persistent infection (Barratt-Boyes and MacLachlan, 1995, Bonneau et al., 
2002, MacLachlan et al., 1994, Singer et al., 2001). In sheep, viraemia can persist in the 
blood for 14 to 54 days (Koumbati et al., 1999) and in cattle up to 60 or even 100 days 
(Sellers and Taylor, 1980). However, BTV RNA can be detected by RT-PCR for 3-100 
days in sheep and up to 220 days in cattle post-infection (Singer et al., 2001, Bonneau et 
al., 2002, MacLachlan et al., 1994). Virus is found in invaginations of the cell membrane 
of erythrocytes, thereby promoting longer viraemia, protection from host immune 
clearance, potentially maintaining infectivity for Culicoides that feed on viraemic 
ruminants (Brewer and MacLachlan, 1992, Brewer and MacLachlan, 1994).  BTV can 
cause persistent infections of gamma-delta T cells (Takamatsu et al., 2003) and infectious 
virus can persist for long in immune-privileged sites, such as the testes, potentially leading 
to venereal transmission. 
 Marked difference in the clinical expression  between sheep and cattle after BTV infection 
could be related to inherent species-specific differences in the sensitivity of endothelial 
cells to BT infection and differential production of inflammatory cytokines (Coen et al., 
1991). Endothelial cells and mononuclear phagocytic cells of the lungs and lymphoid 
tissues are the main site for BTV replication in both sheep and cattle (Barratt-Boyes and 
MacLachlan, 1994, Barratt-Boyes and MacLachlan, 1995, MacLachlan et al., 1990, Pini, 
1976). After infection activated endothelial cells produce many inflammatory mediators, 
including PGF2α thromboxane, prostacyclin, IL-1, IL- 6, IL-8, cyclo-oxygenase-2, and 
nitric oxide synthase (DeMaula et al., 2002a, Schwartz-Cornil et al., 2008). 
Proinflammatory cytokines produced by ovine endothelial cells are substantially greater in 
quantity than bovine endothelial cell (DeMaula et al., 2001, Russell et al., 1996, DeMaula 
et al., 2002b). In addition, markedly increased ratios of prostacyclin to thromboxane are 
detected in cattle (Schwartz-Cornil et al., 2008). Prostacyclin is a vasodilation and platelet 
aggregation inhibitor, while thromboxane is a vasoconstrictor and promotes platelet 
aggregation. Significantly increased ratio of thromboxane to prostacyclin could explain 
enhanced clinical manifestations of microvascular injury, thrombosis and oedema in ovine 
species, in contrast to cattle (DeMaula et al., 2001, DeMaula et al., 2002b).  
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1.10 Evolution and molecular epidemiology of BTV 
Viral quasi-species is a continuously changing swarm or cloud of closely related variants 
centered around a consensus sequence but continuously able to emerge or disappear in 
different directions as a new mutant within a single population (Andino and Domingo, 
2015). Bluetongue virus evolution occurs through the mechanism of quasispecies that is 
driven by accumulation of mutations or nucleotide substitution (genetic drift), reassortment 
(genetic shift), intra-segment recombination and concatemerisation (gene duplication), 
although the latter two mechanisms are thought to be rare but significant outcomes (Carpi 
et al., 2010, Maan et al., 2012c, He et al., 2010, Anthony et al., 2011, Coetzee et al., 2012b, 
Mohd Jaafar et al., 2014, Nomikou et al., 2015, Shafiq et al., 2013, Bonneau et al., 2001, 
Oberst et al., 1987, Stott et al., 1987, Shaw et al., 2013, Batten et al., 2008). Quasispecies 
evolution, together with founder effect and strong purifying selective pressures have over 
time accumulated genetic heterogeneity and variations in BTV strains, that can influence 
replication or transmission efficiency of virion (Niedbalski, 2013, Balasuriya et al., 2008). 
Segmented RNA viruses of the same species, that co-infect a single host cell, can exchange 
genome segments during replication generating hybrid progeny virus strains by a process 
known as ‘reassortment’.  The compatibility of viruses for reassortment is considered as 
the primary determinant showing that different strains belonging to the same virus species 
(Simon-Loriere and Holmes, 2011). Although several studies have confirmed that BTV 
reassortment is frequent and widespread most of these studies are based on limited, sub-
genomic data sets, impeding specific observations into the frequency and patterns of 
reassortment between all ten segments (Nomikou et al., 2015). Samal and colleagues 
demonstrated  reassortment in 5% of the progeny clones from a sheep that was infected 
with BTV 10 and BTV 17 (Samal et al., 1987)  whereas  90% of progeny virions were 
reassortants within a calf infected with BTV-11 and BTV-17 (Stott et al., 1987). Batten et 
al (2008) provided evidence of a European BTV field strain, derived by reassortment of 
two parental live attenuated-vaccine strains of BTV-2 and BTV-16, supporting concerns 
about the use and transmission of live attenuated BTV vaccines in the area. The co-
circulation of multiple BTV serotypes and strains in BTV endemic areas and their 
concurrent infection in the same host and cells provide multiple opportunities for 
reassortment and suggest circulation of a complex quasi-species (McColl and Gould, 
1994). 
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Although BTV outbreak strains are usually identified by serotype, which is determined by 
the sequence of Seg-2, this does not reveal the extensive genotypic and phenotypic 
heterogeneity that exists in BTV field strains and populations, even within the same BTV 
serotype (Nomikou et al., 2015). 
 BTV serogroup, serotypes and topotype  1.10.1
Orbivirus serogroup reflects antigens that are both conserved and cross-reactive between 
members of the individual virus species which exists as a complex spectrum of serotypes, 
topotypes and strains. The BT serogroup specific antigens include most of the non-
structural and core proteins. In contrast, BTV serotype is determined by the BTV outer 
capsid proteins VP2 and VP5, particularly VP2, which primarily controls the specificity of 
interactions with neutralising antibodies in serum neutralisation assays. 
 BTV serotypes can be detected and differentiated by RT-PCR and phylogenetic analyses 
targeting Seg-2 of the virus genome, which codes for outer capsid protein VP2 (Maan et 
al., 2007a, Mertens et al., 2007a) .There are 24 distinct serotypes of BTV that have been 
known for several decades, as well as the recently identified Toggenburg virus which was 
detected during routine surveillance of goats in Switzerland during 2008 and identified as 
as BTV-25  (Hofmann et al., 2008b, Chaignat et al., 2009), BTV-26 was identified in 
clinical samples from infected sheep in Kuwait (Maan et al., 2011b) and BTV-27 was 
recently identified in asymptomatic goats from Corsica, France (Zientara et al., 2014, 
Schulz et al., 2016). Two further putative types, include BTV-28 from the Middle East 
detected in a Sheeppox vaccine preparation (Bumbarov et al., 2016) and BTV-29 in an 
Alpaca from South Africa (Wright, 2014). Studies of BT outbreaks in Mongolia have also 
identified three additional putative novel serotypes (Hoffman personal communication 
2017).  
Sequencing studies indicate that BTV strains in separated geographic regions have evolved 
independently over an extensive period of time. This geographical separation has allowed 
viruses to gain unique point mutations, some of which may make them more fitted to 
transmission and survival in their respective local ecosystems. Genetic heterogeneity of 
BTV strains as a result of genetic drift, genetic shift and selection, have gradually led to the 
appearance of distinctive regional variants that can be divided into eastern and western 
topotypes for all of the genome segments of BTV. The eastern BTV group generally 
constitutes viruses from South Asia, South-East Asia, China and Australia, while viruses 
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from Africa ,the Americas, Europe and the Middle East are mostly included in the western 
BTV group (Maan et al., 2007a, Maan et al., 2008, Mertens et al., 2007a).  
The most conserved structural and non-structural proteins of the BTV are VP1, VP3, VP4, 
VP6, NS1, NS2 and NS4 encoded by the conserved Seg-1, Seg-3, Seg-4, Seg-9, Seg-5, 
Seg-8 and Seg-9 respectively (Maan et al., 2008). Seg-7 and Seg-10 are the third and 
fourth most variable of the all the BTV genome-segments, while Seg-2 and Seg-6 are the 
first and second most variable, respectively (Maan et al., 2008, Huismans and Erasmus, 
1981, Wilson et al., 2000, Balasuriya et al., 2008, Bonneau et al., 1999, Nikolakaki et al., 
2005, Nikolakaki et al., 2004, Anthony et al., 2007, Billinis et al., 2001, Mecham et al., 
2003). 
Sequencing and phylogenetic studies of Indian BTV isolates, have used full length or 
partial analyses of selected individual genome segments (particularly Seg-2) of different 
BTV isolates, rather than full  genome analyses (Sreenivasulu et al., 1999, Biswas et al., 
2015, Tembhurne et al., 2010, Desai et al., 2009, Shafiq et al., 2013). Although these 
studies have contributed significantly to our understanding concerning the serotypes, 
origins and evolutionary relationships of the BTV strains in India, a comprehensive 
approach to the sequencing and analysis of full genome of Indian BTV isolates is still 
missing.  
Recently, full-length whole-genome sequence data have been generated for multiple Indian 
BTV isolates, contributing additional knowledge about reassortment of field strains and 
topotype of each genome segment (Maan et al., 2012a, Maan et al., 2012b, Maan et al., 
2012c, Maan et al., 2012d, Rao et al., 2012b, Chand et al., 2016, Kumar et al., 2016, Rao et 
al., 2015, Maan et al., 2015c, Minakshi et al., 2012).  
Sequencing and phylogenetic analyses of 26 Indian BTV isolates by Maan et al (2015c) 
confirmed that most of the genome-segments are derived from eastern lineages, grouping 
within the major eastern topotype.  However, Seg-5 encoding NS1, from multiple Indian 
BTV isolates post 1982, originate from the major western topotype (Maan et al., 2012b, 
Maan et al., 2015c, Maan et al., 2012e, Maan et al., 2012d). Maan and colleagues showed 
that all 10 segments of BTV-2 isolates (IND2003/01, IND2003/02 and IND2003/03) 
belong to the western topotype and share >99% nucleotide identity with a BTV-2 vaccine-
strain from South Africa, indicating an earlier introduction of this vaccine-strain into India 
(Maan et al., 2015c, Maan et al., 2012b). In addition, all of the segments of BTV-10 
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isolates (IND2003/06; IND2005/04, IND2004/01) are also derived from western lineages, 
sharing >99% nucleotide identity to a BTV-10 vaccine-strain from United States (Maan et 
al., 2012e, Maan et al., 2015c, Rao et al., 2012a). These data raise concerns over the 
movement of western field and/or vaccine-strains of BTV into India, possibly associated 
with livestock trade, importation of infected animals, vector movements, and/or the 
unauthorized importation and use of live attenuated vaccine strains from South Africa and 
America into the country (Rao et al., 2012a). Sequencing databases can be used as a basis 
for tracing the origins, spread, and reassortment events during the evolution of individual 
outbreak strains, as well as improving diagnostics and vaccine development/matching to 
field strains.  
1.11 DNA sequencing 
DNA sequencing is the process to determine the exact order of four nucleotide bases- 
adenine, guanine, cytosine and thymine in a DNA molecule.  
 The Maxam and Gilbert method  1.11.1
Maxam-Gilbert, or chemical sequencing is based on specific chemical fragmentation of 
terminally labelled DNA at Adenine, Guanine, Cytosine or Thymine nucleotides site 
(Maxam and Gilbert, 1977). This was the earliest sequencing technique used to determine 
the genome sequences of Orbivirus isolates (Ghiasi et al., 1985, Purdy et al., 1985, Roy et 
al., 1985) 
  Sanger’s dideoxy sequencing technology 1.11.2
Sanger or dideoxy chain termination sequencing relies on the enzymatic synthesis of the 
complementary strand of DNA, coupled with chain termination. Synthesis of 
complementary strands is terminated by the incorporation of radiolabelled or fluorescently 
labeled dideoxynucleotides (ddNTP), which block progression of a DNA polymerase, at a 
specific base, thereby causing chain termination (Sanger et al., 1977). The  exact order of 
the four nucleotide namely adenine, guanine, thymine and cytosine in a particular strand of 
DNA was identified by separating the fragments of DNA using electrophoresis  and 
exposure of X-ray film to the radiolabeled fragments (at 5' end with P32 or S35), or using 
fluorescently labeled dideoxynucleotides and automated fluorescence sequencing 
equipment,  in the Sanger sequencing approach. Dideoxy chain termination sequencing 
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became the principal sequencing method for analysis of the BTV genome segments, using 
conserved terminal sequence primers (Kowalik and Li, 1989, Gould, 1987, Cooke et al., 
1991). 
 Next generation sequencing 1.11.3
Broadly, there are two sequencing approaches in next generation sequencing: short-read 
and long-read. Short-read sequencing is further categorized into sequencing by ligation 
(SBL) and sequencing by synthesis (SBS). Sequencing by synthesis includes cyclic 
reversible termination and single-nucleotide addition approaches whereas SOLiD and 
Complete Genomics platforms use sequencing by ligation approach of sequencing. The 
long read sequencing approach uses a single-molecule real-time (SMRT) and synthetic 
long-read sequencing approach (Goodwin et al., 2016, Metzker, 2010, Mardis, 2008). 
Long-read sequencing helps to reveal structural features of highly complex genomes, in 
terms of repetitive regions, structural variations (larger than single nucleotide 
polymorphism), genome assembly, large structural features of the genome and copy 
number alterations.  
There are many elemental steps that are common to all high throughout sequencing 
approaches. These steps are: the library preparation from the genomic DNA or 
complementary DNA (cDNA); amplification of molecules within the library; 
immobilization of DNA fragments onto a solid support; massively parallel sequencing; and 
detection by imaging (Shendure and Lieberman Aiden, 2012, Shendure and Ji, 2008) 
 Illumina (MiSeq, NextSeq 500, and HiSeq) 1.11.3.1
This is based on cyclic reversible termination approach that is based on the Sanger 
sequencing principle, involving hybridization of fluorophore-labelled 3ʹ-blocked 
deoxynucleotides to complementary bases, imaging and finally cleavage of fluorophores, 
followed by regeneration of 3̍ OH group. Briefly, in a four color cyclic reversible dye 
terminator sequencing approach, each adapter ligated DNA molecule of the library is 
captured on the glass flow cell and undergoes clonal amplification by bridge PCR, to 
generate a fluorescent cluster. The fluorescence is read for millions of clusters 
simultaneously and dye terminators are removed to regenerate 3̍ OH and process is 
repeated (Goodwin et al., 2016) 
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 Ion Torrent (Life Technologies)  1.11.3.2
This is based on single nucleotide addition approach which uses incorporation of a single 
specific nucleotide by a DNA polymerase during each cycle, to produce a detectable signal 
for that nucleotide. Ion Torrent (Life Technologies) use clonal amplification of adaptor 
ligated DNA, by emulsion PCR and change in pH induced by removal of hydrogen ion 
during base incorporation is measured (Mardis, 2008). 
 Roche pyrosequencing platforms  1.11.3.3
Roche (GS FLX sequencing system) is also based on single nucleotide addition approach 
which uses incorporation of a single specific nucleotide by a DNA polymerase during each 
cycle, to produce a detectable signal for that nucleotide. However, unlike Ion Torrent, 
which measures change in pH is induced by removal of hydrogen ion during base 
incorporation, Roche (GS FLX sequencing system) couples base addition with release of a 
pyrophosphate, which in turn is converted into light by luciferase enzyme (Mardis, 2008, 
Goodwin et al., 2016, Metzker, 2010, Niedringhaus et al., 2011, Zhang et al., 2011). 
  SOLiD sequencing 1.11.3.4
This is based on sequencing by ligation approach of sequencing in which a fluorophore-
labelled degenerate probe, with one or two known bases is hybridized to complementary 
bases in the target DNA fragments, followed by ligation of the fluorescent probe to an 
anchor (a known sequence) which hybridizes to an immobilized adaptor sequence followed 
by imaging to identify the template base complementary to a known base within probe 
(Goodwin et al., 2016). 
 Third generation sequencing 1.11.3.5
Single molecule real-time sequencing (SMRT): The DNA polymerase enzyme is 
immobilized to the bottom of zero-mode waveguides (picolitre wells) in contrast to 
Illumina approach where the polymerase is free to travel along the DNA template. The 
template fragments are converted into circular molecules by ligated hairpin adapters at 
each end of the template, to allow multiple repeated sequencing by the same polymerase 
molecule, for efficient signal production in SMRT approach. This approach involves short-
read technology using barcodes (during library preparation) to generate longer long reads 
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by computational assembly in silico. Pacific Biosciences (PacBio) platform is based on 
SMRT sequencing approach (Goodwin et al., 2016). 
 Sequencing approaches for dsRNA viruses  1.11.4
The development of sequence-independent approaches, namely single primer amplification 
technique (SPAT) and full-length amplification of cDNA (FLAC) for the amplification of 
full-length cDNA copies of segmented dsRNA viruses, permitted full length segment 
sequencing without prior sequence knowledge (Attoui et al., 2000b, Potgieter et al., 2009, 
Lambden et al., 1992, Maan et al., 2007b). Sequencing  of amplified cDNA is 
accomplished by sequencing either cloned individual segments in SPAT (Attoui et al., 
2000b, Lambden et al., 1992, Potgieter et al., 2002, Vreede et al., 1998) or by using 
purified PCR amplicons of individual genome segments (without cloning) in FLAC (Maan 
et al., 2007b). Potgieter et al, 2009 showed a more efficient method of genome 
amplification combined with high throughput approach to obtain the full-length sequence 
of viral dsRNA genomes from clinical samples without prior virus cultivation, sequence 
determination, cloning or separation of PCR amplicons (Potgieter et al., 2009). These 
approaches to sequencing the BTV genome have been further strengthened during the era 
of ‘high-throughput’ or ‘next generation’ sequencing technologies, enhancing our 
understanding of the molecular epidemiology of BTV (Lorusso et al., 2014, Chand et al., 
2016, Yang et al., 2012, Jenckel et al., 2015, van den Bergh et al., 2016, Savini et al., 
2017b, Rao et al., 2012c, Boyle et al., 2012, Caporale et al., 2014, Breard et al., 2016, 
Nomikou et al., 2015, Minakshi et al., 2012). Although extensive BTV sequences are now 
available in public databases, there is still only a limited number of full-length, whole-
genome sequences, for isolates with fully documented metadata concerning their original 
date and place of isolation, passage history, host species, clinical significance and vector 
species. 
1.12 BTV control 
BT was formerly classified as a ‘class A disease’, by the Office International des 
Epizooties (OIE)  and remains a ‘notifiable’ disease due to its economic impact on the 
international livestock trade (OIE, 2017). Taking into account that BTV is non-contagious 
and virus is transmitted primarily through the bites of infected adults of competent 
Culicoides spp., control measures primarily involve prevention of virus spread and include: 
(a) movement restrictions of susceptible and infected animals, (b) control of Culicoides 
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vectors, (c) removal of infected animals to interrupt BTV transmission cycle (d) 
modifications to husbandry practices, which include housing of susceptible animals, 
removal of manure and drainage of wet areas (e) introduction of surveillance and 
protection zones and (f) vaccination (Alpar et al., 2009).  
Though, many types of BTV vaccines have been prepared including inactivated, 
attenuated, subunit and  recombinant vaccines, only attenuated and inactivated BT 
vaccines have been  widely commercially available to vaccinate livestock (Noad and Roy, 
2009, Savini et al., 2008, Di Emidio et al., 2004, Osburn et al., 1996, Niedbalski, 2011). 
Vaccination approaches in various countries are developed according to national policies 
and the local epidemiology of BTV. 
 Attenuated vaccines 1.12.1
 Modified live virus (MLV) vaccines can be produced by serial passage of BTV in cell 
cultures or embryonated chicken eggs in order to attenuate the virus. Although, MLV BT 
vaccines still infect the vaccinated ruminant host, they produce a strong antibody response, 
helping to prevent infection with field strains and severe clinical BT disease (Hunter and 
Modumo, 2001, Lacetera and Ronchi, 2004, Savini et al., 2008).  They are also cost 
effective and require only single inoculation annually. 
However, live vaccines can also present many disadvantages. MLV vaccinated animals 
may show varying degree of clinical signs, including abortions, teratogenic effects, 
decreased milk yield and poor semen quality. In addition, the attenuated vaccine virus 
strain may revert to virulent and can reassort with both field strains or other vaccine strains 
to produce more infectious and more virulent novel strains (Stott et al., 1987, Maclachlan, 
2010, Osburn et al., 1971, Young and Cordy, 1964, Batten et al., 2008, Dungu et al., 
2004a, Monaco et al., 2004, Savini et al., 2010, Patta et al., 2004, Zientara et al., 2010, 
Ferrari et al., 2005). Animals vaccinated with BTV MLV strains can also show high levels 
of viraemia after vaccination, which facilitates transmission of vaccine strain in Culicoides 
vector (Savini et al., 2010, Veronesi et al., 2010, Veronesi et al., 2005, Ferrari et al., 2005). 
Finally, MLV vaccines are not DIVA compliant, thus it is not possible to differentiate 
vaccinated animals from naturally infected animals (Savini et al., 2008, Zientara et al., 
2010).  
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BT vaccination in South Africa (an endemic area for multiple BTV serotypes) is based on 
multivalent live attenuated BT vaccines, administered as three sequential injections 
containing different BTV strains and a total of sixteen different serotypes,  produced by 
Onderstepoort Biological Products , Pretoria, South Africa (Dungu et al., 2004b, Savini et 
al., 2010, Veronesi et al., 2010, Savini et al., 2014).  Monovalent MLV formulations have 
also been used since 2000 in Spain, Italy, Portugal and France according to local 
epidemiology of BT in a given region (Savini et al., 2008, Patta et al., 2004). Due to the 
disadvantages associated with attenuated vaccines, these vaccines have been replaced with 
inactivated BT vaccines in Europe after 2005 (Zientara et al., 2010). However, MLV are 
still in current use in North America (Scott and James, 2015). 
 Inactivated vaccines 1.12.2
 Chemically inactivated, tissue culture grown, BTV vaccines are safe, efficacious and 
protective against the homologous BTV serotype,  but are expensive and may require a 
booster in comparison to MLV vaccine (Zientara et al., 2010, Savini et al., 2007, Savini et 
al., 2008, Wackerlin et al., 2010, Hamers et al., 2009). After the BTV-8 incursion into 
northern Europe in 2006, millions of animals were vaccinated with the BTV-8 inactivated 
vaccine. Commercial inactivated BTV vaccines are not DIVA compliant using serological 
assays, but it is possible to detect and identify animals that have been infected with field 
strains using RT-PCR assays to detect the viral RNA (Calvo-Pinilla et al., 2014).  
 Virus-like particles 1.12.3
 Virus-like particles (VLP) (empty viral capsids) are structurally similar to native BTV 
particles but do not contain the viral RNA genome and are non-infectious.  VLP are 
formed by the expression and assembly of the four major BTV structural proteins, VP2, 
VP3, VP5 and VP7 using recombinant Baculoviruses expression system (French and Roy, 
1990, French et al., 1990), or by expression of these proteins in plants (Thuenemann et al., 
2013). VLP contain functional viral proteins required for penetration and entry into the 
cell, for eliciting immune response (Perez de Diego et al., 2011). VLP can elicit good 
protection with homologous virus and partial protection even with heterologous BTV 
serotypes (Stewart et al., 2012, Roy et al., 1994, Perez de Diego et al., 2011, Stewart et al., 
2013, Noad and Roy, 2009).  VLP have potential for development of multiserotype and 
DIVA compatible vaccines. However, for use as commercial vaccines they need to be 
purifiable from cellular components and be sufficiently stable to give an adequate shelf 
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life. Other important factors include the efficiency, yield and cost of production (Schwartz-
Cornil et al., 2008, Anderson et al., 2014). 
1.13 BTV diagnosis 
Historically, clinical diagnosis was the standard method for detection and monitoring of 
BT and outbreaks of BT-8 in Europe in 2006 and in France during 2015, were initially 
recognised in this way. However, differential clinical diagnosis of the disease in sheep 
requires a well experienced veterinary service (Bexiga et al., 2007). Sub-clinical infections, 
particularly in cattle, goats and resistant breeds of sheep may be unrecognized or go 
unnoticed, particularly in situations where outbreaks are infrequent or previously unknown. 
Consequently, rapid, efficient and reliable laboratory diagnostic tests are essential to 
confirm clinical suspicion of BT and to provide veterinary health authorities adequate time 
to develop and deploy control measures especially during an epidemic. Laboratory 
diagnosis of bluetongue has traditionally included virus isolation, group-specific and type-
specific serological assays, although more recently molecular assays (RT-PCR assays) can 
be reliably performed (even in the face of inactivated vaccination campaigns) directly on 
clinical samples (e.g. blood samples) (Alpar et al., 2009).  
 Virus isolation 1.13.1
Traditionally, initial isolation of BTV required the inoculation of 14 days old embryonated 
hen’s egg, either by yolk sac route (Mason et al., 1940) or more effectively through  an 
intravenous route (Goldsmit and Barzilai, 1985) with blood, semen and tissue samples 
including liver, spleen, lymph nodes or mucosal epithelium from a viremic animal. This is 
followed by (blind) subpassaging of material from infected embryos in cell culture 
including using mammalian cell lines (BHK or Vero cells), or in an insect cell line 
(Culicoides sonorensis (KC) or Aedes albopictus (C6-36) cells) for adaptation of virus 
(Wechsler and Luedke, 1991, OIE, 2017).  
Although cell culture based virus isolation remains as a gold standard for diagnosis and 
provides sufficient material for further characterisation of the virus, it is laborious, time 
consuming, requires specialized skills and cannot be automated. Consequently, alternative 
methods of virus detection include RT-PCR assays (to detect viral RNA), 
immunoperoxidase test (Afshar et al., 1991), fluorescent antibody staining tests (Gould et 
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al., 1989), immunoelectron microscopy (Brookes et al., 1994) and sandwich ELISAs for 
group-specific antigen detection of bluetongue (Hawkes et al., 2000).  
 Serological assays  1.13.2
 Group-specific antibody detection assays 1.13.2.1
 Serological assays for detection of group-specific antibodies against BTV, include: agar 
gel immuno-diffusion (AGID) tests  (Pearson et al., 1985, Jochim and Chow, 1969, Batten 
et al., 2009), complement fixation (CF) tests (Boulanger et al., 1967) and ELISA, both 
competition and blocking  (Afshar et al., 1987, Anderson, 1984, Martyn et al., 1991, 
Thevasagayam et al., 1996, Chand et al., 2009, Reddington et al., 1991).  
The AGID and CF tests lack sensitivity and can show cross-reactivity with related 
orbiviruses (Della-Porta et al., 1985), or against host cell proteins present in antigen 
preparations. Therefore, these tests have largely been replaced by the ELISA. During the 
1980s, ELISA lacked specificity due to the use of semi-purified antigens. Anderson, 
(1984) developed a group-specific monoclonal antibody based ELISA directed against an 
epitope on the highly conserved outer core protein VP7 of BTV. This assay showed no 
cross-reactions with related Orbiviruses, or against cellular proteins present in the antigen 
preparation. VP7 is a serogroup-specific antigen (Gumm and Newman, 1982)  encoded by 
genome segment 7 and is highly immuno-dominant. It is therefore particularly suitable for 
development of group-specific diagnostic assays (Afshar et al., 1992b) to identify members 
of the Bluetongue virus species/serogroup (Mertens, 2000). 
The use of ELISA to detect BTV- specific antibodies in natural infection is compromised 
by non-DIVA vaccination programmes using either live attenuated or partially purified 
inactivated vaccines (Barros et al., 2009). However, Anderson and colleagues also 
described a monoclonal antibody based competitive ELISA for the detection of antibodies 
against BTV serogroup specific non-structural protein 1 [NS1] (Anderson et al., 1993). 
This ELISA could differentiate between BTV-infected and BTV-vaccinated animals with 
an inactivated vaccine. However, this assay is no longer in use, as serum from animals 
vaccinated with live attenuated vaccines gave a positive reaction. 
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 Serotype-specific antibody and antigen detection assays 1.13.2.2
Rapid and reliable BTV serotype differentiation is essential particularly at the start of an 
outbreak, to allow early selection of an appropriate vaccine to help control the spread of 
the virus.  
Traditionally, laboratory conformation of the BTV serotype includes isolation of virus and 
subsequent serotyping by serum neutralisation tests / virus neutralization tests (SNT/VNT) 
via: microtitre neutralization, plaque reduction, plaque inhibition and fluorescence 
inhibition tests (Blacksell and Lunt, 1996).  
VP2 is the serotype-determining antigen, based on the specificity of its interactions with 
neutralizing antibodies generated during infection of the host (Mertens et al., 1989a). The 
less variable VP5 protein also plays a minor role in eliciting the antibody response and can 
also contribute to serotype determination (Mertens et al., 1989a, DeMaula et al., 2000).  
SNT is based on interaction of a serial dilution series of the test serum with a fixed amount 
of a reference strain of each BTV serotype, to determine the concentration at which the test 
serum neutralises the virus (Parsonson and Snowdon, 1985). VNT requires an initial 
isolation of the test virus strain in culture cells. It is based on interaction of a serial dilution 
of the test virus with a fixed amount of reference antisera for each of the BTV serotypes 
(Afshar, 1994, Clavijo et al., 2000). However, confirmation of virus serotype by this route 
requires days to weeks. Such delays can have a significant adverse effect on the extent and 
duration of an epizootic, by causing a delay in selection of an appropriate vaccine 
strain/serotype.  
Serological typing methods require BTV serotype-specific antisera or reference strains for 
all BTV serotypes (Hamblin, 2004). However reference antisera are expensive to produce 
in experimental animals and are in short supply. Also, these serological assays can be 
unreliable particularly if infection and the resulting samples include more than one BTV 
serotype. Low-level cross-reactions can occur with related orbiviruses thereby producing 
false positives (low sensitivity and specificity). Since serological diagnosis requires time 
and often lacks the necessary specificity and sensitivity, molecular assays are currently the 
method of choice for typing of BTV. The amplified cDNA products from RT-PCR can 
also be sequenced, not only to confirm virus serotype but also to identify different virus 
lineages, identification of vaccine/field strains or differentiation of topotypes within each 
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serotype, which is impossible by conventional serological typing methods (Anthony et al., 
2007). 
  Molecular assays 1.13.3
Molecular diagnostic assays for BTV broadly include conventional and real time RT-PCR, 
sequencing analysis and polyacrylamide or agarose gel electrophoresis. Nucleic acid-based 
techniques or ‘molecular assays’ especially RT-PCR, sequence analyses and phylogenetic 
comparisons are used for the detection and typing of BTV (Alpar et al., 2009, Mertens et 
al., 2007b).  
RT-PCR can be used to detect RNA viruses, involving initial synthesis of a complementary 
DNA (cDNA) copy of the RNA using reverse transcriptase (RT), followed by 
amplification and analysis of the cDNA. RT- PCR assay exists in a number of formats 
including conventional or gel based RT-PCR where the targeted viral RNA sequence is 
detected by electrophoretic analyses of the amplified cDNA products.  
A quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) can be 
used to amplify and simultaneously quantify a targeted RNA sequence. Real-time RT-PCR 
assays based on TaqMan technology detect fluorescence signals from an oligonucleotide 
probe that is activated during target amplification. A fluorogenic probe, labeled with both a 
fluorescent reporter and a quencher dye is used in the TaqMan-PCR. The technology 
exploits the 5' exonuclease activity of Taq DNA polymerase to cleave an oligonucleotide 
probe during PCR, thereby generating a detectable signal. After hybridization of the probe 
to the target sequence, the Taq DNA polymerase cleaves the TaqMan probe with its 5’–3’ 
exonuclease activity. The reporter and quencher dyes are separated upon cleavage, as the 
target is amplified, resulting in increased fluorescence of the reporter.  
The benefits of real-time PCR assays over conventional approach include high sensitivity 
and specificity (making then suitable for direct use on clinical samples avoiding the need 
for virus isolation), the ability to quantify viral RNA templates (copy number) and the 
detection of short amplicons. The reactions also take place in a closed tube, reducing risks 
of cross-contamination and false positive (Bustin et al., 2005).  These assays can be scaled 
up for high throughput applications, automation and the potential for accurate target 
quantification. However, the insensitivity of a cell line for BTV isolation or low quality 
RNA in clinical sample or some technical error may also lead to false negative results by 
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PCR (Billinis et al., 2001). The most conserved genome segments or regions, that are also 
unique to the target virus species, should therefore be selected for the design of real-time 
RT-PCR assays and a wide selection of diverse samples should be used for assay 
validation. 
 Group-specific RT-PCR assays 1.13.3.1
Group-specific RT-PCR assays use genome segments that are most conserved across the 
whole BTV species or serogroup. The most conserved segments of the BTV genome are 
Seg-1 (VP1), Seg-3 (VP3), Seg-4 (VP4), Seg-5 (NS1), Seg-7 ( VP7), Seg-8 (NS2) and 
Seg-9 (VP6) and represent potential targets for the development of BTV species or group-
specific RT-PCR assays (Alpar et al., 2009). Several group-specific conventional RT-PCR 
assays targeting different regions of the viral genome, such as Seg- 3 (Harding et al., 1995, 
McColl and Gould, 1991, McColl and Gould, 1994, Parsonson and McColl, 1995), Seg-5 
(Shad et al., 1997, Aradaib et al., 1998, Aradaib et al., 2003, Wilson and Chase, 1993, OIE, 
2017), Seg-7 (Anthony et al., 2004, Wade-Evans et al., 1990) and Seg-10 (Akita et al., 
1992, Billinis et al., 2001) are available for detection of BTV. However, even the most 
conserved of the BTV genome segments do show sequence variations that correlate with 
the geographic origins of the virus isolate (Maan et al., 2008).  
Quantitative real-time RT-PCR (qRT PCR) assays have been reported for the detection of 
BTV species or serogroup targeting Seg-1 (Shaw et al., 2007, Toussaint et al., 2007), Seg-5 
(Jimenez-Clavero et al., 2006, Wilson et al., 2004, Polci et al., 2007, Toussaint et al., 
2007), Seg-10 (Orru et al., 2006, Hofmann et al., 2008a) and Seg-9 (Maan et al., 2015a). 
However, the specificity and sensitivity of RT-PCR assays and  detection of all bluetongue 
serotypes has been hampered by the genomic diversity of BTV which evolves continuously 
by genetic drift, recombination and gene reassortment (Bonneau et al., 2001). Seg-7 is the 
third most variable of the BTV genome segments (Wilson et al., 2000, Mecham et al., 
2003, Anthony et al., 2007, Maan et al., 2008) followed by Seg- 10 as the fourth most 
variable region of the BTV genome segments(Maan et al., 2008). Variations between 
isolates from different regions may require the use of multiplex primer systems. Shaw and 
colleagues  published a duplex assay in which two sets of genotype specific primers and 
probes were designed to target genome segment 1 of the eastern and western BTV 
topotypes, respectively (Shaw et al., 2007). Toussaint and colleagues developed two real-
time RT-qPCRs amplifying and detecting two different genomic regions/segments of BTV 
in parallel. This approach would avoid the risk of missing a mutant, a recombinant or a 
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reassortant strain and detect all serotypes of BTV (Toussaint et al., 2007). The real time 
probes are very sensitive to probe-target mismatches (Jimenez-Clavero et al., 2006), 
therefore mutation in the virus genome within a primer or probe ‘foot-print’ can result in a 
mismatch in the fluorescent probe target region and presents a significant challenge. 
 Serotype-specific RT-PCR assays 1.13.3.2
RT-PCR assays using serotype-specific primers have the potential to reduce the need for 
BTV serotype-specific antisera for serological typing methods. Full-length sequence data 
for genome segment 2 from the 24 BTV reference serotypes (Maan et al., 2004) showed 
that it varies with serotype and represents the least conserved region of the BTV genome. 
Phylogenetic analyses of Seg-2 show the nucleotide sequence variation of 29% to 59% 
between reference strains of different BTV serotypes and up to 32% within the serotype 
from different geographic regions (Maan et al., 2007a, Maan et al., 2010). Nucleotide 
sequence based typing methods include conventional RT-PCR and real-time RT-PCR 
assays. Phylogenetic comparisons of Seg-2 are becoming increasingly important for the 
typing of BTV (Maan et al., 2011b, Maan et al., 2011a, Maan et al., 2010). The 
conventional and real time RT-PCR assay identifying and differentiating   BTV serotypes 
by amplifying serotype-specific genome segment 2 are available (Maan et al., 2016, 
Attoui, 2012, Mertens et al., 2007b, Mertens et al., 2007a). In developing a molecular 
assay for serotype-specific detection of BTV, their genetic diversity presents a significant 
challenge. Real time RT PCR assays function on high-throughput 96-well diagnostic 
formats to handle the high volumes of samples needing to be tested during a national 
surveillance program or diagnostic surge in the event of a BTV outbreak. 
1.14 Bluetongue epidemiology in India 
 Geographical distribution of bluetongue disease in India  1.14.1
The Indian subcontinent is a large geographic area, which includes five countries, namely 
Pakistan, Nepal, Bhutan, Bangladesh and India. India is the world’s seventh largest 
country, with an area of 3.28 million square km (2.4 per cent of the earth's land surface). It 
is situated in the Northern hemisphere, between 8
o
 4' N to 37°6'N latitudes and 68°7'E and 
97°25'E longitudes. The land boundary of India is about 15,200 km with a coast line of 
7,516.6 km. The total population in India is 1210.2 million people, second highest in world 
after China (Narayanan et al., 2018). The geographical area of India is 3.28 million km
2 
with 648 districts of 29 States and 7 Union Territories covering 6.6 lakhs villages and 
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64639 urban wards, according to office of the Registrar General and Census Commissioner 
(ORGI), Ministry of Home Affair, Government of India (ORGI, 2011).  
Bluetongue disease is known to be endemic and has been reported from many states of 
India, including northern, central, western and southern states (Prasad et al., 1992, 
Sreenivasulu et al., 2004, Ranjan et al., 2015, Prasad et al., 2009). However, overt clinical 
outbreaks have mostly been reported from rural native mixed flocks of sheep and goats 
across the four states of Telangana, Andhra Pradesh, Karnataka and Tamil Nadu in the 
southern region of India (Rao et al., 2016b).  
Bluetongue was first reported with overt clinical signs of BT from Maharashtra state in 
Western India (Sapre, 1964). Then in 1970’s, frank clinical outbreaks of BT were recorded 
in Merino sheep at Kothipura farm of Himachal Pradesh, Northern India (Uppal and 
Vasudevan, 1980) and in a Corriedale sheep at the Central Sheep Breeding Farm of 
Haryana, Northern India (Vasudevan, 1982). During 1980’s, severe BT outbreaks were 
reported: in rural sheep flocks from Maharashtra, Western India  (Singh et al., 1982, 
Harbola et al., 1982)  and Karnataka, Southern India (Srinivas et al., 1982); in native 
Chokla and exotic Rambouillet sheep breeds at the Central Sheep and Wool Research 
Institute of Rajasthan, Northern India (Lonkar et al., 1983, Sharma et al., 1985); and in 
exotic Rambouillet sheep at the Central Sheep Breeding Farm of Haryana, Northern India  
(Mahajan et al., 1991).  
Clinical BT in India was originally reported in exotic breeds of sheep from 1970-1980, but 
thereafter, BT outbreaks were reported annually in native breeds of sheep, particularly in 
Southern states (Mehrotra et al., 1991, Kulkarni et al., 1992, Saravanabava, 1992). 
Although, BT is endemic in India, classical BT signs have seldom been reported in the 
native sheep breeds of Northern India during the last two decades. In Tamil Nadu, BT was 
first reported in 1982 with regular incidence thereafter. In 1989-1990, 1997-1998 and 
2005-2006, large epidemics of BT, with severe clinical manifestations, were reported from 
Tamil Nadu resulting in high mortality of sheep (Reddy et al., 2016a).  
  Influence of climate of India on bluetongue disease 1.14.2
India can be divided into six physiographic regions based on physical features, including: 
the Northern and North-eastern Mountains (the Himalayas); the Northern Plain; the 
Peninsular Plateau; the Indian Desert; the Coastal Plains and the Islands. The Deccan 
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plateau is part of the peninsular plateau and is a triangular landmass. Telangana, Andhra 
Pradesh, Karnataka, and Tamil Nadu are the southern states of India and form a part of 
Peninsular Deccan plateau. 
India has a monsoon type of climate, but there are regional and seasonal variations in 
climate in terms of wind pattern, temperature and rainfall.  This explains the unity and 
diversity of the climate of India. For example, temperature in summer is up to 55
0
C in the 
Indian Desert and -45
0
C in Leh (northern mountains) in winter. There are four seasons in 
India namely the cold weather season, the hot weather season, the southwest monsoon 
season and the retreating monsoon season (NCERT, 2014). 
 
Figure 1.3 Map of India showing all the states of India. 
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The cold weather season: starts from mid-November in Northern India, with December 
and January being the coldest months. The mean daily temperature remains less than 21°C 
in northern India, with night temperature sometimes below freezing point in some areas. 
The main reasons for the intense cold in north India during winter season are: the Northern 
landmass away from sea’s moderating influence, altitude, cold winds from the snowfall in 
the Himalayan region and the cold winds coming from the Caspian Sea. The Peninsular 
part of India does not experience an intense cold weather season because of lower altitude 
and the sea’s moderating influence (www.nios.ac.in/media/documents/316courseE/ch17). 
The summer season: is from April to June in North India with temperatures rising to 48
0
C 
in May. Southern India experiences a less intense summer than Northern India, with 
temperatures between 26
0
C to 32
0
C, because of moderating influence of the ocean. 
The southwest monsoon: During April and May, as the sun is exactly vertical to the 
Tropic of Cancer, an intense low pressure is created in the North western landmass of the 
Indian subcontinent. This attracts the southeast trade winds, which get deflected towards 
the Indian subcontinent (South West) while crossing the Equator, dropping large amounts 
of rain. Therefore, broadly, the southwest monsoon is a westerly continuation of the 
southeast trade wind covering the entire subcontinent by mid-July (India, 2017).  
North east monsoon and tropical cyclones: Tropical cyclones and depression bring rain 
in the month of October and November across the Southern Peninsular Coast. These can be 
very destructive potentially causing disasters each year. The retreating monsoon is the 
southward movement of north easterly winds in October and November when the weather 
is dry in North India. However, these winds collect moisture while crossing the Bay of 
Bengal, making October and November the rainiest months of the year for the Eastern 
Peninsula (NCERT, 2014).   
The Tamil Nadu coast, the southern part of Andhra Pradesh, and southeast Karnataka, 
receive 30% of their annual rainfall from the North East monsoon, during October and 
November (Attri and Tyagi, 2010). However, for Tamil Nadu alone, it constitutes nearly 
48% of annual rainfall. As a whole, India gets more than 75% of its annual rainfall from 
June to September. The rest is mainly received in the months of October, November and 
December in the Southern parts of India (Rao et al., 2016b). 
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The occurrence of BT outbreaks in India is influenced by meteorological factors which 
include temperature, relative humidity, and precipitation. The susceptibility of individual 
sheep breeds to BT and the size of the sheep population as a whole determine the 
appearance of overt clinical disease in southern India (Rao et al., 2016b).  The poopulation 
of sheep is highest in Andhra Pradesh, followed by Rajasthan State, with more than 70% of 
the country’s sheep population resident in five states, namely Andhra Pradesh, Telangana, 
Karnataka, Tamil Nadu and Rajasthan (Livestock census, 2014). 
An appropriate climate and a high sheep population density appear to be required to 
maintain BT outbreaks, as indicated by the  negligible incidence of BT in Kerala, a 
Southern State where climatic condition are similar to those of the other four Southern 
States but the sheep population is low (Arun et al., 2014, Ravishankar et al., 2005). In the 
Great Indian Desert (Rajasthan), where the incidence of BT is also low, the sheep 
population is high, (the second largest in the country) but the climate is harsh and not 
conducive for Culicoides. 
 There are significant differences in the disease pattern and clinical manifestation of BT 
between Northern and Southern states of India. Frank clinical BT disease has been 
documented mainly from the Southern states (Prasad et al., 1992, Prasad et al., 2009). In 
northern parts of Andhra Pradesh and Karnataka, BT outbreaks occur during the south west 
monsoon, with the highest incidence during August and September. In contrast, in the 
Southern interior parts of Andhra Pradesh, Karnataka and Tamil Nadu, the disease is 
observed from October to December, during the North East monsoon, (Sreenivasulu et al., 
2004). High ambient temperatures, rainfall and high relative humidity during these two 
rainy seasons are considered likely to contribute to conducive breeding grounds for 
Culicoides population, potentially helping in the spread of BT in southern India (Rao et al., 
2016b). In 2005-2006, a widespread BT outbreak was reported, covering all of the sheep 
rearing regions in Tamil Nadu, but severe clinical disease, associated with high mortality, 
was reported mainly in Southern districts during a very heavy north east monsoon in 
October and December (Reddy et al., 2016a). During the same year, mild to moderate 
clinical BT was reported from Salem, Dhamapuri, and Erode districts of Tamil Nadu 
during July (south-west monsoon) but with no mortality of sheep.  
Bluetongue has not been reported from the Nilgiris district, part of Western Ghats (a chain 
of large mountains) situated at an altitude of 2892 m above sea level (Reddy et al., 2016a). 
However, mild BT was reported in two Nilgiri breed ewes from Ooty, Nilgiri district 
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during 2009, and BTV-23 serotype was confirmed by serum neutralization test 
(Venkataramanan et al., 2010).  
In contrast, frank outbreaks of BT are not observed in North Western and Northern India 
due to the short rainy season (only the south west monsoon), semi-arid to arid agro climatic 
zones , extreme weather conditions with  heat waves in summer, and the harsh winters of 
Western India, all of which are not congenial for Culicoides breeding (Rao et al., 2016b).  
A recent report of concurrent infection of BTV-12 with Peste des Petite Ruminant virus 
(PPRV)  in small ruminants from Haryana State of Northern India, showed early non- 
specific clinical signs of high fever, malaise and anorexia, followed by predominant PPR 
symptoms including hyperaemia of the oral mucosa, diarrhoea and mortality (Maan et al., 
2017). Biswas and colleagues also reported concurrent infection of PPRV and BTV-1 from 
a PPR suspected outbreak in goats in Uttar Pradesh State (Biswas et al., 2010, Mondal et 
al., 2009) during of January, 2008.  BT is usually asymptomatic or inapparent in goats and 
the clinical symptoms in this outbreak included typical PPR signs of pyrexia, erosive 
stomatitis, diarrhoea, pneumonia and coughing.  Mondal and colleagues isolated BTV-1 
from asymptomatic goats during a BT seroprevalence study in the Pithoragarh hills of 
Uttarakhand during January, 2009 (Mondal et al., 2013). Chauhan and colleague isolated 
BTV-1 from the spleen of an aborted goat foetus in Gujarat, 2007 (Chauhan et al., 2014).   
  Landless, small and marginal farmers in India 1.14.3
The livestock sector makes a significant contribution in the socio-economic fabric of rural 
India, helping to reduce rural poverty and improving nutritional security. Millions of small 
and marginal farmers (the ‘landless’) depend on small ruminants for their livelihood and to 
augment their income. According to the classification used in the Agricultural Census, 
2011 marginal farmers hold less than 1 hectare of land, while ‘small’ farmers have a land 
holding of 1 to 2 hectares. Small and marginal farmers account for 85% (117.6 million in 
number) of the total operational holding in the country, but hold only 44.6% of the 
operated area (71.15 million hectares) showing a huge disparity in terms of land holding by 
farmers in India (DACFW, 2011).  
Small ruminants represent crucial livelihood wealth and can be immediately liquidated in 
times of need, distress and emergencies. Therefore, small ruminant husbandry plays a 
significant role in risk management strategies and improving the livelihood of rural India 
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(DADF, 2016).  In recent years, the livestock sector in India has grown faster than the crop 
sector and contributes nearly 28% of the total agricultural gross value added. A sustained 
rise in per capita income and rapid urbanization in the recent past, have led to increased 
growth in demand for animal food products. Although resource poor families have more 
opportunities in demand-driven small-ruminants production, they face formidable 
challenges in terms of fodder scarcity, grazing land shrinkage, ill equipped veterinary 
services, marketing of produce and a high prevalence of various animal diseases around the 
country. Furthermore, it is difficult for state animal husbandry departments to continuously 
monitor migratory flocks for disease, making the situation even more challenging (DADF, 
2016). Small and medium farmers, including landless labourers, rear sheep and goats 
mainly for meat and skin production in Tamil Nadu, Andhra Pradesh and Karnataka, but in 
some parts, especially in Karnataka state, also for wool production. 
In 1997–1998, 0.3 million small ruminants died due to BT during the north east monsoon 
in Tamil Nadu (Ilango, 2006). BT causes significant economic losses to the Indian sheep 
industry annual, particularly in Southern India (Ranjan et al., 2015). During 1991–2005, 
BT has caused huge economic losses, amounting to 60.8% of all infectious diseases in 
Indian sheep, particularly  to landless marginal and small farmers (Ranjan et al., 2015).  
 Livestock population in India 1.14.4
India has the world’s largest livestock population, with a total of 512.05 million livestock 
identified by the 19
th
 livestock census. The livestock census has been conducted in India 
every five years since 1919, by the Department of Animal Husbandry, Dairying and 
Fisheries, Ministry of Agriculture, Government of India. There are about 299.9 million 
bovines (cattle, buffalo, mithun and yak), 65.06 million sheep and 135.17 million goats in 
the country (DAHDF, 2014). According to 19th Livestock Census, distribution of livestock 
amounted to 37.28% cattle with largest share followed by 26.40% goats, 21.23% buffaloes, 
12.71% sheep and 2.01% pigs and 0.37% others (horse, ponies, mule, donkey, camel, 
mithun and yak) of the total livestock population.  
State-wise the percentage share of cattle population is 5.03% for Andhra Pradesh, 4.98% 
Karnataka, 4.62% Tamil Nadu with a maximum share in Madhya Pradesh and Uttar 
Pradesh states amounting to 10.27% each in the country. For the sheep population, the 
state-wise percentage share is 40.57% for Andhra Pradesh with largest share in country, 
14.73% Karnataka, and 7.36 % in Tamil Nadu.  More than 70% of the country’s sheep 
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population is found in four states namely Andhra Pradesh, Karnataka, Tamil Nadu and 
Rajasthan.  
State-wise the percentage share of the goat population is 6.71% for Andhra Pradesh, 3.55% 
Karnataka, 6.02% in Tamil Nadu, with largest share in Rajasthan state, amounting to 
16.03%. The number of cattle, sheep and goats per thousand households are: 477, 1311, 
451 respectively for Andhra Pradesh; 680 cattle, 685 sheep and 343 goats per thousand 
households in Karnataka state; and 508 cattle, 276 sheep and 469 goats per 1000 
households in Tamil Nadu,. These figures show that livestock are reared in very small units 
per family (DAHDF, 2014). 
 Contribution in the national economy 1.14.5
Agriculture contributes 17.4%, to the national gross value added (GVA) of India, with 
~55% of the work force dependent on agriculture and allied activities (DACFW, 2011). 
According to the Central Statistics Office (CSO), the livestock sector contributed 28.5% at 
basic prices to the value output of agricultural and allied sectors, during 2015-16, with ~5 
million small and marginal farmers, including landless labourers, are involved in the 
rearing of sheep and goats in the country, but a total workforce of nearly 70 million are 
involved in the livestock sector (DAHDF, 2014).  
Nearly 0.3 million sheep and goats died due to BT during the north west monsoon season 
in 1997-1998 (Ilango, 2006) causing significant economic losses to the Indian sheep 
industry as a whole. From 1991-2005, BT disease caused the highest reported economic 
losses amongst all leading infectious diseases (Ranjan et al., 2015). 
 Susceptibility to BT of sheep and goat breeds in Southern India  1.14.6
Breeds of sheep found in the Andhra Pradesh and Telangana, are Nellore (the tallest breed 
of sheep resembling a goat in appearance), Deccani, Bellari and Macherla .There are no 
recognized goat breeds from Andhra Pradesh, Telangana and Karnataka states. Sheep 
breeds of Karnatak include Deccani, Bellary, Bannur/Bandur/Mandya, Hassan and 
Kenguri. The sheep breeds from Tamil Nadu include meat-purpose breeds: 
Madras/Chennai Red, Melcher/Mecheri Ramanadhapuram White, Vembur, as well as 
wool-purpose breeds: Coimbatore, Tricky Black, Kilakarisal/Keezhakaraisal, Nilgiri and 
Chevvadu. The goat breeds from Tami Nadu are: Kanniadu in the Thirunelveli district: 
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Ramanadhapuram, Kodiadu in Sivagangai; Ramanadhapuram, Tuticorin and Salem Black 
from the Salem district (Acharya, 1982, ICAR, 1945, Bhatia and Arora, 2005).   
Semi-pastoral and semi-intensive management systems are adopted for rearing sheep in 
these states. While the semi-intensive system, involves both stall feeding and pasture 
grazing; the semi-pastoral system involves seasonal migration of flocks during periods of 
fodder scarcity (Kantwa et al., 2017, Rao et al., 2016b).  
There are no definite reports on breed predispositions to BT in India, and this may even 
vary with different virus strains. In India, BT outbreaks were earlier detected in exotic or 
mixed wool breeds under crossbreeding programmes for breed improvement. However, 
outbreaks are currently reported mostly in native/local breeds (Prasad et al., 2009, Prasad 
et al., 1992, Rao et al., 2016b, Susmitha et al., 2012, Sreenivasulu et al., 1999, Bommineni 
et al., 2008). It has been suggested that this change correlates with the introduction of 
exotic / western topotypes strains into the Indian sub-continent. Trichy black and Ramnad 
white breeds in Tamil Nadu are found to be more susceptible to BT than Vambur and 
Mecheri sheep breeds (Prasad et al., 2009). Similarly in Andhra Pradesh, the short-haired 
mutton Nellore-breed of sheep is more susceptible to BT than the thick coarse carpet-wool 
Deccani breed. In the rest of the country, mostly medium quality wool breeds are found 
which do not show frank clinical BT disease symptoms (Rao et al., 2016b). 
1.15 Serotypes of BTV in India 
Serological evidence suggests that 21 different BTV serotypes exist in India, with at least 
15 BTV-serotypes (BTV- 1, 2, 3, 4, 5, 8, 9, 10, 12, 16, 17, 18, 21, 23 and 24) isolated over 
the last five decades, including BTV-24 & BTV-5 the most recent additions to list in 2016. 
Over the last two decades, 12 serotypes have been reported namely BTV-1, BTV-2, BTV-
3, BTV-4, BTV-5, BTV-9, BTV-10, BTV-12, BTV-16, BTV-21, BTV-23 and BTV-24 
mainly from Southern India (Figure 1.3) (Rao et al., 2016b, Hemadri et al., 2016, 
Krishnajyothi et al., 2016, Bommineni et al., 2008, Chand et al., 2016, Kumar et al., 2016, 
Rao et al., 2015, Sreenivasulu et al., 1999, Reddy et al., 2016b, Reddy et al., 2016a, Rao et 
al., 2012c, Rao et al., 2016a, Pudupakam et al., 2017, Prasad et al., 1992, Prasad et al., 
1994, Mondal et al., 2013, Maan et al., 2012e, Maan et al., 2012d, Maan et al., 2015c, 
Maan et al., 2015b, Maan et al., 2017, Maan et al., 2012c, Maan et al., 2012b, Maan et al., 
2012a, Joardar et al., 2009, Desai et al., 2009, Susmitha et al., 2012). 
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 During the last decade, BTV-1 and BTV-12 have been reported from Northern India 
(Maan et al., 2017, Mondal et al., 2013, Chand et al., 2016, Biswas et al., 2015, Biswas et 
al., 2010, Mondal et al., 2009).  BTV-1 has been  isolated from Gujarat, in Western India 
(Chauhan et al., 2014) and there is one report of the isolation of BTV 3 from west Bengal, 
North Eastern India (Joardar et al., 2009).  
BTV isolates from Andhra Pradesh and West Bengal in 2003 were incorrectly typed as 
BTV-15 but later confirmed as BTV-10 from Andhra Pradesh and BTV-3 from West 
Bengal (Joardar et al., 2009, Bommineni et al., 2008, Gollapalli et al., 2012, AINPBT, 
2010). Therefore, the only evidence for BTV-15 in India is serological, with detection of 
BTV-15 specific antibodies (Prasad et al., 2009). 
1.16 BTV vaccination in India 
Vaccination with a pentavalent inactivated BTV vaccine (containing BTV-1, BTV-2, 
BTV-10, BTV-16 and BTV-23 serotypes) is currently being carried out in the four 
Southern states of India: Telangana, Andhra Pradesh, Tamil Nadu and Karnataka as well as 
Maharashtra, which is a western state. However, inspite of hyperendemic BT transmission 
in these region, vaccination is not done on a ‘mass’ scale. The pentavalent inactivated BTV 
vaccine was developed by Tamil Nadu Veterinary and Animal Science University 
(TANUVAS) under the All India Network Project on Bluetongue, an initiative of Indian 
Council of Agricultural Research (ICAR), Government of India, and subsequently 
technology transfer to Indian Immunological Limited (IIL), Hyderabad was done on 
February, 2011 (www.icar.org.in/node/3516). Since 2010, vaccine was used in 
Maharashtra, Telangana, Andhra Pradesh, Tamil Nadu and Karnataka at farmer’s doorstep 
before its recent commercialization in 2015. The Raksha Blu vaccine (commercial name of 
pentavalent inactivated BTV vaccine, containing serotypes BTV-1, BTV-2, BTV-10, 
BTV-16 and BTV-23) was launched on 8 January 2015 by Indian Immunologicals Limited 
in Hyderabad, Telangana (Maan et al., 2015c, Rao et al., 2016b). The vaccine is available 
to the farmers at the rate of 5 rupees per dose. The five currently circulating and most 
prevalent serotypes in the country BTV-1, -2, -10, -16 and -23 are inactivated with 
formaldehyde in addition to binary ethylenimine, adjuvanted with Montanide  and then  
mixed as a pentavalent BT vaccine formulation (Reddy et al., 2010 ). The Animal 
Husbandry and Veterinary Science (AH & VS) department of Karnataka State runs a 
mandatory vaccination programme for four economically important infectious diseases in 
sheep and goats, namely: Haemorrhagic Septicaemia (HS), Enterotoxaemia (ET), Anthrax 
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and Peste des Petits Ruminants (PPR) but this does not include BT. PPR vaccination is 
carried out in all districts of Karnataka State, twice in a year (May and November). A 
similar situation exists in Telangana, Andhra Pradesh and Tamil Nadu.  
Twelve BTV serotypes including:  BTV-1, BTV-2, BTV-3, BTV-4, BTV-5, BTV-9, BTV-
10, BTV-12, BTV-16, BTV-21, BTV-23 and BTV-24 have been isolated from Southern 
India since 2001, with BTV-5 and BTV-24 as new inclusion to the list in 2016. There are 
also reports of the co-circulation of multiple BTV serotypes with mixed serotype infections 
within a single animal in outbreaks from Southern India (Reddy et al., 2010, Reddy et al., 
2016b). Therefore a regular, rapid and robust virological surveillance is needed to identify 
currently circulating serotypes, ensuring regular re-evaluation of the vaccine composition. 
Indeed, one or more BTV serotypes have been observed as the dominant outbreak strain 
for one or more years, but these are then succeeded and replaced by new dominant 
serotypes (Rao et al., 2016b). Different BTV serotypes can therefore be dominant during 
different years and in different States.  
These changes may be explained by the fact that infection with one BTV serotype provides 
long-lasting herd immunity against that homotypic serotype during its dominance in the 
region and may provide some protection against severe clinical disease, there is little cross 
protection against infection by another serotype, which can therefore emerge as dominant 
in subsequent years. Detection of multiple co-circulating BTV serotypes and co-infection 
of different BTV serotypes within individual animals emphasizes the need for regular 
virological surveillance in India, particularly in light of the emergence of and reassortant 
with exotic (western topotype) BTV strains, and the potential for the generation of novel 
genotypes with modified phenotypes that display different transmission or virulence 
characteristics. It may be particularly valuable to compare isolates from before, during and 
after implementation of the current pentavalent inactivated-vaccine campaign, to see if it 
has influenced the prevalence of different BTV serotypes. 
 
Chapter 1  General introduction 
45 
 
 
Figure 1.4 BTV serotypes reported from different States of India since 2001. 
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1.17 Aims and objectives of Project 
BTV is endemic in India, with regular hyper-endemic outbreaks occurring in the South. 
Serological evidence suggests that 21 BTV serotypes exist in India. However, only twelve 
BTV-serotypes (BTV-1, 2, 3, 4, 5, 9, 10, 12, 16, 21, 23 and 24) have been isolated there 
since 2001. A pentavalent inactivated BTV vaccine, containing dominant serotypes from 
India, (BTV-1, BTV-2, BTV-10, BTV-16 and BTV-23), is currently being used.  
Detection of multiple co-circulating BTV serotypes in India emphasizes the need for 
regular virological surveillance, particularly in light of the ongoing pentavalent inactivated 
vaccination programme. It will be particularly valuable to compare isolates from before, 
during and after implementation of the current pentavalent inactivated-vaccine campaign, 
to see if it has influenced the prevalence of different BTV serotypes. 
Molecular epidemiology studies of BTV depend on the development of sequence databases 
for the RNA segments of individual virus isolates from defined locations, with well 
documented isolation dates and passage histories. Generation of whole-genome sequence 
database for BTV strains from diverse geographical areas of India is needed to support 
molecular epidemiological studies to determine the origins, movements of different virus 
lineages and to determine the genetic variation and phylogenetic relationship with other 
isolates reported from different parts of the India and world. Phylogenetic analyses can 
help to trace evolutionary relationship between BTV strains and determine the origins and 
movement of each virus lineage and even each individual genome segment within an 
outbreak strain. It also helps in the characterization of any novel BTV isolates, as a new 
BTV lineage, identification of its topotype or cross-topotype reassortant that may be 
generated, thus contributes to better understanding of BTV molecular epidemiology and 
supporting the implementation of appropriate control strategies for BT.  
The investigation of field outbreaks of BTV from Southern India in this project will help 
us understand the epidemiology of the disease in endemic regions and in the country as a 
whole. The Southern states of India have a higher incidence of bluetongue disease. High 
sheep population density, congenial monsoon climate for multiplication of Culicoides and 
a susceptible host population, may all be the contributing factors to the disease incidence 
and prevalence.  
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The project is intended to isolate and ‘type’ BTV strains in India, then generate full length 
sequence data, primarily for BTV genome Seg-2, and potentially for the entire genome of 
selected bluetongue virus isolates from India. These sequencing data support the selection 
of conventional type-specific primers for Seg-2 that facilitates cDNA synthesis, 
amplification and sequencing. Full length sequence data for BTV genome Seg-2 provides 
molecular epidemiology information concerning the strains circulating in the region. An 
initial step in this process is the typing of viruses (by real-time RT-PCR assays) confirming 
the circulation of multiple BTV serotypes in the subcontinent.   
Aims of the project include: 
 The investigation of suspected field outbreaks of BTV from Southern India during 
2014-2015. This includes collection of EDTA blood and necropsy (spleen and 
lymph node) samples from outbreaks in mixed flocks of sheep and goats showing 
clinical signs in various districts of Telangana, Andhra Pradesh, Karnataka and 
Tamil Nadu during 2014- 2015. BTV RNA will be detected by BTV specific 
TaqMan based quantitative RT-PCR targeting genome Seg-10 (NS3) (Hofmann et 
al., 2008a) and Seg-9 (Maan et al., 2015a).  Samples (EDTA blood and tissue) that 
are positive (Ct<30) by BTV serogroup-specific qRT-PCR targeting Seg-10 or Seg-
9, will be mainly used to infect KC and BHK cells for virus isolation (Chapter 3). 
 Identification of serotype by serotype-specific TaqMan based qRT-PCR assay 
targeting BTV Seg-2 in Indian BTV field isolates from four Southern states of 
India during 2014 and 2015 BTV outbreaks. It will be particularly valuable to 
compare samples / isolates from before, during and after implementation of the 
current pentavalent inactivated-vaccine campaign, to see if it has influenced the 
prevalence of different BTV serotypes (Chapter 4). 
 To generate full-length sequence data for Genome segment 2 of Indian BTV strains 
isolated during 2014-2015 BT outbreaks from India, on a next generation 
sequencing platform (Chapter 5).     
 To identify the serotype of these field isolates from 2014-2015 outbreaks of BTV in 
India by comparing ORF of Seg-2 sequences with those of reference and field 
strains of 27 serotypes (Chapter 5).    
 Phylogenetic analyses based on Seg-2 of these BTV strains to determine the 
geographic origins, movements of virus lineage and evolutionary relationship with 
other isolates reported from different parts of the India and world (Chapter 5). 
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 Materials and Methods Chapter 2:
The chemicals and reagents used in this study were of analytical grade and purchased from 
Sigma-Aldrich (now Merck) company unless otherwise stated. All plastics used for the 
experiments were purchased from Tarsons Products Ltd, (Kolkata, India) and Nunc, 
Thermo Fisher Scientific (Mumbai, India) unless indicated otherwise. Cell culture flasks 
with growth area of 25 cm
2
 and 175 cm
2
 were purchased from Greiner Bio-One (Noida, 
India, catalogue number 660160). qPCR optical 96 well reaction plates with barcode, 0.1 
mL were purchased from Applied Biosystems, Thermo Fisher Scientific (MicroAmp™ 
Fast Optical 96-Well Reaction Plate with Barcode, 0.1 mL, catalogue number 4346906).  
2.1  Cell culture 
  Cell culture media 2.1.1
 Dulbecco's modified Eagle's medium, DMEM (Sigma-Aldrich, catalogue number 
D5280) for culture of BHK cell line.  
 Schneider’s insect cell culture medium (Sigma-Aldrich, catalogue number S0146) for 
culture of KC cell line. 
 Trypsin-EDTA solution (10 X) with 5.0 g porcine trypsin and 2 g EDTA • 4Na per 
liter of 0.9% sodium chloride (Sigma-Aldrich, catalogue number T4174). 
 Dulbecco’s phosphate buffered saline without Calcium and Magnesium (Sigma-
Aldrich, catalogue number 56064C). 
 L-glutamine solution, 200 mM (Sigma-Aldrich, catalogue number  G7513 ) 
 Penicillin-Streptomycin (100X) with 10,000 units penicillin and 10 mg 
streptomycin/mL (Sigma-Aldrich, catalogue number P4333) for cell culture. 
 Fetal bovine serum for cell culture (Biological Industries, catalogue number 04-007-
1A). 
 Sodium bicarbonate solution, 7.5% (Sigma-Aldrich, catalogue number S8761) 
 Freezing media: 70% maintenance medium, 20% foetal bovine serum, 10% dimethyl 
sulphoxide (DMSO) passed through 0.2 µm sterile syringe filter. 
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 Cell lines 2.1.2
 Mammalian cell lines 2.1.2.1
 Baby Hamster Kidney cells (BHK-21 clone 13), a fibroblast cell line derived from the 
kidney of one day old hamster originally procured from the American Type Culture 
Collection (ATCC, USA), was provided by the Veterinary Type Culture Collection, 
Hisar, Haryana, India for this study. 
 BSR cells (a sub-clone of BHK-21 cells) was kindly provided by Professor Peter 
Mertens, School of Veterinary Medicine and Science, University of Nottingham, UK. 
 Insect cell lines 2.1.2.2
 KC cells, an insect cell line derived from embryos of Culicoides sonorensis (Wechsler 
and McHolland, 1988) was kindly provided by Professor Peter Mertens, School of 
Veterinary Medicine and Science, University of Nottingham, UK.  
 Cell culture technique 2.1.3
 Mammalian cell culture 2.1.3.1
Mammalian cell culture work was carried out aseptically in a Class II biosafety cabinet 
using sterile media, buffer and plastic/glassware. The growth medium consisted of 
Dulbecco's modified Eagle's medium (Sigma-Aldrich, catalogue number D5280) 
supplemented with 10% foetal bovine serum, 100 units/mL penicillin, 100 g/mL 
streptomycin, 2mM glutamine and 7.5% sodium bicarbonate was used to grow BHK-21 
cell line in 25 cm
2 
and 175 cm
2
 flasks. Confluent cell sheets were sub-cultured routinely, 
with a split of 1/3. Monolayer of cells was washed three times with sterile Dulbecco’s 
phosphate buffered saline, 0.2mL/cm
2
 culture flask surface area, to remove traces of serum 
that would inhibit the action of trypsin. The cell sheet was covered with 0.25% trypsin-
EDTA solution, 0.2mL/cm
2
 culture flask surface area, and placed for 2 minute in the 
incubator at 37
0
C. The trypsin-EDTA solution was removed from the culture flask by 
aspiration and flask was again placed in the incubator until the cells detached from the 
surface of the culture flask. Detached cells were re-suspended in growth medium and split 
1 in 3 in culture
 
flask for further cultivation. The BHK-21 cells were incubated at 37
0
C in 
the presence of humidified 5% CO2.  
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 Insect cell culture 2.1.3.2
KC cells were grown at 26
0C in Schneider’s insect medium supplemented with 10% foetal 
bovine serum, 100 units/mL penicillin and 100 g/mL streptomycin. KC cells were 
dispersed by gentle and repeated pipetting up and down over the confluent cell sheets and 
subcultured with a split of 1/10.  
 Cryopreservation of cells: 2.1.4
A standard cryopreservation protocol was followed for cell cultures. Near confluent 
monolayers of BHK cells in log phase were detached from the substrate with 0.25% 
trypsin-EDTA solution and cells were resuspended in a growth medium. The cell 
suspension was centrifuged at 1500 rpm for 2 minute to pellet cells. The supernatant was 
aspirated using a sterile pipette without disturbing the cells pellet and cells were 
resuspended  at a concentration of 1x10
7
 cells per mL in freezing medium, which consisted 
of 70% Dulbecco's modified Eagle's medium, 20% foetal bovine serum, 10% dimethyl 
sulphoxide (DMSO). One mL aliquots were transferred to 2 mL cryogenic vials 
prelabelled with the name of cell line, passage number and date of cryopreservation. 
Cryopreservation was achieved using a slow freezing approach by placing  the vials first at 
4°C refrigerator for 2 hour, then at -20
0
c for 2 hours , frozen at -80
0
C in an insulated box 
overnight and finally transferring to liquid nitrogen tank at -196
0
C. 
For KC cells preservation, a standard cryopreservation protocol was followed. However, 
freezing media consisted of 20% Schneider’s insect medium, 70% foetal bovine serum and 
10% DMSO was used to dispense cell pellet into 2 mL cryogenic vial. 
 Revival of cryopreserved cells 2.1.5
Cryogenic vials were taken out from the liquid nitrogen tank and immediately thawed by 
immersion in a water bath at 37
0
C for 2 minute. Swab with 70% (v/v) ethanol was applied 
to the surface of the cryogenic vial and allowed to air dry for 10 seconds. The thawed 
cryopreserved suspension was transferred to a 2mL microcentrifuge tube and centrifuged 
at 1500 rpm for 5 minute at 4
0
C, to discard the freezing medium. The cell pellet was 
resuspended in 1 mL of growth medium and the cell suspension was transferred into a 25 
cm
2 
culture flask containing 5 mL of growth medium and the flask was incubated at the 
appropriate temperature. The cell lines were maintained under their respective culture 
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condition. The cells were observed after 24 hours for cell attachment and medium was then 
changed with a fresh growth medium to remove traces of DMSO. 
2.2  Reagents for RNA extractions  
 TRIzol reagent (Ambion, life technologies, Invitrogen, catalogue number 
15596026) contains phenol and guanidinium isothiocyanate. 
 Chloroform (Sigma-Aldrich, catalogue number 288306)  
 Isopropanol (Sigma-Aldrich, catalogue number W292907) 
 Ethanol (Sigma-Aldrich, catalogue number E7023) 
 Lithium chloride 8 M (Sigma-Aldrich, catalogue number L7026) 
 Ammonium acetate 7.5 M (Sigma-Aldrich, catalogue number A2706) 
2.3 Blood sample collection 
 EDTA Vacutainer tube 9 mL capacity (Greiner bio-one, catalog number 455045). 
 Vacutainer  needle 20 G, 1inch length, 0.9mm diameter x 25mm length (Greiner bio-
one, catalog number 450073) 
 Vacutainer needle holder (Greiner bio-one, catalog number 450201) 
2.4 Agarose gel electrophoresis 
 10X TAE buffer - 0.4 M Tris, 1.142% (v/v) acetic acid, 0.01 M EDTA, diluted in 
distilled water. Diluted to 1X in distilled water prior to use. 
 Agarose - 1% (w/v) molecular grade agarose (Sigma, catalogue number A9539-
100G) diluted in 1×TAE buffer. 
 Ethidium bromide - 10mg ethidium bromide per mL of distilled water was made as 
stock solution. 5ul of stock solution was added to 100 mL of molten agarose gel 
(Sigma-Aldrich, catalogue number E7637-5G). 
 1 Kb plus DNA Ladder (Invitrogen, catalogue number 10787018). 
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2.5 Primers for qRT-PCR  
 Serogroup-specific oligonucleotide primers and probe  2.5.1
Primers and probe sequences for the detection of BTV RNA were based on qRT-PCR 
assays targeting BTV Seg-10 (NS3),  as described by Hofmann et al., 2008a (Table 2.1). 
The 5’ end of TaqMan probes were labelled with 6-Carboxyfluorescein (FAM) and the 
3’end with a Black Hole Quencher-1 (BHQ-1). Primer and probe sequences are shown in 
the 5’-3’ orientation. Primers and probes were synthesized by Eurofins (India) and ordered 
at 100 nM scale with RNAse-free HPLC purification.  
BTV RNA was also detected by group specific real-time RT-PCR targeting genome 
segment 9 (Maan et al., 2015a) – Table 2.2. 
Table 2.1: Primer and probe sequences to detect BTV RNA by BTV specific qRT-
PCR targeting BTV Seg- 10 . 
 Oligonucleotide Primer 
name 
Primer sequence ( 5̍-3̍ ) 
Forward primer BTV_IVI_F TGG-AYA-AAG-CRA-TGT-CAA-A 
Reverse primer BTV_IVI_R ACR-TCA-TCA-CGA-AAC-GCT-TC 
Probe BTV_IVI_P FAM-ARG-CTG-CAT-TCG-CAT-CGT-ACG-C- BHQ1 
Table 2.2: Primer and probe sequences to detect BTV RNA by BTV specific qRT-
PCR targeting BTV Seg- 9.  
Oligonucleotide Primer sequence ( 5̍-3̍ ) 
Forward primer1  GYRCGGGNGGDGAYRYDAARAYG 
Reverse primer 1 RWRBRAAATCGCMCTACGTCAAG 
Forward primer 2 GTACAGGCGGAGATGTGAAAACG 
Reverse primer 2 GTGTAAAACCGCTATATGCCGTG 
Probe CACCTCTAAAGGGTCCAGGGTACC 
 Serotype-specific oligonucleotide primers and probe  2.5.2
Primers and probes for typing of BTV were based on qRT-PCR assay as described by 
Maan et al. (2016) (Appendix 1). The assay is based on VP2 nucleotide sequences of the 
BTV reference strains, available in the Orbivirus Reference Collection (ORC) at The 
Pirbright Institute, as well as nucleotide sequences in the public domain (GenBank). The 5’ 
end of TaqMan probes were labelled with 6-Carboxyfluorescein (FAM) and the 3’end with 
(Hofmann et al., 2008a) 
(Maan et al., 2015a) 
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a Black Hole Quencher-1 (BHQ-1). Primers and probes were synthesized by Eurofins 
(India). 
2.6 Primers for full-length amplification of cDNA (FLAC)  
 Anchor-primers for ligation 2.6.1
BTV dsRNA was ligated at its 3’ ends to an anchor-primer, as described by Maan et al., 
(2007b). The iSp9 is a C9 spacer (phosphoramidite) that forms a self-priming hairpin 
structure, to initiate synthesis of a cDNA (Table 2.3). The 5̍ terminus of the primer is 
phosphorylated. Primers were synthesized by Integrated DNA Technologies, UK and 
ordered at 100 nM scale with dual PAGE & HPLC purification. 
 Primer for amplification of cDNA  2.6.2
The cDNA that was generated from the anchor-primer ligated RNA, in a reverse 
transcription reaction, was further amplified by PCR using primer 5-15-1 that is 
complementary to the anchor-primer, as described by Maan et al., 2007b  (Table 2.3).  The 
5-15-1 primer was synthesized by Integrated DNA Technologies, USA and ordered at 100 
nM scale with RNAse-free HPLC purification. 
Table 2.3:  Primer sequences for full-length amplification of cDNA (FLAC) technique 
(Maan et al., 2007b). 
Primer name Primer sequence ( 5̍-3̍ ) 
Anchor-primer p-ACCTCTGAGGATTCTAAAC/iSp9/TCCAGTTTAGAATCC-OH 
5-15-1 GAGGGATCCAGTTTAGAATCCTCAGAGGTC 
2.7 Enzymes and kits 
 Ligation, Reverse transcription, cDNA synthesis / purification 2.7.1
 AMV reverse transcription system (Promega, USA, catalogue number A3500) was 
used for Reverse Transcription (RT) reactions.  
 SuperScript III/Platinum Taq One-Step qRT-PCR Kit (Invitrogen, UK, catalogue 
number 11732020) was used for quantitative RT-PCRs.  
 T4 RNA ligase buffer (10 X) (New England Bio Labs, catalogue number B0216L)  
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 T4 RNA ligase (10 U) (New England Bio Labs, catalogue number M0204L)  
 Triple Master PCR system (Eppendorf) was used for cDNA amplification.  
 Next Generation Sequencing-Illumina sequencing, kits / reagents 2.7.2
 TURBO-DNA free kit (Ambion, Thermo  Fisher Scientific, catalogue number 
AM1907)  
 RNA clean & concentrator kit (Zymo research, catalogue number R1015) 
 DNA clean & concentrator kit (Zymo research, catalogue number D4029)  
 Agencourt AMPure XP-PCR purification (Beckman Coulter Genomics, catalogue 
number A63881)  
 KAPA HiFi Hot Start Ready Mix (Kapa Biosystems, catalogue number 
07958927001)  
 T4 RNA Ligase 1, ssRNA Ligase (New England Bio Labs, catalogue number 
M0204L)  
  Tapestation D5000 ScreenTape (Agilent, catalogue number 5067-5588)  
 Tapestation D5000 Ladder and Sample Buffer (Agilent, catalogue number 5067-
5589)  
 Qubit dsDNA HS Assay Kit (Life Technologies, catalogue number Q32851)  
 Nextera XT Index kit , 24 indexes ( Illumina, catalogue number FC-131-1001)  
 Nextera XT DNA Library Prep kit, 24 samples (Illumina, catalogue number FC-
131-1024)  
 PhiX Control v3 (Illumina, catalogue number FC-110-3001)  
 MiSeq reagent kit V2 cartridge V2 (Illumina, MS-102-2002). 
2.8 Description of the study area  
Telangana, Andhra Pradesh, Karnataka, and Tamil Nadu are Southern states of India and 
form part of the Deccan Plateau Peninsular. Karnataka is located between latitude 11
031̍ 
to18
045̍ north and longitude 74012̍ to 780 40̍ east. It shares borders with Andhra Pradesh in 
the east, Maharashtra and Goa in the North, Tamil Nadu in the South and is bounded by 
the Arabian Sea in the West. Tamil Nadu extends between latitudes 80
02̍ to 13009̍ north 
and longitudes 76
050̍ to 80027̍ east.  
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Andhra Pradesh was recently reorganized into two states namely Telangana and Andhra 
Pradesh in 2014. Andhra Pradesh is located between latitudes 12
037̍ to 19054̍ north and 
longitudes 76
045̍ and 84046̍ east, and shares a border with Orissa and Madhya Pradesh in 
the north, Maharashtra and Karnataka in the west, Tamil Nadu in the south and is bounded 
by the Bay of Bengal Sea in the east. 
2.9 Field outbreaks of BT 
Suspected BT outbreaks were attended in mixed flock of sheep and goats, in the Warangal 
and Mehboobnagar districts of Telangana state during October 2014, and during November 
2014 to January 2015 in Karur, Erode, Tirupur, Chengalpattu, Salem and Thoothukudi 
districts of Tamil Nadu state (Figure 2.1). Suspected BT Cases  were also attended in 
Warangal, Medak and Karimnagar of Telangana state during August 2015, Anantpur and 
Chittoor districts of Andhra Pradesh state in October 2015, Devanagere, Tumkure, 
Chickballapur, Kolar and Chikmagalur districts of Karnataka state in November 2015 and 
Perambalur, Shivagangai, Pudukottai, Tirunelveli, Erode and Thoothukudi districts of 
Tamil Nadu state  in December 2015.  
2.10 Collection of field samples 
Four hundred and forty nine (449) EDTA blood samples and seven necropsy (spleen and 
lymph node) samples were collected from outbreaks from mixed flocks of sheep and goat 
showing clinical signs of bluetongue disease (BT) in various districts of Telangana, 
Andhra Pradesh, Karnataka and Tamil Nadu states during 2014-15 (Table 2.4).  
Of 150 samples collected during the 2015 BT outbreak in Tamil Nadu, eleven EDTA 
blood samples and two saliva samples were collected from suspected cattle housed close to 
the mixed flock of sheep and goat. Blood sampling was carried out with the assistance of 
the owner who restrained the animals. The blood was collected in a vacutainer using a 
vacutainer needle and holder. Approximately, 5 mL of blood was collected from each 
animal and transported at 4
0
C to the biotechnology laboratory in LUVAS, Hisar, India. 
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A) Telangana, 2015; B) Karnataka, 2015; C) Andhra Pradesh, 2015 and D) Tamil Nadu, 
2015. 
Table 2.4 Samples collected from four Southern states during 2014-2015 BT 
outbreaks in India. 
State Year of collection   Blood samples                                   Necropsy samples
Hyderabad  2014 9 - 
Hyderabad 2015 22 1
£
 
Karnataka 2015 178 1
*
 
Chennai 2014 145
¥
 5
$
 
Chennai 2014 25 - 
Andhra Pradesh 2015 60 - 
¥ Including two saliva samples; £ spleen, * spleen, $ four spleen and one lymph nodes. 
A B 
C D 
Figure 2.1  The author attending suspected BT outbreaks in mixed flocks of sheep and 
goats in various states of Southern India during 2014-2015. 
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2.11 Viruses  
Ten cell culture adapted BTV isolates were obtained under the Indo-UK project titled 
“Development of diagnostic systems, reference collections and molecular epidemiology 
studies for important arboviral pathogens of livestock in India" funded jointly by the 
Department of Biotechnology, Government of India, and the Biotechnology and Biological 
Sciences Research Council of the UK. The origins (where known) as well as the 
nomenclature of these viruses are listed in Table 2.5, although their passage history and 
year of isolation information are not available. These BTV isolates were provided to me by 
various collaborators namely the Indian Council for Agriculture Research-National 
Institute of Veterinary Epidemiology and Disease Informatics (ICAR-NIVEDI), 
Karnataka; ICAR-Indian Veterinary Research Institute (ICAR-IVRI), Uttar Pradesh and 
Ella Foundation, Hyderabad.   
Table 2.5: Cell culture adapted Indian BTV isolates obtained from collaborators 
under the Indo-UK project.  
Name of BTV isolate  Obtained from Geographic origin 
BTV2DH Dr.Hemadri, ICAR-NIVEDI Karnataka 
BTV1 IVRI Dr. Singh, ICAR-IVRI Uttar Pradesh 
BTV2 IVRI Dr. Singh, ICAR-IVRI Uttar Pradesh 
BTV10 IVRI Dr. Singh, ICAR-IVRI Uttar Pradesh 
BTV 23 IVRI Dr. Singh, ICAR-IVRI Uttar Pradesh 
BTV M1 Ella Foundation, Hyderabad Telangana 
BTV WG103 Ella Foundation, Hyderabad Telangana 
BTV IPGR/10 Ella Foundation, Hyderabad Telangana 
BTV VJW 764 Ella Foundation, Hyderabad Telangana 
BTV KMN 07/05 Ella Foundation, Hyderabad Telangana 
2.12 Preparation of clinical sample 
One mL of clinical blood sample was taken in a 2 mL sterile microcentrifuge tube and 
pelleted by centrifugation at approximately 1900 g for 1 min in a bench top 
microcentrifuge, washed (resuspended and pelleted) three times with 1 mL of Dulbecco’s 
phosphate buffered saline. After the final wash, the blood cells were resuspended in 
Dulbecco’s phosphate buffered saline up to a final volume of 1 mL. The washed blood 
cells were then lysed by adding equal volume sterile water. The sample was then 
centrifuged at 12,000 rpm at 4
0
C to collect the supernatant. The supernatant was passed 
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through a 0.22 µm sterile syringe filter (Millex, Merck, India, catalogue number 
SLGV033RS) then used to infect KC cells.  
For virus isolation a small piece of tissue sample (0.02gm) was transferred to 1.5 mL 
microcentrifuge tube and homogenized in 100 µL of PBS supplemented with 1000 
units/mL penicillin and 1000 µg streptomycin/mL using a tissue homogenizer. After 
grinding, 900 µL of PBS, supplemented with 1000 units/mL penicillin and 1000 µg 
streptomycin/mL was added and the total sample centrifuged at 10,000 g for 5 minute to 
sediment coarse particles and bacterial contamination. The supernatant was transferred to a 
fresh microcentrifuge tube and passed through 0.2 µm syringe filter. The processed tissue 
sample was then used to infect KC cells. 
2.13 Total RNA extraction from clinical samples   
During RNA extraction care was taken to avoid contamination with RNase and cross-
contamination between different BTV samples. Total RNA was extracted from clinical 
samples (EDTA treated blood or supernatant from homogenized tissues) using a 
guanidinium isothiocyanate procedure previously described by (Attoui et al., 2000b), with 
some modifications. Briefly, 400µL of blood sample or supernatant was vigorously 
vortexed with 600 µL of TRIzol reagent (Invitrogen) in a 1.5 mL eppendorf tube, followed 
by addition of 200 µL of chloroform. The solution was mixed by vortexing till a cloudy 
pink solution was obtained, followed by incubation on ice for 10 min. After centrifugation 
at 10,000 g for 10 min, the clear top aqueous phase was transferred into a 1.5 mL labelled 
eppendorf tube and mixed with 900 µL of isopropanol. RNA was allowed to precipitate at 
-20
0
C for 2 hours followed by centrifugation at 10,000 g for 10 min to pellet the RNA. The 
pellet was washed with 1 mL of 70% ethanol and centrifuged at 10,000 g for 10 min to 
remove supernatant. The pellet was air dried and dissolved in 50 μL of nuclease free water 
(NFW) to get total RNA and kept at −200C until used.  
2.14 Laboratory diagnosis by quantitative real-time RT-PCR 
A fluorogenic probe labelled with both a fluorescent reporter (e.g. 6-Carboxyfluorescein 
(FAM) at the 5̍ end) and a quencher dye (e.g. Black Hole Quencher (BHQ) at the 3̍ end) is 
used in the TaqMan-PCR. When the reporter and the quencher are both attached to the 
probe, energy from the excited reporter is transferred to the quencher by fluorescence 
resonance energy transfer (FRET) resulting in the absence of a fluorescent signal. After 
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hybridization of the probe to the specific target template sequence, by complementary base 
pairing, the TaqDNA polymerase extends the upstream primer on the same strand leading 
to cleavage and displacement and of the TaqMan probe by its 5’–3’ exonuclease activity. ,. 
The reporter and quencher dyes are separated by this cleavage mechanism, as the target is 
amplified. The energy is no longer transferred by FRET but is released from the reporter as 
fluorescence, resulting in an increased fluorescence signal. The fluorescence signal can be 
detected and measured in real time using a real-time thermal cycler.   
 Serogroup-specific qRT-PCR  2.14.1
The one-step, BTV specific TaqMan based, quantitative RT-PCR assay, targeting BTV 
Seg-10 (Hofmann et al., 2008a) was performed using the SuperScript III/Platinum Taq 
One-Step qRT-PCR Kit (Invitrogen). The qRT-PCR were carried out in 96-well ‘fast 
optical PCR plates’ (Applied Biosystems) using a real time PCR system apparatus 
(Applied Biosystem step one plus real time PCR system, catalog number 4376600) and 
Software, version 2.3 (Applied Biosystems). The composition of the assay reaction mix is 
presented in Table 2.6. Total RNA extracted from blood or tissue samples were heat 
denaturated at 99
0
C for 5 minute and then chilled on ice prior to addition of the reaction 
mix. The reaction cycling conditions were: 30 min at 55
0
C for cDNA synthesis; 
inactivation of RT and Taq activation for 2 min at 95
0
C; followed by 45 cycles of: 15s at 
95
0
C, 30s at 56
0
C and 30s at 72
0
C (Hofmann et al., 2008a). The cycle threshold (Ct) value 
was defined as the number of amplification cycles required to cross a certain threshold 
level of fluorescence. The analysis of fluorescence data was conducted using real time 
PCR system software version 2.3 (Applied Biosystems). Negative results (for assays that 
did not exceed the threshold level of signal) are reported as ‘No Ct’. Negative results were 
defined as Ct values greater than 40 cycles of amplification (threshold set automatically 
following the instructions of analysis software). The samples (EDTA blood or 
homogenised tissue supernatant) that were positive (Ct<30) by BTV serogroup-specific 
qRT-PCR targeting Seg-10, were mainly used to infect KC cells for virus isolation. 
Cycling conditions for group specific real-time RT-PCR targeting genome segment 9 were: 
30 min at 55
0
C for cDNA synthesis; inactivation of RT and Taq activation for 10 min at 
95
0
C; followed by 50 cycles of 30 s at 95
0
C and 60s at 60
0
C (Maan et al., 2015a). The 
composition of the assay reaction mix is presented in Table 2.7. 
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Table 2.6 Composition of serogroup-specific quantitative RT-PCR assay targeting 
Seg-10  
Reagents Amount (µl) 
2X reaction Mix (SuperScript III/Platinum Taq One-Step qRT-PCR Kit 
(Invitrogen, UK, catalogue number 11732020) 
12.5 
Forward primer (10 mM) 1.0 
Reverse primer (10 mM) 1.0 
Probe (5 mM) 0.5 
ROX (1:10) 0.5 
Nuclease free water  5.6 
SuperScript III RT/Platinum Taq Mix 0.5 
dsRNA 3.4 
Final  reaction volume 25 
Table 2.7: Composition of serogroup-specific quantitative RT-PCR assay targeting 
Seg-9 
Reagents Amount (µl) 
2X reaction Mix SuperScript III/Platinum Taq One-Step qRT-PCR Kit 
(Invitrogen, UK, catalogue number 11732020) 
12.5 
Forward primer 1 (20 mM) 1.0 
Reverse primer 1(20 mM) 1.0 
Forward primer 2 (20 mM) 1.0 
Reverse primer 2 (20 mM) 1.0 
Probe (5 mM) 0.5 
ROX (1:10) 0.5 
Nuclease free water  2.0 
SuperScript III RT/Platinum Taq Mix 0.5 
dsRNA 4.0 
Final  reaction volume 25 
2.15 Virus propagation 
 Virus propagation in KC cells 2.15.1
Primary isolation of virus from clinical samples (blood and tissue) was attempted by one 
passage in KC cells, followed by three passages in BHK-21 cells. Washed confluent cell 
sheets of KC cells in 25 cm
2
 culture flasks were inoculated with 500µL of processed 
clinical blood sample (see section 2.12.) in 1mL of Schneider’s insect cell culture medium. 
After incubation for 1 h at 26
0
C
 
for virus
 
adsorption, 5mL of Schneider’s insect medium 
supplemented with 10% foetal bovine serum, 100 units/mL penicillin and 100 µg/mL 
streptomycin was added and cells were incubated for 7 days at 26
0
C. After 7 days 
incubation, the KC culture flask was gently shaken and the cell suspension harvested. As 
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BTV does not produce cytopathic effect in KC cells, BTV RNA was detected by group-
specific real time RT-PCR targeting genome Seg- 10 (Hofmann et al., 2008a) or by 1% 
agarose gel electrophoresis to visualize typical dsRNA migration pattern of BTV RNA, 
after dsRNA extraction from the cell pellet.  
 Virus propagation in BHK-21 cells 2.15.2
The growth medium was removed from confluent layers of BHK-21 (a susceptible cell line 
for attempting BTV isolation) in 25 cm
2
 culture flasks which were then washed with 
Dulbecco’s phosphate buffered saline (Sigma-Aldrich, catalogue number 56064C). The 
monolayer of BHK-21 cells was inoculated with 100 µL of KC cell-suspension that had 
previously been infected with the sample, and then incubated for 1 h at 37
0
C under 
humidified 5% CO2 for virus adsorption. During incubation, the flask was rocked gently 
every 20 min for an even spread of inoculum on the entire cell surface. The monolayer was 
washed with Dulbecco’s phosphate buffered saline to remove unabsorbed virus particles 
and  5mL of maintenance medium consisting of Dulbecco's modified Eagle's medium 
supplemented with 100 units/mL of penicillin and 100 g/mL streptomycin and  10% 
foetal bovine serum was added. Inoculated and non-inoculated (negative control) 25 cm
2
 
flask cultures were incubated at 37
0
C in 5% CO2 and monitored daily for visualization of 
morphological changes,  cytopathic effects (CPE) in the infected cells, for up to 7 days.  
At least, three blind passages, with an incubation of 7 days each, were attempted in the 
samples not exhibiting cytopathic effects, before discarding the culture. Following 
successful isolation, generally after one passage, the presumptive positive isolates in BHK-
21 cell culture were confirmed as bluetongue virus (BTV) by group-specific real time RT-
PCR targeting genome Seg-10, to detect BTV RNA (Hofmann et al., 2008a),  or after 
dsRNA extraction from cell pellet by 1% agarose gel electrophoresis, to visualize the 
typical dsRNA migration pattern of BTV RNA.  The cells infected with BTV were 
harvested, transferred to a 15 mL sterile centrifuge tube and stored at 4
0
C till further use.   
2.16 Storage of BTV field isolates  
Field isolates of BTV were assigned unique collection numbers, consisting of the country 
code for India (IND), the year of collection and the sample number. Each BTV isolate was 
tested for BTV RNA by group-specific real-time RT-PCR targeting genome segment 10 
(NS3) prior to storage at -80
0
C. The processed original blood or tissue sample, field BTV 
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isolations from KC passage 1(KC1), KC 1 and BHK passage 1 (KC1-BHK1), KC 1 and 
BHK passage 2 (KC1-BHK2) and KC1 and BHK passage 3 (KC1-BHK3) were all stored 
at -80
0
C and were given unique collection numbers. For this purpose, the harvested virus in 
supernatant of the infected cell culture was resuspended in an equal volume of glycerol and 
then this mixture was aliquoted to one ml per cryogenic vial and stored at -80
0
C. 
2.17 BTV dsRNA extraction from virus-infected cell culture 
BTV dsRNA was extracted from virus-infected cell cultures (175 cm
2
 confluent layer of 
BHK-21) using Trizol (Invitrogen, USA). Care was taken to avoid cross-contamination of 
different BTV isolates during RNA extraction. The total RNA was extracted from virus-
infected cell cultures using a guanidinium isothiocyanate procedure as previously 
described by (Attoui et al., 2000b). Briefly, the contents of one 175 cm
2
 culture flask of 
infected BHK cells showing 100% CPE was decanted into a 50 mL centrifuge tube, 
followed by centrifugation at 1912 g for 10 minutes. The supernatant was discarded and 
the pellet was immediately vortexed after addition of 1 mL of Trizol. The mixture was 
transferred into a 1.5 mL labelled eppendorf tube and vortexed after adding 200 μL of 
chloroform, until a cloudy pink solution was obtained. After incubation on ice for 10 min, 
the suspension was centrifuged at 10,000 g for 10 min and the clear top aqueous phase was 
transferred into a fresh 1.5 mL labelled eppendorf tube. Then 900 μL of isopropanol was 
added to precipitate the RNA at -20
0
C for 2 hours. The sample was then centrifuged at 
10,000 g for 10 min to pellet the RNA, which was subsequently washed with 1 mL of 70% 
ethanol, air dried and dissolved in 100 μL of nuclease free water (NFW). Now, 100 μL of 4 
M lithium chloride (LiCl) was added to separate cellular ssRNA from the viral dsRNA by 
incubation at 4
0
C overnight. After centrifugation at 10,000 g for 5 min to pellet ssRNA, the 
supernatant was subsequently pooled in a fresh, labelled 1.5 mL eppendorf tube. An equal 
volume of isopropanol and 0.25 volumes of 7.5 M ammonium acetate were added and 
dsRNA was allowed to precipitate at -20
0
C for 2 hours. The dsRNA was pelleted by 
centrifugation at 10,000 g for 10 min, washed with 70% ethanol and air dried. The dsRNA 
pellet was finally suspended in 50 µL of nuclease free water and then kept at −200C until 
used.  
Agarose gel electrophoresis was carried out using 1% agarose in 1X TAE buffer with 0.5 
g/mL ethidium bromide and run at 7 V/cm in 1X TAE running buffer for an hour. The 
gels were visualized under UV using a transIlluminator, looking for the typical 3-3-3-1 
dsRNA migration pattern of BTV isolates. 
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2.18 Type-specific TaqMan based qRT-PCR  
BTV serotyping qRT-PCR assays were performed to detect serotypes, BTV-1 to BTV-27 
and BTV-29 (Appendix 1). A significant sequence variation occurs in Seg-2 of BTV 
strains from different geographic origins but of the same serotype (Maan et al., 
2009).Therefore, in this assay, two sets of primers and probes as a duplex format in qRT-
PCR were used for BTV-1, BTV-2, BTV-4, BTV-9 and BTV-16, against eastern and 
western topotypes/strains of same serotype. The assays used the SuperScript III/Platinum 
Taq One-Step qRT-PCR Kit (Invitrogen, UK, catalogue number 11732020) in 96-well Fast 
optical PCR plates (Applied Biosystems, UK, catalogue number 4346907) in a real time 
PCR system apparatus and Software, version 2.3 (Applied Biosystems, UK).  
Briefly, the dsRNA test-samples were heat denaturated at 99
0
C for 5 minute, then chilled 
on ice prior to addition of the reaction mix. The composition of the reaction mixes for 
assays with one set of primers and probe, or two sets of primers and probe respectively are 
presented in Table 2.8 and 2.9. Cycling conditions were: 30 min at 55
0
C for cDNA 
synthesis; 10 min at 95
0
C for inactivation of RT and Taq activation; followed by 45 cycles 
of 15s at 95
0
C, and at 10 min 60
0
C. The cycle threshold (Ct) value was defined as the 
number of amplification cycles required to cross a certain threshold level of fluorescence. 
The analysis of fluorescence data was conducted using a real time PCR system Software, 
version 2.3 (Applied Biosystems, UK). Negative results were defined as Ct values greater 
than 40 cycles of amplification (threshold set automatically following the instructions of 
analysis software). 
Table 2.8: Composition of type-specific TaqMan based qRT-PCR assay with two sets 
of primers and probes  
Reagents Amount (ul) 
 2X reaction Mix (SuperScript III/Platinum Taq One-Step qRT-
PCR Kit (Invitrogen, UK, catalogue number 11732020) 
12.5 
Forward primer 1 (10 mM) 1 
Reverse primer 1(10 mM) 1 
Probe 1(5 mM) 0.5 
Forward primer2 (10 mM) 1 
Reverse primer2 (10 mM) 1 
Probe 2(5 mM) 0.5 
MgSO4(50mM) 1 
ROX 0.5 
Nuclease free water  2.1 
SuperScript III RT/Platinum Taq Mix 0.5 
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dsRNA 3.4 
Final  reaction volume   25 
For BTV-1, BTV-2, BTV-4, BTV-9 and BTV-16, two sets of primer and probes as a 
duplex format in qRT-PCR were used against eastern and western topotypes/strains of 
same serotype.   
Table 2.9:  Composition of type-specific TaqMan based qRT-PCR assay with one set 
of primers and probe  
Reagents Amount(µL) 
2X reaction Mix (SuperScript III/Platinum Taq One-Step qRT-PCR Kit 
(Invitrogen, UK, catalogue number 11732020) 
12.5 
Forward primer (10 mM) 1 
Reverse primer (10 mM) 1 
Probe (5 mM) 0.5 
MgSO4(50mM) 1 
ROX 0.5 
Nuclease free water  4.6 
SuperScript III RT/Platinum Taq Mix 0.5 
dsRNA 3.4 
Final  reaction volume 25 
2.19 Agarose gel electrophoresis 
AGE was carried out using 1% agarose in 1X TAE buffer with 0.5 g/mL ethidium 
bromide and run at 7 V/cm in 1X TAE running buffer for an hour at room temperature. 
The gels were visualized under a UV transIlluminator.  Five (5) µL of amplified cDNA 
PCR product, or BTV genomic dsRNA was mixed with 1µL 6X  loading dye and gel 
electrophoresis was carried out alongside a 1 kb DNA ladder. The image produced was 
stored as TIFF or JPEG files.  
2.20 RT-PCR for full-length cDNA amplification (FLAC) 
The viral dsRNA was used for cDNA synthesis as described by (Maan et al., 2007b). Full-
length cDNA copies of BTV genome segments were synthesised and amplified in a 
sequence-independent manner using the “anchor spacer-ligation” method (Maan et al., 
2007b).  
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 Anchor-primer ligation 2.20.1
BTV dsRNA was ligated (at its 3’ ends) to an anchor-primer, using T4 RNA ligase at 4 °C 
for12 h. The ligation reactions were carried out in a total volume of 10 µL and consisted of 
7 μL dsRNA, 1 μL anchor primer, 1 μL T4 RNA ligase buffer (10 X) (New England Bio 
Labs) and 1 μL T4 RNA ligase (10 U) (New England Bio Labs). The reaction was 
incubated at 4
0
C overnight. 
 Heat denaturation of dsRNA 2.20.2
The ligated dsRNA was denatured at 99
0
C for 5 minute, separated into single strands of 
dsRNA molecules and then snap chilled on ice to prevent renaturation. 
 Reverse transcription (RT) 2.20.3
The ligated RNA was reverse transcribed to generate full length cDNAs using the AMV 
reverse transcription system (Promega). Nine microliters of RT mix containing 4µL of 
25mM MgCl2, 2 µL of 10mM  dNTP mix, 0.6 µL (22 U/µL) of AMV reverse 
transcriptase, 0.5 µL (20 U) of RNAsin and 2 µL of 10X RT buffer (Reverse transcription 
System, Promega) was added to 11 µL of denatured ligated RNA. Reverse  transcription 
was carried out at  25
0
C for 10 min, then 37
0
C for 40 min and finally 40
0
C for 10 min. The 
cDNA was then used for PCR amplification. 
 Amplification of cDNA  2.20.4
The cDNA that was generated in RT reactions was further amplified by PCR using the 
‘Triple Master PCR system’ (Eppendorf) with primer 5-15-1(`5-
GAGGGATCCAGTTTAGAATCCTCAGAGGTC-3`) that is complementary to the 
anchor-primer. The PCR was carried out in a final reaction volume of 12 µL containing 1 
µL (∼400 ng) of reverse transcribed cDNA product, 1µL of 10x PCR buffer , 0.2 µL 
dNTPs (10mM each stock), 0.2 µL of 5-15-1 (100 µM) primer, 0.1µL PCR extender 
polymerase mix (5U/µL) and 9 µL of nuclease free water. Amplification was performed 
with cycling conditions consisting of an initial denaturation at 94
0
C for 2 min, followed by 
35 cycles of denaturation for 15s at 95
0
C, annealing for 30s at 62
0
C, extension for 4 min at 
68
0
C and a final extension step for 10min at 72
0
C. Then 5µL of the PCR reaction was 
mixed with 1 µLof 6X loading dye and analysed by 1% agarose gel. The PCR products, 
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corresponding to each of the 10 genome segments, were purified and outsourced for 
sequencing on a 3730 capillary sequencer using BTV- gene specific  primers to generate 
near-terminal sequences (Maan et al., 2007b).  
2.21 Next-generation-Sequencing/Illumina-sequencing of Indian 
BTV isolates 
Next generation sequencing and bioinformatics analysis of the whole genome of selected 
BTV isolates was performed by Dr. Kyriaki Nomikou, at the Medical Research Council, 
Centre for Virus Research (MRC-CVR), University of Glasgow, using the Illumina 
platform. Briefly, dsRNA was extracted from the cell pellets of BSR or BHK cell adapted 
BTV field isolates (n = 46) (Table 2.10) using TRIzol Reagent (Invitrogen). dsRNA was 
extracted using 2M lithium chloride and precipitated with isopropanol in the presence of 
ammonium acetate (7.5M) as described in section 2.17. The viral dsRNA was used for 
cDNA synthesis, and amplification of BTV genome segments was performed in a 
sequence-independent manner using the “anchor spacer-ligation” method, as described by  
(Maan et al., 2007b). After purification of amplified PCR products, libraries were 
constructed using Nextera XT DNA Library Prep kit (Illumina) according to the 
manufacturer’s instructions. Sequencing was performed on an Illumina MiSeq on a 300-
cycle V2 cartridge, as per manufacturer’s protocol. Quality assessment and sequencing 
artefacts were removed, reference sequences were used to map the reads and the consensus 
sequences were finally extracted. 
 DNase Treatment of BTV dsRNA samples 2.21.1
BTV dsRNA was subjected to DNase treatment in order to eliminate containing DNA. 
Briefly, 12 μL of 10X Turbo DNase buffer and 5 μL of 2 Units/ C TURBO DNase (Turbo 
DNase, Ambion Life Technologies) were added to 50 μL of dsRNA and incubated at 370C 
for 30 minutes. Then, 5 μL of DNase inactivation reagent was added per 50 μL of ds RNA 
followed by incubation at 25
0
C for 5 minute with occasional mixing. The DNase treated 
supernatant was finally transferred to a fresh labelled tube after centrifugation at 12000 
rpm for 5 minute 
.
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Table 2.10 Details of the BTV field strains for Illumina sequencing in this study 
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[IND2015/15]22 18/12/2015 Thoothukudi TN 8°56'48.63"N 77°46'25.61"E S B V KC1/BSR6 
[IND2015/18] 40 22/12/2015 Tuticorin TN 8°56'48.63"N 77°46'25.61"E G B UV KC1/BHK4 
[IND2015/148]491 25/12/2015 Kanchipuram TN 12°50'3.02"N 79°42'13.10"E S B UV KC1/BHK5 
[IND2015/151]492 25/12/2015 Kanchipuram TN 12°50'3.02"N 79°42'13.10"E S B UV KC1/BHK6 
[IND2015/157]494 25/12/2015 Kanchipuram TN 12°50'3.02"N 79°42'13.10"E S B UV KC1/BHK6 
[IND2015/208]404 25/12/2015 Erode TN 11°20'27.73"N 77°43'1.79"E S B V KC1/BHK4 
[IND2015/211]406 25/12/2015 Erode TN 11°20'27.73"N 77°43'1.79"E S B UV KC1/BHK5 
[IND2015/214]408 25/12/2015 Erode TN 11°20'27.73"N 77°43'1.79"E S B UV KC1/BHK4 
[IND2015/169]470 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK4 
[IND2015/172]471 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E C B UV KC1/BHK5 
[IND2015/175]472 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E C B UV KC1/BHK4 
[IND2015/178]473 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK4 
[IND2015/181]474 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E C B UV KC1/BHK4 
[IND2015/184]475 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK4 
[IND2015/187]476 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK5 
[IND2015/190]477 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK5 
[IND2015/193]478 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E G B V KC1/BHK4 
[IND2015/196]480 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK5 
[IND2015/199]483 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK4 
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[IND2015/202]484 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E G B V KC1/BHK4 
[IND2015/205]486 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK4 
[IND2015/160]CS4 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK4 
[IND2015/163]CS6 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK4 
[IND2015/166]CS9 25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E S B V KC1/BHK5 
[IND2015/76]534 25/12/2015 Thoothukudi TN 8°45'51.00"N 78° 8'5.41"E G B UV KC1/BHK4 
[IND2015/2017]547 
tissue 
25/12/2015 Thoothukudi TN 8°45'51.00"N 78° 8'5.41"E 
S 
Sp UV KC1/BHK4 
[IND2015/220]228 
tissue 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E 
S 
Sp UV KC1/BHK4 
[IND2015/223]34 tissue 25/12/2015 Thoothukudi TN 8°45'51.00"N 78° 8'5.41"E S Sp UV KC1/BHK4 
[IND2015/232]556 
saliva 
25/12/2015 Thoothukudi TN 8°45'51.00"N 78° 8'5.41"E C Sa UV KC1/BHK5 
[IND2014/34]BTV-1 06/12/2014 Thanjavur TN 10°47'13.20"N 79° 8'16.18"E S B UV KC1/BHK4 
[IND2014/35]BTV-2 06/12/2014 Thanjavur TN 10°47'13.20"N 79° 8'16.18"E S B UV KC1/BHK4 
[IND2015/118]V1 26/11/2015 Chikballapur K 13°11'35.03"N 78° 1'14.86"E S B V KC1/BHK5 
[IND2015/121]V2 26/11/2015 Chikballapur K 13°11'35.03"N 78° 1'14.86"E S B V KC1/BHK5 
[IND2015/136]V41 26/11/2015 Chikballapur K 13°29'43.12"N 77°58'4.05"E S B V KC1/BHK5 
[IND2015/142]V44 26/11/2015 Chikballapur K 13°29'43.12"N 77°58'4.05"E S B V KC1/BHK4 
[IND2015/145]V44 lamb 26/11/2015 Chikballapur K 13°29'43.12"N 77°58'4.05"E S B V KC1/BHK4 
[IND2015/133]V Severe 26/11/2015 Chikballapur K 13° 2'21.52"N 77°23'33.83"E S B V KC1/BHK4 
IND2015/241]K3 10/09/2015 Karimnagar T 18°19'20.63"N 80°14'29.70"E S B UV KC1/BHK4 
[IND2015/244]K4 10/09/2015 Karimnagar T 18°26'22.78"N 79° 7'44.26"E S B UV KC1/BHK4 
[IND2015/250]K9 10/09/2015 Karimnagar T 18°32'54.90"N 78°17'29.98"E S B UV KC1/BHK6 
[IND2015/252]K13 12/09/2015 Karimnagar T 18°41'50.52"N 79° 4'26.61"E S B UV KC1/BHK6 
[IND2015/256]K14 12/09/2015 Karimnagar T 18°41'50.52"N 79° 4'26.61"E S B UV KC1/BHK4 
[IND2015/238]6PK 07/09/2015 Warangal T 18°11'51.79"N 79°42'9.80"E S B UV KC1/BHK4 
[IND2014/37] 10NLG 03/10/2014 Nalgonda T 16°56'34.67"N 79°12'55.83"E S B UV KC1/BHK4 
[IND2015/271]7A 08/11/2015 Anantpur AP 14°41'37.97"N 77°38'3.41"E S B UV KC1/BHK4 
[IND2015/]14A 08/11/2015 Anantpur AP 14°41'37.97"N 77°38'3.41"E G B UV KC1/BHK4 
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*
 Virus collection number: [Country code, year / sample number] 
£ 
Number of passages in KC cell line  
$ 
Number of passages in BHK cell line.
  
& 
Number of passages in BSR cell line. 
 Abbreviations: TN, Tamil Nadu; K, Karnataka; T, Telangana; AP, Andhra Pradesh; B, Blood; Sp, Spleen; Sa, Saliva; V, Vaccinated; UV, 
Unvaccinated; S, Sheep; G, Goat; C, Cattle. 
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 Anchor-primer ligation and purification of dsRNA 2.21.2
DNase treated dsRNA was ligated to an anchor-primer (as explained in section 2.20.1), 
then ‘cleaned’ using the RNA Clean & Concentrator kit (Zymo research, USA) according 
to the manufacturer’s protocol. Briefly, 20 µL of RNA binding buffer was added to 10 µL 
ligated dsRNA product followed by addition of 30 µL absolute ethanol. The content was 
transferred to the Zymo-spin column in a collection tube, centrifuged at 12,000 g for 30 
seconds and flow-through was discarded. Then 400 µL RNA-prep-buffer was added to the 
column and centrifuged at 12,000 g for 30 seconds to remove flow-through. This was 
followed by addition of 700 µL RNA-wash-buffer and then 400 µL RNA wash buffer to 
the column prior to centrifugation at 12,000 g for 30 seconds. The RNA was eluted in 15 
µL RNase-free-water by transferring the column to a new tube followed by centrifugation 
at 12,000 g for 30 seconds and stored at -80
0
C till used. 
 Synthesis and amplification of cDNA 2.21.3
The ligated and purified dsRNA was denatured at 99
0
C for 5 minute to separate the ssRNA 
strands, then snap chilled on ice to prevent renaturation. The ligated RNA was reverse 
transcribed to generate full length cDNAs using the AMV reverse transcription system 
(Promega).  Second strand synthesis was done by PCR using the ‘Triple Master PCR 
system’ (Eppendorf) with primer 5-15-1 as described in section 2.20.3 and 2.20.4 
respectively. 
Alternatively, the ligated and purified dsRNA was reverse transcribed to generate full 
length cDNA using SuperScript III first-strand synthesis system (Thermo Fisher Scientific, 
catalogue number 18080051). Briefly, 10 μL of ligated RNA, 10 mM dNTPs, 2 μL 10X 
RT buffer, 1 μL SuperScript III RT (200 U/µL), 1 μL RNase-OUT (40 U/ µL), 2 μL 0.1 M 
DTT and 4 μL of 25 mM MgCl2  were mixed and  incubated at 250C for 10 min followed 
by 50
0
C for 50 min. Finally, the reaction mix was incubated with 1 μL RNase H (2 U) at 
37
0
C for 20 min. Amplification of the resulting cDNA was performed using KAPA HiFi 
Hot Start Ready Mix (Kapa Biosystems, UK) using the ‘5-15-1’ primer, which is 
complementary to the anchor primer. Briefly, 12.5 μL of 2 × KAPA HiFi HotStart DNA 
Polymerase ready mix, consisting of KAPA HiFi HotStart DNA Polymerase (0.5 U/25ul 
reaction), 0.3 mM of each dNTP and 2.5 mM of MgCl2), was added with 0.2 μL of 100 
μM primer 5-15-1 to 2 μL of cDNA and 10.3 μL nuclease free water. Cycling conditions 
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were 95
0
C for 3 min followed by 35 cycles of 98
0
C for 20 s, 65 °C for 15 s, 72 
0
C for 4 
min with a final cycling step of 72 
0
C for 10 min.  
 Amplified cDNA purification 2.21.4
The dsDNA PCR products were purified using the DNA Clean & Concentrator kit (Zymo 
research) according to manufacturer’s protocol. Briefly, 5 volumes (60 µL) of DNA binding 
buffer was added to one volume of PCR product (12 µL) and transferred to Zymo-spin 
column inside a collection tube followed by centrifugation at 12,000 g for 1 minute. Now, 
600 µL DNA wash buffer was added to column and centrifuged for 60 seconds to remove 
flow-through. The DNA was eluted in 20 µL RNase-free water by transferring column to a 
new tube followed by centrifugation at 12,000 g for 30 seconds. 
 DNA Quantification 2.21.5
The amount of ds DNA (in ng/ul) was measured prior to library preparation using a Qubit 
fluorometer and Qubit dsDNA high sensitivity (HS) Assay Kit (Life Technologies), 
according to manufacturer’s instructions. After quantification the concentration of each 
sample was adjusted to 0.2 ng/μL for library preparation using Nextera XT DNA library 
preparation kit. 
 Library preparation 2.21.6
One nanogram of dsDNA in 5 µL (0.2ng/µL) was taken to prepare sequencing libraries 
using the Nextera XT DNA sample preparation kit (Illumina, USA) according to 
manufacturer’s protocol. All reagents were thawed on ice and mixed properly before use. 
Nuclease free 0.2 µL PCR tubes were used for all reactions. 
  ‘Tagmentation’ of input DNA 2.21.7
To each reaction, 10 µL of tagment DNA buffer (TD), 5 µL containing 1 ng of DNA 
sample and 5 µL amplicon tagment mix (ATM) were added, mixed by pipetting gently and 
centrifuged briefly at 280 g for 1 minute. Reactions were then incubated on a PCR 
thermocycler at 55
0
C for 5 minute and then a 10
0
C hold for a second followed by a brief 
spin down at 280 g for 1 minute. Then, 5 µL of neutralize-tagment-buffer (NT) was added, 
mixed and centrifuged briefly at 280 g for 1 minute to stop the reaction. The mixture was 
incubated at room temperature for 5 minutes. 
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 cDNA Library Indexing and PCR amplification 2.21.8
Nextera PCR master mix (NPM) was thawed on ice while the index primers (S5XX and 
N7XX) were thawed at room temperature, for 20 minutes each before making the master 
mix. The i7 index primers with orange caps were arranged in order horizontally whereas 
the i5 index primers with white caps were arranged in order vertically (Figure 2.2). Now 
15 μL of NPM was added to each sample, followed by 5 μL of the corresponding index 
primer 1 and index primer 2. The original caps of each primer were replaced with fresh 
caps to avoid cross-contamination.  The mixture was mixed by gentle pipetting and briefly 
centrifuged at 280 g for 1 minute room temperature, prior putting on a PCR machine using 
the following programme: 72
0
C for 3 min, 95
0
C for 30 seconds, 15 cycles of 95
0
C for 10 
seconds, 55
0
C for 30 seconds, 72
0
C for 30 seconds, then a final extension step of 72
0
C for 
5 min, followed by a hold at 10
0
C. Barcode tags were incorporated into to each sample 
through PCR amplification. The reaction could be stored at -20
0
C or at 4
0C for next day’s 
work. 
 Ampure XP dsDNA purification 2.21.9
The amplified PCR reaction products as described in section 2.21.8 were purified using 
Ampure XP beads (Agencourt, Beckman Coulter). The beads were resuspended by 
vortexing and then allowed to warm up at room temperature. The samples were also 
equilibrated at room temperature and 90 μL of Ampure XP beads were added to 50 μL of 
each sample (at a ratio of 1:1.8) followed by gentle pipetting to mix the components, 
followed a brief centrifugation at 280 g for 2 minutes, and finally incubation at room 
temperature for 15 min. The solution was then put on a magnetic rack until the beads and 
solution were completely separated. The supernatant was removed and the beads were 
washed twice with 200 μL of freshly prepared 80% ethanol. The beads were allowed to air 
dry after removing traces of ethanol for 5-10 minute at room temperature. The dried pellet 
was eluted in 52.5 μL resuspension buffer (RSB) followed by incubation at room 
temperature for 2 minutes. The samples were then put on a magnetic rack for 5 minutes, 
until the beads and solution were completely separated. Finally, 50 μL dsDNA supernatant 
was transferred to fresh tube and stored at -20
0
C, or 4
0C for the next day’s work 
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Figure 2.2 TruSeq index plate fixture setup for 24 libraries 
 A) Index 1 (i7) adapters with orange caps in columns 1–6, B) Index 2 (i5) adapters with 
white caps in rows A–D, C) TruSeq index plate fixture, D) PCR plate. Image adapted from 
Nextera XT DNA library preparation kit reference guide (Illumina). 
 Library Quantification 2.21.10
The concentration of library DNA was measured using Qubit fluorometer and Qubit 
dsDNA high sensitivity (HS) Assay Kit (Life Technologies), as described in Section 
2.21.5. The library sizing (quality and distribution) and quantification were determined 
using the High Sensitivity D5000 Screen Tape assay (Agilent) in a 4200 Tape Station 
System (Agilent) according to manufacturer’s instructions. Readings on Tape Station 
should be more than 100 and can range from 100 to 5,000 bp. Another washing with 
Ampure XP beads was required if primer dimers were detected by Tape Station analysis. 
 Pooling of sequencing library, denaturation and dilution  2.21.11
Unique barcode indexes attached to the samples during the sequencing library preparation 
subsequently allowed multiple libraries to be pooled i.e. barcode multiplexing of multiple 
samples and could be sequenced simultaneously during a single sequencing run. Each 
library for sequencing was diluted to 4 nM with nuclease-free water, based on their sizing 
and quantification of DNA fragments on Tape Station. 5 μl from each diluted library were 
pooled into a single fresh tube and the pooled library quantified again to measure its 
concentration using a Qubit florometer and the fragment size by Tape station. The pooled 
libraries were denatured with 0.2 N NaOH for 5 min at room temperature. The pooled 
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denatured library was further diluted to 12.5 pM with HT1 buffer (Illumina). An internal 
control library, PhiX control v3 library (Illumina) was added to the concentration of 1%. 
The diluted library pool was loaded in the MiSeq reagent kit Version (V) 2 cartridge 
(Illumina) and pair-end reads of 150 bp were produced on a MiSeq platform. 
2.22 Processing and assembly of the raw sequencing data  
Bioinformatics analysis of the raw sequencing data was carried out by Dr. Kyriaki 
Nomikou. Briefly, quality check of the raw sequence reads was done by using FastQC 
(www.bioinformatics.babraham.ac.uk/projects/fastqc/). TrimGalore was used for Primer, 
adapter and low quality read trimming 
(www.biopinformatics.babraham.ac.uk/projects/trim_galore/ ). Mapping of quality passed 
and trimmed sequenced reads to reference genome has been done using Bowtie 2 
(www.bowtie-bio.sourceforge.net/bowtie2/index.shtml) and Tanoti 
(http://bioinformatics.cvr.ac.uk/Tanoti/). Post assembly processing and consensus sequence 
generation was done using SAMtools (Li et al., 2009).  
2.23 Sequence data phylogenetic analysis of Seg-2 
Sequence analysis of Seg-2 was done to identify the serotype of Indian field isolates from 
BT outbreaks in Southern India, 2014-15, by comparing Seg-2 sequences with those of 
reference strains of the 27 BTV serotypes. The phylogenetic analyses of Seg-2 of these 
Indian BTV strains will help to determine their geographic origins, movements of different 
virus lineages and evolutionary relationships with other isolates from different parts of the 
India and world. 
Sequences of Seg-2 used in the phylogenetic analyses were initially aligned in Seaview 
using Clustal W program (Gouy et al., 2010). Additionally, sequence alignment of Seg-
2/VP2 gene sequences of Indian BTV isolates of 2014-2015 generated in this study, 
together with Seg-2/VP2 gene sequences of the 27 BTV reference serotypes and Seg-
2/VP2 sequences of the corresponding serotype sequences publically available retrieved 
from NCBI (accessed on 01.12.17) , was done using Clustal Omega for phylogenetic 
analysis (Sievers et al., 2011). 
Maximum Likelihood (ML) phylogenetic trees  were built using  PhyML program 
(Guindon and Gascuel, 2003) under the best-fit nucleotide substitution model calculated by 
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JModel test v2.1.4 using Corrected Akaike information criterion (AICc) (Darriba et al., 
2012, Posada, 2008). The Maximum Likelihood (ML) method implemented in PhyML was 
used to attain the best tree topology. The bootstrapping method was used with 100 
replicates for maximum-likelihood method.  Graphical representation and phylogenetic 
tree editing was achieved in FigTree (Rambaut, 2009) and further graphic  adjustments 
were done in Inkscape 0.48.4 (Inkscape, 2013).  
In a tree, each strain retrieved from the Genbank was annotated by serotype followed by 
country code, year of sample collection where applicable and Genbank accession number 
as “serotype/country code/year of sample collection_Genbank accession number”. The 
Indian strains sequenced in this study were indicated as country code, IND followed by 
year of sample collection, original sample ID and date of sampling. 
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 Field outbreaks of bluetongue Chapter 3:
disease in Southern India during 2014-15. 
3.1 Introduction 
India has the largest livestock population of any country in the world and more than 70% 
of country’s sheep population is found in four states, including: Rajasthan which is a 
North-western desert state; Telangana, Andhra Pradesh, Tamil Nadu and Karnataka. About 
5 million small and marginal farmers including ‘landless labourers’ are involved in the 
rearing of sheep and goats in India (Livestock census, 2014), with both ‘semi-pastoral’ and 
‘semi-intensive’ management systems used for rearing sheep in the Southern states 
(Kantwa et al., 2017, Rao et al., 2016b).  
Clinical BT was first reported from Maharashtra state in Western India (Sapre, 1964), but 
is now considered both endemic and widespread on the sub-continent, with outbreaks 
reported in Northern, Central, Western and Southern states (Prasad et al., 1992, 
Sreenivasulu et al., 2004, Ranjan et al., 2015, Prasad et al., 2009). From 1970-1980, 
clinical BT disease was reported mostly in exotic breeds of sheep involved in a 
crossbreeding programme for breed improvement, in Himachal Pradesh (Uppal and 
Vasudevan, 1980), Haryana, (Vasudevan, 1982) and Rajasthan states of Northern India 
(Lonkar et al., 1983, Sharma et al., 1985, Mahajan et al., 1991).  However there were also a 
few reports of disease in native sheep breeds in Maharashtra, Western India  (Singh et al., 
1982, Harbola et al., 1982) and Karnataka, Southern India., (Srinivas et al., 1982). After 
1982, BT outbreaks were reported annually in native sheep breeds, particularly in the 
Southern states (Mehrotra et al., 1991, Kulkarni et al., 1992, Saravanabava, 1992, Prasad et 
al., 2009, Prasad et al., 1992, Rao et al., 2016b, Susmitha et al., 2012, Sreenivasulu et al., 
1999, Bommineni et al., 2008). 
There is a clear difference in the pattern of disease and clinical symptoms of BT between 
the Northern and Southern states of India. While frank clinical BT outbreaks have mostly 
been reported from sheep and goats in the Southern part of India over the last two decades 
(Rao et al., 2016b), overt BT signs have only occasionally been reported in local or 
crossbred sheep breeds in Northern India.  
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Concurrent infections of small ruminants with BTV and peste des petite ruminant virus 
(PPRV) have been reported in Haryana, Uttar Pradesh and Uttarakhand States of Northern 
India, showing clinical signs of fever, anorexia, oral mucosa congestion, gastroenteritis and 
mortality  (Maan et al., 2017, Biswas et al., 2010, Mondal et al., 2009, Mondal et al., 
2013). In 1989-1990, 1997-1998 and 2005-2006, BT outbreaks with severe clinical 
manifestations were reported from Tamil Nadu, resulting in high sheep mortality (Reddy et 
al., 2016a) and nearly 0.3 million small ruminants died in Tamil Nadu in the 1997-98 BT 
outbreak (Ilango, 2006).   
The incidence of BT outbreaks in India is considered to be influenced by temperature, 
humidity, precipitation and sheep population densities, which collectively provide 
conducive breeding grounds for the local Culicoides population that is involved in BTV 
transmission, and these are therefore factors in the widespread incidence of overt clinical 
BT disease in the Southern states (Rao et al., 2016b). In Telangana, northern parts of 
Andhra Pradesh and Karnataka, BT outbreaks occur during south west monsoon with 
highest incidence during August and September. In contrast, in the Southern interior parts 
of Andhra Pradesh, Karnataka and Tamil Nadu, the disease is observed during north east 
monsoon from October to December (Sreenivasulu et al., 2004).  
The clinical signs of BT disease are not pathognomonic and could be confused with 
diseases such as foot and mouth disease (FMD), peste des petits ruminants (PPR), sheep 
pox, goat pox and contagious ecthyma which are also endemic in India. Consequently, 
differential diagnosis of BT requires confirmation by laboratory testing (Prasad et al., 
2009). 
The four Southern states of India Telangana, Andhra Pradesh, Tamil Nadu, Karnataka 
including Maharashtra, which is a western state, are being covered by pentavalent 
inactivated BTV vaccine (containing BTV-1, BTV-2, BTV-10, BTV-16 and BTV-23) but 
on voluntary basis. The vaccine was tested in Maharashtra, Telangana, Andhra Pradesh, 
Tamil Nadu and Karnataka at farmer’s doorstep from 2010 onwards. The Raksha Blu 
vaccine (commercial name of pentavalent inactivated BTV vaccine, containing serotypes 
BTV-1, BTV-2, BTV-10, BTV-16 and BTV-23) was launched on 8 January 2015 by 
Indian Immunologicals Limited in Hyderabad, Telangana (Maan et al., 2015c, Rao et al., 
2016b). However, inspite of hyperendemic status of BTV transmission in these states, 
vaccination is not done at mass scale. The presence of multiple co-circulating BTV 
serotypes also shows the importance of routine virological surveillance, especially as it 
Chapter 3  Field outbreaks 
78 
 
provides a basis for the current vaccination programme and would help to ensure the use of 
vaccines of the appropriate BTV serotype (Rao et al., 2016b). 
It will be therefore useful to analyse BTV isolates from before, during and after the start of 
the current pentavalent inactivated-vaccine programme, to see if it has altered the 
prevalence of different BTV serotypes circulating in the region. An initial step in this 
process is to attend BT field outbreaks from Southern India, to collect well documented 
samples for virus isolations, which will subsequently help us understand the epidemiology 
of the disease in endemic regions and in the country as a whole. 
The objectives for the work described in this chapter include: 
 To attend suspected field outbreaks of BTV in various districts of Telangana, 
Andhra Pradesh, Karnataka and Tamil Nadu in India during 2014- 2015. 
 To collect blood and necropsy samples from outbreaks in small ruminants and 
cattle along with well documented information including sample collection date, 
geographical location of sample collection, geographical coordinates, host species 
affected, vaccination status against BT and symptoms of disease.  
 Process and analyse the collected samples, to detect BTV RNA by TaqMan based 
quantitative RT-PCR targeting genome Seg-10 (NS3), thereby identifying infected 
animals.  
 To use samples those are positive by BTV serogroup-specific qRT-PCR for BTV 
isolation, by infecting KC and BHK cells.  
3.2 Results 
 Field outbreaks in 2014   3.2.1
In October 2014, nine EDTA blood samples (n=9) were collected from sheep that were 
suspected of BTV infection, in flocks that had not been vaccinated against BT in the 
Warangal (n=5) and Mehboobnagar (n=4) districts of Telangana (Figure 3.11). There was 
no official BT outbreak reported from Telangana and Andhra Pradesh in 2014 (AICRP, 
2014). State Andhra Pradesh was divided into two states, namely Telangana and Andhra 
Pradesh in 2014. The pentavalent inactivated BTV vaccine is being used in four states of 
Southern India: Telangana, Andhra Pradesh, Tamil Nadu and Karnataka since 2011 at 
farmer’s doorstep under All India Network Project on Bluetongue 
(www.icar.org.in/node/3516) to test the efficacy of vaccine and now recently, the vaccine 
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has been commercialized in 2015 for use by farmers on voluntary basis. These sporadic 
suspect BT cases showed mostly nonspecific signs, including nasal discharge (89%) and 
mild congestion of gum mucosa (78%). However other clinical manifestations including 
head oedema, pyrexia (40 - 41.1
0
C) and lameness were observed in one case each (Table 
3.1 and 3.2). 
Suspected BT cases were also attended in the Karur, Erode, Tirupur, Chengalpattu, Salem 
and Thoothukudi districts of Tamil Nadu, during November 2014 to January 2015, and 
twenty five (n = 25) EDTA blood samples were collected (Figure 3.11). The most obvious 
clinical signs included congested oral mucosa (76%), limping (72%), erosions of oral 
mucosa (56%), fever (32%), excess salivation (16%) and nasal discharge (12%). These 
flocks had not been vaccinated with pentavalent inactivated BT vaccine (Table 3.1 and 
3.3).  
 BT Field outbreaks in 2015  3.2.2
 Telangana, 2015 3.2.2.1
Twenty four (24) animals (suspect BT cases that had not been vaccinated against BTV) 
were sampled from mixed flocks of sheep and goats (including twenty three EDTA blood 
samples, twenty one from sheep and two from goats and one necropsy (spleen) sample 
from PPR suspected goat) from Telangana during September 2015 (Table 3.4, Figure 
3.10). These sporadic suspect BT cases were from Warangal, Karimnagar and Medak 
districts of Telangana. The most common clinical signs were congested oral mucosa 
(58%), oral lesions (50%), nasal discharge and high fever, 104-106
0
F (38% each) in these 
flocks (Table 3.1).  
 Andhra Pradesh, 2015 3.2.2.2
A severe outbreak of BT occurred in mixed flocks of sheep and goat, which had not been 
vaccinated against BT, in the Anantpur and Chitoor districts of Andhra Pradesh during 
early November 2015. The suspected animals (n=60) showed clinical signs that included 
ulcers and erosions in the mouth, particularly on the dental pad (58%), congested mucosa 
(48%), high fever, 40 - 41.1
0
C (43%), salivation (8%), nasal discharge (5%), limping (7%), 
head oedema (3%) and blood speckled nasal discharge (2%) (Table 3.1 and 3.8, Figure 3.6, 
3.10). The goats were apparently healthy and did not show clinical signs, except pyrexia 
and nasal discharge. 
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Table 3.1 Main clinical signs and their frequency in sheep and goats affected by BTV. 
Symptoms T 
2014 
TN 
2014 
T 
2015 
AP 
2015 
K 
2015 
TN 
2015 
Overall 
Total clinical cases (n) 9 25 24 60 179 145
*
 442 
Pyrexia (n) 1 8 9 26 79 57 180 
 Percentage (%) 11 32 38 43 44 39 41 
Oral lesions (n) 0 14 12 35 120 89 270 
Percentage (%) 0 56 50 58 67 61 61 
Nasal discharge (n) 8 3 9 3 32 19 74 
Percentage (%) 89 12 38 5 18 13 17 
Salivation (n) 0 4 1 5 23 25 58 
Percentage (%) 0 16 4 8 13 17 13 
Limping (n) 1 18 0 4 76 103 202 
Percentage (%) 11 72 0 7 42 71 46 
Head oedema (n) 1 0 0 2 4 1 6 
Percentage (%) 11 0 0 3 2 1 1 
Torticollis (n) 0 0 0 0 2 4 6 
Percentage (%) 0 0 0 0 1 3 1 
Blood stained  
nasal discharge (n) 
0 0 0 1 3 5 4 
Percentage (%) 0 0 0 2 2 3 1 
Congested oral mucosa (n) 7 19 14 48 80 60 228 
Percentage (%) 78 76 58 80 45 43 52 
*Mortality cases (five) from Tamil Nadu state are not included. 
Abbreviations: AP, Andhra Pradesh; T Telangana, TN; Tamil Nadu and K, Karnataka 
  Karnataka, 2015 3.2.2.3
One hundred and seventy eight EDTA blood samples (n=178) and one necropsy (spleen) 
sample were collected, from severe disease outbreaks (suspected BT) during November 
2015, that were attended in mixed flocks of sheep (n=176) and goats (n=2) in the 
Chickballapur, Devanagere, Tumkure, Kolar and Chikmagalur districts of Karnataka State 
(Figure 3.10). The majority of BT-suspect sheep showed clinical signs that included ulcers 
on oral mucosa (67%) particularly on the dental pad, congested oral mucosa with swollen 
muzzle and lips (45%), fever (44%), limping (42%) and excessive salivation and frothing 
at the mouth (13%). Swollen cyanotic tongue (2%), nasal discharge speckled with blood 
(2%), submandibular & head oedema (2%), oral mucosa bled on touch (2%) and torticollis 
(1%) were the rare clinical symptoms (Table 3.1 and 3.8, Figure 3.1-3.5). Wool-break was 
evident in almost all cases (Figure 3.7). 
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Although some animals had been vaccinated, only ten blood samples could be collected 
from three small flocks showing clinical signs of BT. Of these, three blood samples were 
collected from a vaccinated sheep in village Vemgal, Sidlaghatta, Chikballapur district of 
Karnataka State using the inactivated bivalent (BTV-1 and 23) vaccine. Three blood 
samples from inactivated pentavalent (BTV-1, -2, -10, -16 and -23) vaccinated sheep in 
village Lakkenahalli, Sidlaghatta and four blood samples from inactivated pentavalent 
vaccinated sheep in village Genjigunte, Sidlaghatta of  Chikballapur district of Karnataka 
State were collected. Primary vaccination with pentavalent BTV vaccine was done in the 
month of August followed by a booster dose of vaccine 28 days after the primary 
vaccination. The clinical presentation and disease severity during BT outbreaks, 2015 in 
this study varied from less severe to more severe, although severity of disease did not 
differ substantially in vaccinated and non-vaccinated field cases of BT outbreak in this 
study. 
 Tamil Nadu, 2015 3.2.2.4
In mid-December 2015, suspected outbreaks of BT were reported from Perambalur, 
Shivagangai, Pudukottai, Tirunelveli, Erode and Thoothukudi districts of Tamil Nadu. One 
hundred and fifty samples were collected (Figure 3.10). Of these, one hundred and forty 
five animals, from mixed populations of sheep (n=106), goat (n=26) and cattle (n=13) were 
sampled to take EDTA blood and five necropsy (spleen) samples from sheep were also 
collected. The clinical signs observed in sheep, included limping (71%), erosions and 
ulcers of the oral mucosa (61%), pyrexia (39%), congested oral mucosa (43%), salivation 
(17%) and nasal discharge (13%). Torticollis was observed in four cases (3%) whereas 
blood tinged nasal discharges in five (3%) and head oedema in one (1%) case respectively 
(Table 3.1, Figure 3.7, 3.8). The goats were apparently healthy and did not show clinical 
signs of infection, other than pyrexia. However, abortion and still birth cases were 
observed in four goats with no fever but with a history of limping. 
Of one hundred and fifty samples from Tamil Nadu, 2015, thirty seven samples were from 
sheep (n=33) and goats (n=4) vaccinated with the pentavalent inactivated BT vaccine 
(Table 3.6). Clinical manifestations of BT were noticed even in the sheep vaccinated with 
the pentavalent inactivated BTV vaccine and disease severity was similar in vaccinated and 
non-vaccinated field cases varying from acute to subclinical in both in this study. 
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Interestingly ten cattle from Thoothukudi, in a mixed population of infected sheep and goat 
flocks, showed clinical sign of lameness and excessive salivation. These included, two rare 
cases of nasal discharge speckled with blood, as well as profuse salivation. Mild oral 
lesions and limping were also evident in three cattle from infected mixed flocks of sheep 
and goats in Tirunelveli, Tamil Nadu. The cattle had not been vaccinated against BT. 
 Laboratory diagnosis based on qRT-PCR 3.2.3
 Telangana sporadic field outbreak, 2014 3.2.3.1
RNA extracted from clinical samples collected during field outbreaks in 2014, were 
subjected to serogroup-specific real-time RT-PCR targeting genome segment 9 (Maan et 
al., 2015a). These were not tested with BTV serogroup-specific qRT-PCR targeting Seg-10 
(Hofmann et al., 2008a). 
Only one sample, 4WGL/14 from Warangal, Telangana (11%) was positive for the 
presence of BTV RNA with cycle threshold (Ct) value of 27.5 (Table 3.2). All other eight 
samples had cycle threshold (Ct) values greater than 40 and thus were considered negative 
for BTV RNA. 
Table 3.2 Seg-9 based qRT-PCR results from Telangana state, 2014 
*
 Ct values in TaqMan serogroup-specific qRT- PCR targeting Seg-9 of BTV. 
Sample No. 
*
Ct 
value 
Clinical signs 
1MBNR/14 >40 103
0
F temperature, depressed, nasal discharge and congestion of 
gum mucosa. 
2MBNR/14 >40 103
0
F temperature, nasal discharge and congestion of gum 
mucosa. 
3MBNR/14 >40 103
0
F temperature, nasal discharge and congestion of gum 
mucosa. 
4MBNR/14 >40 103
0
F temperature, nasal discharge and congestion of gum 
mucosa, lameness. 
1WGL/14 >40 102
0
F temperature ,Congestion of gum mucosa  
2WGL/14 >40 105
0
F temperature, nasal discharge and congestion of gum 
mucosa. 
3WGL/14 >40 103
0
F temperature, nasal discharge and congestion of gum 
mucosa. 
4WGL/14 27.5 102
0
F temperature, nasal discharge and swelling of head.  
5WGL/14 >40 103
0
F temperature, nasal discharge. 
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 Tamil Nadu field outbreaks, 2014 3.2.3.2
Out of twenty five clinical samples (EDTA blood) from Tamil Nadu BT 2014 outbreak, 
sixteen samples (69.5%) were positive for BTV RNA by BTV serogroup-specific qRT-
PCR targeting Seg-9, with cycle threshold (Ct) value ranging from 23 to 38 (Table 3.3). 
All other samples had cycle threshold (Ct) value more than 40 and thus were considered 
negative for BTV RNA. These were not tested with BTV serogroup-specific qRT-PCR 
targeting Seg-10 (Hofmann et al., 2008a). 
Table 3.3 Seg-9 based qRT-PCR results from Tamil Nadu state, 2014.  
Sample 
ID 
Type of 
sample 
*
Ct value Host 
spp 
Date of 
sampling 
Place of sampling 
CHN 1 blood 35 sheep 22/11/2014 Erode, TN   
CHN 2 blood 28 sheep 22/11/2014 Erode, TN   
CHN 3 blood 34 sheep 22/11/2014 Karur, TN 
CHN 4 blood 23 sheep 22/11/2014 Thoothukudi,TN 
CHN 5 blood 34 sheep 22/11/2014 Tiruppur, TN 
CHN 6 blood 34 sheep 22/11/2014 Tiruppur,TN 
CHN 7 blood 40 sheep 22/11/2014 Karur,TN 
CHN 8 blood 36 sheep 22/11/2014 Karur, TN 
CHN 9 blood 38 sheep 22/11/2014 Karur,TN 
CHN 10 blood 32 sheep 22/11/2014 Karur,TN 
CHN 11 blood 32 sheep 22/11/2014 Karur,TN 
CHN 12 blood 30 sheep 22/11/2014 Karur,TN 
CHN 13 blood 30 sheep 22/11/2014 Karur,TN 
CHN 14 blood 29 sheep 22/11/2014 Karur,TN 
CHN 15 blood 34 sheep 4/12/2014 Kolathur,Salem,TN 
CHN 16 blood 40 sheep 4/12/2014 Kolathur,Salem,TN 
CHN 17 blood 40 sheep 4/12/2014 Kolathur,Salem,TN 
CHN 18 blood 30 sheep 4/12/2014 Kolathur,Salem,TN 
CHN 19 blood 40 sheep 2/01/2015 
$
Chengalpattu,TN 
CHN 20 blood 40 sheep 2/01/2015  Chengalpattu,TN 
CHN 21 blood 40 sheep 2/01/2015  Chengalpattu,TN 
CHN 22 blood 40 sheep 2/01/2015  Chengalpattu,TN 
CHN 23 blood 40 sheep 2/01/2015  Chengalpattu,TN 
CHN 24 blood 40 sheep 2/01/2015  Chengalpattu,TN 
CHN 25 blood 36 sheep 22/11/2014  Thoothukudi,TN 
*
 Ct values in TaqMan serogroup-specific qRT- PCR targeting Seg-9 of BTV 
$
 Chengalpattu is a town in Kanchipuram district of Tamil Nadu. 
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 Telangana field outbreaks, 2015 3.2.3.3
RNA extracted from blood samples and necropsy samples collected from 2015 field 
outbreaks in Telanagana were subjected to BTV RNA detection using BTV serogroup-
specific qRT-PCR targeting Seg-10 (Hofmann et al., 2008a). Initially, samples were tested 
by BTV serogroup-specific qRT-PCR targeting Seg-9, but no amplification was detected in 
any samples by this assay. 
Out of twenty three EDTA blood samples and one necropsy sample from Telangana BT 
2015 outbreaks, twenty one samples (91%) were positive for BTV RNA by BTV 
serogroup-specific qRT-PCR targeting Seg-10, with cycle threshold (Ct) value ranging 
from 20 to 32 (Table 3.4). Three samples had cycle threshold (Ct) value more than 40 and 
thus were considered negative for BTV RNA.  
Table 3.4  Seg-10 based qRT-PCR results of samples from Telangana state, 2015 
*
Ct  
value 
Place of sampling Date of sampling Virus collection number 
ND Dharmaram, Warangal  07/09/2015 1/PKL/15 
32 Dharmaram, Warangal  07/09/2015 2/PKL/15 
 ND Dharmaram, Warangal  07/09/2015 3/PKL/15 
 ND Jukal,Parkal, Warangal 07/09/2015 4/PKL/15 
 31 Jukal,Parkal, Warangal  07/09/2015 5/PKL/15 
24 Jukal,Parkal, Warangal 07/09/2015 [IND2015/236]6PK 
30 Medaram, Karimnagar  10/09/2015 K1/15 
 32 Medaram, Karimnagar 10/09/2015 K2/15 
 22 Medaram, Karimnagar  10/09/2015 [IND2015/239]K3 
27 Mallesham, Karimnagar 10/09/2015 [IND2015/242]K4 
32 Oongathurthi, Karimnagar 10/09/2015 K5/15 
 32 Oongathurthi, Karimnagar  10/09/2015 K6/15 
33 Oongathurthi, Karimnagar  10/09/2015 K7/15 
28 Oongathurthi, Karimnagar 10/09/2015 [IND2015/245]K8 
21 Oongathurthi, Karimnagar  10/09/2015 [IND2015/248]K9 
30 Madhurampally Karimnagar   12/09/2015 [IND2015/251]K10 
31 Madhurampally, Karimnagar 12/09/2015 K11/15 
31 Madhurampally, Karimnagar 12/09/2015 K12/15 
31 Madhurampally, Karimnagar 12/09/2015 [IND2015/252]K13 
20 Madhurampally, Karimnagar 12/09/2015 [IND2015/254]K14 
25 Madhurampally, Karimnagar 12/09/2015 [IND2015/257]K15 
31 Nalthur , Medak
 $
  14/09/2015 [IND2015/260]PPR2 
30 Nalthur , Medak
 $
 14/09/2015 [IND2015/224]PPR spleen 
31 Rauiapalli, Medak
 $
 14/09/2015 [IND2015/263]PPR1 
Abbreviations: ND, not detectable by q RT-PCR. 
Chapter 3  Field outbreaks 
85 
 
$
 Host spp was goat. All other samples were from sheep. 
*
 Ct value by BTV serogroup-specific qRT-PCR targeting Seg-10 (Hofmann et al., 2008a). 
 Andhra Pradesh field outbreaks, 2015 3.2.3.4
BTV RNA was detected in all sixty EDTA blood samples (100%) using BTV serogroup-
specific qRT-PCR targeting Seg-10, with cycle threshold (Ct) value ranging from 18-37 
(Table 3.5 and 3.7). Initially, samples were tested by BTV serogroup-specific qRT-PCR 
targeting Seg-9, but no amplification was obtained in any sample by this assay. 
 Karnataka field outbreaks, 2015 3.2.3.5
Eighty samples, EDTA blood and one necropsy sample (44.7%, 80/179) from Karnataka 
were positive for the presence of BTV RNA using BTV serogroup-specific qRT-PCR 
targeting Seg-10, with cycle threshold (Ct) value ranging from 12-39 (Table 3.5). Ninety 
nine samples had cycle threshold (Ct) value more than 40 and thus were negative for BTV 
RNA. Of the 10 samples from BT vaccinated sheep, all samples were positive by 
serogroup-specific qRT-PCR targeting Seg-10, with cycle threshold (Ct) value ranging 
from 18-30 (Table 3.6). 
 Tamil Nadu field outbreaks, 2015 3.2.3.6
Of the one hundred and forty three EDTA blood, two saliva and five necropsy samples 
from BT suspected 2015 outbreaks in Tamil Nadu, seventy five samples (50%) including 
saliva and necropsy samples were positive for BTV RNA by BTV serogroup-specific qRT-
PCR targeting Seg-10, with cycle threshold (Ct) value ranging from 15 to 39 (Table 3.5). 
Seventy five samples had cycle threshold (Ct) value more than 40 and thus were 
considered negative for BTV RNA. Of the thirty seven  samples from BT vaccinated sheep 
and goats, twenty five samples were positive by serogroup-specific qRT-PCR targeting 
Seg-10, with cycle threshold (Ct) value ranging from 20 to 37 (Table 3.6). Ten cattle from 
Thoothukudi and three from Tirunelveli were found positive by BTV serogroup-specific 
qRT-PCR targeting Seg-10 with Ct value ranging from 25 to 34. Interestingly, four 
vaccinated healthy sheep without clinical signs were positive in qRT-PCR for BT with Ct 
value ranging from 25 to 32 (Table 3.8).  
One possible reason for BTV detection in animals with no clinical signs could be the 
collection of blood samples during the initial incubation period, or later on, during the 
recovery period after the animal has recovered from clinical signs.  The presence of active 
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hemagglutinin associated with VP2 on the BTV virus surface, allows the virus to stick to 
red blood cells, even after it has been inactivated by neutralising antibodies (Hassan and 
Roy, 1999, Eaton and Crameri, 1989).  Some animals are known to remain asymptomatic 
even though infected with BTV (MacLachlan, 1994). 
Table 3.5 Serogroup-specific real-time RT-PCR results to diagnose BT 
State 
Samples 
collected 
qRT-PCR
$
 
Prevalence of BTV in 
samples 
positive 
(Ct <40) 
negative 
(Ct >40) 
Telangana,2014 9 1* 8 11% 
Tamil Nadu,2014 25 16* 9 69.5% 
Telangana,2015 24 21 3 91% 
Andhra Pradesh, 
2015 
60 60 0 100% 
Karnataka, 2015 179 80 99 44.7% 
Tamil Nadu, 2015 150 75 75 50% 
Overall 447 236 194 53% 
* Clinical samples collected from field outbreaks, 2014 were subjected to serogroup-
specific real-time RT-PCR targeting genome segment 9 (Maan et al., 2015a). 
$
 All samples except 2014 outbreaks were subjected to BTV RNA detection using BTV 
serogroup-specific qRT-PCR targeting Seg-10 (Hofmann et al., 2008a). 
Table 3.6 Serogroup-specific real-time RT-PCR results in vaccinated flocks. 
 Samples 
collected 
qRT-PCR 
positive
$
 
Ct value (min - max) Samples with Ct <30 
Karnataka, 2015 10
*
 10 18-30 10 
Tami Nadu, 2015 37 25 20-37 15 
     
*
 Seven samples were collected from pentavalent inactivated BT vaccinated sheep and 
three samples were from bivalent inactivated BT vaccinated animals. 
$
 Samples were subjected to BTV RNA detection using BTV serogroup-specific qRT-PCR 
targeting Seg-10 (Hofmann et al., 2008a). 
 Samples used to infect KC and BHK cells  3.2.4
Out of four hundred forty seven samples, one hundred and eighty samples were positive 
with Ct value <30 by BTV serogroup-specific qRT-PCR. Of these one hundred and eighty 
samples, only one hundred and seventeen samples from 2015 outbreak and six from 2014 
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outbreaks with Ct value <30 were attempted for virus isolation (Table 3.7). These samples 
were used to infect KC and BHK cells for virus isolation. Eighteen samples from 
vaccinated flocks and cattle with Ct value > 30 from 2015 outbreaks were also used to 
make virus isolation. Overall, one hundred and forty one samples were attempted for virus 
isolation from 2014-2015 outbreaks. Detail about these 141 samples was given in Table 
3.8.   
Table 3.7 Samples with Ct value <30 by BTV group specific qRT-PCR 
State Samples collected qRT-PCR positive (Ct<30) 
Telangana,2014 9 1
*
 
Tamil Nadu,2014 25 6
*
 
Telangana, 2015 24 16 
Andhra Pradesh, 2015 60 30 
Karnataka, 2015 179 57 
Tamil Nadu, 2015 150 70 
Overall 447 180 
*
 Clinical samples collected from field outbreaks, 2014 were subjected to serogroup-
specific real-time RT-PCR targeting genome segment 9 (Maan et al., 2015a) 
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Muzzle and lips were congested and swollen, hyperaemic and inflamed oral mucosa bled 
on touch 
 
 
Figure 3.1 Hyperaemic oral mucosa and swollen muzzle in sheep suspected for 
bluetongue disease, Karnataka 2015. 
. 
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Figure 3.2 Oral erosions and ulcers particularly on the dental pad in BT suspected 
sheep, Karnataka 2015.  
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Figure 3.4 Vulvar lips haemorrhages & pyrexia in sheep suspected for 
bluetongue disease, Karnataka 2015. 
 
Figure 3.3 Erosion, crusting of muzzle and nasal discharge speckled with blood 
in BT suspected sheep, Karnataka 2015. 
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Figure 3.5 Excessive salivation, frothing at the mouth and swollen cyanotic tongue in 
BT suspected sheep, Karnataka 2015. 
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Figure 3.6 Submandibular and head oedema in BT suspected sheep, Andhra Pradesh 
2015. 
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A: Sheep suspected for BT infection from Tamil Nadu state, 2015; B, C, D, E & F from 
Karnataka state, 2015 
 
 
A B 
D 
C E F 
Figure 3.7 Coronitis resulting in lameness and break in wool in BT suspected sheep,  
Chapter 3  Field outbreaks 
94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A, B, C, D: Erosion of muzzle, nasal discharge and oral erosions in BT suspected sheep, 
Tamil Nadu 2015; E: coronitis; F: mortality 
 
 
 
 
 
A B C 
D E F 
Figure 3.8 BT suspected cases from Tamil Nadu, 2015. 
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Figure 3.9 Map of India showing the geographical location of the study, 2014-15. 
 
 
 
Chapter 3  Field outbreaks 
96 
 
 
 
 
A) Andhra Pradesh; B) Telangana; C) Karnataka; D) Tamil Nadu. Locations of outbreaks 
are depicted in dots. 
 
 
Figure 3.10 Locations of bluetongue suspected outbreaks in this study from Southern 
India, 2015 
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Figure 3.11 Locations of bluetongue suspected outbreaks in this study from Southern 
India, 2014 
A) Telangana; B) Tamil Nadu. Locations of outbreaks are depicted in dots. 
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Figure 3.12 Locations of bluetongue suspected outbreaks in Karnataka recorded by 
ICAR-NIVEDI, 2014-15.  
A) Karnataka, 2014; B) Karnataka, 2015BT outbreaks officially recorded by Indian 
Council of Agriculture Research-National Institute of Veterinary Epidemiology and 
Disease Informatics (ICAR-NIVEDI, 2015, ICAR-NIVEDI, 2016). Only the districts 
affected by BT outbreaks, 2014 were available in NIVEDI report 2014, not the exact 
location of outbreaks. 
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Figure 3.13 Locations of bluetongue suspected outbreaks in Karnataka recorded by 
ICAR-NIVEDI, 2007-11 
BT outbreaks officially recorded by  Indian Council of Agriculture Research-National 
Institute of Veterinary Epidemiology and Disease Informatics from 2007-2011 (ICAR-
NIVEDI, 2013) 
 
 
 
 
 
 
 
Chapter 3  Field outbreaks 
100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The information was taken from (Reddy et al., 2016b). The serotypes BTV-1. BTV-2, 
BTV-4, BTV-9, BTV-10, BTV-12, BTV-16 and BTV-21 were isolated in different BT 
outbreaks from Telangana, 2002-2013. Recently, BTV-24 has been isolated from Medak, 
Telangana in 2010 (Krishnajyothi et al., 2016). 
 
 
 
Figure 3.14 Different serotypes isolated from Telangana, 2002-2013. 
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Figure 3.15 Different serotypes isolated from Andhra Pradesh, 2006-2011. 
The information was taken from (Reddy et al., 2016b). The serotypes BTV-1. BTV-2, 
BTV-4, BTV-9, BTV-16 were isolated in different BT outbreaks from Andhra Pradesh, 
2002-2013. 
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Table 3.8 Detail of clinical samples positive for BTV and used for virus isolations.  
S.No. 
original sample 
collection number 
*Ct 
value 
Vaccination 
status 
Symptoms Place of sampling 
Collection 
date 
Host 
spp 
Sample 
1. [IND2015/01]2 24 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 18/12/2015 S B 
2. [IND2015/04]8 19 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 18/12/2015 S B 
3. [IND2015/07]12 27 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 18/12/2015 S B 
4. [IND2015/10]14 19 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 18/12/2015 S B 
5. [IND2015/13]22 24 V Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 18/12/2015 S B 
6. [IND2015/16]40 26 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 G B 
7. [IND2015/19]36 24 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
8. [IND2015/22]34 28 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
9. [IND2015/24]42 28 V Lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
10. [IND2015/27]52 27 V Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
11. [IND2015/30]54 25 V Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
12. [IND2015/34]56 20 V Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
13. [IND2015/37]62 33 V Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
14. [IND2015/41]68 25 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
15. [IND2015/45]70 22 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
16. [IND2015/48]72 26 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
17. [IND2015/51]76 23 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
18. [IND2015/54]80 29 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
19. [IND2015/57]98 28 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 S B 
20. [IND2015/60]100 21 UV Pyrexia, oral lesions, lameness Kayathar,Thoothukudi, TN 22/12/2015 G B 
21. [IND2015/62]530 32 UV Salivation, limping Ottadanpathi, Thoothukudi, TN 25/12/2015 C B 
22. [IND2015/65]531 33 UV Oral lesions, limping Ottadanpathi, Thoothukudi, TN 25/12/2015 C B 
23. [IND2015/68]532 34 UV Excess salivation Ottadanpathi, Thoothukudi, TN 25/12/2015 C B 
24. [IND2015/71]533 34 UV Limping , salivation Ottadanpathi, Thoothukudi, TN 25/12/2015 C B 
25. [IND2015/74]534 34 UV Limping, mouth lesions Ottadanpathi, Thoothukudi, TN 25/12/2015 G B 
26. [IND2015/77]535 33 UV Limping, mouth lesions Ottadanpathi, Thoothukudi, TN 25/12/2015 G B 
27. [IND2015/80]536 24 UV Limping, fever Ottadanpathi, Thoothukudi, TN 25/12/2015 G B 
28. [IND2015/84]541 26 UV Aborted on 10/12/2015, limping Ottadanpathi, Thoothukudi, TN 25/12/2015 G B 
29. [IND2015/87]543 22 UV Mouth lesions, blood speckled nasal  discharge Ottadanpathi, Thoothukudi, TN 25/12/2015 S B 
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30. [IND2015/90]545 27 UV Mouth lesions, Ottadanpathi, Thoothukudi, TN 25/12/2015 S B 
31. [IND2015/93]548 27 UV Mouth lesions, limping Ottadanpathi, Thoothukudi, TN 25/12/2015 C B 
32. [IND2015/96]549 27 UV Mouth lesions, limping Ottadanpathi, Thoothukudi, TN 25/12/2015 C B 
33. [IND2015/99]550 27 UV Excess salivation Ottadanpathi, Thoothukudi, TN 25/12/2015 C B 
34. [IND2015/102]551 28 UV Excess salivation Ottadanpathi, Thoothukudi, TN 25/12/2015 C B 
35. [IND2015/105]552 33 UV Limping Ottadanpathi, Thoothukudi, TN 25/12/2015 G B 
36. [IND2015/108]479 29 V Pyrexia, limping Tirunelveli, TN 22/12/2015 G B 
37. [IND2015/111]482 33 V Blood stained nasal discharge Tirunelveli, TN 22/12/2015 S B 
38. [IND2015/114]481 28 V Oral lesions, limping Tirunelveli, TN 22/12/2015 S B 
39. [IND2015/116]V1 30 V 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Vemgal,Sidlaghattataluk, Chikballapur,K 26/11/2015 S B 
40. [IND2015/119]V2 21 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Vemgal, Sidlaghattataluk, Chikballapur,K 26/11/2015 S B 
41. [IND2015/122]V13 30 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Vemgal, Sidlaghattataluk, Chikballapur,K 26/11/2015 S B 
42. [IND2015/125]V43 19 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Genjigunte  Sidlaghattataluk, Chikballapur, K 26/11/2015 S B 
43. [IND2015/128]V40 22 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Genjigunte,  Sidlaghattataluk, Chikballapur  K 26/11/2015 S B 
44. [IND2015/131]V 18 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Lakkenahalli, Sidlaghattataluk,Chikballapur,K 26/11/2015 S B 
45. [IND2015/134]V41 18 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Genjigunte,  Sidlaghattataluk, Chikballapur,K 26/11/2015 S B 
46. [IND2015/137]V42 20 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Genjigunte,  Sidlaghattataluk, Chikballapur,K 26/11/2015 S B 
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47. [IND2015/140]V44 25 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Lakkenahalli, Sidlaghattataluk, Chikballapur,K 26/11/2015 S B 
48. [IND2015/143]V44 19 V 
Erosion and crusting of muzzle,hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break 
Lakkenahalli, Sidlaghattataluk, Chikballapur,K 26/11/2015 S B 
49. [IND2015/146]491 34 UV Rhinitis, lameness, footrot, high mortality group Kanchipuram, TN 25/12/2015 S B 
50. [IND2015/149]492 34 UV Rhinitis, lameness, footrot, high mortality group Kanchipuram, TN 25/12/2015 S B 
51. [IND2015/152]493 32 UV Rhinitis, lameness, footrot, high mortality group Kanchipuram, TN 25/12/2015 S B 
52. [IND2015/155]494 34 UV Rhinitis, lameness, footrot, high mortality group Kanchipuram, TN 25/12/2015 S B 
53. [IND2015/158]CS4 25 V Healthy BTV vaccinated sheep Tirunehveli, TN 25/12/2015 S B 
54. [IND2015/161]CS6 26 V Healthy BTV vaccinated sheep Tirunehveli, TN 25/12/2015 S B 
55. [IND2015/164]CS9 32 V Healthy BTV vaccinated sheep Tirunehveli, TN 25/12/2015 S B 
56. [IND2015/167]470 28 V Slight oral lesions and limping Tirunehveli, TN 25/12/2015 S B 
57. [IND2015/170]471 25 UV Slight oral lesions and limping Tirunehveli, TN 25/12/2015 C B 
58. [IND2015/173]472 28 UV Slight oral lesions and limping Tirunehveli, TN 25/12/2015 S B 
59. [IND2015/176]473 29 V Slight oral lesions and limping Tirunehveli, TN 25/12/2015 S B 
60. [IND2015/179]474 28 UV Slight oral lesions and limping Tirunehveli, TN 25/12/2015 C B 
61. [IND2015/182]475 32 V Slight oral lesions and limping Tirunehveli, TN 25/12/2015 S B 
62. [IND2015/185]476 28 V Slight oral lesions, abortion and limping Tirunehveli, TN 25/12/2015 S B 
63. [IND2015/188]477 30 V Slight oral lesions and limping Tirunehveli, TN 25/12/2015 S B 
64. [IND2015/191]478 29 V Slight oral lesions and limping Tirunehveli, TN 25/12/2015 G B 
65. [IND2015/194]480 25 V Oral   lesions Tirunehveli, TN 25/12/2015 S B 
66. [IND2015/197]483 32 V Blood speckled nasal discharge Tirunehveli, TN 25/12/2015 S B 
67. [IND2015/200]484 33 V limping Tirunehveli, TN 25/12/2015 G B 
68. [IND2015/203]486 34 V Healthy BTV vaccinated sheep Tirunehveli, TN 25/12/2015 S B 
69. [IND2015/206]404 30 V 
Oral lesions were there few days back but now 
recovered. 
Erode, TN 23/12/2015 S B 
70. [IND2015/209]406 24 UV 
Oral lesions were there few days back but now 
recovered. 
Erode, TN 23/12/2015 S B 
71. [IND2015/212]408 26 UV Oral lesions , head oedema and limping Erode, TN 23/12/2015 S B 
72. [IND2015/2015]547 30 UV Mortality Thoothukudi, TN 25/12/2015 S Sp 
73. [IND2015/218]228 32 UV Mortality Tirunelveli, TN 25/12/2015 S Sp 
74. [IND2015/221]34 23 UV Mortality Thoothukudi,TN 25/12/2015 S Sp 
75. [IND2015/224]PPR S 30 UV Mortality Medak, T 14/09/2015 S Sp 
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76. [IND2015/227]555 32 UV Excessive salivation, blood speckled nasal discharge Thoothukudi, TN 25/12/2015 C Sa 
77. [IND2015/230]556 33 UV Excessive salivation, blood specked nasal discharge Thoothukudi, TN 25/12/2015 C Sa 
78. [IND2015/233]BTV14 30 UV Mortality Thoothukudi, TN 26/11/2015 S LN 
79. [IND2015/236]6PK 24 UV Temperature 104 
0
F, nasal discharge, oral lesions Jukal, Parkal, Warangal,T 07/09/2015 S B 
80. [IND2015/239]K3 22 UV Temperature 102.1
 0
F,oral lesions Medaram, Dharmaram, Karimnagar,T 10/09/2015 S B 
81. [IND2015/242]K4 27 UV Temperature 102
 0
F,oral lesions Mallesham, Khilavanaparthi ,  Karimnagar,T 10/09/2015 S B 
82. [IND2015/245]K8 28 UV Temperature 103.1
 0
F,oral lesions Oongathurthi, Karimnagar,T 10/09/2015 S B 
83. [IND2015/248]K9 21 UV Temperature 101
 0
F Oongathurthi, Karimnagar, T 10/09/2015 S B 
84. [IND2015/251]K10 30 UV Temperature 103
0
F Madhurampally,Pegadapally,  Karimnagar, T 12/09/2015 S B 
85. [IND2015/254]K14 20 UV Temperature 105
 0
F,nasal discharge, oral lesions Madhurampally,Pegadapally Karimnagar,  T 12/09/2015 S B 
86. [IND2015/257]K15 25 UV Temperature 104
 0
F,nasal discharge, oral lesions Madhurampally,Pegadapally,  Karimnagar, T 12/09/2015 S B 
87. [IND2015/260]PPR2 30 UV Temperature 103
 0
F, nasal discharge Nalthur , Medak,  T 14/09/2015 G B 
88. [IND2015/263]PPR1 30 UV Temperature 103
 0
F,nasal discharge,ocular discharge Rauiapalli,  Medak,T 14/09/2015 G B 
89. [IND2015/266] 6A 22 UV 
Nasal discharge, oral lesions, temperature 102
 0
F, 
swollen head, salivation 
Open air jail,Bukkarayasamundram,Anantpur, AP 08/11/2015 S B 
90. [IND2015/269] 7A 18 UV Temperature 103
 0
F,mucocutaneous lesions near lips Open air jail,  Bukkarayasamundram,Anantpur, AP 08/11/2015 S B 
91. [IND2015/272] 9A 26 UV Temperature 102
 0
F,nasal discharge Ammavarapalli,Bukkarayasamundram,Anantpur,AP 08/11/2015 S B 
92. [IND2015/275]11A 18 UV Temperature 103.2
 0
F,nasal discharge Ammavarapalli,Bukkarayasamundram,Anantpur,AP 08/11/2015 S B 
93. [IND2015/278]12A 27 UV 
Temperature 104.2 
0
F,oral lesions, blood tinged nasal 
discharge 
Ammavarapalli,Bukkarayasamundram,Anantpur,AP 08/11/2015 S B 
94. [IND2015/281]25A 21 UV Temperature 103.2
 0
F Ammavarapalli,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
95. [IND2015/284]27A 20 UV Temperature 102
 0
F nasal discharge, salivation Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
96. [IND2015/287]28A 22 UV Temperature 104
 0
F, nasal discharge Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
97. [IND2015/290]29A 20 UV Temperature 103
 0
F Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
98. [IND2015/293]30A 21 UV Temperature 104
 0
F,  salivation Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
99. IND2015/296 40A 31 UV Temperature 103
 0
F Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
100. [IND2015/299]12Karn 27 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Gonimoradahalli,Sidlaghattataluk,Chikballapur,K 25/11/2015 S B 
101. [IND2015/302]18Karn 19 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperemia, painful, 
wool break. 
G.Kuruboahalli,Sidlaghattataluk,Chikballapur,K 25/11/2015 S B 
102. [IND2015/305]31Karn 25.8 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Vemgal,Sidlaghattataluk,Chikballapur,K 26/11/2015 S B 
Chapter 3  Field outbreaks 
106 
 
103. [IND2015/308]35Karn 27.28 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Genjigunte, Sidlaghattataluk, Chikballapur,  K 26/11/2015 S B 
104. [IND2015/311]40Karn 26 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Lakkenahalli,Sidlaghattataluk, Chikballapur, K 26/11/2015 S B 
105. [IND2015/314]K1-K 29 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Vemgal,Sidlaghattataluk, Chikballapu, K 26/11/2015 S B 
106. [IND2015/317]K2-K 26 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Vemgal   Sidlaghattataluk, Chikballapur, K 26/11/2015 S B 
107. [IND2015/320]K3-K 26 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Vemgal,Sidlaghattataluk, Chikballapur,  K 26/11/2015 S B 
108. [IND2015/323]K16-K 19 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Burudugun, chintamani, Chikballapur, K 26/11/2015 S B 
109. [IND2015/326]K20-K 26 UV 
Erosion and crusting of muzzle, hard palate ulcers. The 
coronary bands of the feet exhibit hyperaemia 
(Coronitis) and painful, wool break. 
Gangireddypalya , chintamani, Chikballapur,  K 26/11/2015 S B 
110. [IND2015/]A14 28 UV 
Temperature 103.8
0
F,blood tinged nasal discharge , eye 
discharge, excess salivation 
Madhurampally,Pegadapally,Karimnagar,T 12/11/2015 S B 
111. [IND2015/]26A 21 UV Temperature 102 
0
F Ammavarapalli,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
112. IND2015/296]31A 26 UV Temperature 102.3 
0
F, salivation Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
113. [IND2015/]32A 24 UV Temperature 103.2 
0
F Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
114. [IND2015/]33A 19 UV Temperature 104 
0
F Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
115. [IND2015/]34A 19 UV Temperature 103 
0
F Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
116. [IND2015/]35A 28 UV Temperature 102.5 
0
F Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
117. [IND2015/]36A 21 UV Temperature 103 
0
F,Frothy salivation Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
118. [IND2015/]37A 21 UV Temperature 102 
0
F Bomnalatapaly,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
119. [IND2015/]38A 30 UV Temperature 103 
0
F Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
120. [IND2015/]39A 30 UV Temperature 103 
0
F,Head swelling Bomnalatapally,Bukkarayasamundram,Anantpur,AP 12/11/2015 S B 
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121. [IND2015/]07Karn 21 UV 
Erosion and crusting of muzzle,hard palate ulcers.The 
coronary bands of the feet exhibit hyperaemia 
Coronitis) and painful, wool break. 
Gowdanahalli, Chikballapur, K 25/11/2015 S B 
122. [IND2015/]08Karn 20 UV 
Hyperemic  oral mucosa .swollen lips . BT disease 
course just started. Very high temp 105
0
F 
Gowdanahalli , Chikballapur,  K 25/11/2015 S B 
123. [IND2015]32Karn 24 UV 
Erosion and crusting of muzzle,hard palate ulcers.The 
coronary bands of the feet exhibit hyperaemia 
Coronitis) and painful, wool break 
Vemgal,Sidlaghattataluk,Chikballapur,K 26/11/2015 S B 
124. [IND2015/]33Karn 25 UV 
Erosion and crusting of muzzle,hard palate ulcers.The 
coronary bands of the feet exhibit hyperaemia 
Coronitis) and painful, wool break 
Vemga,Sidlaghattataluk,Chikballapur,K 26/11/2015 S B 
125. [IND2015/]K1 30 UV Temperature 103.7
 0
FOral lesions Medaram,Dharmaram,Karimnagar,T 10/09/2015 S B 
126. [IND2015/]K11 30 UV Temperature 103.2
0
F Madhurampally,Pegadapally,Karimnagar, T 12/09/2015 S B 
127. [IND2015/]K12 30 UV Temperature 104
 0
FNasal discharge, Oral lesions Madhurampally,Pegadapally,  Karimnagar, T 12/09/2015 S B 
128. [IND2015/]K13 30 UV Temperature 103.8
 0
FNasal discharge, Oral lesions Madhurampally,Pegadapally, Karimnagar ,T 12/09/2015 S B 
129. [IND2015/]PPR1 30 UV Temperature 102
 0
F, Nasal discharge Nalthur, Medak, T 14/09/2015 G B 
130. [IND2015/] 4A 26 UV 
Temperature 102.8
0
FSwollen head, salivation, erosions 
on upper palate 
Open air jail, Bukkarayasamundram, Anantpur, AP 08/11/2015 S B 
131. [IND2015/]spleen K 30 UV Mortality Gowdanahalli, MandikalMandal, Chikballapur, K 26/11/2015 S Sp 
132. [IND2015/]3 organ 30 UV Mortality Thoothukudi,TN 16/12/2015 S Sp 
133. [IND2015/]19Karn 24 UV 
Erosion and crusting of muzzle,hard palate ulcers.The 
coronary bands of the feet exhibit hyperaemia 
Coronitis) and painful, wool break. 
G.Kuruboahalli,Sidlaghattataluk,Chikballapur,K 25/11/2015 S B 
134. [IND2015/]20Karn 26 UV 
Erosion and crusting of muzzle,hard palate ulcers.The 
coronary bands of the feet exhibit hyperaemia 
Coronitis) and painful, wool break. 
Chokkanahalli,Sidlaghatta,Chikballapur,K 25/11/2015 S B 
135. [IND2015/]21Karn 28 UV 
Erosion and crusting of muzzle,hard palate ulcers.The 
coronary bands of the feet exhibit hyperaemia 
Coronitis) and painful, wool break. 
Chokkanahalli,Sidlaghatta,Chikballapur,K 25/11/2015 S B 
136. [IND2014/]CHE2 28 UV Pyrexia, oral lesions Erode,TN 22/11/2014 S B 
137. [IND2014/]CHE5 23 UV Pyrexia, oral lesion Tirupur,TN 22/11/2014 S B 
138. [IND2014/]CHE12 30 UV Oral lesions, coronitis Karur,TN 22/11/2014 S B 
139. [IND2014/]CHE14 29 UV Oral lesion, coronotis Karur, TN 22/11/2014 S B 
140. [IND2014/]CHE3 28 UV Pyrexia, oral lesions Karur, TN 22/11/2014 S B 
141. [IND2014/]4WGL/14 28 UV Nasal discharge Warangal, TN 13/10/2014 S B 
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 *based on BTV specific qRT-PCR targeting BTV Seg- 10 (Hofmann et al; 2008) for 2015 outbreak and BTV specific qRT-PCR targeting BTV Seg-9 
for 2014 outbreaks (Maan et al., 2015a) 
Abbreviations: TN, Tamil Nadu; T, Telangana; K, Karnataka; AP, Andhra Pradesh; V, Vaccinated; UV, Unvaccinated; S, Sheep; G, Goat; C, Cattle; B, 
Blood; Sp, Spleen; LN, Lymph node; Sa, Saliva 
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3.3 Discussion 
BTV is endemic in India, with regular hyper-endemic outbreaks occurring in the Southern 
states. To date it has been reported that bluetongue is positively associated with climatic 
factors in various parts of India, as well as the local size / density of the sheep population 
(Prasad et al., 2009, Rao et al., 2016b, Rao et al., 2016a, ICAR-NIVEDI, 2010). Rao and 
colleagues reported that in Southern India, there was a correlation between BT outbreaks 
and climatic conditions, with BT particularly following the pattern of monsoons(Rao et al., 
2016a). Severe BT outbreaks were reported during 2005 in Southern India because of 
flooding and heavy south west monsoon as well as north east monsoon in India (Rao et al., 
2016b, Reddy et al., 2016a, ICAR-NIVEDI, 2013).  Johnson and colleagues noted more 
BT outbreaks when temperature, relative humidity, and wind speed were 26°C, 60-65% 
and 5 kmph, respectively (Johnson et al. 2006) because this climate is very congenial for 
Culicoides breeding and survival. 
Climatic changes can affect the incidence, circulation and evolution of infectious diseases, 
especially arboviral diseases (Jimenez-Clavero, 2012). In Telangana, BT outbreaks occur 
mostly during the south west monsoons with highest occurrence during August and 
September. The south west monsoon as a whole was deficient in 2014 (Bhan et al., 2015) 
which led to few sporadic BT outbreaks in Telangana during 2014 (AICRP, 2014). It is 
considered likely that the deficit of monsoon conditions in Telangana generated an 
environment that was less-suitable for Culicoides.  
In contrast, the north east monsoon is generally responsible for the rainfall in most of 
Tamil Nadu from October to December (Rao et al., 2016b) and hence, the normal north 
east monsoon contributed to BT outbreaks in Tamil Nadu during 2014. However, in 2015, 
a strong northeast monsoon, together with cyclonic storms, caused heavy rainfall in 
November and December and resulted floods in Tamil Nadu (Gaitonde and Gopichandran, 
2016). This climatic and environmental change generated a climate that was suitable for 
the breeding of Culicoides, which also resulted in severe outbreaks of BT in Tamil Nadu 
compared to 2014. 
Due to the heavy north east monsoon during 2015, there was also a higher incidence of BT 
outbreaks in the southern interior of Karnataka state. ICAR-National Institute of Veterinary 
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Epidemiology and Disease Informatics (NIVEDI) reported large number of  BT outbreaks 
(n=56) in months of November and December, Karnataka, 2015(ICAR-NIVEDI, 2016, 
AICRP, 2016) as compared to 13 BT outbreaks reported in previous year (AICRP, 2014) 
(Figure 3.12, 3.13). Studies based on reliable and precise meteorological data will show a 
correlation between rainfall patterns and BT outbreaks, which will further help in the 
development of a predictive model for the disease, and in planning the strategies to 
forecast BT outbreaks well in advance. 
A pentavalent inactivated BTV vaccine containing BTV-1, BTV-2, BTV-10, BTV-16 and 
BTV-23 is currently used in Southern India. Although BT is endemic in India, particularly 
in the Southern states, BT vaccination is not carried on a large scale. Furthermore, only 
sheep and goats are currently vaccinated while cattle are ignored in the vaccination 
campaigns. Cattle vaccination against BT should be given due importance, as cattle are 
usually considered to play a more important role in the transmission of BTV than sheep 
(Elbers et al., 2008a).  
According to the 2012 Livestock Census, distribution of livestock between species in India 
was 37.28% cattle, 26.40% goats, 21.23% buffaloes, 12.71% sheep and 2.01% pigs and 
0.37 % other species (camel, mithun ,yak, horse, ponies, mule and donkey). State-wise the 
percentage of the national cattle population was: 5.03% for Andhra Pradesh, 4.98% 
Karnataka and 4.62% Tamil Nadu.   However, BT disease is frequently  asymptomatic or 
inapparent in cattle and goats, with severe disease mostly restricted to sheep  and some 
wildlife species (Verwoerd and Erasmus, 2004). Vaccination of cattle against BT is not 
therefore considered essential in these BT endemic areas. However, cattle may be 
preferentially bitten by adult Culicoides and can serve as a reservoir host for BTV (Brewer 
and MacLachlan, 1994). BT disease may be less severe in cattle but present as a prolonged 
subclinical infection and associated viraemia, with potential to infect Culicoides, causing 
transmission of the virus and disease (Alpar et al., 2009). 
The clinical manifestation of BT in cattle includes a mild form of the disease showing 
viremia, anorexia, oral and nasal mucosae congestion, serous or mucopurulent nasal 
discharge, excessive frothy salivation, erosions, coronitis and decrease in milk production 
(Williamson et al., 2008). These clinical signs can be confused with FMD, which is also an 
endemic disease in India, highlighting importance of differential diagnosis of disease.  
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Thirteen suspected cases of BT were observed in cattle during the outbreaks in Tamil Nadu 
during 2015, showing symptoms of profuse salivation, lameness and nasal discharge. 
These cattle were being reared along with sheep and goat as a mixed population. This is 
the first time that samples have been taken simultaneously from suspected clinical cases of 
BT in cattle, sheep and goat in India. Mixed populations of these species in Thoothukudi 
and Tirunelveli districts, Tamil Nadu, were shown to be positive for BT infections by BTV 
serogroup-specific qRT-PCR targeting Seg-10, with Ct value ranging from 25 to 34. These 
samples were not tested for differential diagnosis of FMD or other multifactorial etiology 
because of the scarcity of the required logistics and resources for this project. Although, 
the sheep in these mixed populations showed severe clinical manifestations of BT disease, 
the only clinical signs in goats were lameness and pyrexia. Thirteen of the cattle in a mixed 
population that included sheep and goats in Tamil Nadu: ten cattle in Thoothukudi and   
three in Tirunelveli, Tamil Nadu, 2015 showed clinical signs of profuse salivation and 
lameness.  Other cattle in these mixed populations showed no clinical signs of the disease. 
Generally, BT is asymptomatic in cattle, however clinical cases may be evident 
particularly when new serotypes affect naive population (Dedolli et al., 2017).  
 The detection of 12 BTV serotypes in Southern India since 2001 emphasizes the need for 
regular virological surveillance, to ensure a regular re-evaluation of the serotype and strain 
composition of the available vaccines. The well characterised and documented BTV strains 
may provide seed stock for relevant vaccine development. It is therefore important to 
collect samples from both unvaccinated and BT-vaccinated animals showing clinical signs 
of BT, so that the circulating field serotypes can be detected and identified.  In this study, 
only three small flocks that had been vaccinated against BT in the Chikballapur district 
were available for observation and sampling during the 2015 outbreak in Karnataka state. 
One flock in village Vemgal, Sidlaghatta, Chikballapur district of Karnataka State had 
been vaccinated with a bivalent inactivated BT vaccine containing serotypes 1 and 23, 
while the other two flocks, one from village Lakkenahalli, Sidlaghatta and another from 
village Genjigunte, Sidlaghatta of Chikballapur district of Karnataka State, 2015 were 
vaccinated with the pentavalent inactivated BT vaccine, containing serotypes BTV-1, 
BTV-2, BTV-10, BTV-16 and BTV-23. These animals were vaccinated in the month of 
August with pentavalent BTV vaccine and booster dose of vaccine was given after 28 days 
of primary vaccination. The vaccinated and non-vaccinated sheep showed BT suspected 
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clinical signs of same severity and were diagnosed positive for BT by BTV serogroup-
specific qRT-PCR targeting Seg-10. Similarly, six other flocks vaccinated with BT 
pentavalent inactivated vaccine were observed in Tirunelveli and one flock from Erode 
(Tamil Nadu) were observed, highlighting the fact that vaccination was not done on a 
massive scale. 
As well as BT, India is also endemic for Foot and Mouth Disease Virus (FMDV), Peste 
des Petits Ruminants Virus (PPRV), Sheeppox Virus (SPPV), Goatpox Virus (GTPV) and 
Orf Virus (ORFV) with natural hosts that include small ruminants and cattle. The clinical 
signs of BT disease can be easily confused with these diseases and thus diagnosis requires 
differential diagnosis confirmation by laboratory testing. There are many reports of BT 
infection in small ruminants from India, but mixed infections or multifactorial aetiologies 
have not been frequently reported (Maan et al., 2017, Biswas et al., 2010) and few 
diagnostic facilities have been developed for differential diagnosis.  
Historically, clinical diagnosis has been the standard method for the detection and 
monitoring of BT but this not only opens the possibility of false positives and false 
negatives, it also requires a well experienced veterinary service for the differential 
diagnoses of BT (Bexiga et al., 2007). Sub-clinical BTV infections, particularly in cattle 
and goats are likely to go unnoticed or unrecognized, particularly in situations where 
outbreaks are infrequent or previously unknown. Consequently, rapid, efficient and reliable 
laboratory diagnostic tests are important especially during an epidemic in order to confirm 
a clinical suspicion of BT and provide veterinary health authorities with adequate time to 
develop and deploy appropriate control measures. 
The most frequent clinical signs observed in this study were oral lesions, congested 
mucosa, coronitis and pyrexia, followed by nasal discharge and salivation. The severity 
and range of clinical signs of BTV infection are influenced by the age, breed, species, 
immune status of the host, as well as environmental stress and the pathogenicity of the 
BTV strain involved (Mertens et al., 2009). It is therefore unsurprising that the clinical 
manifestation of the disease observed in this study varied from severe and acute to 
subclinical forms.  
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In the present study, the prevalence of BTV in one hundred seventy nine (n=179) field 
samples, tested by Seg-10 based qRT-PCR was 44.7% (80/179) from Karnataka BT 
outbreak, 2015 whereas it was 50% (75/150) in one hundred and fifty (n=150) samples 
tested from Tamil Nadu, 2015 BT outbreaks. The low prevalence of BTV in these samples 
may be due to involvement of multifactorial etiology and thus highlighting the importance 
of differential diagnosis of BT from other endemic diseases prevalent in the region. 
Moreover, some of the published BTV serogroup-specific, qRT-PCR diagnostic assays 
cannot detect all BTV strains belonging to  different BTV serotypes or topotypes, with the 
exception of the Seg-10 based assay (Hofmann et al., 2008a) which appears to detect most 
BTV strains (Hoffmann et al., 2009). However as this assay is also RNA sequence 
dependent, it is still possible that some other variant strains may still go undetected.   
 In this study, the BTV RNA detection efficiencies and mean Ct values generated were not 
directly compared for Indian field samples using the Seg-9 based and Seg-10 based group-
specific qRT-PCR assays.  However in this study, the Seg-10 based assay was clearly more 
effective than the Seg-9 based assay, for the detection of BTV RNA.  
It is possible that different BTV topotypes have sequence differences in the target 
footprints for either primers or probes in the Seg-9 assay, significantly decreasing its 
relative efficiency for detection of Indian field strains. Full length sequence data for the 
genome segments of the BTV isolates generated in this study, will be added to databases to 
support the development, evaluation of alternative primers and probes required for BTV 
serogroup specific and serotype specific RT-PCR assays to ensure their relevance for the 
typing and detection of  Indian BTV field strains. 
Poor infrastructure for veterinary clinics highlights a gap in diagnostic provision, which 
results in unreported and undiagnosed clinical cases in the field. The serotypes involved in 
BT outbreaks in India may change every year.  A robust and timely virological 
surveillance is needed for effective control of BT, so that circulating serotypes can be 
identified and incorporated in vaccine formulations in a timely manner. An initial step in 
this process is to attend BT field outbreaks from Southern India and to collect well 
documented samples for virus isolations which will subsequently help us understand the 
epidemiology of the disease in the endemic regions and in the country as a whole. 
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 This study has involved the collection of well documented diagnostic samples, with 
records of collection date, geographical location, coordinates, and vaccination status of 
host species. These well documented samples will be used to make virus isolation, for 
typing and subsequent sequence analysis.  
The recent trends of BT outbreaks in India emphasize the importance of an organized mass 
vaccination campaign to break the epidemiological cycle of BT in the endemic areas. 
Veterinary hospitals, polyclinics and Veterinary dispensaries, mostly have an inadequate 
infrastructure, equipment, and technically qualified and/or experienced manpower to 
support important health issues for the world’s largest national livestock population. There 
is therefore a requirement to extend veterinary hospital facilities at the field level for 
prompt diagnosis, surveillance, monitoring and treatment of animal diseases in India. 
There is also a need to improve and extend mobile veterinary services to provide 
‘doorstep’ veterinary support. 
3.4 Summary 
This study shows that: 
 There is a correlation between BT outbreaks and climatic conditions, particularly 
in Southern India with BT following the pattern of the monsoons, especially in 
Southern India. 
 Although, BT is endemic particularly in Southern India, BT vaccination is not 
done on a large scale, with only sheep and goats currently being vaccinated, Cattle 
are ignored in vaccination campaign. 
 Thirteen suspected cases of BT disease were observed in cattle showing symptoms 
of profuse salivation, lameness and nasal discharge during outbreaks in Tamil 
Nadu during 2015.  These cattle which were positive for BT by BTV serogroup-
specific qRT-PCR targeting Seg-10 with Ct value ranging from 25 to 34, were 
being reared along with sheep and goats as mixed populations. 
 Vaccinated sheep were diagnosed positive for BT by BTV serogroup-specific 
qRT-PCR targeting Seg-10 and showed clinical signs of suspected BT with the 
same severity as unvaccinated sheep. These observations indicate that the 
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vaccination campaign did not prevent BTV infection or the disease in individual 
animals. 
 The most frequent clinical signs in this study were oral lesions (61%), congested 
mucosa (52%), coronitis (46%) and pyrexia (41%) followed by nasal discharge 
(17%) and salivation (13%). The clinical manifestations of the disease observed 
during this study varied from acute to subclinical forms. 
 Prevalence of BTV in four hundred and forty seven (447) samples collected from 
four Southern states during 2014-2015 outbreaks was 53% (447/236). The negative 
samples might be from the animals that may not actually had BTV infection, in 
spite of presenting with BT- like symptoms. This highlights the importance of 
differential diagnosis of BT from other endemic diseases prevalent in the region to 
address the involvement of multifactorial aetiology in field cases. Moreover, it is 
still possible that some of the variant BTV strains may go undetected by Seg-10 
based assay (Hofmann et al., 2008a). 
 Of the 447 field samples, 236 were positive for BTV RNA. Total 141 BTV virus 
isolations were made from positive samples and deposited with virus collection 
number in Veterinary Biotechnology lab, LUVAS, Haryana under the Indo-UK 
project titled “Development of diagnostic systems, reference collections and 
molecular epidemiology studies for important arboviral pathogens of livestock in 
India".  
 Sixty three BTV isolates were serotyped by qRT-PCR assay based on Seg-2 (Maan 
et al., 2016) reported in later chapters of this thesis. Seg-2 sequencing of 46 BTV 
isolates by NGS was done at Centre for Virus Research (MRC-CVR), University 
of Glasgow reported in chapter 5 and the full genome sequencing and analyses is 
still ongoing in Glasgow. 
 This current study was undertaken to collect the well documented field samples 
including sample collection date, geographical location of sample collection, 
geographical coordinates, host species affected, vaccination status against BT and 
symptoms of disease.  
 All India Network Project on Bluetongue, supported by the Indian Council of 
Agricultural Research (ICAR-AINPB) at eleven centres in various states of India is 
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functioning on BT in India. This is first time that large number of samples (n=447) 
were collected simultaneously from all four hyperendemic Southern states for BT 
during 2014-15, 141 BTV isolations were attempted from these clinical samples 
and 63 BTV isolates were typed and finally 46 were sequenced. Till date, only 46 
well documented whole genome sequences of Indian BTV isolates were available 
in Genbank. 
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 Isolation and Molecular typing Chapter 4:
of BTV from Southern India in 2014-2015. 
4.1 Introduction 
Prior to 2000, BTV isolation and serotyping in India was mainly carried out at the World 
Reference Laboratories for Bluetongue, in the Onderstepoort Veterinary Institute, South 
Africa and at the Pirbright Institute, UK .(Prasad et al., 2009). Since 2001, the ICAR-All 
India Network Project on BT (ICAR-AINPBT) and individual research groups have been 
working on the isolation and typing of BTV (AINPBT, 2013). Although BT is endemic 
and a notifiable disease in India, the majority of the state diagnostic laboratories are not 
well-equipped to diagnose and type BTV (Rao et al., 2016b). 
Virus isolation represents a gold standard for the identification of BT. This can be acheived 
by yolk sac (Mason et al., 1940) or  intravenous inoculation (Goldsmit and Barzilai, 1985) 
of  clinical samples into embryonated chicken eggs, followed by subpassaging  in 
mammalian cells, usually BHK-21 or Vero cells. BTV can also be isolated by directly 
inoculating clinical samples into an insect cell line, such as Culicoides sonorensis cells 
(KC cells) (Wechsler and McHolland, 1988) or Aedes albopictus cells (C6-36), followed 
by adaptation to BHK-21 or Vero cells. The clinical samples suitable for BTV isolation  
include EDTA treated blood, semen or tissue samples including  liver, spleen, brain, lymph 
nodes or mucosal epithelium (Mertens et al., 2009).  
BTV serotype has been used as an important identifier of BTV strains that has traditionally 
been used to follow BT outbreaks. It is also a major factor in the selection of an 
appropriate vaccine strains to combat the disease.  BTV serotype is determined by outer 
capsid proteins VP2 and VP5, particularly VP2, which primarily controls the specificity of 
interactions between VP2 and neutralizing antibodies generated during infection of the 
host (Mertens et al., 1989a). Traditionally, the typing of BTV strains has involved serum 
neutralization tests (SNT), or virus isolation followed by virus neutralization tests (VNT). 
SNTs  require reference strains of each of the BTV serotypes, to determine if they can be 
neutralised by the serum sample being tested (Parsonson and Snowdon, 1985). In contrast 
VNTs require the initial isolation of the outbreak virus, which is then assayed for its 
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susceptibility to neutralisation by reference antisera for each of the BTV serotypes (Afshar, 
1994).   
 These serological typing methods are labour intensive, expensive, time consuming and 
unreliable, particularly if the test serum contains antibodies to more than one BTV 
serotype, or if the diagnostic tissue samples contain more than one BTV serotype. 
Consequently nucleic acid-based assays which do not require either reference virus strains 
or reference antisera are increasingly being used for the typing of BTV, although they do 
require a well-equipped laboratory. 
 As the least conserved of the BTV genome segments,  sequence variations in Seg-2 
(which encodes VP2),  present a basis for the design of primers and probes for 
conventional and real time RT-PCR assays that can be used to identify different BTV 
serotypes and topotypes (Mertens et al., 2007a, Maan et al., 2016). However, the 
geographical separation of BTV strains over an extensive period of time has allowed BTV 
strains in different regions to evolve independently within their respective local 
ecosystems, resulting in the appearance of distinctive regional variants (namely eastern and 
western topotypes) for all of the BTV genome segments.  The genetic diversity of Seg-2 
between different BTV strains within individual BTV serotypes, presents a significant 
challenge for the development of molecular serotyping assays that will reliably detect and 
identify of all BTV strains within each serotype and may require the use of multiplex 
primers and probes.   
The BTV serotype can also be determined directly by sequencing and phylogenetic 
analysis, of Seg-2 comparing it to the sequences of known reference strains (Maan et al., 
2007a, Maan et al., 2004). These techniques will usually also identify the topotypes of Seg-
2 and may indicate its geographic origin. Nucleic acid-based assays are increasingly being 
used for the characterisation and typing BTV but require a well-equipped laboratory. The 
RT-PCR assays using serotype-specific primers have the potential to reduce the need for 
BTV serotype-specific antisera for serological typing methods.  
Since 2001, twelve BTV-serotypes (BTV-1, 2, 3, 4, 5, 9, 10, 12, 16, 21, 23 and 24) have 
been isolated in India. However, serological evidence suggests that a total of 21 different 
BTV serotypes exist in India (Maan et al., 2015c).  A pentavalent inactivated BTV vaccine 
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containing serotypes 1, 2, 10, 16 and 23 is currently being used in Southern India since 
2010, although not on a large scale. No live BTV vaccine has been used in India till date. 
Experimental monovalent, bivalent or trivalent inactivated BT vaccines were developed 
under the All India Network Program on BT which started in 2001. The experimental 
inactivated monovalent vaccine inactivated with binary ethylenimine and saponified: BTV-
1 and BTV-2 have been reported from India. Experimental bivalent inactivated BT 
vaccines incorporating BTV-1 and BTV-23 have also been reported from Tamil Nadu 
Veterinary and Animal Science University (TANUVAS) and Institute of Animal Health 
and Veterinary Biologicals (IAHVB), Hebbal, Bangaluru (Bhanuprakash et al., 2009). 
None of these except pentavalent inactivated vaccine have been commercialized. 
The design of an appropriate vaccine requires regular virological surveillance for accurate 
identification of the serotypes currently circulating in the region. By comparing BTV 
isolates from before, during and after implementation of the current pentavalent 
inactivated-vaccine campaign, it may be possible to determine if it has influenced the 
prevalence of different BTV serotypes. 
The objectives for this chapter include: 
 Isolation of BTV from suspected field BTV outbreaks in four Southern states of 
India during 2014-15. 
 Identification of serotype in these Indian BTV field isolates by serotype-specific 
TaqMan based qRT-PCR assay targeting BTV Seg-2 (Maan et al., 2016) . 
 Typing of BTV isolates obtained from various collaborators under the Indo-UK 
project by serotype-specific TaqMan based qRT-PCR assay targeting BTV Seg-2 
(Maan et al., 2016). 
4.2  Results 
 Isolation of BTV  4.2.1
Overall, one hundred and forty one BTV isolations were made from suspected BTV 
outbreaks in Southern India during 2014-2015 under the present study (Table 4.1, 
Appendix 2). One hundred and thirty five (135) of these were derived from EDTA blood 
(n=126), tissues [spleen (n=6), lymph node (n=1)] or saliva (n=2) during 2015 (Table 4.1, 
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Appendix 2). Six isolates were made from EDTA blood samples during 2014, one from 
Telangana and five from Tamil Nadu. Briefly, clinical blood sample was washed thrice 
with Dulbecco’s phosphate buffered saline and washed blood cells were then lysed with 
sterile water. For tissue sample, the homogenization of tissue was done in 10 % PBS 
supplemented with 1000 units/mL penicillin and 1000 µg streptomycin/mL. The 
supernatant of processed samples were then passed through a 0.22 µm sterile syringe filter 
to infect KC cells (200 µL of filtered inoculum) in 25 cm
2 
culture flask (Chapter 2, Section 
2.12, 2.15). Primary isolation of virus from clinical samples (blood, tissue and saliva) was 
attempted by KC passage 1(KC1), followed by KC1 and BHK passage 3 (KC1-BHK3). 
Following successful isolation, the presumptive positive isolates in BHK-21 cell culture 
were confirmed as bluetongue virus (BTV) by group-specific real time RT-PCR targeting 
genome Seg-10, to detect BTV RNA (Hofmann et al., 2008a),  or after dsRNA extraction 
from cell pellet by 1% agarose gel electrophoresis, to visualize the typical dsRNA 
migration pattern of BTV RNA. Virus isolations used 25 cm
2
 culture flask containing KC 
cells (KC1), followed by three passages on BHK-21 cells.  
Seg-9 based serogroup-specific real-time RT-PCR targeting genome segment 9 (Maan et 
al., 2015a) and Seg-10 based assay (Hofmann et al., 2008a) were used to detect BTV in 
clinical samples from 2014 and 2015 outbreaks respectively. One hundred and seventeen 
of the clinical samples from 2015, gave Ct value <30, with eighteen with Ct value > 30. 
The virus was successfully isolated from these (141) one hundred and forty one clinical 
samples (KC1-BHK3) (Table 4.1, Appendix 2). Characteristic cytopathic effects (CPE) 
indicated by cell rounding and cell detachment, were usually observed at 3-4 days post 
inoculation in BHK-21 cells (Figure 4.1). Each BTV isolate was tested for BTV RNA by 
group specific real-time RT-PCR targeting genome segment 10 (NS3) (Table 4.1). Details 
concerning BTV virus isolates from Southern India, 2014-15 are given in appendix 2. 
 Assigning unique collection number to BTV field strains 4.2.2
After testing positive for BTV RNA by group specific real-time RT-PCR targeting genome 
segment 10, the BTV field isolates (KC1 and BHK3) were given unique virus-collection 
numbers, consisting of country code, year / sample number (Appendix 2), prior to storage 
at -80
0
C.  
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A: healthy uninfected BHK-21 cells two days old monolayers; B: cytopathic effects 
induced in BHK-21 by BTV isolate [IND2015/169]470 from sheep on day 2 post infection.   
 
A 
B 
Figure 4.1 Cytopathic changes induced by the BTV isolate from sheep in BHK-21 
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Table 4.1 Isolation of BTV from qRT-PCR positive clinical samples (n=141) 
Indian State qRT-PCR 
positive clinical 
samples
$
 
(Ct<30) 
qRT-PCR 
positive clinical 
samples
$
 
(Ct>30) 
qRT-PCR 
positive in 
KC1-BHK3
$
 
(Ct<30) 
qRT-PCR 
positive 
KC1-
BHK3
$
 
(Ct>30) 
Telangana,2014 1
*
 - 1 - 
Tamil Nadu,2014 5
*
 - 5 - 
Telangana, 2015 16
¥
 - 16 - 
Andhra Pradesh, 2015 23 - 23 - 
Karnataka, 2015  28
µ
 - 27 1 
Tamil Nadu, 2015 50
£
 18 38 30 
Overall 123 18 110 31 
* Clinical samples collected from field outbreaks, 2014 were subjected to serogroup-
specific real-time RT-PCR targeting genome segment 9 (Maan et al., 2015a). 
¥
 including one necropsy spleen sample. 
µ
 including one necropsy spleen sample. 
£ 
including four necropsy spleen and one lymph node samples  
$
 All samples except 2014 outbreaks were subjected to BTV RNA detection using BTV 
serogroup-specific qRT-PCR targeting Seg-10 (Hofmann et al., 2008a). 
 Virus propagation for typing 4.2.3
Sixty three (n=63) of the cell culture adapted Southern Indian field strains of BTV from 
2014-2015 (Table 4.2), were cultivated in BHK-21 cells using 175 cm
2
 culture flasks, prior 
to extraction of viral dsRNA for further typing and sequencing work. The details of these 
cultivated field strains, along with their passage history are given in Table 4.2. Viral RNA 
from these BTV isolates was extracted from pelleted infected BHK-21 cells (175 cm
2 
culture flask) using TRIzol (Invitrogen) (Chapter 2, Section 2.17), then tested using a BTV 
serogroup-specific qRT-PCR targeting Seg-10. These isolates gave Ct values ranging from 
5.0 to 31.0 (Table 4.2). The dsRNA migration patterns of isolates with Ct < 20, were 
analysed by 1% agarose gel electrophoresis (AGE) generating a 3-3-3-1 migration pattern, 
typical of BTV (Figure 4.2). The RNAS of isolates with Ct>20 were not detectable by 
AGE. 
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Ten additional cell culture adapted BTV isolates (Table 4.3) were obtained under the Indo-
UK project titled “Development of diagnostic systems, reference collections and molecular 
epidemiology studies for important arboviral pathogens of livestock in India" and were 
cultivated in BHK-21 cells using 175 cm
2
 culture flasks.  dsRNAs extracted from the 
infected BHK-21 cell pellets, were used to confirm that these isolates were positive for 
BTV, by BTV serogroup-specific qRT-PCR targeting Seg-10, generating cycle threshold 
(Ct) value ranging from 10 to 19 (Table 4.3). 
 
 
 
 
 
 
 
 
 
 
 
 
A) Lane M: 1Kb plus DNA Ladder (Invitrogen); Lanes 1-10 contained dsRNAs from the 
following viral isolates: [IND2015/15]22; [IND2014/34]BTV-1; [IND2014/35] BTV-2; 
Seg-7,8,9 1Kbp 
Seg-1 
M         1 
Seg-2+3 
Seg-4,5,6 
Seg-10 
4Kbp 
2Kbp 
500bp 
B 
M          1 
Seg-1 
Seg-2+3 
Seg-4,5,6 
Seg-7,8,9 
Seg-10 
1Kbp 
2Kbp 
4Kbp 
C 
L                   1       2        3         4        5      6       7        8       9      10         
4 Kbp 
2 Kbp 
500bp 
1 Kbp 
A 
Figure 4.2 Electrophoretic analysis of BTV dsRNA in a 1 % agarose gel. 
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[IND2015/118]V1; [IND2015/121]V2; [IND2015/124]V13; [IND2015/238]6PK; 
[IND2015/184]475; [IND2015/187]476; [IND2015/190]477; B) Lane M: 1Kb plus DNA 
Ladder (Invitrogen); Lanes 1: dsRNAs of [IND2015/196]480; C) Lane M: 1Kb plus DNA 
Ladder (Invitrogen); Lanes 1: dsRNAs of [IND2015/199]483. The ssRNA was not 
precipitated efficiently during dsRNA extraction (Chapter 2, section 2.17) and is visible as 
smeared bands at the bottom of the gel with different intensity for each isolate 
Table 4.2: Indian field strains of BTV (n=63) serotyped by Seg-2 based qRT-PCR. 
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[IND2015/60]100 Thoothukudi,TN   Goat Blood UV KC1/BSR6 16 
[IND2015/15]22 Thoothukudi,TN   Sheep Blood V  KC1/BSR6 16 
[IND2015/18] 40 Thoothukudi,TN   Goat Blood UV KC1/BHK4 15 
[IND2015/148]491 Kanchipuram,TN Sheep Blood UV KC1/BHK5 7 
[IND2015/151]492 Kanchipuram,TN Sheep Blood UV KC1/BHK6 18 
[IND2015/154]493 Kanchipuram,TN Sheep Blood UV KC1/BSR5 5 
[IND2015/157]494 Kanchipuram,TN Sheep Blood UV KC1/BHK6 6 
[IND2015/208]404 Erode,TN Sheep Blood UV KC1/BHK4 9 
[IND2015/211]406 Erode,TN Sheep Blood UV KC1/BHK5 6 
[IND2015/214]408 Erode,TN Sheep Blood UV KC1/BHK4 18 
[IND2015/169]470 Tirunehveli,TN Sheep Blood V  KC1/BHK4 6 
[IND2015/172]471 Tirunehveli,TN Cow Blood UV KC1/BHK5 8 
[IND2015/175]472 Tirunehveli,TN Cow Blood UV KC1/BHK4 7 
[IND2015/178]473 Tirunehveli,TN Sheep Blood V  KC1/BHK4 7 
[IND2015/181]474 Tirunehveli,TN Cow Blood UV KC1/BHK4 5 
[IND2015/184]475 Tirunehveli,TN Sheep Blood V  KC1/BHK4 6 
[IND2015/187]476 Tirunehveli,TN Sheep Blood V  KC1/BHK5 7 
[IND2015/190]477 Tirunehveli,TN Sheep Blood V  KC1/BHK5 8 
[IND2015/193]478 Tirunehveli,TN Goat Blood V  KC1/BHK4 7 
[IND2015/196]480 Tirunehveli,TN Sheep Blood V  KC1/BHK5 5 
[IND2015/199]483 Tirunehveli,TN Sheep Blood V  KC1/BHK4 7 
[IND2015/202]484 Tirunehveli,TN Goat Blood V  KC1/BHK4 20 
[IND2015/205]486 Tirunehveli,TN Sheep Blood V  KC1/BHK4 9 
[IND2015/160]CS4 Tirunehveli,TN Sheep Blood V  KC1/BHK4 6 
[IND2015/163]CS6 Tirunehveli,TN Sheep Blood V  KC1/BHK4 8 
[IND2015/166]CS9 Tirunehveli,TN Sheep Blood V  KC1/BHK5 17 
[IND2015/76]534 Thoothukudi,TN Goat Blood UV KC1/BHK4 20 
[IND2015/2017]547  Thoothukudi,TN Sheep spleen UV KC1/BHK4 10 
[IND2015/220]228  Tirunehveli Sheep spleen UV KC1/BHK4 5 
[IND2015/223]34  Thoothukudi,TN Sheep spleen UV KC1/BHK4 15 
[IND2015/232]556  Thoothukudi,TN Cattle saliva UV KC1/BHK5 7 
[IND2015/118]V1 Chikballapur,K Sheep Blood V KC1/BHK5 8 
[IND2015/121]V2 Chikballapur,K Sheep Blood V KC1/BHK5 6 
[IND2015/124]V13 Chikballapur,K Sheep Blood V KC1/BHK5 7 
[IND2015/136]V41 Chikballapur,K Sheep Blood V KC1/BHK5 5 
[IND2015/139]V42 Chikballapur,K Sheep Blood V KC1/BHK5 10 
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# 
Virus collection number: [Country code, year / sample number] 
$
All samples except 2014 outbreaks were subjected to BTV RNA detection using BTV 
serogroup-specific qRT-PCR targeting Seg-10 (Hofmann et al., 2008a). 
* These BTV field isolates from BTV suspected outbreaks in Tamil Nadu, 2014 were 
provided by Dr. K.M.N Reddy.  
€
 These BTV field isolates from BTV suspected outbreaks in Telangana, 2014 were 
provided by Dr. Y.V. Reddy. 
¥ 
These BTV field isolates were from samples collected during BTV suspected outbreaks in 
Tamil Nadu, 2014. 
Abbreviations: TN, Tamil Nadu; T, Telangana; K, Karnataka; AP, Andhra Pradesh; V, 
vaccinated and NV, nonvaccinated.  
 
[IND2015/142]V44 Chikballapur,K Sheep Blood V KC1/BHK4 7 
[IND2015/145]V44 L Chikballapur,K Sheep Blood V KC1/BHK4 8 
[IND2015/133]V S Chikballapur,K Sheep Blood V KC1/BHK4 9 
[IND2015/]07Karn Chikballapur,K Sheep Blood UV KC1/BHK6 6 
IND2015/241]K3 Karimnagar,T  Sheep Blood UV KC1/BHK4 7 
[IND2015/244]K4 Karimnagar,T  Sheep Blood UV KC1/BHK4 5 
[IND2015/250]K9 Karimnagar,T  Sheep Blood UV KC1/BHK6 21 
[IND2015/253](K10) Karimnagar,T  Sheep Blood UV KC1/BHK7 25 
[IND2015/]K13 Karimnagar,T  Sheep Blood UV KC1/BHK6 16 
[IND2015/256]K14 Karimnagar,T  Sheep Blood UV KC1/BHK4 7 
[IND2015/238]6PK Warangal,T Sheep Blood UV KC1/BHK4 7 
[IND2015/271]7A  Anantpur,AP Sheep Blood UV KC1/BHK4 9 
[IND2015/]14A  Anantpur,AP Goat Blood UV KC1/BHK4 24 
[IND2014/34]BTV-1
*
 Thanjavur,TN Sheep Blood UV KC1/BHK4 8 
[IND2014/35]BTV-2
*
 Thanjavur,TN Sheep Blood UV KC1/BHK4 9 
[IND2014/36] 3NLG
€
 Nalgonda,T Sheep Blood UV KC1/BHK6 6 
[IND2014/37] 10NLG
€
 Nalgonda,T Sheep Blood UV KC1/BHK4 7 
[IND2015/289]28A Anantpur,AP Sheep Blood UV KC1/BHK5 30 
[IND2015/224]PPR 
spleen 
Medak, 
Telangana 
Sheep Blood UV KC1/BHK5 29 
[IND2015/335]33A Anantpur,AP Sheep Blood UV KC1/BHK5 30 
[IND2015/292]29A Anantpur,AP Sheep Blood UV KC1/BHK5 29 
[IND2015/70]532 Thoothukudi,TN Cow Blood UV KC1/BHK5 31 
CHE 14
¥
 Karur,TN Sheep Blood UV KC1/BHK4 7 
CHE 2
¥
 Erode,TN Sheep Blood UV KC1/BHK4 8 
CHE 12
¥
 Karur,TN Sheep Blood UV KC1/BHK4 25 
CHE5
¥
 Tirupur,TN Sheep Blood UV KC1/BHK4 25 
WGL4
¥
 Warangal,T Sheep Blood UV KC1/BHK4 28 
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Table 4.3 Details of Indian field strains of BTV (n=10) obtained from collaborators 
for typing by Seg-2 based qRT-PCR 
BTV isolate Geographic origin 
Serogroup specific qRT-PCR
$
 
(Ct value) 
BTV2DH Karnataka 14 
BTV1 IVRI Uttar Pradesh 15 
BTV2 IVRI Uttar Pradesh 14 
BTV10 IVRI Uttar Pradesh 19 
BTV 23 IVRI Uttar Pradesh 17 
BTV MP Telangana 14 
BTV WG103 Telangana 19 
BTV IPGR/10 Telangana 13 
BTV VJW 764 Telangana 15 
BTV KMN 07/05 Telangana 16 
$
 BTV RNA detection using BTV serogroup-specific qRT-PCR targeting Seg-10 
(Hofmann et al., 2008a). 
 Typing of BTV isolates  4.2.4
Typing assays for BTV-1 to BTV-24, BTV-26, BTV-27 and BTV-29 were performed on 
RNA samples from Southern Indian BTV field isolates 2014-15 (n=63) using serotype-
specific TaqMan based qRT-PCR assays (Maan et al., 2016). For BTV-1, -2, -4, -9 and -
16, two sets of qRT-PCR primers and probes were used in a duplex format in order to 
detect both eastern and western topotypes/strains of each serotype.  
Multiple co-circulating BTV serotypes, including BTV-1, BTV-2, BTV-4, BTV-5, BTV-9, 
and BTV-10 & BTV-12 were identified circulating during BTV outbreaks in four states of 
Southern India, Telangana, Andhra Pradesh, Karnataka and Tamil Nadu during 2014 and 
2015 (Table 4.4).  
Infection involving only one serotype was found in thirty six of the BTV isolates (Table 
4.6 and 4.7) with BTV-12 in fourteen isolates [IND2015/169]470; [IND2015/175]472; 
[IND2015/178]473; [IND2015/199]483; [IND2015/202]484; [IND2015/160]CS4; 
[IND2015/163]CS6; [IND2015/136]V41; CHE5; [IND2015/232]556 saliva; 
[IND2015/223]34 tissue; [IND2015/211]406; [IND2015/145]V44lamb and 
[IND2015/133]V severe, from Tamil Nadu and Karnataka, 2014-15.  BTV-5 was detected 
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in nine of the single type BTV isolates, [IND2015/172]471; [IND2015/184]475; 
[IND2015/193]478; [IND2015/166] CS9; [IND2015/205]486; [IND2015/142] V44; 
[IND2015/76]534; [IND2015/208]404; [IND2015/214]408 from Tamil Nadu and 
Karnataka, 2015. Serotype BTV-2 was identified in five BTV isolates, [IND2015/241] K3; 
[IND2015/250] K9; [IND2015/253] K10; [IND2015/] K13; [IND2015/256] K14 from 
Telangana, 2015, one each [IND2015/] 14A from Andhra Pradesh, 2015 and 
[IND2015/18] 40 from Tamil Nadu, 2015 (Table 4.6 and 4.7). BTV-1 was detected in three 
BTV isolates from Andhra Pradesh, 2015: [IND2015/289]28A ; [IND2015/292]29A; 
[IND2015/335]33A and BTV-10 in one BTV isolate [IND2015/2017]547 tissue from 
Tamil Nadu, 2015. Dual and triple BTV co-infections were also detected in twenty two and 
four BTV isolates respectively, of sixty three total BTV isolates typed. (Table 4.8 and 4.9). 
One of the field BTV isolate, [IND2015/] 07Karn from unvaccinated sheep in Karnataka 
state, 2015 BT outbreak could not be typed using qRT-PCR assay against BTV-1 to BTV-
24, BTV-26, BTV-27 and BTV-29 serotypes (Maan et al., 2016) and may therefore 
contains another serotype.  
 BTV isolates from vaccinated flock of Tamil Nadu state, 2015 4.2.4.1
Fourteen BTV isolations (Table 4.2, 4.4) were made from animals vaccinated with 
pentavalent inactivated BTV vaccine (BTV-1, BTV-2, BTV-10, BTV-16 and BTV-23) in 
outbreaks in Tamil Nadu during 2015 BT.  These viruses were typed as BTV-4, BTV-5, 
BTV-9 and BTV-12, with Ct values ranging from 7 to 27 from extracted RNA of cell 
culture adapted BTV isolates. The animals were vaccinated during August 2015, with 
pentavalent BTV vaccine and booster dose of vaccine was given after 28 days of primary 
vaccination. Clinical samples were taken in December, 2015 during BT outbreak and after 
four months of primary vaccination. Six BTV isolates [IND2015/169]470; 
[IND2015/178]473; [IND2015/199]483; [IND2015/202]484; [IND2015/160] CS4 and 
[IND2015/163] CS6 typed as BTV-12, with Ct value ranging from 7 to 23. Four isolates 
typed as BTV-5: [IND2015/184]475; [IND2015/193]478; [IND2015/205]486 and 
[IND2015/166] CS9, with Ct value ranging from 15 to 23. Interestingly, mixed infections 
were identified in four BTV isolates: [IND2015/15]22 (BTV-12, Ct 10 and BTV-4, Ct20); 
[IND2015/187]476 (BTV-5, Ct15 and BTV-12, Ct32); [IND2015/190]477 (BTV-4, Ct 30 
and BTV-9, Ct25) and [IND2015/196]480 (BTV-4, Ct23 and BTV-12, Ct9) (Table 4.8). 
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 BTV isolates from vaccinated flock of Karnataka state, 2015 4.2.4.2
Five BTV isolates from animals vaccinated with the pentavalent inactivated BTV vaccine 
(BTV-1, BTV-2, BTV-10, BTV-16 and BTV-23) and three from  animals vaccinated with 
the bivalent inactivated BTV vaccine (BTV-1 and BTV-23) during BT outbreaks in 
Karnataka state during 2015, were typed as BTV-4, BTV-5  and  BTV-12 with Ct value 
ranging from 8 to 25 (Table 4.2, 4.4). These animals were vaccinated with the pentavalent 
BTV vaccine during August 2015 with booster doses of the vaccine given after 28 days. 
Clinical samples were taken in late November, 2015 during BT outbreak and nearly after 
three months of primary vaccination. One BTV isolate [IND2015/142] V44 from a 
vaccinated animal was typed as BTV-5 with a Ct of 14. Three BTV isolates were typed as 
BTV-12: [IND2015/136] V41 with Ct 9-16. Eight BTV isolations were made from a 
vaccinated flock during BT outbreaks in Karnataka state during 2015, four of which typed 
as mixed infections: [IND2015/118] V1 (BTV-5, Ct15 and BTV-12, Ct25); 
[IND2015/121] V2 (BTV-5, Ct14 and BTV-12, Ct22); [IND2015/124] V13 (BTV-5, Ct19 
and BTV-12, Ct21) and [IND2015/139] V42 (BTV-4, Ct21 and BTV-12, Ct8) (Table 4.8). 
 BTV isolates from unvaccinated flock of Tamil Nadu state, 2014 4.2.4.3
Six BTV isolates from an unvaccinated flock during BT outbreaks in Tamil Nadu in 2014 
were typed as BTV-2, BTV-10, and BTV-12, with Ct value ranging from 10 to 34 (Table 
4.2, 4.4). Of these, one isolate CHE5 was typed as BTV-2 with a Ct value of 27. Mixed 
infections were detected in five BTV isolates [IND2014/34] BTV-1 (BTV-10, Ct 19 and 
BTV-12, Ct28); [IND2014/35] BTV-2 (BTV-2, Ct26, BTV-10, Ct15, and BTV-12, Ct34); 
CHE 2 (BTV-2, Ct11 and BTV-12, Ct30); CHE 12 (BTV-2, Ct30 and BTV-12, Ct25) and 
CHE 14 (BTV-2, Ct32 and BTV-12, Ct10) (Table 4.8). One BTV isolate (IND2014/01) 
collected from the Karur district, Tamil Nadu, 2014, was typed by Dr. Lalit Kumar, 
College of Veterinary Sciences, LLR University of Veterinary and Animal Sciences, 
Haryana, India as BTV-16 (Kumar et al., 2016). 
 BTV isolates from unvaccinated flock of Tamil Nadu state, 2015 4.2.4.4
Eighteen BTV isolates taken from unvaccinated flocks during BT outbreaks in Tamil Nadu 
2015, were typed as BTV-2, BTV-5, BTV-9, BTV-10, and BTV-12, with Ct values 
ranging from 6 to 33 (Table 4.2, 4.4). Of these, one isolate [IND2015/18] 40 from sheep 
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was typed as BTV-2 with a Ct value 30. One isolate from sheep [IND2015/2017]547 tissue 
was typed as BTV-10 with a Ct value 25. Four isolates, [IND2015/172]471 from cattle 
[IND2015/76]534, [IND2015/208]404 and [IND2015/214]408 from a mixed flock were 
typed as BTV-5 with Ct value 18-27. Four isolates [IND2015/232]556 saliva from cattle) 
and [IND2015/223]34 tissue, [IND2015/211]406 & [IND2015/175]472 from mixed flock 
were typed as BTV-12 with Ct values of 8 to 20. Mixed infections were found in eight 
isolates [IND2015/60]100 (BTV-10, Ct 23 and BTV-12, Ct14); [IND2015/70] 532 (BTV-
2, Ct19 and BTV-12, Ct16); [IND2015/148] 491 (BTV-2, Ct25, BTV-5, Ct10 and BTV-
12, Ct23); [IND2015/151]492 (BTV-5, Ct13 and BTV-12, Ct24); [IND2015/154] 493 
(BTV-2, Ct35 and BTV-12, Ct 25); [IND2015/157] 494 (BTV-2, Ct30 and BTV-12, Ct 6); 
[IND2015/181]474 (BTV-12, Ct19 and BTV-10, Ct 33) and  [IND2015/220]228 tissue 
(BTV-5, Ct20 and BTV-9, Ct22) (Table 4.8). One isolate (IND2014/01) collected from the 
Karur district of Tamil Nadu, in 2014 was typed by Dr. Lalit Kumar, College of Veterinary 
Sciences, LLR University of Veterinary and Animal Sciences, Haryana, India as BTV-16.  
 BTV isolates from unvaccinated flock of Telangana state, 2014 4.2.4.5
Three BTV isolates derived from unvaccinated flocks during BT outbreaks in Telangana, 
2014, were typed as BTV-2, BTV-5, BTV-9 and BTV-12, with Ct value ranging from 16 
to 32 (Table 4.2, 4.4). All were mixed infections: BTV isolate WGL4 (BTV-2, Ct32 and 
BTV-12, Ct 30); [IND2014/36] 3NLG (BTV-2, Ct26; BTV-5, Ct30 and BTV-9, Ct 27) and 
[IND2014/37] 10NLG (BTV-2, Ct30; BTV-5, Ct16 and BTV-12, Ct 22) from mixed flock 
(Table 4.8) 
 BTV isolates from unvaccinated flock of Telangana state, 2015 4.2.4.6
Eight BTV isolates derived from unvaccinated flocks during BT outbreaks in Telangana, 
2015, were typed as BTV-2, BTV-4 and BTV-12 with Ct value ranging from 10 to 35 
(Table 4.2, 4.4). Of these, five isolates IND2015/241] K3, [IND2015/250] K9, 
[IND2015/253] K10, [IND2015/] K13 and [IND2015/256] K14 were typed as BTV-2 with 
Ct values of 10 to 35. Two isolates [IND2015/244] K4 and [IND2015/224] PPR spleen 
typed as BTV-4, with Ct values of 10 to 16.  Mixed infection were found in one isolate 
[IND2015/238]6PK containing BTV-4, Ct13 and BTV-12, Ct 23 (Table 4.8). 
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 BTV isolates from unvaccinated flock of Andhra Pradesh state, 2015 4.2.4.7
Five BTV isolates derived from unvaccinated flocks of sheep during BT outbreaks in 
Andhra Pradesh, 2015, were typed as BTV-1, BTV-2, BTV-4 and BTV-12, with Ct values 
ranging from 10 to 35 (Table 4.2, 4.4). Of these, three isolates [IND2015/289]28A, 
[IND2015/292]29A and [IND2015/335]33A were typed as BTV-1 with Ct values of 35 to 
36. One isolate [IND2015/] 14A was typed as BTV-2 with a Ct of 8. A mixed infection 
was found in one BTV isolate [IND2015/271]7A containing BTV-4, Ct20 and BTV-12, Ct 
23 (Table 4.8). 
 Mixed infections 4.2.4.8
Of sixty three BTV isolates, dual and triple BTV co-infections were detected in twenty two 
and four isolates respectively (Table 4.8 and 4.9). The dominant BTV serotype in these 
dual and triple mixed infection BTV isolates based on a low Ct value were: BTV-12, with 
Ct of 6 to 30 in eleven BTV isolates; BTV-5, with Ct of 10 to 20 in eight BTV isolates; 
BTV-2, with Ct of 11 to 26 in three isolates; BTV-9, with a of Ct 25 in one isolate; BTV-
10, with Ct values of 15 and 19 in two isolates and BTV-4, with a Ct value of 13 in one 
isolate (Table 4.9).  The second BTV serotype in these mixed infection BTV isolates, 
based on Ct values were: BTV-12, with Ct values of 21 to 32 in eleven isolates, BTV-2, 
with Ct values of 22 to 27 in seven isolates; BTV-9, with Ct values of 22 to 27 in two 
isolates; BTV-10, with Ct values of 32 to 33 in two isolates and BTV-4, with Ct values of 
20 to 33 in four mixed isolates (Table 4.9).   
Table 4.4 
®
Serotyping of Indian field isolates of BTV (n=63) from 2014-15 BT 
outbreaks in Southern India. 
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   Ct values
$
 
[IND2015/15]22
£
  Thoothukudi ,TN  KC1/BSR6 16 - - 20 - - - 10 
[IND2015/18] 40*  Thoothukudi ,TN  KC1/BHK4 24 - 30 - - - - - 
[IND2015/60]100*  Thoothukudi ,TN  KC1/BSR6 16 - - - - - 23 14 
[IND2015/76]534*  Thoothukudi,TN KC1/BHK4 17 - - - 18 - - - 
[IND2015/70]532
∞
 Thoothukudi,TN KC1/BHK5 31 - 19 - - - - 16 
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[IND2015/2017]547 
tissue
&
 
Thoothukudi,TN KC1/BHK4 20 - - - - - 25 - 
[IND2015/223]34 
tissue
&
 
Thoothukudi,TN KC1/BHK4 5 - - - - - - 8 
[IND2015/232]556 
saliva
∞ ©
 
Thoothukudi,TN KC1/BHK5 15 -  - - - - 20 
[IND2015/148]491 Kanchipuram,TN KC1/BHK5 5 - 25 - 10 - - 23 
[IND2015/151]492 Kanchipuram,TN KC1/BHK6 7 -  - 13 - - 24 
[IND2015/154]493 Kanchipuram,TN KC1/BSR5 18 - 35 - - - - 25 
[IND2015/157]494 Kanchipuram,TN KC1/BHK6 5 - 30 - - - - 6 
[IND2015/208]404 Erode,TN KC1/BHK4 6 - - - 24 - - - 
[IND2015/211]406 Erode,TN KC1/BHK5 9 - - - - - - 19 
[IND2015/214]408 Erode,TN KC1/BHK4 6 - - - 19 - -  
[IND2015/169]470
£
 Tirunehveli,TN KC1/BHK4 18 - - - - - - 21 
[IND2015/172]471
∞
 Tirunehveli,TN KC1/BHK5 6 - - - 27 - -  
[IND2015/175]472
∞
 Tirunehveli,TN KC1/BHK4 8 - - - - - - 16 
[IND2015/178]473
£
 Tirunehveli,TN KC1/BHK4 7 - - - - - - 12 
[IND2015/181]474
∞
 Tirunehveli,TN KC1/BHK4 7 - - - - - 33 19 
[IND2015/184]475
£
 Tirunehveli,TN KC1/BHK4 5 - - - 21 - - - 
[IND2015/187]476
£
 Tirunehveli,TN KC1/BHK5 6 - - - 15 - - 32 
[IND2015/190]477
£
 Tirunehveli,TN KC1/BHK5 7 - - 30  25 - - 
[IND2015/193]478*
£
 Tirunehveli,TN KC1/BHK4 8 - - - 18 - - - 
[IND2015/196]480
£
 Tirunehveli,TN KC1/BHK5 7 - - 23 - - - 9 
[IND2015/199]483
£
 Tirunehveli,TN KC1/BHK4 5 - - - - - - 11 
[IND2015/202]484*
£
 Tirunehveli,TN KC1/BHK4 7 - - - - - - 7 
[IND2015/205]486
£
 Tirunehveli,TN KC1/BHK4 20 - - - 23 - - - 
[IND2015/160]CS4
£
 Tirunehveli,TN KC1/BHK4 9 - - - - - - 19 
[IND2015/163]CS6
£
 Tirunehveli,TN KC1/BHK4 6 - - - - - - 23 
[IND2015/166]CS9
£
 Tirunehveli,TN KC1/BHK5 8 - - - 18 - - - 
[IND2015/220]228 
tissue
&
 
Tirunehveli,TN KC1/BHK4 10 - - - 20 22 - - 
[IND2014/34]BTV-1 Thanjavur,TN KC1/BHK4 7 - - - - - 19 28 
[IND2014/35]BTV-2 Thanjavur,TN KC1/BHK4 8 - 26 - - - 15 34 
CHE 2
¥
 Erode,TN KC1/BHK4 8 - 11 - - - - 30 
CHE5
¥
 Tirupur,TN KC1/BHK4 25 - 27 - - - - - 
CHE 12
¥
 Karur,TN KC1/BHK4 25 - 30 - - - - 25 
CHE 14
¥
 Karur,TN KC1/BHK4 7 - 32 - - - - 10 
[IND2015/118]V1
€
 Chikballapur,K KC1/BHK5 9 - - - 15 - - 25 
[IND2015/121]V2
€
 Chikballapur,K KC1/BHK5 8 - - - 14 - - 22 
[IND2015/124]V13
€
 Chikballapur,K KC1/BHK5 6 - - - 18 - - 21 
[IND2015/136]V41
£
 Chikballapur,K KC1/BHK5 7 - - - - - - 11 
[IND2015/139]V42
£
 Chikballapur,K KC1/BHK5 5 - - 21 - - - 8 
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[IND2015/142]V44
£
 Chikballapur,K KC1/BHK4 0 - - - 14 - - - 
[IND2015/145]V44
£
 
lamb 
Chikballapur,K KC1/BHK4 7 - - - - - - 9 
[IND2015/133]V
£
 
Severe 
Chikballapur,K KC1/BHK4 8 - - - - - - 16 
[IND2015/]07Karn Chikballapur,K KC1/BHK6 9 - - - - - - - 
WGL4
β
 Warangal,T KC1/BHK4 28 - 32 - - - - 30 
IND2015/241]K3 Karimnagar,T  KC1/BHK4 6 - 10 - - - - - 
[IND2015/244]K4 Karimnagar,T  KC1/BHK4 7 -  10 - - - - 
[IND2015/250]K9 Karimnagar,T  KC1/BHK6 5 - 10 - - - - - 
[IND2015/253]K10 Karimnagar,T  KC1/BHK6 21 - 30 - - - - - 
[IND2015/]K13 Karimnagar,T  KC1/BHK6 25 - 35 - - - - - 
[IND2015/256]K14 Karimnagar,T  KC1/BHK4 16 - 23 - - - - - 
[IND2015/238]6PK Warangal,T KC1/BHK4 7 - - 13 - - - 23 
[IND2015/224]PPR 
spleen
&
 
Medak, T KC1/BHK5 29 - - 16 - - - - 
[IND2014/36] 3NLG Nalgonda,T KC1/BHK6 7 - 26 - 30 - 27 - 
[IND2014/37] 
10NLG 
Nalgonda,T KC1/BHK4 6 - 30 - 16 - - 22 
[IND2015/271]7A  Anantpur,AP KC1/BHK4 7 - - 20 - - - 23 
[IND2015/]14A*  Anantpur,AP KC1/BHK4 9 - 8 - - - - - 
[IND2015/289]28A  Anantpur,AP KC1/BHK5 30 35 - - - - - - 
[IND2015/335]33A  Anantpur,AP KC1/BHK5 30 36 - - - - - - 
[IND2015/292]29A  Anantpur,AP KC1/BHK5 29 36 - - - - - - 
# 
Virus collection number: [Country code, year / sample number] 
$ 
Ct values were depicted below corresponding serotype detected by Seg-2 based qRT-PCR 
(Maan et al., 2016). 
*
 Host species for these samples were goat. 
∞ 
Host species for these samples were Cattle. 
&
 These were necropsy spleen samples. 
©
 This was saliva sample from cattle. 
π
 All samples except 2014 outbreaks were subjected to BTV RNA detection using BTV 
serogroup-specific qRT-PCR targeting Seg-10 (Hofmann et al., 2008a). 
¥
 These BTV field isolates from samples collected during BTV suspected outbreaks in 
Tamil Nadu, 2014. 
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β
 These BTV field isolates from BTV suspected outbreaks in Telangana, 2014 were 
provided by Dr. Y.V. Reddy. 
€ 
Bivalent inactivated BTV vaccine (BTV-1 and 23) was used to vaccinate animals. 
£
 Pentavalent inactivated BTV vaccine (BTV-1, BTV-2, BTV -10, BTV -16 and BTV -23) 
®
 Typing assays for BTV-1 to BTV-24, BTV-26, BTV-27 and BTV-29 were performed on 
RNA samples from Southern Indian BTV field isolates 2014-15 (n=63) using serotype-
specific TaqMan based qRT-PCR assays (Maan et al., 2016). 
Abbreviations: TN, Tamil Nadu; T, Telangana; K, Karnataka; AP, Andhra Pradesh 
Table 4.5:  Serotyping of BTV isolates provided by various collaborators. 
BTV isolates 
Place of 
sampling 
qRT-PCR
*
 
 
B
T
V
-1
 
B
T
V
-2
 
B
T
V
-5
 
B
T
V
-9
 
B
T
V
-1
0
 
 
B
T
V
-1
6
 
B
T
V
-2
3
 
   Ct value
$
 
BTV2DH K 7 - 14 24 24 - - - 
BTV1IVRI U.P 10 15 - - - 32 25 - 
BTV2IVRI U.P 8 - 14 - - - - - 
BTV10IVRI U.P 12 - - - - 19 - - 
BTV23IVRI U.P 10 - - - - - - 17 
BTVMP T 8 - - - - 14 - - 
BTVWG T 12 - - - - - 19 - 
BTVIPGR T 12 - - - 13 - - - 
BTVVJW  T 10 - - - - - 15 - 
BTVKMN  T 10 - - - 16 - 38 - 
*
 BTV RNA detection was done using BTV serogroup-specific qRT-PCR targeting Seg-10 
(Hofmann et al., 2008a). 
$ 
Ct values were depicted below corresponding serotype detected by Seg-2 based qRT-PCR 
(Maan et al., 2016). 
Abbreviations: T, Telangana; K, Karnataka; UP, Uttar Pradesh 
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Table 4.6 BTV isolates (n=36
*
) with single serotype infections during BT outbreaks in 
Southern India, 2014-15. 
Virus collection number 
B
T
V
-1
 
B
T
V
-2
 
B
T
V
-4
 
B
T
V
-5
 
B
T
V
-9
 
B
T
V
-1
0
 
B
T
V
-1
2
 
 Ct value
$
 
[IND2015/18] 40 - 30 - - - - - 
[IND2015/76]534 - - - 18 - - - 
[IND2015/2017]547 tissue - - - - - 25 - 
[IND2015/223]34 tissue - - - - - - 8 
[IND2015/232]556 saliva - - - - - - 20 
[IND2015/208]404 - - - 24 - - - 
[IND2015/211]406 - - - - - - 19 
[IND2015/214]408 - - - 19 - - - 
[IND2015/169]470 - - - - - - 21 
[IND2015/172]471 - - - 27 - - - 
[IND2015/175]472 - - - - - - 16 
[IND2015/178]473 - - - - - - 12 
[IND2015/184]475 - - - 21 - - - 
[IND2015/193]478 - - - 18 - - - 
[IND2015/199]483 - - - - - - 11 
[IND2015/202]484 - - - - - - 7 
[IND2015/205]486 - - - 23 - - - 
[IND2015/160]CS4 - - - - - - 19 
[IND2015/163]CS6 - - - - - - 23 
[IND2015/166]CS9 - - - 18 - - - 
CHE5  27 - - - - - 
[IND2015/136]V41 - - - - - - 11 
[IND2015/142]V44 - - - 14 - - - 
[IND2015/145]V44lamb - - - - - - 9 
[IND2015/133]V Severe - - - - - - 16 
[IND2015/]07Karn
*
 - - - - - - - 
IND2015/241]K3 - 10 - - - - - 
[IND2015/244]K4 - - 10 - - - - 
[IND2015/250]K9 - 10 - - - - - 
[IND2015/253]K10 - 30 - - - - - 
[IND2015/]K13 - 35 - - - - - 
[IND2015/256]K14 - 23 - - - - - 
[IND2015/224]PPR spleen - - 16 - - - - 
[IND2015/]14A - 8 - - - - - 
[IND2015/289]28A 35 - - - - - - 
[IND2015/335]33A 36 - - - - - - 
[IND2015/292]29A 36 - - - - - - 
$
 Ct values were depicted below corresponding serotype detected by Seg-2 based qRT-
PCR (Maan et al., 2016) 
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*
 [IND2015/] 07Karn from unvaccinated sheep in Karnataka state, 2015 BT outbreak could 
not be typed using serotype-specific TaqMan based qRT-PCR assay against BTV-1 to 
BTV-24, BTV-26, BTV-27 and BTV-29 serotypes (Maan et al., 2016). 
Table 4.7 Serotype detected in BTV isolates (n=36) involving single serotype during 
BT outbreaks in Southern India, 2014-15. 
Serotype Number of BTV isolates (n=36) Ct
$
 value 
BTV-1 3 35-36 
BTV-2 7 8-35 
BTV-4 2 10-16 
BTV-5 9 14-27 
BTV-10 1 25 
BTV-12 14 7-23 
Table 4.8 BTV isolates with mixed infections(n=26) during BT outbreaks in Southern 
India, 2014-15. 
Virus collection number 
B
T
V
-1
 
B
T
V
-2
 
B
T
V
-4
 
B
T
V
-5
 
B
T
V
-9
 
B
T
V
-1
0
 
B
T
V
-1
2
 
 Ct value
$
 
[IND2015/15]22 - - 20 - - - 10 
[IND2015/60]100 - - - - - 23 14 
[IND2015/70]532 - 19 - - - - 16 
[IND2015/148]491 - 25 - 10 - - 23 
[IND2015/151]492 - - - 13 - - 24 
[IND2015/154]493 - 35 - - - - 25 
[IND2015/157]494 - 30 - - - - 6 
[IND2015/181]474 - - - - - 33 19 
[IND2015/187]476 - - - 15 - - 32 
[IND2015/190]477 - - 30 - 25 - - 
[IND2015/196]480 - - 23 - - - 9 
[IND2015/220]228 tissue - - - 20 22 - - 
[IND2014/34]BTV-1 - - - - - 19 28 
[IND2014/35]BTV-2 - 26 - - - 15 34 
CHE 2 - 11 - - - - 30 
CHE 12 - 30 - - - - 25 
CHE 14 - 32 - - - - 10 
[IND2015/118]V1 - - - 15 - - 25 
[IND2015/121]V2 - - - 14 - - 22 
[IND2015/124]V13 - - - 18 - - 21 
[IND2015/139]V42 - - 21 - - - 8 
WGL4  32 - - - - 30 
[IND2015/238]6PK - - 13 - - - 23 
[IND2014/36] 3NLG - 26 - 30 - 27 - 
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[IND2014/37] 10NLG - 30 - 16 - - 22 
[IND2015/271]7A - - 20 - - - 23 
$
 Ct values were depicted below corresponding serotype detected by Seg-2 based qRT-
PCR (Maan et al., 2016) 
Table 4.9 Dominant serotype detected in mixed co-infection BTV isolates (n=26). 
 First dominant serotype  Second dominant serotype  
Serotype 
Number of BTV 
isolates (n=26) 
Ct
$ 
value 
Number of BTV 
isolates(n=26) 
Ct value
$
 
BTV-1 - - - - 
BTV-2 3 11-26 7 19-35 
BTV-4 1 13 4 20-33 
BTV-5 8 10-20 - - 
BTV-9 1 25 2 22-27 
BTV-10 2 15-19 2 32-33 
BTV-12 11 6-30 11 21-32 
$
 Ct values were depicted below corresponding serotype detected by Seg-2 based qRT-
PCR (Maan et al., 2016). 
Table 4.10 Distribution of BTVserotypes in BTV isolates (n=62) during 2014-15 BT 
outbreaks in Southern India. 
 
Single serotype 
infection 
Mixed serotype 
infection   
Serotype 
Number of 
BTV isolates 
(n=36) 
Number of BTV 
isolates(n=26) 
Total BTV 
isolates
*
 (n=62) 
Percentage 
(%) 
BTV-1 3 0 3 4.8 
BTV-2 7 12 19 30.6 
BTV-4 2 5 7 11.3 
BTV-5 9 9 18 29.0 
BTV-9 - 3 3 4.8 
BTV-10 1 4 5 8.1 
BTV-12 14 23 37 59.7 
*
 [IND2015/] 07Karn from unvaccinated sheep in Karnataka state, 2015 BT outbreak could 
not be typed using serotype-specific TaqMan based qRT-PCR assay against BTV-1 to 
BTV-24, BTV-26, BTV-27 and BTV-29 serotypes (Maan et al., 2016). 
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 BTV serotype distribution 4.2.4.9
Of sixty two BTV isolates, BTV-1 was detected in three (4.8%), BTV-2 in nineteen 
(30.6%), BTV-4 in seven (11.3%), BTV-5 in eighteen (29%), BTV-9 in three (4.8%), 
BTV-10 in five (8.1%) and BTV-12 in thirty seven BTV isolates (59.7%) (Table 4.10). 
Thus, BTV-12 was found to be predominant serotype (59.7%) and a substantial proportion 
of 62 samples were infected with serotype BTV-2 (30.6%) and BTV-5 (29%) as well.  
BTV isolate [IND2015/] 07Karn, derived from an unvaccinated sheep during a BT 
outbreak in Karnataka state, 2015, could not be typed using serotype-specific TaqMan 
based qRT-PCR assay against BTV-1 to BTV-24, BTV-26, BTV-27 and BTV-29 
serotypes (Maan et al., 2016), suggesting that it belongs to a different serotype, or contains 
point mutations in the primer or probe footprints.  
4.3  Discussion 
BTV is endemic in India and serotypes BTV-1, BTV-2, BTV-4, BTV-9, BTV-10, BTV-12, 
BTV-16 and BTV-23 have been prevalent across the four states of Telangana, Andhra 
Pradesh, Karnataka and Tamil Nadu since 2007 (Reddy et al., 2016a). To date, 15 BTV-
serotypes i.e. BTV-1, 2, 3, 4, 5, 6, 9, 10, 12, 16, 17, 18, 21, 23 and 24 have been isolated 
by the framework project of  the ‘’All India Network Program on Bluetongue’’ (AINPBT, 
2010, AINPBT, 2013) and by individual research laboratories (Krishnajyothi et al., 2016, 
Hemadri et al., 2016). During the last decade, 12 serotypes have been isolated namely 
BTV-1, BTV-2, BTV-3, BTV-4, BTV-5, BTV-9, BTV-10, BTV-12, BTV-16, BTV-21, 
BTV-23 and BTV-24, mainly from peninsular India (Maan et al., 2015c). Recently, Maan 
and colleagues have reported isolation of BTV-12 from Haryana State of Northern India 
(Maan et al., 2017). BTV-1 was also isolated from goats in Uttar Pradesh State, during 
2008 (Biswas et al., 2010, Mondal et al., 2009), and from the Pithoragarh hills of 
Uttarakhand, 2009 (Mondal et al., 2013) and has previously been reported from the spleen 
of an aborted goat foetus in Gujarat, Western India, 2007 (Chauhan et al., 2014). 
In the present study, seven different serotypes of BTV (BTV-1, BTV- 2, BTV- 4, BTV-5, 
BTV-9, BTV-10 and 12) were identified using serotype-specific real time RT-PCR 
targeting Seg-2 of BTV-1 to BTV-24, BTV-26, BTV-27 and BTV-29 (Maan et al., 2016), 
in sixty two Indian isolates (n=62) from BTV outbreaks from Southern India during 2014-
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2015. This study confirms the circulation of seven BTV serotypes, including BTV-1, BTV-
2, BTV-4, BTV-5, BTV-9, BTV-10 & BTV-12, with predominance of BTV-12 (59.7%) 
followed by BTV-2 (30.6%) and  BTV-5 (29%) in 62 BTV isolates, in four southern states 
of India during 2014 and 2015 BTV outbreaks.  
In Tamil Nadu state, serotypes BTV-2, BTV-5, BTV-9, BTV-10,  BTV-12 and BTV-16 
(Kumar et al., 2016) were identified in unvaccinated animals (n=24) during 2014-15 BT 
outbreaks, whereas serotypes BTV-4, BTV-5 and BTV-12 were identified in flocks (n=14) 
vaccinated with the pentavalent inactivated vaccine. Overall, multiple co-circulating BTV 
serotypes BTV-2, BTV-4, BTV-5, BTV-9, BTV-10,  BTV-12 and BTV-16 were identified 
during the 2014-15 BT outbreaks in Tamil Nadu. Reddy and colleagues have reported the 
isolation of serotypes BTV-1, BTV-2, BTV-16 and BTV-23 from Tamil Nadu between 
2003-2011 (Reddy et al., 2016a). 
 The pentavalent inactivated BTV vaccine, currently being used in the Southern India, 
contains serotypes 1, 2, 10, 16 and 23. Interestingly, none of these serotypes were found in 
the vaccinated animals, including serotypes BTV-2, BTV-10, and BTV-16 that were 
detected in unvaccinated animals, suggesting protection against these serotypes by 
vaccination. For the first time, BTV-4, BTV-5 and BTV-9 serotype were identified during 
BT outbreaks in Tamil Nadu during 2014-15. 
In Telangana state, serotypes BTV-2, BTV-4, BTV-5, BTV-9 and BTV-12 were identified 
in unvaccinated animals (n=11) during the 2014-15 BT outbreaks. Between 2002 - 2013, 
serotypes BTV-1, BTV-2, BTV-4, BTV-9, BTV-10, BTV-12, BTV-16, BTV-21 and 
BTV-24 had been isolated from Andhra Pradesh and Telangana States (Gollapalli et al., 
2012, Krishnajyothi et al., 2016, Reddy et al., 2016b, Susmitha et al., 2012, Reddy et al., 
2018).   
In Karnataka state, serotypes BTV-4, BTV-5 and BTV-12 were identified in vaccinated 
animals (n=8) during the 2015 BT outbreaks. BTV-4 was also identified for the first time, 
in Karnataka state during the 2015 BT outbreaks. Recently BTV-2 and BTV-5 have also 
been isolated as a dual infection in sheep from Karnataka state, 2010 (Hemadri et al., 
2016). 
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In Andhra Pradesh state, serotypes BTV-1, BTV-2, BTV-4 and BTV-12 were identified in 
unvaccinated animals (n=5) during the 2015 BT outbreaks. During 2002-2013, serotypes 
BTV-1, BTV-2, BTV-4, BTV-9, BTV-10, BTV-12, BTV-16, BTV-21 and BTV-24 had 
been isolated from Andhra Pradesh (Rao et al., 2016b). 
The clinical presentation and disease severity during the 2014-15 BT outbreaks sampled in 
this study, varied from less to more severe, although the severity of disease did not differ 
substantially in vaccinated and non-vaccinated field cases. 
One of the BTV field isolates, [IND2015/] 07Karn, from unvaccinated sheep during the 
2015 BT outbreak in Karnataka state, could not be typed using the serotype-specific 
TaqMan based qRT-PCR assay against BTV-1 to BTV-24, BTV-26, BTV-27 and BTV-29 
serotypes (Maan et al., 2016). The failure of these assays to identify the virus type may be 
due to variations in the sequence of the VP2 gene of the strains currently circulating in I 
dia, leading to a mismatch in the footprints of the either the primers or probes used in the 
typing assays, compared to the reference strains of the relevant serotype. It is also possible, 
although less likely that this virus represents an entirely novel BTV serotype, or a perhaps 
novel topotypes of one of the known serotypes.  However, it is likely that the typing of this 
isolate can be achieved by next generation sequencing of Seg-2.  
Significant sequence variations occurs in Seg-2 of BTV strains from different geographic 
origins but of the same serotype (topotypes) (Maan et al., 2009). Therefore, close 
monitoring of circulating BTV strains and BTV typing by serotype-specific TaqMan based 
qRT-PCR assay is important to ensure that the assays used in regular virological 
surveillance and to assess the molecular remain epidemiology of BT in India, remain  
relevant to currently circulating strains in India. 
BTV-5, which is a rare serotype in India, was recently reported by Hemadri and colleagues 
during the 2010-11 BT outbreaks in Karnataka state (Hemadri et al., 2016). A significant 
observation from the present study is the identification of BTV-5 in a substantial 
proportion of samples (29%) analysed as shown in Table 4.10.  
In the present study, more than one BTV serotype, including BTV-1, BTV-2, BTV-4, 
BTV-5, BTV-9, BTV-10 & BTV-12 was detected in several Indian field isolates (n=63) 
from the four states in southern India during the 2014 and 2015 outbreaks (Table 4.4). 
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From a total of sixty two BTV isolates, BTV-12 was found to be the predominant serotype 
(59.7%) along with a substantial proportion of samples infected with BTV-2 (30.6%) and 
BTV-5 (29%) (Table 4.10). The BTV isolate [IND2015/]07Karn, derived from 
unvaccinated sheep in Karnataka state, during the BT outbreak in 2015, could not be typed 
using the serotype-specific TaqMan based qRT-PCR assays against BTV-1 to BTV-24, 
BTV-26, BTV-27 and BTV-29 serotypes.  
BTV-12 predominated (with 14 isolates) among the BTV isolates involving only one 
serotype (n=36), including, [IND2015/169]470; [IND2015/175]472; [IND2015/178]473; 
[IND2015/199]483; [IND2015/202]484; [IND2015/160]CS4; [IND2015/163]CS6; 
[IND2015/136]V41; CHE5; [IND2015/232]556 saliva; [IND2015/223]34 tissue; 
[IND2015/211]406; [IND2015/145]V44lamb and [IND2015/133]V severe from Tamil 
Nadu and Karnataka, 2014-15;  followed by serotype BTV-5 (9 BTV isolates), 
[IND2015/172]471; [IND2015/184]475; [IND2015/193]478; [IND2015/166]CS9; 
[IND2015/205]486; [IND2015/142]V44; [IND2015/76]534; [IND2015/208]404; 
[IND2015/214]408 from Tamil Nadu and Karnataka,2014-15.  
A significant finding of this study is the co-circulation of multiple BTV serotypes within 
endemic areas, which provides an opportunity for the occurrence of bluetongue outbreaks 
involving multiple serotypes (Brenner et al., 2010, Reddy et al., 2010, Reddy et al., 
2016b). Several investigators have previously described BT outbreaks involving multiple 
co-circulating BTV serotypes. Brenner and colleagues reported the co-circulation of BTV-
4, BTV-8, BTV-16 and BTV-24 in Israel, 2008 (Brenner et al., 2010). Reddy and 
colleagues reported the occurrence of BTV-9 and BTV-10 from Andhra Pradesh, in 2010 
(Reddy et al., 2010). The involvement of multiple circulating serotypes in the same 
outbreak may be a common phenomenon in subtropical regions, where a congenial climate 
exists for the multiplication of Culicoides throughout the year (Rao et al., 2016a). 
Detection of multiple co-circulating BTV serotypes in India emphasizes the need for 
regular virological surveillance, particularly to ensure the relevance of the ongoing 
pentavalent inactivated vaccination programme.  
A second finding of this study is the occurrence of mixed serotype infections within the 
same animal. Guimaraes and colleagues reported co-circulation of multiple serotypes 
involving BTV-1, BTV-4 and BTV-17 in an outbreak in Brazil, 2014, as well as triple or 
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dual co-infection with these serotypes within the same animal (Guimaraes et al., 2017). 
Recently dual infection of BTV-2 and BTV-5 has been reported in a sheep from 
Karnataka, in 2010 (Hemadri et al., 2016). Of the 62 BTV isolates typed here from the 
2014-2015 BT outbreaks in Southern India, dual and triple BTV co-infections were 
detected in twenty two and four of the BTV isolates respectively. Dual infection was 
detected in four of the BTV isolates from fourteen vaccinated flocks in Tamil Nadu, during 
2015. Dual infections by BTV-12 and BTV-4 were found in two BTV isolates: 
[IND2015/15]22 and [IND2015/196]480. Dual infections with serotype BTV-5 and BTV-
12 were detected in BTV isolate [IND2015/187]476, while BTV-4 and BTV-9 were 
detected in [IND2015/190]477 (Table 4.4). 
Dual and triple co-infections were detected in eleven and two respectively of the BTV 
isolates derived from twenty-four unvaccinated flocks in Tamil Nadu, during 2014-15. 
Dual infection with BTV-2 and BTV-12 was detected in six BTV isolates: CHE 2; CHE 
12; CHE 14; [IND2015/70] 532; [IND2015/154] 493; [IND2015/157] 494; while BTV-12 
and BTV-10 were detected in three isolates: [IND2014/34] BTV-1; [IND2015/60]100; 
[IND2015/181]474. BTV-5 and BTV-12 were detected in [IND2015/151]492, while BTV-
5 and BTV-9 were detected in [IND2015/220]228.  
Two BTV isolates have triple co-infections: [IND2014/35]: BTV-2, BTV-10, BTV-12 and 
[IND2015/148] 491; BTV-2, BTV-5 and BTV-12. Mixed infections involving serotypes 
BTV-2 and BTV-10 (serotypes which are present in the BTV pentavalent inactivated 
vaccine) were not found in any of the vaccinated animals from Tami Nadu, although dual 
or triple co-infections involving serotype BTV-2, BTV-10 were detected in samples from 
the unvaccinated animals analysed in the present study.  
Out of a total of eight BTV isolates from vaccinated flocks in Karnataka, during 2015, 
three isolates showed dual co-infections with BTV-5 and BTV-12: [IND2015/118] V1; 
[IND2015/121] V2; [IND2015/124] V13 and a dual infection involving BTV-4 and BTV-
12 was detected  in isolate [IND2015/139] V42 (Table 4.8, 4.9).  
Out of eleven BTV isolates derived from unvaccinated mixed flocks in Telangana during 
the 2014 BT outbreaks, two BTV isolates were identified as dual mixed infections: WGL4 
(BTV-2, BTV-12); [IND2015/238]6PK (BTV-4, BTV-12) and three isolates as triple 
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mixed infections: [IND2014/36]3NLG (BTV-2,BTV-5,BTV-9) and [IND2014/37]10NLG 
(BTV-2, BTV-5, BTV-12). Similarly, one BTV isolate [IND2015/271]7A from Andhra 
Pradesh during 2015 was detected as a dual mixed infection with serotype BTV-4 and 
BTV-12.  
Five BTV isolates from cattle were typed as:  mono serotype infection with BTV-12 in 
[IND2015/232]556 saliva and dual infection with BTV-2, BTV-12 in [IND2015/70]532 
from Thoothukudi, Tamil Nadu, 2015; mon infection BTV-5 in [IND2015/172]471; BTV-
12 in [IND2015/175]472 and dual inection with BTV-12, BTV-10 in [IND2015/181]474 
from Tirunehveli, Tamil Nadu, 2015. 
The clinical presentation and disease severity during the BT outbreaks of 2014-15 
examined in this study varied from acute to less severe or even asymptomatic. So far, no 
investigations have been carried out to study the role of mixed BTV infections in clinical 
presentation and severity of BT in India. Further extensive studies involving large numbers 
of clinical cases that are suspected BT, are needed to understand the severity and clinical 
presentation of dual or multiple mixed BT infections. Two different BTV strains could 
potentially cause dual infections of an individual Culicoides vector by consecutive bites on 
two different infected hosts, or by a single bite of a co-infected host.  
Moreover, a mixed BTV infection may occur in the mammalian host due to infection via a 
bite from a Culicoides that has a dual or triple co-infection with different BTV types.  
Alternatively bites from different Culicoides, each infected with a different BTV serotype 
could also cause dual/multiple co-infections.  The chance of mixed infections with two or 
more BTV serotypes is more likely in endemic areas where multiple serotypes co-circulate. 
These mixed infections may affect the evolution of BTV in terms of infectivity and 
pathogenicity of BTV.   The co-circulation of multiple BTV serotypes and strains in BTV 
endemic areas and their concurrent infection in the same host and cells also provide 
multiple opportunities for reassortment and suggest circulation of a complex quasi-species 
(McColl and Gould, 1994). Co-infection with multiple BTV serotypes pose the risk of 
emergence of novel reassortant BTV strains that could have distinct properties in terms of 
infectivity and pathogenicity (Maan et al., 2012d, Maan et al., 2015b, Shafiq et al., 2013). 
Rao and colleagues have reported that a few BTV serotypes dominate outbreaks in India 
for 4-5 years, followed by the domination by other types (Rao et al., 2016b, Rao et al., 
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2016a). Therefore, continuous surveillance for identification of serotypes and genotypes 
circulating in the endemic region is required for proper identification and characterization 
of BT infections. This would further help with the design and implementation of control 
measures for BT outbreaks and towards development of relevant and effective vaccines.  
A pentavalent inactivated BTV vaccine containing serotypes 1, 2, 10, 16 and 23, has been 
developed depending on local BTV epidemiology and is currently being used in southern 
part of India. In the present study, BTV serotypes, including BTV-1, BTV-2, BTV-4, 
BTV-5, BTV-9, BTV-10 & BTV-12 were detected in field isolates (n=62) from four 
southern states of India during 2014 and 2015 outbreaks. The pentavalent vaccination was 
commercialized in 2015 but is not used on a large scale. In this study, nineteen BTV 
isolates were derived from vaccinated flocks and were typed to detect serotype. Serotypes 
BTV-4, BTV-5 and BTV-12 were identified in vaccinated flocks from Tamil Nadu (n=14) 
and Karnataka state, (n=8) during the 2015 BT outbreaks.    A future study performed on a 
larger scale would be helpful to further strengthen these findings to show the efficacy of 
vaccination against different BTV serotypes. The currently circulating serotypes BTV-4, 
BTV-5, BTV-9 and BTV-12 are not present in the pentavalent inactivated BT vaccine. 
However, no final conclusions can be made because of small sample size from vaccinated 
animals in the present study.  
Immunization with one serotype does not elicit strong cross-protection against other  
serotypes, making the design of effective vaccination strategies more difficult, particularly 
in endemic areas where multiple BTV serotypes circulate (Eschbaumer et al., 2009).  In 
India, the control of BT is therefore difficult to achieve where multiple serotypes are 
circulating. However, vaccination programmes using inactivated vaccines containing 
currently circulating serotypes, or subunit vaccines targeting current serotypes, may help to 
reduce the clinical signs caused by the disease in India and form a component of future 
control strategies. Studies to characterise circulating strains and virological surveillance in 
India would improve our understanding of the serotypes / strains causing disease and help 
to support the design of appropriate control strategies / vaccination programmes.  
Since 2010, BTV12 has been shown to circulate in Telangana and Andhra Pradesh (Rao et 
al., 2016a). However, four to five years were dominated by a single serotype: BTV-1 and 
BTV-10 in 2003, BTV-1 again from 2006-11, BTV-2 in 2007 -10, BTV-4 from 2007-13, 
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BTV-9 from 2002-07, BTV-16 from 2007-11 (Rao et al., 2016a). The results presented 
here confirm the persistant circulation of BTV serotypes, BTV-1, BTV-2, BTV-4, BTV-5, 
BTV-9, BTV-10 and BTV-12 in Southern India during the 2014-15 BT outbreaks. Further 
monitoring will be essential to detect and identify the serotypes that continue to circulate in 
India, especially, as the introduction of the pentavalent vaccine in endemic areas of 
Southern India may affect / alter the identity of the BTV strains that are dominant in the 
region. 
4.4 Summary 
 One hundred and thirty five (135) BTV isolations were made from clinical samples, 
including EDTA blood, tissues (spleen, lymph node) and saliva from suspected 
BTV outbreaks in Southern India during 2015. BTV isolations were also made 
from one / five EDTA blood samples from suspected outbreaks in Telangana / 
Tamil Nadu respectively during 2014. 
 Sixty three (n=63) cell culture adapted Indian field strains of BTV from 2014-2015 
outbreaks in Southern India were used for further typing. 
 The results presented here confirm the current circulation of seven BTV serotypes, 
including BTV-1, BTV-2, BTV-4, BTV-5, BTV-9, BTV-10 & BTV-12, with 
predominance of BTV-12 followed by BTV-2 and BTV-5 in 62 samples typed, 
from four southern states of India during the 2014 and 2015 BTV outbreaks. 
  BTV infection involving only one serotype was found in 36 out of 62 BTV isolates 
from Tamil Nadu and Karnataka, 2014-15. BTV-12 predominated (14 isolates), 
followed by BTV-5 (9 isolates).  
 Dual and triple BTV co-infections were detected in twenty two and four BTV 
isolates, respectively. The dominant BTV serotype in the dual and triple mixed 
isolates based on lower Ct values was: BTV-12, Ct values of 6 to 30 in eleven BTV 
isolates. 
 Out of sixty two BTV isolates, BTV-12 was found to be predominant serotype 
(59.7%) with a substantial proportion of samples infected with BTV-2 (30.6%) and 
BTV-5 (29%).   
 BTV isolate [IND2015/] 07Karn, from unvaccinated sheep in Karnataka state, 2015 
BT outbreak could not be typed using serotype-specific TaqMan based qRT-PCR 
Chapter 4  Isolation and typing of BTV 
145 
 
assay against BTV-1 to BTV-24, BTV-26, BTV-27 and BTV-29 serotypes (Maan 
et al., 2016). 
 Serotypes BTV-2, BTV-5, BTV-9, BTV-10,  BTV-12 and BTV-16 (Kumar et al., 
2016) were identified in unvaccinated animals (n=24) during the 2014-15 BT 
outbreaks in Tamil Nadu state. Serotypes BTV-4, BTV-5 and BTV-12 were 
identified in flocks (n=14) vaccinated with pentavalent inactivated vaccine. 
 In Karnataka state, serotypes BTV-4, BTV-5 and BTV-12 were identified in 
vaccinated animals (n=8) during 2015 BT outbreaks, BTV-4 was identified for the 
first time in Karnataka state during the 2014-15 BT outbreaks. 
 None of the serotypes present in the pentavalent vaccine were identified in 
vaccinated animals, suggesting that the vaccine was indeed effective against the 
homologous serotype field strains. 
 A significant observation of the present study is the identification of BTV-5, a 
previously rare serotype in India, in a substantial proportion of samples (29%). 
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 Phylogenetic analysis of Chapter 5:
genome segment 2 from bluetongue virus 
strains isolated in India during 2014-2015 
5.1 Introduction 
Twenty four distinct serotypes of BTV have been recognised for several decades.  In 
addition Toggenburg virus which was detected during routine surveillance of goats in 
Switzerland during 2008 has been identified as BTV-25 (Hofmann et al., 2008b, Chaignat 
et al., 2009).  BTV-26 was detected in clinical samples from sheep  in Kuwait (Maan et al., 
2011b) and BTV-27 was detected in asymptomatic goats on the island of Corsica, France 
(Zientara et al., 2014, Schulz et al., 2016, Savini et al., 2017a, Jenckel et al., 2015). Two 
further putative types have also been detected: BTV-28 in a Sheep pox vaccine preparation 
from the Middle East (Bumbarov et al., 2016), and BTV-29 in an Alpaca from South 
Africa (Wright, 2014, Posada, 2008). Recent studies of BTV strains circulating in 
Mongolia suggest the existence of several more novel types namely BTV-30, 31 and 32 
(EPIZONE, 2017).  
Serological evidence suggests that 22 BTV serotypes exist in India  and at least 15 BTV 
serotypes (BTV-1, 2, 3, 4, 5, 8, 9, 10, 12, 16, 17, 18, 21, 23 and 24) have been isolated 
over the last five decades including BTV-5 & BTV-24 which were recently added to this  
list in 2016 (Maan et al., 2015c). Since 2001, 12 serotypes have been isolated, namely 
BTV-1, BTV-2, BTV-3, BTV-4, BTV-5, BTV-9, BTV-10, BTV-12, BTV-16, BTV-21, 
BTV-23 and BTV-24, mainly from Southern India(Bommineni et al., 2008, Chand et al., 
2016, Desai et al., 2009, Hemadri et al., 2016, Krishnajyothi et al., 2016, Kumar et al., 
2016, Maan et al., 2012a, Maan et al., 2012b, Maan et al., 2012c, Maan et al., 2012d, Maan 
et al., 2012e, Maan et al., 2015b, Maan et al., 2015c, Maan et al., 2017, Minakshi et al., 
2012, Mondal et al., 2013, Prasad et al., 1992, Prasad et al., 1994, Pudupakam et al., 2017, 
Rao et al., 2012b, Rao et al., 2012c, Rao et al., 2015, Rao et al., 2016a, Rao et al., 2016b, 
Reddy et al., 2016a, Reddy et al., 2016b, Sreenivasulu et al., 2004, Susmitha et al., 2012)  
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BTV has seven structural proteins (VP1 to VP7) and at least 5 non-structural proteins (NS1 
to NS5) (Chapter 1, Section 1.5). Genome segment 2 has the highest level of sequence 
variation, showing 29% to 59% nucleotide variation between different BTV 24 serotypes 
(Maan et al., 2004, Maan et al., 2007a, Batten et al., 2008).  Genome segment 2 encodes 
outer-capsid protein VP2, the most variable of the BTV proteins, which determines  BTV 
serotype based on the specificity of its interactions with the neutralizing antibodies 
generated during infection of the mammalian host (Mertens et al., 1989b, Inumaru and 
Roy, 1987, Cowley and Gorman, 1989, Gould and Eaton, 1990, Huismans and Van Dijk, 
1990). The second most variable BTV protein, VP5 (encoded by genome segment 6) can 
also make a contribution to determination of the virus serotype, although it is less 
significant in this role than VP2 (Maan et al., 2008, Singh et al., 2004, Cowley and 
Gorman, 1989). 
 Phylogenetic analyses of Seg-2 from multiple BTV isolates have shown that Seg-2 divides 
into 27 distinct groups, precisely representing the different virus serotypes, with <33% 
variation in nucleotide sequence within each serotype and 29–59% nucleotide sequence 
variation between types(Maan et al., 2007a, Maan et al., 2010, Mertens et al., 2007a, 
Mertens et al., 2007b, Schulz et al., 2016). Sequencing studies also indicate that BTV 
strains in different geographic regions have evolved independently over an extensive 
period of time. This geographical separation has resulted in the accumulation of unique 
point mutations, some of which may enhance the transmission and survival of the viruses 
in their respective local ecosystems and vector populations (Maan et al., 2009). Genetic 
heterogeneity of BTV strains as a result of genetic drift, genetic shift and selection have 
gradually led to the appearance of distinctive regional variants, which can be divided into 
eastern and western topotypes for all segments of BTV(Maan et al., 2009). 
The eastern BTV group generally constitutes viruses isolated from countries in Southern 
and South-Eastern Asia, India, China and Australia, while viruses that are mostly isolated 
from countries in Africa, America, Europe and Middle East, are included in the western 
BTV group(Maan et al., 2007a, Maan et al., 2008, Maan et al., 2009, Mertens et al., 
2007a).As the least conserved of the BTV genome segments, the analysis of sequence 
variations in Seg-2 provide a basis for molecular evolutionary and phylogenetic studies, to 
identify the BTV serotype and the geographical origins of the Seg-2 lineage, and for the 
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design of RT-PCR assays to identify both virus-serotype and topotype (Mertens et al., 
2007a). 
The objectives for this chapter are: 
 To generate full-length Seg-2 sequence data for BTV strains isolated during BT 
suspected outbreaks in Southern India during 2014-2015. 
 To confirm the serotype of Indian field isolates, as previously identified by 
serotype-specific real-time RT-PCR assays (Maan et al., 2016) as described in the 
chapter 4, by comparing Seg-2 sequences with those of reference strains of the 27 
BTV serotypes.  
 Phylogenetic analyses of Seg-2 from different Indian BTV strains, to determine 
their geographic origins, movements of different virus lineages and evolutionary 
relationships with other isolates from different parts of the India and world. 
5.2 Results 
 Phylogenetic characteristics of Seg-2/VP2 5.2.1
Genome segment 2 was sequenced from forty six (n=46) Indian BTV strains, isolated from 
BT outbreaks in Southern India during 2014-2015 (Table 5.1). Serotype-specific TaqMan 
based qRT-PCR assay on these Indian field isolates of BTV against BTV-1 to BTV-24, 
BTV-26, BTV-27 and BTV-29 serotypes (Maan et al., 2016) identified BTV serotypes, 
including BTV-2, BTV-4, BTV-5, BTV-9, BTV-10 & BTV-12 (Chapter 4, Section 4.2.4 
and Table 5.1). Seg-2 sequences from these forty six Indian BTV strains were initially 
compared with Seg-2 sequences of reference strains of BTV serotypes BTV-1 to BTV-27 
available from GenBank (Figure 5.1).  
Data for reference strains retrieved from Genbank are abbreviated with a serotype followed 
by a three-letter international country code (https://countrycode.org/) depicting 
geographical origin of each isolate, year of sample collection where accessible and 
Genbank accession number at the end of each sequence (serotype/three-letter country 
code/year of sample collection_Genbank accession number) e.g. 1/AUS/1979_JN881986 
stands for serotype BTV-1 from Australia collected in 1979. Similarly, RSArrrr stands for 
a reference strain (rrrr) supplied to the Orbivirus Reference Collection by Onderstepoort 
Laboratory in the Republic of South Africa. The Indian strains sequenced in this study 
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were indicated as country code (IND) followed by year of sample collection, field sample 
ID number and date of sampling e.g. IND2015/40_2015-12-22 stands for an Indian isolate, 
with original sample ID number 40,  dated 22 December 2015. 
 
 
 
 
 
. 
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Table 5.1 Details of the BTV field strains sequenced in this study 
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[IND2015/15]22 
IND2015/22_20
15-12-18 
18/12/2015 Thoothukudi TN 8°56'48.63"N 77°46'25.61"E Sheep Blood V KC1/BSR6 BTV-12 
[IND2015/18] 40 
IND2015/40_20
15-12-22 
22/12/2015 Tuticorin TN 8°56'48.63"N 77°46'25.61"E Goat Blood UV KC1/BHK4 BTV-1 
[IND2015/148]491 
IND2015/491_2
015-12-25 
25/12/2015 Kanchipuram TN 12°50'3.02"N 79°42'13.10"E Sheep Blood UV KC1/BHK5 BTV-5 
[IND2015/151]492 
IND2015/492_2
015-12-25 
25/12/2015 Kanchipuram TN 12°50'3.02"N 79°42'13.10"E Sheep Blood UV KC1/BHK6 BTV-5 
[IND2015/157]494 
IND2015/494_2
015-12-25 
25/12/2015 Kanchipuram TN 12°50'3.02"N 79°42'13.10"E Sheep Blood UV KC1/BHK6 BTV-12 
[IND2015/208]404 
IND2015/404_2
015-12-25 
25/12/2015 Erode TN 11°20'27.73"N 77°43'1.79"E Sheep Blood V KC1/BHK4 BTV-5 
[IND2015/211]406 
IND2015/406_2
015-12-25 
25/12/2015 Erode TN 11°20'27.73"N 77°43'1.79"E Sheep Blood UV KC1/BHK5 BTV-12 
[IND2015/214]408 
IND2015/408_2
015-12-25 
25/12/2015 Erode TN 11°20'27.73"N 77°43'1.79"E Sheep Blood UV KC1/BHK4 BTV-5 
[IND2015/169]470 
IND2015/470_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood V KC1/BHK4 BTV-12 
[IND2015/172]471 
IND2015/471_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Cow Blood UV KC1/BHK5 BTV-5 
[IND2015/175]472 
IND2015/472_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Cow Blood UV KC1/BHK4 BTV-12 
[IND2015/178]473 
IND2015/473_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood V KC1/BHK4 BTV-12 
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[IND2015/181]474 
IND2015/474_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Cow Blood UV KC1/BHK4 BTV-12 
[IND2015/184]475 
IND2015/475_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood V KC1/BHK4 BTV-5 
[IND2015/187]476 
IND2015/476_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood 
V 
KC1/BHK5 BTV-5 
[IND2015/190]477 
IND2015/477_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood 
V 
KC1/BHK5 BTV-9 
[IND2015/193]478 
IND2015/478_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Goat Blood 
V 
KC1/BHK4 BTV-5 
[IND2015/196]480 
IND2015/480_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood 
V 
KC1/BHK5 BTV-12 
[IND2015/199]483 
IND2015/483_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood 
V 
KC1/BHK4 BTV-12 
[IND2015/202]484 
IND2015/484_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Goat Blood 
V 
KC1/BHK4 BTV-12 
[IND2015/205]486 
IND2015/486_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood 
V 
KC1/BHK4 BTV-5 
[IND2015/160]CS
4 
IND2015/CS4_
2015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood 
V 
KC1/BHK4 BTV-12 
[IND2015/163]CS
6 
IND2015/CS6_
2015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood 
V 
KC1/BHK4 BTV-12 
[IND2015/166]CS
9 
IND2015/CS9_
2015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Blood 
V 
KC1/BHK5 BTV-5 
[IND2015/76]534 
IND2015/534_2
015-12-25 
25/12/2015 Thoothukudi TN 8°45'51.00"N 78° 8'5.41"E Goat Blood UV KC1/BHK4 BTV-5 
[IND2015/2017]54
7 tissue 
IND2015/547_2
015-12-25 
25/12/2015 Thoothukudi TN 8°45'51.00"N 78° 8'5.41"E Sheep Spleen UV KC1/BHK4 BTV-5 
[IND2015/220]228 
tissue 
IND2015/228_2
015-12-25 
25/12/2015 Tirunehveli TN 8°42'33.27"N 77°44'21.85"E Sheep Spleen UV KC1/BHK4 BTV-5 
[IND2015/223]34 
tissue 
IND2015/34_tis
sue_2015-12-25 
25/12/2015 Thoothukudi TN 8°45'51.00"N 78° 8'5.41"E Sheep Spleen UV KC1/BHK4 BTV-12 
[IND2015/232]556 
saliva 
IND2015/556_s
aliva_2015-12-
25 
25/12/2015 Thoothukudi TN 8°45'51.00"N 78° 8'5.41"E Cattle Saliva UV KC1/BHK5 BTV-12 
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[IND2014/34]BTV
-1 
IND2014/BTV1
_2014-12-06 
06/12/2014 Thanjavur TN 10°47'13.20"N 79° 8'16.18"E Sheep Blood UV KC1/BHK4 BTV-10 
[IND2014/35]BTV
-2 
IND2014/BTV2
_2014-12-06 
06/12/2014 Thanjavur TN 10°47'13.20"N 79° 8'16.18"E Sheep Blood UV KC1/BHK4 BTV-10 
[IND2015/118]V1 
IND2015/V1_2
015-11-26 
26/11/2015 Chikballapur K 13°11'35.03"N 78° 1'14.86"E Sheep Blood 
V 
KC1/BHK5 BTV-5 
[IND2015/121]V2 
IND2015/V2_2
015-11-26 
26/11/2015 Chikballapur K 13°11'35.03"N 78° 1'14.86"E Sheep Blood 
V 
KC1/BHK5 BTV-5 
[IND2015/136]V4
1 
IND2015/V41_
2015-11-26 
26/11/2015 Chikballapur K 13°29'43.12"N 77°58'4.05"E Sheep Blood 
V 
KC1/BHK5 BTV-12 
[IND2015/142]V4
4 
IND2015/V44_
2015-11-26 
26/11/2015 Chikballapur K 13°29'43.12"N 77°58'4.05"E Sheep Blood 
V 
KC1/BHK4 BTV-5 
[IND2015/145]V4
4 lamb 
IND2015/V44_l
amb_2015-11-
26 
26/11/2015 Chikballapur K 13°29'43.12"N 77°58'4.05"E Sheep Blood 
V 
KC1/BHK4 BTV-12 
[IND2015/133]V 
Severe 
IND2015/V44S
evere_2015-11-
26 
26/11/2015 Chikballapur K 13° 2'21.52"N 77°23'33.83"E Sheep Blood 
V 
KC1/BHK4 BTV-12 
IND2015/241]K3 
IND2015/K3_2
015-09-10 
10/09/2015 Karimnagar T 18°19'20.63"N 80°14'29.70"E Sheep Blood UV KC1/BHK4 BTV-2 
[IND2015/244]K4 
IND2015/K4_2
015-09-10 
10/09/2015 Karimnagar T 18°26'22.78"N 79° 7'44.26"E Sheep Blood UV KC1/BHK4 BTV-4 
[IND2015/250]K9 
IND2015/K9_2
015-09-10 
10/09/2015 Karimnagar T 18°32'54.90"N 78°17'29.98"E Sheep Blood UV KC1/BHK6 BTV-2 
[IND2015/]K13 
IND2015/K13_
2015-09-12 
12/09/2015 Karimnagar T 18°41'50.52"N 79° 4'26.61"E Sheep Blood UV KC1/BHK6 BTV-1 
[IND2015/256]K1
4 
IND2015/K14_
2015-09-12 
12/09/2015 Karimnagar T 18°41'50.52"N 79° 4'26.61"E Sheep Blood UV KC1/BHK4 BTV-2 
[IND2015/238]6P
K 
IND2015/6PK_
2015-09-07 
07/09/2015 Warangal T 18°11'51.79"N 79°42'9.80"E Sheep Blood UV KC1/BHK4 BTV-4 
[IND2014/37] 
10NLG 
IND2014/10NL
G_2014-10-03 
03/10/2014 Nalgonda T 16°56'34.67"N 79°12'55.83"E Sheep Blood UV KC1/BHK4 BTV-5 
[IND2015/271]7A 
IND2015/7A_2
015-11-08 
08/11/2015 Anantpur AP 14°41'37.97"N 77°38'3.41"E Sheep Blood UV KC1/BHK4 BTV-1 
[IND2015/]14A 
IND2015/14A_
2015-11-08 
08/11/2015 Anantpur AP 14°41'37.97"N 77°38'3.41"E Goat Blood UV KC1/BHK4 BTV-2 
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*
 Virus collection number: [Country code, year / sample number] 
£ 
Number of passages in KC cell line  
$ 
Number of passages in BHK-21 cell line.
  
& 
Number of passages in BSR cell line. 
€
 Based on Seg-2 phylogenetic analysis. 
  Abbreviations: TN, Tamil Nadu; K, Karnataka; T, Telangana; AP, Andhra Pradesh; V, Vaccinated; UV, Unvaccinated. 
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 Seg-2 based phylogenetic analysis for confirmation of serotypes detected by 5.2.1.1
real-time RT-PCR.  
Phylogenetic analysis of the full open reading frame (ORF) of Seg-2 showed that the forty 
six Indian isolates were grouped into five Seg-2 nucleotypes A, E, G, H and I (Maan et al., 
2007a) along with their corresponding reference strains confirming the serotypes (Figure 
5.1). The majority of isolates were confirmed as BTV-5 and BTV-12; seventeen isolates 
each, while the remaining (twelve isolates) were identified as BTV-1 (three isolates), BTV-
2 (four isolates), BTV-4 (two isolates), BTV-9 (one isolate) and BTV-10 (two isolates).  
However for isolates [IND2015/151]492, [IND2015/2017]547 tissue, [IND2015/] K13, 
[IND2015/271]7A and [IND2015/18] 40, the serotype detected by qPCR was different of 
that detected by NGS. 
In addition, the full-length sequence of the ORF of Seg-2 from Indian BTV isolates 
(n=46), generated in this study were compared with genome Seg-2 sequences of Indian 
BTV field strains of eleven serotypes namely BTV-1, 2, 3, 4, 5, 9, 10, 12, 16, 21 and 23 
available from GenBank (n=46) (accessed on 01.12.2017).This analyses showed that 
Indian BTV are grouped into eight “Seg-2 nucleotypes” A, B, C, D, E, G, H and I (Maan et 
al., 2007a) (Figure 5.2).  
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BTV-5 
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BTV-1 
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BTV-2 
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BTV-10 A 
BTV-4   
A 
Figure 5.1 Unrooted Maximum Likelihood (ML) phylogenetic tree of the nucleotide 
sequences of Seg-2 coding region of Indian BTV isolates (n=46) and BTV reference 
strains of 27 serotypes isolated worldwide.   
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The Tree was constructed as described in Chapter 2, Section 2.23. Indian strains are 
indicated in different colours for each serotype in dark shade, whereas the corresponding 
reference serotypes are shown light coloured and underlined. Scale bar, 0.4 nucleotide 
substitutions per site. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BTV-12 G 
BTV-4 
A 
BTV-10 
A 
BTV-23 
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BTV-1 
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BTV-9 
E 
BTV-16 
B 
BTV-3 
B 
BTV-21 
C 
Figure 5.2 ML unrooted phylogenetic tree of Seg-2 coding sequences of Indian BTV 
isolates (n=46) during 2014-2015 (Table 5.1) and other Indian BTV field strains (n=46) 
available in GenBank (n=46).  
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The identified serotypes of Indian strains sequenced and analysed in this study were 
marked with bold triangle. The eight Seg-2 nucleotypes  (A-E,G,H & I) were indicated 
(Maan et al., 2007a) with identified eleven serotypes (BTV-1, 2, 3, 4, 5, 9, 10, 12, 16, 21 
and 23). Scale bar, 0.4 nucleotide substitutions per site 
 Phylogenetic analysis of genome segment 2 of BTV-1 within the 5.2.2
Indian context 
BTV-1: Three Indian isolates of BTV-1 (IND2015/K13_2015-09-12, IND2015/40_2015-
12-22 and IND2015/7A_2015-11-08), were collected from Telangana, Tamil Nadu and 
Andhra Pradesh States respectively as part of this study during the 2015 BT outbreak. The 
length of Seg-2 obtained by NGS, ORF and size of VP2 protein were given in Table 5.2.   
The phylogenetic analysis of the Seg-2 of these isolates showed that, they grouped with the 
BTV-1 reference strains (1/RSArrrr_FJ969720, 1/AUS/1979_JN881986) within the ‘Seg-
2-based nucleotype H’ confirming their serotype (Figure 5.1). These three Indian isolates 
showed average nucleotide and amino acids (nt/aa) similarity of 74.69/83.71% with 
1/RSArrrr_FJ969720, confirming as serotype BTV-1 (Appendix 3). These isolates also 
clustered more closely with 1/AUS/1979_JN881986 showing average nt/aa similarities of 
87.25/94.24%, thus belonging to eastern topotype (Figure 5.1).  
Comparison of the ORF nucleotide-sequences of Seg-2 from BTV-1 isolates from 
Telangana (IND2015/K13_2015-09-12) and Tamil Nadu (IND2015/40_2015-12-22) 
showed that they are identical, with 99.17/ 99.58 % nt/aa similarity to the BTV-1 isolate 
from Andhra Pradesh (IND2015/7A_2015-11-08).  These high levels of sequence identity 
indicate that all three isolates represent extensions of a single outbreak. Comparisons of 
Seg-2/VP2 of these three BTV-1 isolates, with earlier BTV-1 isolates from Southern India 
during 2007-2008 (1/IND/2007_KF563933, 1/IND/2008_JX399149, 
1/IND/2008_KF664124) showed nt and aa similarity of 98.72%-99.34% and 98.86%-
99.9% respectively, while nt/aa similarities of 99.31%-99.72 % / 99.58-100 % were 
observed with BTV-1 strains from Southern India in 2010 (1/IND/2010_KP339145, 
1/IND/2010_KP339135), indicating a recent common ancestral relationship and continuing 
circulation of the same BTV-1 lineage over time.  
Chapter 5  Phylogenetic analysis of Seg-2 
158 
 
 Phylogenetic analysis of BTV-1 Seg-2 in a global context 5.2.3
Phylogenetic analysis of the full coding region of Seg-2, from global BTV-1 isolates, 
clearly segregated them into eastern and western topotypes that reflect the geographical 
origin of the isolate. Furthermore, two major subclades (supported by high bootstrap value 
96% and 71%) were clearly evident within the western topotype of BTV-1 (Figure 5.3). 
One subclade or lineage comprised strains from South Africa, Sudan, Italy, Spain,    
Nigeria, Cameroon, Libya, Morocco, Tunisia, Algeria, Gibraltar, Portugal, France-Corsica, 
(71 % bootstrap support)  showing nt / aa identity of 74.53% to 75.36 % and 80.96% to 
83.25 % with the Indian strains sequenced in this study.   
The BTV-1 isolate from the United States (1/USA/2010_KX164020), along with isolates 
from French-Guyana (1/GUF/2011_JQ436736, 1/GUF/2011_KY049844 and 
1/GUF/2015_KY049854) form a distinct lineage (96 % bootstrap support) that shares 
overall nt and aa identity of  73.56%  to 73.80 % and 80.855% to 81.27 % respectively 
with the Indian isolates sequenced in this study (IND2015/K13_2015-09-12, 
IND2015/40_2015-12-22 and IND2015/7A_2015-11-08).   
Four subgroups of Seg-2 were evident within the eastern topotype of BTV-1 (Figure 5.3). 
One subgroup comprised strains from Australia (supported by 91 % bootstrap value), 
sharing overall nt and aa identity of 86.66% to 87.35 % and 93.13% to 94.07 % 
respectively with the Indian BTV-1 strains sequenced in this study (IND2015/K13_2015-
09-12, IND2015/40_2015-12-22 and IND2015/7A_2015-11-08). The Chinese BTV-1 
isolate (1/CHN/1997_JN848760) along with the BTV-1 isolates from Malaysia and South 
Korea (1/MYS/1987_AJ585116, 1/KOR/2010_KC153300) formed another subgroup (97 
% bootstrap support) that shared overall nt and aa identity of 90.515 to 91.09 % and 
95.94% to 97.29 % respectively, with the Indian BTV-1 isolates (IND2015/K13_2015-09-
12, IND2015/40_2015-12-22 and IND2015/7A_2015-11-08).  
The three Indian BTV-1 isolates from the 2015 outbreak (IND2015/K13_2015-09-12, 
IND2015/40_2015-12-22 and IND2015/7A_2015-11-08) grouped with other Indian BTV-
1 strains (supported by bootstrap values of 99%), sharing nt and aa identities of 96.29% to 
99.72% and 96.98% to 100 % respectively, collectively forming an eastern sublineage  of 
Indian BTV-1 strains.  
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A fourth subgroup was identified within the eastern BTV-1 Seg-2 topotype, comprising 
isolates from the Mediterranean region, Greece (1/GRC/2001_AJ585121, 
1/GRC/2001_KP821005, 1/GRC/2001_KP821006, 1/GRC/2001_KP821007 and 
1/GRC/2001_JN635334). The Indian BTV-1 isolates grouped closely with these Greek 
BTV-1 strains, showing overall nt and aa identity levels of 94.32% to 94.70 % and 96.25% 
to 97.4 %.  
The average nt /aa identity levels were 94.75% / 96.27 % within the eastern group and 
95.91% / 97.83 % within the western group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 ML unrooted phylogenetic tree of coding region Seg-2/VP2 
gene of Indian BTV-1 isolates (n=3) during 2015 (Table 5.1) with reference 
and field strains of BTV-1 from around the world.  
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The trees were represented as circular (top) and rectangular (bottom) tree. The Indian 
BTV-1 strains analysed in this study are shown coloured maroon, and marked by a bold 
triangle. Scale bar, 0.2 nucleotide substitutions per site. 
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Table 5.2 Genetic characterization of Seg-2 from Indian BTV isolates sequenced. 
Virus collection 
number 
Coding region 
length (bp) 
*Total length of 
Seg-2 (bp) 
Size of 
VP2 
 ( Da) 
5’terminal sequences of the positive 
strand 
3’ terminal sequences of the positive strand 
BTV- 1      
[IND2015/271]7A 2887 2934 961 ATAGTGTCGCGATG TGACCGCGGGTCCGCGCGCTATTCCACTTAC 
[IND2015/]K13  2886 2934 961 ATAGTGTCGCGATG TGACCGCGGGTCCGCGCGCTATTCCACTTAC 
[IND2015/18] 40 2886 2936 961 AAATAGTGTCGCGATG TGACCGCGGGTCCGCGCGCTATTCCACTTAC 
BTV- 2      
[IND2015/250]K9 2898 2938 962 AACATGCTCGCGATG TGACTGCAGGCCCGCGATCTGTTACACTTAC 
[IND2015/256]K14 2898 2939 962 AAACATGCTCGCGATG TGACTGCAGGCCCGCGATCTGTTACACTTAC 
IND2015/241]K3 2889 2938 961 AACAGTCTCGCGATG TGACTGCAGGCCCGCGATCTGTTACACTTAC 
[IND2015/]14A 2898 2937 962 ACATGCTCGCGATG TGACTGCAGGCCCGCGATCTGTTACACTTAC 
BTV- 4      
[IND2015/244]K4   2871 2926 955 GTTAAAAGAGTGTTCCATCATG TGACACGGGTCGGTGGCCTC-TTACACTTAC 
[IND2015/238] 6PK  2871 2926 956 GTTAAAAGAGTGTTCCATCATG TGACACGGGTCGGTGGCCTC-TTACACTTAC 
BTV- 5      
[IND2015/142]V44 2869 2908 955 GCTTCTCAGGATG TGACATGAGACTCCTGGAGC-TTAC 
[IND2015/121]V2 2868 2914 955 AGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACTTA 
[IND2015/118]V1 2869 2910 954 AGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACA 
[IND2015/220]228  2868 2915 954 AAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACTTA 
[IND2015/2017]547  2868 2915 955 AAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACTTA 
[IND2015/76]534 2868 2911 954 AAAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTAC 
[IND2015/205]486 2868 2910 955 AGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTAC 
[IND2015/193]478 2868 2910 955 AAAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTA 
[IND2015/187]476 2868 2912 955 CTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACTTA 
[IND2015/172]471 2868 2910 955 CTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACT 
[IND2015/214]408 2868 2910 955 AAAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTA 
[IND2015/151]492 2868 2914 955 AAAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACT 
[IND2015/148]491 2868 2913 955 CTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACTTAC 
[IND2015/166]CS9 2868 2914 955 AAAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACT 
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(IND2014/37 ) 10NLG 2868 2914 955 GTTAAAAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTA 
[IND2015/184]475 2868 2916 955 AAAGCTTCTCAGGATG TGACATGAGACTCCTGGAGCTTACACTTA 
[IND2015/208]404 2868 2916 955 GTTAAAAGCTTCTCAGGATG TGACATGAGACTCCTGGAGC-TTACA 
BTV- 9      
[IND2015/190]477 2868 2911 955 AAAGTTATCTAGGATG TGACATGGGACTCCTAGAGCTTAC 
BTV- 10      
[IND2014/34]BTV1 2871 2917 955 GTGTTCTACCATG TGACATGGACCGGTAGCCTCTTACACTTAC 
[IND2014/35]BTV2 2871 2917 955 GTGTTCTACCATG TGACATGGACCGGTAGCCTCTTACACTTAC 
BTV- 12      
[IND2015/133]VSevere 2853 2900 949 AAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/145]V44L 2853 2901 949 AAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/136]V41 2853 2900 950 AAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/232]556  2853 2904 949 GTTAAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/223]34  2853 2904 949 GTTAAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/163]CS6 2853 2900 950 AAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/160]CS4 2853 2901 950 AAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/202]484 2853 2901 950 AAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/199]483 2853 2897 950 AAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACT 
[IND2015/196]480 2853 2899 950 AAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCAGCTTCAACTT 
[IND2015/181]474 2853 2901 950 AAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/178]473 2853 2899 950 AAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/175]472 2853 2901 950 AAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/169]470 2853 2898 950 AGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/211]406 2853 2903 950 TTAAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/15]22 2853 2901 950 AAAAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
[IND2015/157]494 2853 2898 950 AAGTTGCGAGGATG TGACAAGGCTCCCTCGCGGCTTCAACTTAC 
* Total length of Seg-2 obtained by NGS. 
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 Phylogenetic analysis of Seg-2 from Indian BTV-2 isolates 5.2.4
Phylogenetic analysis of Seg-2 revealed that the Indian BTV-2 strains isolated during the 
2015 BT outbreaks from Telangana [IND2015/K3_2015-09-10, IND2015/K9_2015-09-10, 
and IND2015/K14_2015-09-12] and Andhra Pradesh [IND2015/14A_2015-11-08] 
grouped with the reference strains of BTV-2 (2/RSArrrr/1959_KP821030 and 
2/AUS/2008_JQ086242) within nucleotype I (Figure 5.1). The length of Seg-2 obtained by 
NGS, ORF and size of VP2 protein were given in Table 5.2.  These four Indian isolates 
showed average nt and aa identity of 71.56% to 80.47% with 2/RSArrrr_KP821030, 
confirming the results of serotype-specific real time RT-PCR targeting Seg-2, which 
identified these strains as BTV-2. They clustered more closely with 
2/AUS/2008_JQ086242 showing average nucleotide and amino acid (nt/aa) identities of 
88.85/95.01 %, thus belonging to eastern topotype of BTV-2 (Figure 5.1). They also show 
nt/aa identities of 99.07% to 100% and 99.48% to 100% to each other, reflecting a recent 
common ancestry, and suggesting that they represent extensions of a single outbreak 
(Appendix 3). 
Seg-2 of the four Indian BTV-2 isolates sequenced as part of this study, is most closely 
related to those of BTV-2 strains from Southern India isolated during 1982 to 2010 
(2/IND/2010_KP339165, 2/IND/1993_KP696583, 2/IND/1982_AJ585152, 
2/IND/1994_KP268775, 2/IND/1993_KP339155 and 2/IND_KC751422) sharing 98.29% 
to 98.38 % and 99.08% to 99.20% nt and aa identities, respectively (Figure 5.4).The four 
Indian BTV-2 isolates were more tightly clustered with recent isolates of BTV-2 strains 
circulating in southern India during 2010 (2/IND/2010_KP339165), showing 99.45% to 
99.48% and 99.58% to 99.69 % nt and aa identity. This supports the conclusion that these 
Indian BTV-2 strains share a common ancestry reflecting the circulation and persistence of 
same BTV-2 Seg-2 lineage over time.  
 Phylogenetic analysis of Seg-2 / VP2 of Indian BTV-2 isolates within 5.2.5
a global context 
Phylogenetic analysis of the nucleotide sequences of the Seg-2 ORF from global BTV-2 
strains clearly identified two major topotypes that correspond to eastern and western 
subgroups (Figure 5.4). The overall percentage nucleotide identity was >81.17% within the 
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western group.  However, two major subclades (supported by high bootstrap value 96% 
and 78%) were clearly evident within the western BTV-2 Seg-2 topotype (Figure 5.4). One 
subclade or lineage (bootstrap value 96%) comprised of strains from France-Martinique 
Island, Panama, United States of America, France-Guyane, which showed nt and aa 
identity of only 71.1-72.17 % and 79.31-80.25 % with the recent Indian strains sequenced 
in this study (IND2015/K3_2015-09-10, IND2015/K14_2015-09-12, IND2015/K9_2015-
09-10 and IND2015/14A_2015-11-08), indicating that they belong to the eastern topotypes 
(Figure 5.4). The other western sub-group / lineage (78% bootstrap support) consisted of 
four earlier Indian BTV-2 isolates (2/IND/2008_JQ904072, 2/IND/2003_KP696593, 
2/IND/2003_JQ681258 and 2/IND/2003_KP696603), along with isolates from France-La 
Reunion Island, Canada, Nigeria, Sudan, South Africa, United States, Italy, Spain, Israel, 
Portugal, France-Corsica, Tunisia which shared overall nucleotide and amino acid identity 
of only 71.3-72.86 % and 79.42-80.46% respectively with the recent Indian isolates 
sequenced in this study (IND2015/K3_2015-09-10, IND2015/K14_2015-09-12, 
IND2015/K9_2015-09-10 and IND2015/14A_2015-11-08).  
The four Indian BTV-2 isolates from the 2015 outbreak analysed here 
(IND2015/K3_2015-09-10, IND2015/K14_2015-09-12, IND2015/K9_2015-09-10 and 
IND2015/14A_2015-11-08) showed only 71.44% to 71.79 % nt and 79.73% to 80.25 % aa 
identity respectively to the previous BTV-2 strains from India (2/IND/2003_KP696603, 
2/IND/2003_KP696593, 2/IND/2003_JQ681258 and 2/IND/2008_JQ904072, which had 
shown very high nt and aa identities (>99%) with the South African BTV-2 vaccine strain 
(2/RSAvvvv_KP821031) .This indicated grouping of the earlier Indian BTV-2 strains 
within the western topotype of BTV-2 and reflects the introduction and spread of BTV-2 
Seg-2 from the western vaccine strain in India, as previously reported by (Maan et al., 
2015c) 
Previous Indian BTV-2 isolates from 2003 to 2008 (2/IND/2003_KP696603, 
2/IND/2003_KP696593, 2/IND/2003_JQ681258 and 2/IND/2008_JQ904072) collectively 
represent an Indian cluster, sharing overall nt and aa identities of 88.54% to 90.03% and 
93.35% to 96.15% in Seg-2 / VP2 respectively, with eastern BTV-2 strains from Australia, 
Taiwan and Japan (2/AUS/2008_JQ086242, 2/AUS/2010_JQ240322, 
2/JPN/2007_AB686224 and 2/TWN/2003_AY493687), but branched distinctly from these 
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strains (Figure 5.4). The overall percentage nucleotide identity was >88.7% within the 
eastern group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The identified serotype BTV-2 of Indian strains sequenced and analysed in this study are 
shown dark green coloured and marked in bold triangle. Scale bar, 0.2 nucleotide 
substitutions per site 
 
Figure 5.4 ML unrooted phylogenetic tree of Seg-2 coding region of Indian BTV-
2 isolates (n=4) during 2015 (Table 5.1), reference strains of BTV-2 from around 
the world represented as circular (top) and rectangular (bottom) tree.  
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 Phylogenetic analysis of Seg-2 from Indian BTV-4 isolates 5.2.6
Two Indian BTV isolates from the outbreak in Telangana during 2015 
(IND2015/K4_2015-09-10 and IND2015/6PK_2015-09-07), were identified as BTV-4 by 
real-time RT-PCR assays targeting Seg-2. The length of Seg-2 obtained by NGS, ORF and 
size of VP2 protein were given in Table 5.2. The ORF of Seg-2 of these isolates was 
identical, indicating a common origin.  Phylogenetic analyses showed that they were  
closely related to recent BTV-4 strains circulating in Southern India 
(4/IND/2013_KY947349, 4/IND/2013_KY947347, 4/IND/2007_KY947343, 
4/IND/2013_KY947350, 4/IND/2013_KY947348, 4/IND/2013_KY947342, 
4/IND/2013_KY947351, 4/IND/2013_KY947346, 4/IND/2012_KY947345, 
4/IND/2008_KF560418 and 4/IND/2008_KY947344) with high nt and aa identity level of 
98.33% to 99.69% and 98.85% to 99.79% respectively (Figure 5.5). The Indian BTV-4 
isolates grouped closely with BTV-4 strain from China (4/CHN/1997_JX560414) showing 
overall nucleotide and amino acid identity of 91.15-91.57 % and 96.34-96.86% to the 
Chinese strain. 
 Phylogenetic analysis of Seg-2 / VP2 of Indian BTV-4 isolates within 5.2.7
a global context 
Phylogenetic analyses of the Seg-2 coding region of global BTV-4 strains (obtained from 
Gen Bank, Appendix 3) segregated them into eastern and western topotypes, that reflect 
the geographic origin of the virus isolates (Figure 5.5) Phylogenetic analysis of Seg-2 from 
the two Indian isolates (IND2015/K4_2015-09-10 and IND2015/6PK_2015-09-07) 
sequenced in this study showed that they group within ‘Seg-2- nucleotype A’ along with 
reference strains for serotype BTV-10 (BTV-4 (4/RSArrrr_KP821066), 
10/RSArrrr_AJ585131), BTV-11  (11/RSArrrr_AJ585132), BTV-17 
(17/RSArrrr_AJ585138), BTV-20 (20/RSArrrr_AJ585141) and BTV-24 
(24/RSArrrr_AJ585145) with average nt and aa identities of  71.54%  and 78.43%, 68.1% 
and 70.69%, 67.2% and 69.76%, 69.9%  and 72.24%, 70.3% and 74.41% , 68.1% and  
69.87 % respectively (Figure 5.1).  However, both isolates clustered even more closely 
with the Chinese field strain of BTV-4 (4/CHN/1997_JX560414) with average nt identity 
of 91.19%  and aa identity of 93.91% (Figure 5.1 and 5.5), confirming that they  belong to 
an eastern topotypes of BTV-4.  
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In contrast, Seg-2 of BTV-4 isolates from Africa, Europe and America grouped separately 
as a western topotype of BTV-4, showing only 71.4% to 72.52 % nt and 79.5% to 80.65%  
aa identity with BTV-4 isolates sequenced in this study (IND2015/K4_2015-09-10 and 
IND2015/6PK_2015-09-07). Four subgroups were evident within the western BTV-4 
topotype (Figure 5.5). One subgroup comprised of strains (4/CYP/2011_KP821042, 
4/CYP/2011_KP821043, 4/CYP/2011_KP821044,  4/CYP/2011_KP821045, 
4/CYP/2011_KP821046, 4/CYP/2004_KP821041, 4/CYP/1969_KP821040,  
4/CYP/1969_AJ585180, 4/GRC/2012_KP821056, 4/GRC/2012_KP821057, 
4/GRC/2012_KP821058, 4/GRC/2000_KP821055, 4/GRC/1999_KP821053,  
4/GRC/1999_AY839947, 4/GRC/1999_KP821052, 4/GRC/1999_DQ191277, 
4/GRC/2000_AJ585167, 4/GRC/2000_AY839946, 4/GRC/2000_KP821054,  
4/GRC/1979_KP821051, 4/ISR/2006_KP821059, 4/ISR/2001_DQ191278, 
4/ISR/2001_DQ191279, 4/TUR/1978_AJ585165, 4/TUR/1999_DQ825670) from the 
eastern Mediterranean region (Israel, Greece, Cyprus, Turkey) and the reference strains of 
BTV-4 – originally from Cyprus (4/RSArrrr_AJ585125,  4/RSArrrr_KP821066), sharing 
overall nucleotide and amino acid identity of 71.4% to 72.07 % and 80.13% to 80.44% 
with the Indian BTV-4 strains sequenced in study (IND2015/K4_2015-09-10 and 
IND2015/6PK_2015-09-07).  
Seg-2 of the Argentinian BTV-4 isolates (4/ARG/1999_JX024950, 
4/ARG/1999_JX024940, 4/ARG/1999_JX024945, 4/ARG/2002_AJ585169, 
4/ARG/2009_JX024955 and  4/ARG/2010_JX024960 ) along with isolates from South 
Africa, Turkey, Italy, Egypt and vaccine strain of BTV-4 from South Africa 
(4/ZAF/2004_AY839948, 4/ZAF/1900_JN255943, 4/ZAF_JX272580, 4/ZAF_KM233615, 
4/TUR_AJ585164 4/ITA/2002_DQ191276, 4/EGY/1977_KP821047 and 
4/RSAvvvv_AJ585163) form another subgroup (64 % bootstrap support) that shares 
overall nt and aa identities  of 71.4%  to 72.52 % and  79.5% to 80.33% respectively with 
the Indian BTV-4 isolates (IND2015/K4_2015-09-10 and IND2015/6PK_2015-09-07). 
 A third BTV-4 Seg-2 subgroup was identified within the western topotype, comprising  
isolates (4/MAR/2009_KP821065, 4/MAR/2009_KP821062, 4/MAR/2009_KP821063, 
4/MAR/2009_KP821064, 4/MAR/2004_KP821061, 4/ESP/2003_KP821067, 
4/ESP/2004_KP821068, 4/ESP/2005_KP821069, 4/ESP/2010_KP821070, 
4/FRA/2003_AY839945, 4/FRA/2003_KP821048, 4/FRA/2003_KP821049, 
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4/FRA/2003_KP821050, 4/PRT/2004_EF434176, 4/ITA/2003_JN255893, 
4/ITA/2003_DQ191280,  4/ITA/2003_DQ191281 and  4/ITA/2003_JN255883) from the 
western Mediterranean region (Morroco, Spain, France, Portugal, Italy), supported by 
bootstrap values of 97%. These strains are only distantly related to the Indian BTV-4 
strains IND2015/K4_2015-09-10 and IND2015/6PK_2015-09-07, sharing nt and aa 
identities of 72.14% to 72.34% and 80.33% to 80.65% respectively. The average nt / aa 
identity levels within the eastern group was 98.2% / 99.13% and 93.81% / 97.04% within 
the western group respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 ML unrooted phylogenetic tree of coding region Seg-2/VP2 gene of 
Indian BTV-4 isolates (n=2) during 2014-2015 (Table 5.1) with reference strains 
of BTV-4 around the world represented as circular (top) and rectangular 
(bottom) tree.  
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The identified serotype BTV-4 of Indian strains sequenced and analysed in this study are 
shown dark green coloured and marked in bold triangle. Scale bar, 0.4 and 0.3 nucleotide 
substitutions per site for circular and rectangular trees respectively. 
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 Phylogenetic analysis of Seg-2 from Indian BTV-5 isolates 5.2.8
The coding region of Seg-2 was sequenced from seventeen Indian isolates, from Tamil 
Nadu, Karnataka and Telangana during 2014-2015: (IND2015/471_2015-12-25, 
IND2015/475_2015-12-25, IND2015/476_2015-12-25, IND2015/478_2015-12-25, 
IND2015/491_2015-12-25, IND2015/492_2015-12-25, IND2015/404_2015-12-25, 
IND2015/408_2015-12-25, IND2015/486_2015-12-25, IND2015/534_2015-12-25, 
IND2015/547_2015-12-25, IND2015/228_2015-12-25, IND2015/CS9_2015-12-25, 
IND2015/V1_2015-11-26, IND2015/V2_2015-11-26, IND2015/V44_2015-11-26 and 
IND2014/10NLG_2014-10-03). The length of Seg-2 obtained by NGS, ORF and size of 
VP2 protein were given in Table 5.2. 
Seg-2 of these Indian isolates clustered closely with the reference strain of BTV-5 
(5/RSArrrr_KP821101), with average nt and aa identities of 94.96% and 97.77% 
respectively, confirming the results of serotype-specific real time RT-PCR, identifying 
them as isolates of BTV-5 except isolates IND2015/547_2015-12-25 and 
IND2015/492_2015-12-25. These two isolates IND2015/547_2015-12-25 and 
IND2015/492_2015-12-25 were typed wrong as BTV-10 and BTV-12 by serotype-specific 
real time RT-PCR.  
 Phylogenetic analysis of Seg-2 / VP2 of Indian BTV-5 isolates within 5.2.9
a global context 
A phylogenetic tree constructed on the basis of full length coding region of Seg-2 of BTV-
5 sequences from different parts of the world segregated into two subclades (Figure 5.6). 
While seventeen BTV-5 isolates of the present study clustered within one subclade of 
BTV-5 together with the previously reported isolates from the China, Africa and 
Cameroon. The BTV-5 isolates from India, China, Cameroon and South Africa were 
further segregated into four subclades proposed as the distinct Indian, Chinese, and 
Cameroon and African subgeographical evolutionary lineages.  
Phylogenetic analyses of the full ORF of Seg-2 showed that the Indian BTV-5 isolates 
sequenced as part of this study (IND2015/471_2015-12-25, IND2015/475_2015-12-25, 
IND2015/476_2015-12-25, IND2015/478_2015-12-25, IND2015/491_2015-12-25, 
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IND2015/492_2015-12-25, IND2015/404_2015-12-25, IND2015/408_2015-12-25, 
IND2015/486_2015-12-25, IND2015/534_2015-12-25, IND2015/547_2015-12-25, 
IND2015/228_2015-12-25, IND2015/CS9_2015-12-25, IND2015/V1_2015-11-26, 
IND2015/V2_2015-11-26, IND2015/V44_2015-11-26 and IND2014/10NLG_2014-10-03) 
grouped within the Seg-2 nucleotype E, along with the reference strains for BTV-5 
(5/RSArrrr_KP821101) and BTV-9 (9/RSArrrr_KP821088) as shown in Figure 5.1. These 
Indian BTV-5 strains were grouped within the western topotype of BTV-5, sharing average 
nt/aa identity of 94.9 /97.47 % with BTV-5 reference strains from South Africa 
(5/RSArrrr/1953_AJ585126). These isolates also clustered with the reference strains of 
BTV-9 (9/RSArrrr/1942_KP821088, 9/AUS/1985_JQ086302 and IND2015/477_2015-12-
25), but with lower average nt and aa identities (70.38% / 76.14%, 68.25% / 73.03 %, 
68.49/73.34 respectively) than with the reference strain of BTV-5 (Figure 5.1).  
The seventeen Indian BTV-5 strains clustered together, identifying as a single Indian 
sublineage, with overall nt and aa identity of 99.93% to 100% and 99.79% to 100%, 
indicating a common origin (Figure 5.6). These Indian BTV-5 strains, which were closely 
related to Chinese strains of BTV-5 showing average nt / aa identity of 98.71% / 98.93% 
respectively (suggesting a recent common ancestry), also clustered closely with a strain of 
BTV-5 from Cameroon (5/CMR/1982_AJ585181), showing an average nt/aa identity of 
95.7% /97.26%. However, they were only distantly related to western BTV-5 strains from 
the French Guadeloupe Island (5/GLP/2010_HQ241072), Nigeria 
(5/NGA/1982_AJ585182) and USA (5/USA/2003_KX164060), with average nt/aa 
identities of  77.02% /85.75 %, 77.47% / 87.62 % and 77.57%  /86.47 % respectively. 
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The identified serotype BTV-5 of Indian strains sequenced and analysed in this study are 
shown maroon coloured and in bold triangle. Scale bar, 0.2 and 0.07 nucleotide 
substitutions per site for circular and rectangular trees.   
 
 
Figure 5.6 ML unrooted phylogenetic tree of coding region Seg-2/VP2 gene of 
Indian BTV-5 isolates (n=17) during 2014-2015 (Table 5.1) with reference and 
field strains of BTV-5 around the world represented as circular (top) and 
rectangular (bottom) tree.. 
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 Phylogenetic analysis of Seg-2 from Indian BTV-9 isolates 5.2.10
Seg-2 was sequenced from one Indian strain (IND2015/477_2015-12-25) isolated from 
Tamil Nadu State during the 2015 BTV outbreak, which was identified by RT-PCR as 
BTV-9. This isolate grouped within Seg-2-nucleotype E, along with the reference strains of 
BTV-9 (9/RSArrrr_KP821088) and BTV-5 (5/RSArrrr_KP821101). However, 
IND2015/477_2015-12-25 shared only 68.83% nt and 75.36% aa identity with BTV-9 
(9/RSArrrr_KP821088). The length of Seg-2 obtained by NGS, ORF and size of VP2 
protein were given in Table 5.2. 
IND2015/477_2015-12-25 clusters closely with  BTV-9 strains from Southern India, 
reflecting a close evolutionary relationship and indicating  a recent common ancestry, 
sharing 97.11% to 99.09 % and 98.85% to 99.37% nt and aa identity respectively with: 
IND/2007_JX003688; IND/2006_JN579710; IND/2004_KP696613; 
IND/2005_JQ414046; IND/2005_KJ679573; IND/2003_KP696633; IND/2003_JF443155; 
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IND/2002_JF443156; IND/2003_JF443157; IND/2003_KP339175; IND/2003_KP339185; 
IND/2005_KP696642; IND/2004_KP696623 and IND/2005_KP696652, as part of an 
monophyletic clade of Indian BTV-9 strains (Figure 5.7).  
 Phylogenetic analysis of Seg-2 / VP2 of Indian BTV-9 isolates 5.2.11
within a global context 
Phylogenetic analysis of the full coding region of Seg-2 clearly splits global BTV-9 
isolates into eastern and western topotypes that reflect the geographical origins of Seg-2 
(Figure 5.7). The overall nt / aa identity within the eastern group was 98.02% /98.35%, 
with 95.6% / 97.31% within the western group.  
 IND2015/477_2015-12-25 clusters more closely with eastern field strains of BTV-9 (e.g. 
9/AUS/1985_JQ086302, showing 89.37% nt and 93.72aa identity), than with the reference 
strain of BTV-9 from South Africa, indicating its grouping within the eastern Seg-2 
topotype of BTV-9. 
Four subgroups of BTV-9 Seg-2 were evident within the eastern topotypes, including 
isolates from Australia, Japan, India and the Mediterranean region (Figure 5.7). One 
subgroup contains Australian isolate 9/AUS/1985_JQ086302, sharing nt and aa identity of 
89.37% and 93.72% with the Indian BTV-9 isolate (IND2015/477_2015-12-25). Japanese 
BTV-9 isolate (JPN/2003_AB686223) represents another subgroup (45% bootstrap 
support) sharing nt / aa identities of 91.04% / 93.61% respectively with the Indian BTV-9 
isolate.  
The third subgroup includes isolates from India (IND2015/477_2015-12-25, 
IND/2007_JX003688, IND/2006_JN579710, IND/2004_KP696613, IND/2005_JQ414046, 
IND/2005_KJ679573, IND/2003_KP696633, IND/2003_JF443155, IND/2002_JF443156, 
IND/2003_JF443157, IND/2003_KP339175, IND/2003_KP339185, 
IND/2005_KP696642, IND/2004_KP696623 and IND/2005_KP696652), collectively 
shares  nt and aa  identity of 97.11% to 97.32% and 93.61% to 99.37%  with 
IND2015/477_2015-12-25, collectively forming an Indian sublineage within the eastern 
topotype  (supported by bootstrap values of 94 %).   
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The fourth  subclade within the eastern BTV-9 Seg-2 topotype, contains isolates from the 
Mediterranean region (Greece, Turkey, Bulgaria, Italy, Serbia, Bosnia and Hezegovina, 
Kosovo - supported by bootstrap values of 97%) with nt and aa identities of 96.97% to 
97.34 % and 97.8 to 98.32 % with Indian strain IND2015/477_2015-12-25, indicating that 
these European strains had an eastern, possibly Indian origin. In contrast, Seg-2 of Africa 
and America isolates group separately, as a western BTV-9 topotype, showing nucleotide 
and aa identities of only 68.62% to 69.32 % and 73.3% to -74.97 % with Indian BTV-9 
isolate IND2015/477_2015-12-25.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 ML unrooted phylogenetic tree of coding region of Seg-2/VP2 gene of 
Indian BTV-9 isolate (n=1) during 2015 from Tamil Nadu, India (Table 5.1) with 
reference strains of BTV-9 around the world represented as circular (top) and 
rectangular (bottom) tree. 
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The identified serotype BTV-9 of Indian strain sequenced and analysed in this study was 
marked in a bold triangle. Scale bar, 0.5 and 0.3 nucleotide substitutions per site for 
circular and rectangular trees respectively. 
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 Phylogenetic analysis of Seg-2 from Indian BTV-10 isolates 5.2.12
The full coding regions of Seg-2 from two Indian isolates (IND2014/BTV1_2014-12-06 
and IND2014/BTV2_2014-12-06) from Thanjavur district of Tamil Nadu, 2014 were 
sequenced as part of these studies. The length of Seg-2 obtained by NGS, ORF and size of 
VP2 protein were given in Table 5.2. The Indian isolates (IND2014/BTV1_2014-12-06 
and IND2014/BTV2_2014-12-06) clustered closely with the reference strain of BTV-10 
(10/RSArrrr_AJ585131) showing average nucleotide and amino acid (nt/aa) identity of 
89.34/92.78% and thus serotype was confirmed as BTV-10, consistent with the results of 
serotype-specific real time RT-PCR targeting Seg-2.  
Phylogenetic analysis of Seg-2 showed that Indian BTV-10 isolates 
IND2014/BTV1_2014-12-06 and IND2014/BTV2_2014-12-06 are identical, indicating a 
common origin from a single epizootic.  These isolates were most closely related to other 
BTV-10 strains from Southern India (10/IND/2004_JQ740772, 10/IND/2003_KP339245, 
10/IND/2003_JF727655 and 10/IND/2004_JN704634) (Figure 5.8) sharing high nt and aa 
identities  of 99.69% to 100 % and 99.48% to 100 % respectively, collectively grouping  
them within the western topotype of BTV-10 isolates (Figure 5.8). 
 Interestingly, the two Indian BTV-10 isolates (IND2014/BTV1_2014-12-06 and 
IND2014/BTV2_2014-12-06), which are from an outbreak in 2014, have  identical Seg-2 
sequences to an earlier  Indian isolate of BTV-10 from Southern India, 2003 
(10/IND/2003_KP339245),  indicating continuing circulation or reintroduction of BTV-10 
with the same Seg-2. 
 Phylogenetic analysis of Seg-2 / VP2 of Indian BTV-10 isolates 5.2.13
within a global context 
Indian isolates (IND2014/BTV1_2014-12-06 and IND2014/BTV2_2014-12-06) group 
within ‘Seg-2- nucleotype A’ along with reference strains of BTV-10 
(10/RSArrrr_AJ585131), BTV-4 (4/RSArrrr/_KP821066),  BTV-11 
(11/RSArrrr_AJ585132), BTV-17 (17/RSArrrr_AJ585138), BTV-20 
(20/RSArrrr_AJ585141) and BTV-24 (24/RSArrrr_AJ585145) (Figure 5.1). 
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 Within this nucleotype the two Indian isolates cluster most  closely with the reference 
strain of BTV-10 (10/RSArrrr_AJ585131), showing average nt and aa (nt/aa) identities of 
89.34%  /  92.78% confirming their serotype as BTV-10, consistent with results of the 
serotype-specific real time RT-PCR targeting Seg-2. These Indian isolates showed lower 
average nt and aa identities of:  67.88% / 75.93%; 67.88% / 72.76 %; 66.06% / 72.03%; 
67.67%/75.03 %; and 67.25%/72.14% respectively with: BTV-24 
[24/RSArrrr_AJ585145]; BTV-17 [17/RSArrrr_AJ585138]; BTV-11 
[11/RSArrrr_AJ585132]; BTV-4 [4/RSArrrr_KP821066] and BTV-20 
[20/RSArrrr_AJ585141], respectively.  
The Indian strains of BTV-10 sequenced here, were closely clustered with five USA 
isolates (10/USA_M11787, 10/USA/1953_NC_006013, 10/USA_L29026, 
10/USA_L29027 and 10/USA_U06786 – Figure 5.9) showing 99.48% to 99.69% nt and 
99.72% to 99.9 % aa identity levels. The two Indian BTV-10 isolates 
(IND2014/BTV1_2014-12-06 and IND2014/BTV2_2014-12-06) were also closely related 
to a subgroup formed by three other USA isolates (10/USA/1980_U06780, 
10/USA/1980_U06782 and 10/USA/1980_U06783) showing overall nt and aa identities of 
99.16% to 99.27% and 99.48% to 99.55% respectively (Figure 5.9). Three other American 
BTV-10 isolates (10/USA/1990_U06781, 10/USA/1990_U06784 and 
10/USA/1990_U06785) form another subgroup (100% bootstrap support) that shares 
overall nt and aa identities of 95.23% to 95.33 % and 95.71% to 95.82% with the Indian 
BTV-10 isolates (IND2014/BTV1_2014-12-06 and IND2014/BTV2_2014-12-06).  
In contrast, BTV-10 isolates from South Africa and the French administrative areas of 
Martinique Island and Guyana in the Caribbean, were only distantly related to the Indian 
BTV-10 isolates (IND2014/BTV1_2014-12-06 and IND2014/BTV2_2014-12-06) showing 
88.71%  to 89.24 % nt and 92.47% to 92.99% aa identity.  
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Trees are represented as circular (top) and rectangular (bottom) .The identified serotype 
BTV-10 of Indian strains sequenced and analysed in this study are shown dark red in 
colour andmarked with bold traingle. Scale bar, 0.03 nucleotide substitutions per site 
 
 
 
Figure 5.8 ML unrooted  phylogenetic tree of coding region Seg-2/VP2 
gene of Indian BTV-10 isolates (n=2) during 2014-2015 (Table 5.1) with 
reference strains of BTV-10 all over the world . 
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 Phylogenetic analysis of Seg-2 from Indian BTV-12 isolates 5.2.14
Seg-2 from seventeen Indian isolates that were identified as BTV-12 by RT-PCR, were 
sequenced as part of this study, including: IND2015/22_2015-12-18; IND2015/494_2015-
12-25; IND2015/406_2015-12-25; IND2015/470_2015-12-25;     IND2015/472_2015-12-
25; IND2015/473_2015-12-25; IND2015/474_2015-12-25; IND2015/480_2015-12-25; 
IND2015/483_2015-12-25; IND2015/484_2015-12-25; IND2015/CS4_2015-12-25; 
IND2015/CS6_2015-12-25; IND2015/34_tissue_2015-12-2; IND2015/556_saliva_2015-
12-25; IND2015/V41_2015-11-26; IND2015/V44_lamb_2015-11-26; 
IND2015/V44Severe_2015-11-26. The length of Seg-2 obtained by NGS, ORF and size of 
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VP2 protein were given in Table 5.2. These seventeen Indian isolates group with the 
reference strains for BTV-12 (12/RSArrrr_KP821100)  and BTV-22 
(22/RSArrrr_AJ585143) within Seg-2-based nucleotype G (Figure 5.1) showing nt and aa 
identities of 97.13% to 98 %, with the reference strain of BTV-12 
(12/RSArrrr/1941_KP821100), confirming results  of serotype-specific real time RT-PCR 
targeting Seg-2. 
The Seg-2 coding region of these Indian strains showed identical nucleotide/amino acid 
sequences, indicating a common origin, from a single outbreak. The Indian BTV-12 strains 
were most closely related to other Indian strains 12/IND/2015_KX905151, 
12/IND/2016_MF615238 from Haryana state and 12/IND/2011_KC662613 from Adilabad 
district in Telangana State, showing average nt/aa identities of 99.93% to 100%; 99.89% to 
99.8%; and 99.4% to 99.6% respectively, reflecting their origin from a single virus lineage 
(Figure 5.9). 
 Phylogenetic analysis of Seg-2 / VP2 of Indian BTV-12 isolates 5.2.15
within a global context 
These Indian BTV-12 isolates also cluster with the reference strains of BTV-22 
(22/RSArrrr_AJ585143) within nucleotype G, showing average nt and aa identities of 
69.54% and 76.40% respectively. These Indian BTV-12 strains group within the western 
topotype of BTV-12, sharing average nt/aa identity of 97.06% to 97.58% and 97.13% to 
98% with the BTV-12 reference strains from South Africa (12/RSArrrr_AJ585133 and 
12/RSArrrr_KP821100) respectively.  
Seg-2 of the seventeen Indian strains shared 97.16% / 98% nt/aa identities with the BTV-
12 strain (12/ZAF_JX272500) from South Africa and showed 95.69/96.42 % and 
96.42/96.95 % nt/aa identities to BTV-12 strains from Taiwan (12/TWN/2003_GU390659) 
and Japan (12/JPN/1990_AB686216) respectively. However, they showed some 
divergence from BTV-12 strains 12/USA/2008_KX164080, 12/USA/2012_KX164090 and 
12/GUF/2011_KC633278 from USA and French Guyana respectively (87.94% / 92.53%, 
88.36% / 93.79% and 87.49% / 92.74% nt/aa identity). 
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Trees are represented as circular (top) and rectangular (bottom) The identified serotype 
BTV-12 of Indian strains sequenced and analysed in this study are shown maroon coloured 
and marked with bold traingle Scale bar, 0.02 nucleotide substitutions per site.  
 
 
 
Figure 5.9 ML unrooted phylogenetic tree of coding region Seg-2/VP2 gene of 
Indian BTV-12 isolates (n=17) during 2014-2015 (Table 5.1) with reference 
strains of BTV-12 from all over the world. 
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5.3 Discussion 
Seven different serotypes of BTV including: BTV-1, BTV- 2, BTV- 4, BTV-5, BTV-9, 
BTV-10 and  BTV-12, were identified by phylogenetic analysis of full ORF Seg-2 in forty 
six Indian BTV isolates (n=46) from  BT suspected outbreaks in Southern India during 
2014-2015. The majority of isolates were confirmed as BTV-5 and BTV-12, seventeen 
isolates each, while the remaining (twelve isolates) were identified as BTV-1 (three 
isolates), BTV-2 (four isolates), BTV-4 (two isolates), BTV-9 (one isolate) and BTV-10 
(two isolates).    
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Phylogenetic analyses have previously established that Seg-2 divides into 27 distinct 
groups precisely representing virus serotype, with sequence identity of 68.4% to 100 % at 
nt and 72.6% to 100 % at aa level within each serotype(Maan et al., 2010, Maan et al., 
2011b, Schulz et al., 2016) .To confirm the findings of RT-PCR typing assays, the coding 
region of Seg-2 from these Indian isolates was sequenced and compared to the reference 
strains of BTV serotypes, BTV-1 to BTV-27 available in GenBank (Figure 5.1). Seg-2 
sequences of putative types BTV-28 in a Sheep pox vaccine preparation from the Middle 
East (Bumbarov et al., 2016), and BTV-29 in an Alpaca from South Africa (Wright, 2014, 
Posada, 2008) available in GenBank are not included in analysis. Three further putative 
types have also been detected: BTV-30, 31 and 32 from ruminants in Mongolia 
(EPIZONE, 2017) .  In each case phylogenetic analysis revealed > 68.4 % nt sequence 
identity with reference strains of the corresponding serotypes, confirming the results of 
serotype-specific Seg-2 real time RT-PCR for serotype identification  (Maan et al., 2010) 
except for isolates [IND2015/2017]547 tissue, [IND2015/] K13, [IND2015/271]7A and 
[IND2015/18] 40, the serotype detected by qPCR was different of that detected by NGS. 
Sequencing studies suggest that geographical separation over an extensive period of time 
along with genetic drift, genetic shift and selection has contributed to genetic heterogeneity 
and the evolution of distinctive regional variants (eastern and western topotype or lineages) 
of BTV strains in different geographic regions/ecosystems. Seg-2 sequences of BTV 
isolates belonging to the same topotype, within each serotype, show nt / aa sequence 
identities of 78.2% to100% / 86.1% to 100% respectively. In contrast nt / aa identity levels 
of 68.4%to75.2% / 72.6%to83.2 % have been demonstrated  in Seg-2 / VP2 ,  respectively 
between the major east / west  topotypes of the same serotype (Maan et al., 2010). 
 Geographical separation has shaped BTV strains into the independently evolving eastern 
and western topotype over an extended period of time as represented by the evolutionary 
distance inferred for each genome segment (Maan et al., 2015c, Carpi et al., 2010). While 
the  aa  and nt sequences of VP2/Seg-2 show two distinct, eastern and western topotypes 
for serotypes BTV-1, BTV-2, BTV-3, BTV-4, BTV-9, BTV-15 and BTV-16, the 
remainder of the 27 BTV serotypes belong solely to either the eastern (BTV-20, BTV-21, 
BTV-23) or as western lineage / topotype (BTV-5, BTV-6, BTV-7, BTV-8, BTV-10, 
BTV-11, BTV-12, BTV-13, BTV-14, BTV-17,BTV-18, BTV-19, BTV-22, BTV-24, BTV-
25, BTV-26, BTV-27). The presence of definite eastern and western topotypes of Seg-2 
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within BTV serotypes BTV-1, BTV-2, BTV-3, BTV-4, BTV-9, BTV-15 and BTV-16, 
suggests that these serotypes diverged and became genetically distinct as a first step, prior 
to their geographic dispersal into different regions/ ecosystems permitting them to acquire 
regionally unique point mutations, producing distinct topotypes within each serotype. 
The serotypes that are restricted to single major topotypes, may have evolved in the same 
region after the early dispersal of different strains. Therefore the existence of more distinct 
BTV serotypes that are restricted to western ecosystems / topotypes, suggests that BTV 
may have originated in the west.   
Seg-2 from the Indian isolates of four serotypes (BTV-1 [IND2015/K13_2015-09-12, 
IND2015/40_2015-12-22 and IND2015/7A_2015-11-08];  BTV-2 [IND2015/K3_2015-
09-10, IND2015/14A_2015-11-08, IND2015/K9_2015-09-10 and IND2015/K14_2015-09-
12]; BTV-4 [IND2015/K4_2015-09-10 and IND2015/6PK_2015-09-07] and BTV-9 
[IND2015/477_2015-12-25]) all showed >87 % nucleotide and > 93 % amino acid identity 
with earlier defined eastern strains of the same serotype, but<75% nucleotide and < 83 % 
amino acid identity to ‘western’ topotype strains of the same BTV serotypes, identifying 
them as ‘eastern topotype’ and indicating their origin from Australasia.  
In contrast Seg-2 from Indian isolates of three serotypes,BTV-5 [IND2015/471_2015-12-
25, IND2015/475_2015-12-25, IND2015/476_2015-12-25, IND2015/478_2015-12-25, 
IND2015/491_2015-12-25, IND2015/492_2015-12-25, IND2015/404_2015-12-25, 
IND2015/408_2015-12-25, IND2015/486_2015-12-25, IND2015/534_2015-12-25, 
IND2015/547_2015-12-25, IND2015/228_2015-12-25, IND2015/CS9_2015-12-25, 
IND2015/V1_2015-11-26, IND2015/V2_2015-11-26, IND2015/V44_2015-11-26 and 
IND2014/10NLG_2014-10-03], BTV-10 [IND2014/BTV1_2014-12-06 and 
IND2014/BTV2_2014-12-06] and BTV-12  [IND2015/22_2015-12-18; 
IND2015/494_2015-12-25; IND2015/406_2015-12-25; IND2015/470_2015-12-25; 
IND2015/472_2015-12-25; IND2015/473_2015-12-25; IND2015/474_2015-12-25; 
IND2015/480_2015-12-25; IND2015/483_2015-12-25; IND2015/484_2015-12-25; 
IND2015/CS4_2015-12-25; IND2015/CS6_2015-12-25; IND2015/34_tissue_2015-12-2; 
IND2015/556_saliva_2015-12-25; IND2015/V41_2015-11-26;  ND2015/V44_lamb_2015-
11-26;  IND2015/V44Severe_2015-11-26] all showed >89 % nt and > 92 % aa identity 
with previously defined western strains of the same serotype, identifying them as members 
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of the ‘western topotype’ and indicating their origin from Africa or America. No BTV-5. 
BTV-10 and BTV-12 strains belonging to the eastern topotypes are available for Seg-2 
based phylogenetic analysis in GenBank.  
BTV strains belonging to different serotypes but the same “Seg-2 nucleotype” are 
characterised by 66.9% to 71.5% nt and 69.4% to 77.8% aa sequence identity (Maan et al., 
2010, Maan et al., 2007a). Comparison of sequences of genome segment-2 from Indian 
isolates generated in this study, with data for Indian BTVs available from GenBank 
(accessed on 01.12.2017) show that the Indian viruses are collectively grouped into eight 
of the eleven “Seg-2 nucleotypes” A, B, C, D, E, G, H and I (Maan et al., 2007a) (Figure 
5.2) and eleven serotypes namely BTV-1, 2, 3, 4, 5, 9, 10, 12, 16, 21 and 23. Phylogenetic 
analyses of Seg-2 of the Indian BTV strains sequenced in this study grouped them into five 
Seg-2 nucleotypes A, E, G, H and I (Maan et al., 2007a) along with the reference strains of 
the same serotype (Figure 5.1). 
A high level of nucleotide sequence identity could be expected for BTV isolates 
originating from a single epizootic, reflecting a common lineage. BT outbreaks were 
reported at approximately the same time (November-December 2015) in Karnataka and 
Tamil Nadu, two adjacent states in southern India (Chapter 3, Figure 3.8).   
Comparison of nt sequences of BTV-5 isolates from Karnataka state 2015, with BTV-5 
strains isolated from Tamil Nadu 2015 and Telangana of 2014 characterised during this 
study, show average nt / aa sequence identities of 99.99% / 99.99 %, supporting the 
conclusion that they are derived from the same Seg-2 lineage and represent a single 
outbreak. This reflects the known interstate migration of small ruminants in India, as well 
as movement of adult Culicoides, providing transmission routes spreading the virus and 
disease. 
The Indian BTV-5 strains cluster together identifying an Indian sublineage with Seg-2 
based nt / aa sequence-identity of 99.99% / 99.99%. Evolution of a distinct Indian sub- 
lineage of BTV-5 Seg-2 is thought likely reflect the geographic separation of these virus 
strains, along with the acquisition of point mutations over a long period of time. Seg-2 of 
these Indian BTV-5 strains is most closely related to BTV-5 strains circulating in recent 
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years in mainland China, with 98.71% / 98.93% nt / aa sequence identity, indicating a 
recent common ancestry. 
 Seg-2 of the Indian and Chinese BTV-5 strains, are also collectively related to African 
BTV-5 strains, sharing average nt and aa identities of 94.96% and 97.77% respectively, 
which indicates that they share of a recent common ancestry strains and suggests the 
introduction of an African-lineage BTV-5 into India. The first report of BTV-5 was from 
South Africa (Howell and Verwoerd, 1971) and  it has subsequently been isolated from 
Cameroon(Ekue et al., 1985b), Nigeria(ReoID, 2017), the United States of America 
(Johnson et al., 2007), the French administrative areas on the Caribbean-island of 
Guadeloupe (Legisa et al., 2014) and most recently from China (Yang et al., 2017) and 
India (Hemadri et al., 2016).The isolation of serotype BTV-5 has recently been reported 
from clinical cases of BT in sheep in Karnataka state during 2010-2011 (Hemadri et al., 
2016) as well as from Telangana state during 2013 (P.P.Rao unpublished data). The 
presence of neutralizing antibodies to BTV-5 was previously reported in India from Tamil 
Nadu, Maharashtra and Gujarat state (Prasad et al., 2009). The studies reported here show 
that BTV-5 was involved in 2014-15 BTV outbreaks in the states of Karnataka, Telangana 
and Tamil Nadu in southern India, indicating the origin of these BTV-5 strains from a 
single virus lineage, and either the re-emergence of a pre-existing strain of Indian BTV-5, 
or (re-)introduction of an exotic strain. No full length Seg-2 sequence data of Indian BTV-
5 isolates other than those sequenced in this study are as yet available from Genbank for 
phylogenetic comparison. 
Following its first identification in South Africa (Gerdes, 2004), serotype BTV-12 has also 
been reported from other African countries such as Egypt (Barsoum, 1992), Cameroon 
(Ekue et al., 1985a), Kenya (Davies et al., 1992, Toye et al., 2013), Nigeria  (Herniman et 
al., 1983) and Zimbabwe (ReoID, 2017). BTV-12 has also been reported from Central and 
South America, including Jamaica , Colombia, Brazil, (Homan et al., 1990, Mo et al., 
1994, Clavijo et al., 2002), Asia, including Japan (Miura et al., 1982),China (Bonneau et 
al., 1999, Kirkland et al., 2002), Taiwan (Lee et al., 2011), Indonesia (Sendow et al., 
1991), and India (Rao et al., 2015, Maan et al., 2017)and the Middle East, including  Israel 
(Golender, 2013).   
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Serological evidence for the presence of BTV-12 antibodies in sheep and cattle have been 
documented in India from Haryana, Gujarat, Maharashtra, Andhra Pradesh, Karnataka and 
Tamil Nadu states (Prasad et al., 2009)and the first isolation of BTV-12 was reported from 
Andhra Pradesh in 2013a (Rao et al., 2015). Recently the circulation of BTV-12 has been 
reported from several states of India including the southern state of Andhra Pradesh in 
2010-2013 (Rao et al., 2016b, Rao et al., 2016a) and the Northern state of Haryana in 
2015-16 (Maan et al., 2017).The seventeen Indian isolates identified as BTV-12 in this 
study, from Karnataka and Tamil Nadu, and are nearly identical, indicating a common 
origin from a single epizootic. This is the first report / time that BTV serotype BTV-12 has 
been isolated in Tamil Nadu and Karnataka (Southern India) from BTV outbreaks in 2015. 
These Indian BTV-12 strains are most closely related to other recent Indian strains 
12/IND/2015_KX905151, 12/IND/2016_MF615238 isolated from Haryana State in 2015-
16, and recent isolates 12/IND/2011_KC662613 from the Adilabad district, Telangana 
State in 2013, showing average nt/aa identities of 99.93% / 100%, 99.89% / 99.8% and 
99.4% / 99.6% respectively, reflecting their origin from a single Seg-2 lineage.  
These Indian BTV-12 strains isolated in 2011 to 2016 (12/IND/2015_KX905151, 
12/IND/2016_MF615238, 12/IND/2011_KC662613), share a high nt sequence-identity (> 
99%) reflecting the circulation and maintenance of the same endemic BTV-12 strain. VP2 
is responsible for essential functions of virus attachment and entry into host cells, defining 
serotype, leading to functional constraints that potentially reduce the level of variation in 
the VP2 Seg-2 (and consequently Seg-2) sequences of these Indian BTV-12 strains over 
the time (Bonneau et al., 1999, Legisa et al., 2013).  
Cattle can act as asymptomatic viral reservoirs, potentially allowing a BTV strain to persist 
in the field for several years (Breard et al., 2003).  Phylogenetic analyses of Seg-2 showed 
that BTV-12 strains from India cluster together, collectively representing an Indian lineage 
that is closely related to BTV-12 strains from South Africa, Taiwan and Japan, with <3.58 
% nt variation overall.  This suggests that all of these BTV-12 strains share a relatively 
recent common ancestry, suggesting that Seg-2 of the Indian strains may be derived from 
an African origin (with <2.84% nt variation). However Seg-2 of the Indian BTV-12 strains 
do diverge from the American BTV-12 strains with an average 12.07 % nucleotide 
diversity. 
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In India, BTV-4 was isolated from Andhra Pradesh and Telangana States sporadically 
during 2007–2012. BTV-4 was also isolated from these states in 2013 during a widespread 
BTV-4 outbreak (Reddy et al., 2018). Serological evidence for presence of BTV-4 
antibodies in sheep has been reported from India in 1973-75 (Prasad et al., 1992, Maan et 
al., 2009).  
BTV-4 has also been reported in Africa (Coetzee et al., 2012a, van den Bergh et al., 2016), 
the Mediterranean region, the Middle East, southern and central Europe (Breard et al., 
2007, Gomez-Tejedor, 2004, Nomikou et al., 2009, Hornyak et al., 2015 , Savini et al., 
2008, Saegerman et al., 2008), USA (Groocock and Campbell, 1982, Price and Hardy, 
1954), Central and South American countries including  Trinidad and Tobago, Barbados, 
Puerto Rico, Dominican Republic, Argentina, Brazil (Balaro and Pituco, 2014 , Lager, 
2004, Legisa et al., 2014, Legisa et al., 2013, Mo et al., 1994) and Australasia, including 
China (Yang et al., 2012). 
Two Indian isolates from sporadic outbreaks in Telangana State during 2015, were 
analysed in this study, showing that they share identical Seg-2 coding sequences and 
identifying them as BTV-4.  This indicates that their Seg-2 has a common origin. These 
Indian BTV-4 strains share a high nucleotide identity of 98.33% to 99.69 % with recent 
BTV-4 strains circulating during sporadic BT outbreak in Andhra Pradesh and Telangana 
States in Southern India during 2007–2013, reflecting continuing circulation of the same 
BTV-4 Seg-2 lineage.  
The Indian BTV-4 isolates cluster closely with a BTV-4 strain from China (>91% 
nucleotide identity), identifying their collective derivation from an eastern Seg-2 topotype, 
showing >91 % nt and >96 % aa identity overall. In contrast, BTV-4 isolates from Africa, 
the Mediterranean region and South America grouped separately, as members of a western 
BTV-4 Seg-2topotype, showing only 71.4% to 72.52 % nucleotide and 79.5-80.65 % 
amino acid identity with the eastern BTV-4 isolates sequenced in this study. 
The first report of BTV-9 was from Africa (Dungu et al., 2004a) and it has subsequently 
been reported from Australia, South East Asia, India (Pritchard et al., 2004, Maan et al., 
2009), the Mediterranean region, central Europe (Maan et al., 2009) and America 
(Sperlova and Zendulkova, 2011 ) 
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BTV-9 was previously reported as responsible for BT outbreaks in Andhra Pradesh during 
2002-2006 (Rao et al., 2012b). The BTV-9 strain isolated during the 2015 BT outbreak in 
Tamil Nadu and analysed here, is most closely related and shares high nt sequence identity 
(> 99%) with other BTV-9 strains belonging to the eastern Seg-2 topotype / lineage of 
BTV-9 from Southern India during 2002-2003. This suggests that this lineage of BTV-9 
Seg-2 has persisted for at least a decade in the region. However, the first time that BTV-9 
was isolated from Tamil Nadu which shares borders with Telangana and Andhra Pradesh 
states was in 2015. This may reflect the interstate migration of ruminants and wind- driven 
movement of Culicoides spp. vectors in this region of India.  
Seg-2 sequences of global isolates of BTV-9 are clearly split them into major eastern and 
western topotypes that reflect the geographic origin of the virus. Indian BTV-9 strains 
belong to the same eastern geographic group as BTV-9 from Australia, Europe and Japan 
but are distinct from the African/American BTV-9 strains which belong to a distinct 
western BTV-9 Seg-2 topotype. The Indian BTV-9 isolates show a close relationship to 
BTV-9 strains from the Mediterranean region (>97% nt identity), raising concerns over 
intercontinental livestock trade. 
BTV-10 was previously isolated in India from Telangana States during 2003 (Gollapalli et 
al., 2012, Rao et al., 2016a)  and in 2004 from Andhra Pradesh (Maan et al., 2012e). 
Serological evidence for the presence of BTV-10 specific antibodies in Indian ruminants 
was reported in 1982 (Maan et al., 2009, Choudhary, 1982, Sriguppi, 1982). BTV-10 has 
also been reported from America (Barber, 1979), Africa (Coetzee et al., 2012a) and the 
French  administrative areas of Martinique and Guyane in the Caribbean (Legisa et al., 
2014).  
Phylogenetic analysis of Seg-2 sequences showed that the Indian BTV-10 isolates 
(IND2014/BTV1_2014-12-06 and IND2014/BTV2_2014-12-06) sequenced in study have 
identical Seg-2 coding regions, indicating their common origin.  Seg-2 of these viruses is 
most closely related to BTV-10 strains from Southern India isolated during 2003-2004 
sharing > 99% nt identity, collectively grouping them within a western / American lineage 
/ topotype of BTV-10 (Fig. 1).  
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The coding region of Seg-2 from the two Indian BTV-10 isolates from the 2014 outbreak 
in  Thanjavur district of Tamil Nadu are identical to each other and to another Indian strain 
of BTV-10 isolated in 2003 from Khamman district, Andhra pradesh 
(10/IND/2003_KP339245), indicating circulation and maintenance of the same BTV-10 
Seg-2 lineage over time. The clustering of Seg-2 of Indian strains of BTV-10 with BTV-10 
isolates from the USA showing >99% nt identity, strongly suggests that BTV-10 was 
introduced to India from the United States. Animals have been imported to India from the 
USA for a breed improvement programme and it is considered possible that they were 
carrying BTV, resulting in the introduction of this exotic BTV-10 topotype. Seg-2 of the 
Indian BTV-10 strains also shares >99% nucleotide identity with the live attenuated 
vaccine strain of BTV-10 (10/USA/1980_U06782) from the United States. This raises 
concerns that the western vaccine strain may have been  introduction / used, either by its 
illegal use in India or by international trade of livestock that were (persistently) infected 
(Maan et al., 2015c, Maan et al., 2012e, Rao et al., 2012a). The level of viraemia in 
ruminants caused by the use of modified attenuated BTV vaccines can be sufficient to 
infect midges feeding on the vaccinated animal and therefore onward virus transmission 
(Batten et al., 2008, Veronesi et al., 2010). In contrast, Seg-2 of BTV-10 isolates from 
South Africa, Martinique and French Guyana in the Caribbean, are more distantly related 
to Indian BTV-10 isolates with 88.71% to 89.24 % nt identity.  
BTV-1 and BTV-2 are endemic in India and are reported to be among the most common 
serotypes circulating  in the country, especially in Northern India (Rao et al., 2016b, 
Biswas et al., 2015, Biswas et al., 2010, Prasad et al., 1994, Jain et al., 1986). The three 
Indian BTV-1 isolates (IND2015/K13_2015-09-12, IND2015/40_2015-12-22 and 
IND2015/7A_2015-11-08) from Telangana, Tamil Nadu and Andhra Pradesh respectively, 
as well as  four Indian BTV-2 isolates from Telangana (IND2015/K3_2015-09-10, 
IND2015/K9_2015-09-10, and IND2015/K14_2015-09-12) and Andhra Pradesh 
(IND2015/14A_2015-11-08) from the 2015 BT outbreaks, cluster closely with the 
Australian  BTV-1 (1/AUS/1979_JN881986)  and BTV-2 strains (2/AUS/2008_JQ086242) 
respectively with average nt/aa identities of >87/94%, indicating in both cases that they 
belong to eastern topotypes. 
Seg-2 of three Indian BTV-1 isolates (IND2015/K13_2015-09-12, IND2015/40_2015-12-
22 and IND2015/7A_2015-11-08) from Telangana, Tamil Nadu and Andhra Pradesh 
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States respectively, during the 2015 BT outbreak, that were sequenced here, share high 
nt/aa sequence identity (> 99 %)  with BTV-1 strains isolated from Southern India isolated 
in 2010 (1/IND/2010_KP339145, 1/IND/2010_KP339135), indicating a close ancestral 
relationship and a common origin. Similarly, the four Indian BTV-2 isolates during the 
2015 BT outbreaks from Telangana [IND2015/K3_2015-09-10, IND2015/K9_2015-09-10, 
and IND2015/K14_2015-09-12] and Andhra Pradesh [IND2015/14A_2015-11-08], 
sequenced in this study, share > 99 % nt/aa identity to each other reflecting their common 
origin and represented an extension of a single outbreak. They are also closely related (> 
99 % nt and aa identity) to recent BTV-2 strains isolated in southern India during 2010 
(2/IND/2010_KP339165). This suggests that geographic separation and acquisition of 
unique point mutations over time, has led to the evolution of a distinct Indian lineages of 
BTV-2 Seg-2. 
This is the first time that BTV-5, BTV-9 and BTV-12 have been isolated from BTV 
outbreaks in Tamil Nadu (Southern India) during 2015. BTV-5 was previously isolated 
from sheep with clinical signs of BT during 2010-2011, and has been reported recently in 
Karnataka state during 2013 (Hemadri et al., 2016) and from Telangana state (P.P.Rao 
unpublished data).  However, no full length sequence of BTV-5 has as yet been reported 
from India. The data presented here represent the first coding region Seg-2 sequence 
comparison of Indian field strains of BTV-5 isolated during 2015, with other BTV-5 
strains from around the world.   
The full length full genome sequences (n=45) were available in Genbank database for BTV 
strains from India. No full Seg-2 ORF sequence data has been reported for BTV-5 from 
India to date. In this study, full ORF of Seg-2 from BTV serotypes BTV-1, BTV-2, BTV-
4, BTV-5, BTV-9, BTV-10 and BTV-12 in 46 BTV field strains isolated during 2014-2015 
from India, with well documented isolation dates, geographical location of sample 
collection and passage histories have been analysed. This study substantially increases 
number of well documented full ORF Seg-2 sequence database of BTV isolates from India. 
At the time of writing, forty five full length full genome sequences of BTV strains from 
India were available in Genbank. The forty six full ORF of Seg-2 of BTV strains 
sequences, from the 2014-2015 BTV outbreaks in Southern India, generated in this study 
increase the number of full length ORF Seg-2 sequence database of Indian BTV strains 
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substantially,  facilitating more robust molecular epidemiological studies of the evolution, 
geographical lineage and spread of BTV in India. 
5.4 Summary 
 The data presented here for genome Seg-2 of forty six Indian isolates of BTV from 
outbreaks in Southern India during 2014-2015, identifies seven different BTV 
serotypes (BTV-1, BTV- 2, BTV- 4, BTV-5, BTV-9, BTV-10 and 12). For isolates 
[IND2015/2017]547 tissue, [IND2015/] K13, [IND2015/271]7A and [IND2015/18] 
40, the serotype detected by qPCR was different of that detected by NGS. BTV 
isolates [IND2015/K13], [IND2015/18] 40 and [IND2015/271]7A and 
[IND2015/2017]547 tissue, the discrepancy in Ct values between the corresponding 
group-specific and serotype-specific qRT-PCR results was noticed. Serotype BTV-
1 (which was not detected by serotype-specific qRT-PCR) was confirmed by 
sequence analysis of BTV isolates [IND2015/] K13, [IND2015/18] 40 and 
[IND2015/271]7A. Low sensitivity to Indian strains/ topotypes due to primer/probe 
mismatching could also result in some mixed infections being missed. The results 
from BTV isolate [IND2015/271]7A (which was typed by serotype-specific qRT-
PCR as BTV-4, but detected as BTV-1 by sequencing) and [IND2015/] K13 and 
[IND2015/18] 40 (which were typed by serotype-specific qRT-PCR as BTV-2, but 
detected as BTV-1 by sequencing) indicate that atleast one mixed infection was 
missed by the serotype-specific rRT-PCR assay. Similarly, BTV isolate 
[IND2015/2017]547 tissue] typed as BTV-10 by qRT-PCR was confirmed BTV-12 
by NGS. Sequencing of the VP2 genes of the Indian BTV isolates would allow 
development of better matched primers and probes and would enable further 
optimization of the serotype-specific rRT-PCR assays for use to identify Indian 
BTV serotypes.   
 Phylogenetic analyses of genome segment 2 of the Indian BTV strains sequenced in 
this study, grouped them into five Seg-2 nucleotypes A, E, G, H and I (Maan et al., 
2007a) along with the reference strains of the same serotypes. 
 Genome Seg-2 from Indian isolates of four serotypes BTV-1, BTV-2, BTV-4 and 
BTV-9, all showed >87 % nt and > 93 % aa identity with earlier, defined eastern 
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strains of the same serotype, identifying them as ‘eastern topotypes’ for Seg-2 and 
indicating their eastern origins. 
 Genome Seg-2 from Indian isolates of three serotypes, BTV-5, BTV-10 and BTV-
12 all showed >89 % nucleotide and > 92 % amino acid identity with previously 
defined western strains of the same serotype, identifying them as ‘western 
topotype’/ introductions. 
 Genome Seg-2 of Indian BTV-5 and BTV-12 strains share a recent common 
ancestry with African-lineage Seg-2 BTV-5 and BTV-12 strains, whereas Indian 
BTV-10 strain sequenced in study share a recent common ancestry with American 
BTV-10 Seg-2 lineage. However, geographical separation has allowed them to 
acquire unique point mutations, which over time has led to the evolution of distinct 
Indian sub-lineages. 
 This is the first time that BTV serotypes BTV-5, BTV-9 and BTV-12 have been 
isolated from the BTV outbreaks in Tamil Nadu (Southern India) during 2015.  
 No full ORF Seg-2 sequence data of serotype BTV-5 has been reported from India 
to date. 
 This study increases the number of well documented full coding sequence of Seg-2 
in the database for BTV isolates from India, by adding forty six full ORF Seg-2 
sequences of BTV strains from India, representing a valuable addition to sequence 
database. 
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 General discussion and future Chapter 6:
work 
6.1 Bluetongue in India 
BT is one of the most important arboviral disease in tropical and subtropical countries of 
the world (Elbers et al., 2008b).  Bluetongue was first reported in Maharashtra state of  
Western India, in 1964 (Sapre, 1964), with subsequent outbreaks reported in other parts of 
the country (Prasad et al., 1992, Sreenivasulu et al., 2004, Ranjan et al., 2015, Prasad et al., 
2009). BT is now considered endemic in India, with overt clinical outbreaks reported 
mostly in rural mixed flocks of native sheep and goats in the Southern states (Karnataka, 
Tamil Nadu, Telangana and Andhra Pradesh)  (Rao et al., 2016b). Since 2001, twelve 
serotypes (BTV-1, BTV-2, BTV-3, BTV-4, BTV-5, BTV-9, BTV-10, BTV-12, BTV-16, 
BTV-21, BTV-23 and BTV-24) of BTV have been identified, mainly in Southern India 
(Rao et al., 2016b, Hemadri et al., 2016, Krishnajyothi et al., 2016). 
A pentavalent inactivated BTV vaccine (Reddy et al., 2010) was developed by the all India 
Network Project on Bluetongue, a partnership supported by the Indian Council of 
Agricultural Research (ICAR), the Government of India and the Tamil Nadu Veterinary 
and Animal Science University (TANUVAS).  The technology was transferred to Indian 
Immunological Limited (IIL), Hyderabad, in February 2011 (www.icar.org.in/node/3516). 
The vaccine was tested from 2010 onwards in five states of Southern India, including 
Maharashtra (a western state), Telangana, Andhra Pradesh, Tamil Nadu and Karnataka.  It 
was subsequently commercialized on 8 January 2015, by Indian Immunologicals Limited 
in Hyderabad, Telangana, as the ‘Raksha Blu’ vaccine (a pentavalent inactivated BTV 
vaccine, containing serotypes BTV-1, BTV-2, BTV-10, BTV-16 and BTV-23). Presently, 
this vaccine is being used in five states of Southern India (including: Maharashtra, 
Telangana, Andhra Pradesh, Tamil Nadu and Karnataka) on a voluntary basis but not as a 
mass vaccination programme. 
 For effective control of BTV, there is a requirement for rapid and accurate diagnosis, to 
support the appropriate and timely vaccination of susceptible populations. It is also 
important to understand the epidemiology of the disease within endemic regions, and in the 
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country as a whole. Routine virological surveillance is very important for identifying 
currently circulating BTV serotypes, to ensure the use of vaccines of the appropriate BTV 
serotypes and strains as part of the BT control program (Rao et al., 2016b). 
The primary objectives of this project include the identification and charcaterisation of 
BTV strains circulating in India, to assess the efficacy of the vaccines used, and their 
impact on the control of homologous and heterologous BTV serotypes in vaccinated 
individuals and in the animal population as a whole. 
6.2 Attending BT field outbreaks from Southern India  
As per the official reports, no BT outbreak was identified in the unified state of Andhra 
Pradesh, during 2014 (AICRP, 2014). However the State of Andhra Pradesh was divided 
into two states, namely Telangana and Andhra Pradesh in June, 2014. In October 2014, 
two suspected BT outbreaks that occurred in sheep flocks that had not been vaccinated 
against BT, were attended as part of this project, following unofficial reports from field 
veterinarians, in the Warangal and Mehboobnagar districts of Telangana. No further 
official outbreak information was available for the present study, either from Telangana, 
2014, or from the All India Coordinated Research Project on Animal Disease Monitoring 
and Surveillance, 2014 (AICRP, 2014). 
According to the Indian Council of Agriculture Research - National Institute of Veterinary 
Epidemiology and Disease Informatics (ICAR-NIVEDI), 13 suspected BT outbreaks were 
reported from 7 districts of Karnataka state, from July to January 2014: including, 
Chikkaballapur, Koppal, Raichur, Bagalkot, Gadog, Davanagere and Tumkur. These 
outrbreaks affected 990 animals and caused 160 deaths in sheep during 2014 (ICAR-
NIVEDI, 2015, AICRP, 2014).  
Despite the official reports of 13 BT outbreaks from Karnataka state in 2014, overall the 
BT outbreaks information from field veterinarians was poorly communicated during 2014. 
This could be due to only sporadic and mild or suspected cases of BT during that year. 
Generally, BT outbreak reporting is poor in India as BT, even though it is a notifiable 
disease, and reporting only occurs when there is a severe problem in the field (ICAR-
NIVEDI, 2013).  
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BT outbreaks were reported in Thoothukudi, Tirunelveli, Karur, Erode, Tiruppur, 
Chengalpattu, Salem, Dindugal, Namakkal, Sivagangai and Kancheepuram districts of 
Tamil Nadu, from November to January 2014-2015 during the north east monsoon 
(http://www.tanuvas.tn.nic.in/lab) (information provided by Pro. K.M.N. Reddy, Head 
of Vaccine Research Centre-Viral Vaccines, Centre for Animal Health Studies Tamil Nadu 
Veterinary and Animal Sciences University, Tamil Nadu).  As part of this study, suspected 
BT cases were investigated during this period, in the Karur, Erode, Tirupur, Chengalpattu, 
Salem and Thoothukudi districts, with twenty five (n = 25) EDTA blood samples collected 
from unvaccinated flocks.  
The annual report from ICAR-NIVEDI for 2010 mentioned that the incidence of 
bluetongue was positively associated with climatic factors, such as temperature, humidity 
and particularly the pattern of monsoons (ICAR-NIVEDI, 2010). Rao and colleagues also 
reported that in Southern India, there is a correlation between BT and climatic conditions, 
with outbreaks following the pattern of the monsoons, which provide conducive breeding 
grounds for the local Culicoides populations involved in BTV transmission (Rao et al., 
2016a). Severe BT outbreaks were reported in Southern India during 2005, which were 
linked with widespread flooding caused by heavy south-west and north east monsoons 
(Rao et al., 2016b, Reddy et al., 2016a, ICAR-NIVEDI, 2013). Similarly, severe BT 
outbreaks in 1989-1990 and 1997-1998 were reported from Tamil Nadu, linked to intense 
north east monsoons and  flooding (Reddy et al., 2016a, Ilango, 2006). 
The BT season is very long in Telangana, northern Andhra Pradesh and Karnataka states, 
with the highest incidence starting with the south west monsoon during August and 
September through to the end of north east monsoon in November to December. In 
contrast, in the Southern interior parts of Andhra Pradesh, south east Karnataka and Tamil 
Nadu, the disease is observed from October to December during the north east monsoon 
(Sreenivasulu et al., 2004). Overall, most outbreaks occur during September to December 
in these four Southern states, indicating that this period of the year is conducive for 
Culicoides breeding.   
There were no ‘official’ BT outbreaks in Telangana during 2014 (AICRP, 2014), which 
may be correlated with a weak south west monsoon that year (Bhan et al., 2015), 
generating an environment that was less-suitable for Culicoides. Although, the south west 
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monsoon was weak, a ‘normal’ north east monsoon in 2014 contributed to BT outbreaks in 
Tamil Nadu and the interior of Karnataka states.  However, only 13 suspected BT 
outbreaks were officially reported from 7 districts of Karnataka state (ICAR-NIVEDI, 
2015, AICRP, 2014).  Thirty five BT outbreaks were reported from Andhra Pradesh in 
2015, with of no official reports of BT outbreaks in 2014 (AICRP, 2014). In contrast, a 
strong northeast monsoon, together with cyclonic storms, caused heavy rainfall in 
November and December during 2015, resulting in floods in Tamil Nadu (Gaitonde and 
Gopichandran, 2016). The moist soil after floods, coupled with ideal wind speeds, 5 
kilometer per hour may have generated a climate that was more suitable compared to 2014, 
for the large scale breeding of Culicoides, resulting in severe outbreaks of BT in the 
interior of Karnataka and Tamil Nadu during late 2015.  The ICAR-National Institute of 
Veterinary Epidemiology and Disease Informatics (NIVEDI) reported 56 BT outbreaks in 
14 districts of Karnataka state, with 120,529 BT suspected cases and 1,4168 fatalities, 
during the months of November and December of 2015, (ICAR-NIVEDI, 2016, AICRP, 
2016), compared to 13 BT outbreaks reported in the previous year (AICRP, 2014).  
Sporadic cases of suspect BT were attended in Warangal, Karimnagar and Medak districts 
of Telangana state during the south west monsoon in September 2015. Severe outbreaks of 
BT were also attended during the  north east monsoon season in: the Anantpur and Chitoor 
districts of southern Andhra Pradesh, during early November 2015; the Chickballapur, 
Devanagere, Tumkure, Kolar and Chikmagalur districts of southeatern Karnataka State, 
during late November 2015; and the Perambalur, Shivagangai, Pudukottai, Tirunelveli, 
Erode and Thoothukudi districts of Tamil Nadu, during mid-December 2015.  
Studies based on ecological factors, extracting weather parameters from outbreak areas, 
statistical analysis involving digital maps of water bodies, rivers, soil type and land cover 
together with meteorological factors such as temperature (Wittmann et al., 2002), rainfall 
and humidity indicate that these factors can all play potentially important roles in the 
incidence and progression of BT outbreaks (Johnson et al., 2006, Jacquot et al., 2017). 
Such studies also help in the further development of a predictive model for disease 
outbreaks, and in planning strategies to forecast and control them (ICAR-NIVEDI, 2010). 
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6.3 Clinical signs in BT suspected cases 
Oral lesions, congested mucosa, coronitis, pyrexia, nasal discharge and salivation were 
among the most frequent clinical signs observed in the affected sheep flocks during the 
2014-15 BT outbreaks, in four Southern states of India (Table 3.1). A swollen cyanotic 
tongue, nasal discharge speckled with blood, submandibular & head oedema, oral mucosa 
bleeding on touch and torticollis were also observed as rare clinical symptoms. However, 
more severe clinical signs were noticed during the outbreaks in Karnataka and Tamil Nadu 
states in 2015.  
This finding may reflect the involvement of more virulent strains of BTV in these 
outbreaks. Waldvogel and colleagues showed that BTV virulence is strain/topotype 
dependent, not serotype dependent (Waldvogel et al., 1986). With multiple BTV strains co-
circulating in the region, it is considered likely that frequent reassortment events would 
have occurred, which may have generated novel genotypes/ strains with more virulent 
phenotypes.  This hypothesis could potentially be confirmed or discounted by further 
phylogenetic analyses of the full genomes of the circulating viruses, to determine the 
parental-origins / topotypes of each genome segment.  
The clinical manifestations of BTV infection are also influenced by several factors related  
to the age, breed, species, immune and reproductive status of the host, as well as 
environmental stress factors and the pathogenicity of the BTV strain involved (Mertens et 
al., 2009). It is therefore unsurprising that the clinical manifestations and disease severity 
during BT outbreaks in 2015, and observed in this study, varied from acute to subclinical 
forms in sheep. However, during this study symptoms were seen to the same degree in 
both vaccinated and non-vaccinated sheep during outbreaks in Tamil Nadu and Karnataka 
states in 2015. Although the goats observed during these outbreaks were mostly 
asymptomatic, some clinical signs including pyrexia, abortion, still-birth and ‘limping’ 
were observed in a few goats in Tamil Nadu, 2015.  
Interestingly ten unvaccinated cattle from Thoothukudi, in a mixed infected population of 
mainly sheep and goat flocks, showed clinical sign of lameness and excessive salivation. 
Mild oral lesions and limping were also evident in three unvaccinated cattle from infected 
mixed flocks, again mainly of sheep and goats in Tirunelveli, Tamil Nadu state during 
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2015.  BT is generally asymptomatic in cattle and the observation of clinical signs in these 
animals suggests the possible involvement of a new strain / genotype or serotype, in naïve 
animals (Dedolli et al., 2017).  
Cattle can act as an asymptomatic reservoir, potentially allowing a BTV strain to persist in 
the field for several years (Breard et al., 2003). Five BTV isolates from cattle were typed 
as part of this study, including: [IND2015/232]556 saliva, as a mono-serotype infection; by 
BTV-12; [IND2015/70]532 from Thoothukudi, Tamil Nadu, 2015, as a dual infection by 
BTV-2 and BTV-12; [IND2015/172]471, as a mono-serotype infection by BTV-5; 
[IND2015/175]472 as a mono-serotype infection with BTV-12; and [IND2015/181]474 
from Tirunehveli, Tamil Nadu, 2015, as a dual infection by BTV-12 and BTV-10.  These 
serotypes, mixed strains and infections may therefore be persistent in the field providing 
further opportunities for multiple genome-segment reassortment-events and the emergence 
of novel strains / genotypes. 
There are reports of clinical symptoms of BT in cattle, including viremia, anorexia, 
hyperemic oral and nasal mucosa, nasal discharge, excessive frothy salivation, coronitis 
and a decrease in milk production (Williamson et al., 2008). Clinical signs of BT can be 
confused with FMD and other vesicular diseases, such as those caused by such peste des 
petits ruminants virus (PPRV), sheeppox virus (SPPV), goatpox virus (GTPV) and Orf 
virus (ORFV), which all have small ruminants and cattle as natural hosts and are endemic 
in India.  These viruses must therefore be excluded in the ‘differential diagnosis’ of BT in 
cattle, goats and sheep (Bexiga et al., 2007). There are also reports of concurrent infections 
of BT and PPR in small ruminants from India (Maan et al., 2017, Biswas et al., 2010, 
Mondal et al., 2013, Mondal et al., 2009). Therefore, reliable laboratory diagnostic tests 
play important role in diagnosis, in order to identify BTV and confirm clinical cases and as 
a basis for implementation of appropriate control measures, e.g vaccination. 
6.4 Serogroup specific qRT-PCR to diagnose BT 
Although, diagnosis based on clinical signs, remains a traditional method for the detection 
and monitoring of BT, this requires well experienced veterinarians for differential 
diagnoses (Bexiga et al., 2007). Furthermore, asymptomatic BT infection in cattle and 
goats can go unnoticed.  Sensitive and specific qRT-PCRs for the detection and 
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quantitation of BTV are therefore important, especially for the positive and reliable 
diagnosis of BTV infections, in a situation where a number of other clinically similar 
infectious diseases, like FMD and PPR occur.  
Chand and colleagues developed a sandwich ELISA (s-ELISA) for the detection of 
bluetongue virus in clinical samples (Chand et al., 2009). However, serological tests are 
cumbersome, time consuming and need production of reference antiserum against purified 
antigens. Furthermore, the use of inactivated BT vaccines, which raise antibodies to all of 
the viral proteins in the host, makes it difficult or impossible to ‘differentiate infected from 
vaccinated animals’ (DIVA) (Maan et al., 2015a). However, RT-PCR assays do not give 
significantly positive signals as a result of vaccination with the inactivated BT vaccines.  
They can therefore be used to detect BTV reliably in clinical samples from infected 
animals, even in the face of inactivated vaccination campaigns (Alpar et al., 2009). Due to 
the persistent viraemia induced, BTV RNA can be detected in previously infected animals, 
for (at least) several weeks by RT-PCR, (Mertens et al., 2009). The real-time RT-PCR 
assays are sensitive and specific, with the ability to quantify viral RNA templates (copy 
number) and importantly, avoid the need for virus isolation. However, the very high 
sensitivity and specificity of qRT-PCR primers and probes can also lead to false negative 
results due to cross contamination in the laboratory, particularly in situations where 
conventional RT-PCR assays have been used and have produced very large amounts of 
viral cDNA. 
Several  serogroup-specific, quantitative real-time RT-PCR (qRT PCR) assays targeting 
different regions of the BTV genome, such as Seg-1 (Shaw et al., 2007, Toussaint et al., 
2007), Seg-5(Jimenez-Clavero et al., 2006, Wilson et al., 2004, Polci et al., 2007, 
Toussaint et al., 2007), Seg-9 (Maan et al., 2015a) and Seg-10 (Orru et al., 2006, Chaignat 
et al., 2009) are available for detection of the virus. However, the specificity and sensitivity 
of RT-PCR assays may be reduced by sequence variations and genomic diversity of BTV 
strains from different  geographic origins (Batten et al., 2008), which have evolved by 
genetic drift, recombination and gene reassortment (Bonneau et al., 2001).  
In this study, the serogroup-specific, real-time RT-PCR assay targeting Seg-9 (Maan et al., 
2015a) and the Seg-10 based assay (Hofmann et al., 2008a) were used to detect BTV in 
clinical samples from the 2014 and 2015 outbreaks respectively. The BTV RNA detection 
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efficiencies and mean Ct values generated were not directly compared for Indian field 
samples, using these assays. However in this study, the Seg-10 based assay appeared to be 
much more effective at detecting diverse BTV strains than the Seg-9 based assay.  
In the present study, the prevalence of BTV in 9 field samples, tested by BTV serogroup-
specific qRT-PCR targeting Seg-9 was 11% (1/9) from the Warangal and Mehboobnagar, 
Telangana BT outbreak in 2014 and was 69.5% (16/25) in 25 samples tested by the Seg-9 
based assay, from the Tamil Nadu BT outbreaks in 2015. However, BTV RNA was 
detected in 21 out of 23 clinical samples (91% , 21/23) (21 EDTA blood and 1 necropsy 
spleen) and all 60 EDTA blood samples (100%, 60/60) from Anantpur and Chitoor district 
of Telangana, in 2015, using the BTV serogroup-specific qRT-PCR targeting Seg-10. The 
prevalence of BTV in 179 field samples (all EDTA blood, except 1 necropsy spleen), 
tested by Seg-10 based qRT-PCR was 44.7% (80/179) from the Karnataka BT outbreak in 
2015, and was 50% (75/150) in 150 samples (143 EDTA blood, 2 saliva and 4 necropsy 
spleen plus 1 lymph node), tested from Tamil Nadu during the 2015 BT outbreaks.  
Overall, the prevalence of BTV in 447 samples collected from the four Southern states, of 
Telangana, Andhra Pradesh, Karnataka and Tamil Nadu during 2014-2015 outbreaks was 
53% (236/447) by BTV serogroup-specific qRT-PCR. The use of the Seg-10 based assay 
to detect BTV in clinical samples, appears to provide a reliable, sensitive and rapid 
diagnostic assay to distinguish BTV infections from other clinically similar diseases and 
therefore to study BTV epidemiology during outbreaks in India. Our findings are in line 
with BTV Seg-10 based qRT-PCR amplification of BTV RNA from clinical samples 
carried out by Brown-Joseph and colleagues (Brown-Joseph et al., 2017).  
The samples that were detected as negative, are thought to be from animals that did not 
have a BTV infection, in spite of presenting with BT- like symptoms. However it is also 
possible that other BTV strains were also circulating in the region that was not detected by 
the standard qRT-PCR assays.  The probes used in real-time PCRs are very sensitive to 
probe-target mismatches (Jimenez-Clavero et al., 2006).  Mutations in the virus genome 
within the primer or probe ‘foot-print’ can therefore result in a ‘mismatch’ in the 
fluorescent probe target region and BTV strains belonging to different BTV serotypes, or 
different topotypes, may go undetected (false-negatives). Such problems might explain the 
lower-sensitivity thought to have occurred with the Seg-9 specific qRT-PCR assay. This 
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highlights the importance of validating the assays for the regional ecosystem and viruses 
for which they will be used and some of the problems that can occur with differential 
diagnosis of BT from other endemic diseases prevalent in the region.  However, the Seg-10 
based assay (Hofmann et al., 2008a) appears to be able  to detect all BTV strains 
(Hoffmann et al., 2009).  
Full length sequence data for the genome segments of the BTV isolates generated in this 
study, will be added to databases to support the development and evaluation of alternative 
primers and probes required for BTV serogroup-specific and serotype-specific RT-PCR 
assays, to ensure their relevance for the typing and detection of  Indian BTV field strains. 
Variations between different BTV topotypes from India make the periodic validation of 
group-specific quantitative real-time RT-PCR assays important for these regions, and may 
require the use of multiplex primer systems.  
BT disease may be present as a long lived subclinical infection in cattle, along with an 
associated viraemia with potential to infect Culicoides, causing transmission of the virus 
and disease (Alpar et al., 2009).  Cattle are also thought to be preferentially bitten by adult 
Culicoides and can serve as a reservoir host for BTV, playing a more important role in the 
transmission of BTV than sheep (Brewer and MacLachlan, 1994).  However, BTV 
infections are frequently  asymptomatic or inapparent in cattle and goats, with severe 
disease mostly restricted to sheep and some wildlife species (Verwoerd and Erasmus, 
2004). 
 Despite their likely role in the maintenance and onward transmission of BTV, vaccination 
of cattle against BT is not considered essential in endemic areas of India. Although sheep 
and goats may be vaccinated against BTV, cattle are ignored in the ongoing pentavalent 
vaccination campaign in Southern India. However, cattle from Thoothukudi (n=10) and 
Tirunelveli (n=3), in Tamil Nadu state, 2015 were found positive by BTV serogroup-
specific qRT-PCR targeting Seg-10.  These results suggest that a more widespread 
vaccination campaign against BTV in cattle might also help to reduce the size and spread 
of BT outbreaks. 
From 2010 onwards, a pentavalent inactivated BTV vaccine was tested in four states of 
Southern India before its commercialization in 2015. Presently, this vaccine against BTV-
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1, BTV-2, BTV-10, BTV-16 and BTV-23, is being used on a voluntary basis although not 
on a massive scale. Farmers are in the practice of vaccinating sheep during October, after 
the rainy season has started (August-September) and after clinical signs of bluetongue 
disease and the outbreaks have started. During this study, it was noticed that many flocks 
in Tirunelveli, Tamil Nadu were vaccinated in December, 2015 after the onset of BT. 
Although this may help to protect the individual vaccinated animals, and none of the 
vaccine serotypes were detected in vaccinated animals, it may be too late to significantly 
reduce the scale or spread of the outbreak.  Keeping these facts in view, it would be 
prudent to adopt a more prophylactic vaccination for BT, on a basis timed to precede the 
seasonal outbreaks.  
The Animal Husbandry and Veterinary Science (AH & VS) departments of each state run a 
mandatory vaccination programme for endemic disease, including Peste des petits 
ruminants (PPR) but this does not include BT. The circulation of multiple BTV serotype in 
Southern India since 2001 emphasizes a need for regular virological surveillance, to 
provide information to support a regular re-evaluation of the serotypes and strain 
composition of the available vaccines. 
In this study, only 3 small flocks that had been vaccinated against BT in the Chikballapur 
district were available for observation and sampling during the 2015 outbreak in Karnataka 
state.  One of these flocks of sheep, in the village Vemgal, Sidlaghatta, Chikballapur 
district of Karnataka State, had been vaccinated with a bivalent inactivated BT vaccine 
containing serotypes 1 and 23. Booster dose was given after 28 days generally. The other 
two flocks of sheep from the village Lakkenahalli, Sidlaghatta, and from the village 
Genjigunte, Sidlaghatta in the Chikballapur district of Karnataka State, 2015 were 
vaccinated with the pentavalent inactivated BT vaccine. These sheep were all vaccinated 
during August with the pentavalent BTV vaccine wth a booster dose given after 28 days of 
primary vaccination.  
To date, no study of BT suspected clinical cases that had previously vaccinated with 
pentavalent inactivated BTV vaccine, has been carried out in India. Six other flocks of 
sheep and goats were vaccinated with the pentavalent inactivated BT vaccine in Tirunelveli 
and one flock of sheep and goats from Erode (Tamil Nadu), highlighting the fact that 
vaccination was not done on a massive scale. Of the 10 samples from BT vaccinated sheep 
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from Karnataka, 2015, all samples were positive by serogroup-specific qRT-PCR targeting 
Seg-10. Of the 37 samples from BT vaccinated sheep and goats in Tamil Nadu during 
2015, 25 samples were positive by serogroup-specific qRT-PCR targeting Seg-10. 
However none of the samples taken from vaccinated animals contained any of the vaccine 
serotypes, suggesting that vaccination may be effective in protecting individual animals 
against the homologous serotypes.   
6.5 Well characterised and documented BTV strains 
In the present study, BTV isolates were made using KC and BHK cells, from well 
documented diagnostic samples, with records of collection date, geographical location, 
coordinates, species and vaccination status of the individual hosts. Overall, 141 BTV 
isolations were made from BTV outbreaks in Southern India: 6 during 2014 from EDTA 
treated blood samples (5 from Tamil Nadu and 1 from Telangana); and 135 during 2015 
from EDTA blood (n=126), tissues [spleen (n=6), lymph node (n=1)] or saliva (n=2).  
Virus isolation represents a gold standard for the identification of BT. In India, BTV 
isolation is usually attempted by yolk sac (Mason et al., 1940) or  intravenous inoculation 
(Goldsmit and Barzilai, 1985) of  clinical samples into embryonated chicken eggs.  This is 
followed by subpassaging  in mammalian cells, usually BHK-21 or Vero cells (Bommineni 
et al., 2008, Gollapalli et al., 2012, Rao et al., 2015, Rao et al., 2012b, Susmitha et al., 
2012)). However, in this study, BTV was isolated by inoculating clinical samples directly 
onto an insect cell line Culicoides sonorensis cells (KC cells) (Wechsler and McHolland, 
1988) followed by adaptation to BHK-21 cells. This greatly increased the success of BTV 
isolation, as  reported by Rao and colleagues (Rao et al., 2016a).  The 141 BTV isolates 
made during the 2014-15 Indian BT outbreaks, were deposited with appropriate virus 
collection numbers in the Veterinary Biotechnology lab, LUVAS, Haryana under the Indo-
UK project titled “Development of diagnostic systems, reference collections and molecular 
epidemiology studies for important arboviral pathogens of livestock in India". Of these, 62 
BTV isolates were serotyped by qRT-PCR assay targetting Seg-2 (Maan et al., 2016) and 
Seg-2 sequencing of 46 BTV isolates by NGS, at the Centre for Virus Research (MRC-
CVR), University of Glasgow. These well characterised and documented BTV strains may 
provide seed stock for relevant vaccine development, or for development and validation of 
diagnostic assays. 
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6.6 Typing of BTV isolates  
The detection of 12 BTV serotypes in India since 2001 (BTV-1, BTV-2, BTV-3, BTV-4, 
BTV-5, BTV-9, BTV-10, BTV-12, BTV-16, BTV-21, BTV-23 and BTV-24), mainly from 
the peninsular region (Maan et al., 2015c), emphasizes the need for a regular re-evaluation 
of the serotype and strain composition of the available vaccines. It is important to know 
which serotypes of BTV are currently circulating in the country and region in order to 
select appropriate vaccine strains to control BT outbreaks, or protect individual vaccinated 
animals. 
 In this study, a combination of BTV virus isolation, followed by serotype-specific real 
time RT-PCR assays for Seg-2, targeting BTV-1 to BTV-24, BTV-26, BTV-27 and BTV-
29 (Maan et al., 2016), were used to analyse 62 isolates from BTV outbreaks in Southern 
India during 2014-2015.  This study detected the circulation of 7 BTV serotypes in four 
Southern states (Telangana, Andhra Pradesh, Karnataka and Tamil Nadu) during the 2014 
and 2015 BTV outbreaks,  including BTV-1, BTV-2, BTV-4, BTV-5, BTV-9, BTV-10 & 
BTV-12, with predominance of BTV-12 (59.7%) followed by BTV-2 (30.6%), BTV-5 
(29%), BTV-4 (11.3%), BTV-10 (8.1%), BTV-9 and BTV-1 each 4.8%  in 62 BTV 
isolates typed by qRT-PCR.These results agree with the findings of several investigators 
who have previously described BT outbreaks involving multiple co-circulating BTV 
serotypes.  
The involvement of multiple circulating serotypes in the same outbreak may be a common 
phenomenon in subtropical regions, where multiple serotypes are endemic and a congenial 
climate exists for the multiplication of Culicoides throughout the year (Rao et al., 2016a). 
Reddy and colleagues previously reported the occurrence of BTV-9 and BTV-10 from 
Andhra Pradesh in 2010 (Reddy et al., 2010). Brenner and colleagues previously reported 
the co-circulation of BTV-4, BTV-8, BTV-16 and BTV-24 in Israel, during 2008 (Brenner 
et al., 2010). 
However, for isolates [IND2015/2017]547 tissue, [IND2015/] K13, [IND2015/271]7A and 
[IND2015/18] 40, the serotype detected by qRT-PCR (Maan et al., 2016) was different to 
that detected by NGS. In these BTV isolates, [IND2015/]K13, [IND2015/18] 40, 
[IND2015/271]7A and [IND2015/2017]547 tissue, a discrepancy was noticed in the Ct 
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values between the corresponding group-specific and serotype-specific qRT-PCR results. 
The Ct value was lower in the group specific assay than in the type specific assay in these 
samples which suggest that there may have been more group specific RNA than type 
specific RNA for a single type, and therefore, more than one serotype in the sample.  
BTV-1 (which was not detected in the serotype-specific qRT-PCR assays) was identified 
by sequence analysis of BTV isolates [IND2015/] K13, [IND2015/18] 40 and 
[IND2015/271]7A. Low sensitivity to Indian strains / topotypes due to mismatches in the 
footprints of the either the primers or probes used in the typing assays, could result in some 
serotypes and mixed infections being missed. The results from BTV isolate 
[IND2015/271]7A (which was typed by serotype-specific qRT-PCR as BTV-4, but 
identified as BTV-1 by sequencing) and [IND2015/] K13 and [IND2015/18] 40 (which 
were typed by serotype-specific qRT-PCR as BTV-2, but identified as BTV-1 by 
sequencing) indicate that at least one mixed infection was missed by the serotype-specific 
rRT-PCR assay. Similarly, BTV isolate [IND2015/2017]547 tissue, typed as BTV-10 by 
qRT-PCR was identified as BTV-12 by NGS.  
Significant sequence variations occurs in Seg-2 of BTV strains that are the same serotype 
but from different geographic origins (different topotypes) (Maan et al., 2009). Full length 
sequence data of the VP2 genes of the 46 Indian BTV isolates sequenced in this study will 
be added to databases to allow development of better matched primers and probes. They 
could also be used in further evaluation of alternative qRT-PCR assays required for the 
serotype-specific qRT-PCR assays to identify Indian BTV serotypes.  These results also 
confirm that there is a need to re-evaluate qRT-PCR assays from time to time, to ensure 
their ability to detect circulating serotypes in the region. The detection of BTV strains that 
were ‘missed’ by qRT-PCR targeting Seg-2 (Maan et al., 2016), is in line with the findings 
of several other studies  (Rao et al., 2016b, Krishnajyothi et al., 2016, Susmitha et al., 
2012, Brown-Joseph et al., 2017). 
One of the BTV field isolates, [IND2015/] 07Karn, from an unvaccinated sheep during the 
2015 BT outbreak in Karnataka state, could not be typed using the serotype-specific 
TaqMan based qRT-PCR assay against BTV-1 to BTV-24, BTV-26, BTV-27 and BTV-29 
(Maan et al., 2016). This may be due to variations in the sequence of the VP2 gene of this 
strain, which is currently circulating in India, leading to a mismatch in the footprints of the 
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either the primers or probes, compared to the sequences of the primarily western reference 
strains used to design the typing assays. However, it is also possible, although less likely 
that this virus represents an entirely novel BTV serotype, or a perhaps novel Seg-2 
topotype of one of the known serotypes.  A similar failure to ‘type’ recently occurred with 
the novel serotypes BTV-25 to BTV-29.  However, the typing of this isolate could be 
achieved by next generation sequencing and phylogenetic comparison of Seg-2 to the 
previously characterised strains. The seg-2 has not yet been sequenced by NGS for this 
isolate to identify its serotype. 
BTV-2, BTV-5, BTV-9, BTV-10, BTV-12 and BTV-16 (Kumar et al., 2016) were 
identified in 24 unvaccinated animals from Tamil Nadu state during the 2014-15 BT 
outbreaks. Reddy and colleagues had previously reported the isolation of BTV-1, BTV-2, 
BTV-16 and BTV-23 from Tamil Nadu, between 2003-2011 (Reddy et al., 2016a). 
However, these strains were isolated before the start of field trails of pentavalent 
inactivated BT vaccination at farmer’s doorstep in 2010 onwards suggesting that these 
strains would not be affected by vaccination programme. BTV-4, BTV-5 and BTV-12 
were also identified during the current project, in 11 sheep and 3 goats that had been 
vaccinated with the pentavalent inactivated vaccine from Tamil Nadu, 2015. The animals 
were vaccinated during August 2015, with booster dose of vaccine after 28 days of primary 
vaccination generally. Clinical samples were taken in BT outbreak, December, 2015, four 
months after primary vaccination.None of the vaccine serotypes (BTV-1, BTV-2, BTV-10, 
BTV-16 and BTV-23) were detected in the vaccinated but infected animals, even though 
BTV-2, BTV-10 and BTV-16 were shown to be actively circulating in the region, 
suggesting that the vaccination may have protected individual animals against the 
homologous serotypes.  
In Telangana state, serotypes BTV-2, BTV-4, BTV-5, BTV-9 and BTV-12 were identified 
in 11 unvaccinated animals, during the 2014-2015 BT outbreaks under study.  BTV-1, 
BTV-2, BTV-4 and BTV-12 were identified in 5 unvaccinated animals in Andhra Pradesh, 
during the 2015 BT outbreaks., BTV-1, BTV-2, BTV-4, BTV-9, BTV-10, BTV-12, 
BTV-16, BTV-21 and BTV-24 had previously been isolated, between 2002 – 2013, from 
Andhra Pradesh and Telangana States (Gollapalli et al., 2012, Krishnajyothi et al., 2016, 
Reddy et al., 2016b, Susmitha et al., 2012, Reddy et al., 2018). During 2002-2013, 
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serotypes BTV-1, BTV-2, BTV-4, BTV-9, BTV-10, BTV-12, BTV-16, BTV-21 and 
BTV-24 were isolated from Andhra Pradesh (Rao et al., 2016b).  
In this study, 22 BTV isolates were derived from 11 sheep and 3 goats from Tamil Nadu, 
and 8 sheep from Karnataka state during 2015, all of which had been vaccinated with the 
pentavalent inactivated BTV vaccine (BTV-1, BTV-2, BTV-10, BTV-16 and BTV-23).   
The 14 BTV isolates from Tamil Nadu were typed as BTV-4, BTV-5, BTV-9 and BTV-12 
(with BTV-12 in 6 isolates, BTV-5 in 4 isolates, and 4 isolates containing mixed 
infections: BTV-12 and BTV-4; BTV-5 and BTV-12; BTV-4 and BTV-9; BTV-4 and 
BTV-12). Again none of the vaccine serotypes were detected in the vaccinated but infected 
animals. 
Similarly, The 5 BTV isolates from animals vaccinated with the pentavalent inactivated 
BTV vaccine and 3 from animals vaccinated with the bivalent inactivated BTV vaccine 
(BTV-1 and BTV-23) during BT outbreaks in Karnataka state during 2015, were typed as 
BTV-4, BTV-5 and BTV-12: BTV-5 in 1 isolate, BTV-12 in 3 isolates and mixed 
infections in 4 isolates (including  3 isolates of BTV-5 and BTV-12,  and 1 isolate of BTV-
4, BTV-12). Again none of the vaccine serotypes were detected in the vaccinated but 
infected animals, although vaccination did not appear to influence the wider circulation of 
these serotypes in the unvaccinated population.  
A future study performed on a larger scale could help to strengthen these findings to show 
the efficacy of vaccination against different BTV serotypes. However, no final conclusions 
can currently be made because of small sample size from vaccinated animals, the relatively 
small scale of the vaccination programme and the short duration of the present study after 
the start of vaccination use.  
BTV-4, BTV-5 (a rare serotype in India) and BTV-9 were identified for the first time, in 
Tamil Nadu, during outbreaks in 2014-2015, along with and BTV-4 identified in 
Karnataka state during the 2014-2015. This study also confirms the frequent occurrence of 
dual or triple serotype mixed infections within the same animal.  
Guimaraes and colleagues have reported co-circulation of multiple serotypes involving 
BTV-1, BTV-4 and BTV-17 in an outbreak in Brazil during 2014, as well as triple or dual 
co-infections with these serotypes within the same animal (Guimaraes et al., 2017). 
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Recently dual infection by BTV-2 and BTV-5 has been reported in a sheep from 
Karnataka, in 2010 (Hemadri et al., 2016). Co-infection with multiple BTV serotypes 
poses the risk of the generation and emergence of novel reassortant BTV strains that could 
have distinct properties in terms of infectivity and pathogenicity (Maan et al., 2012d, Maan 
et al., 2015b, Shafiq et al., 2013).  
BT outbreaks in India can be dominated by a single  serotype for a number of years before 
its dominance changes: for example BTV-12 has been shown to circulate in Telangana and 
Andhra Pradesh since 2010 (Rao et al., 2016a). BTV-1 and BTV-10 in 2003, BTV-1 again 
from 2006-11, BTV-2 in 2007 -10, BTV-4 from 2007-13, BTV-9 from 2002-07, BTV-16 
from 2007-11 (Rao et al., 2016a). Continuous surveillance is required for proper 
identification and characterization of BT serotypes and topotypes circulating in the 
endemic regions. The results presented here confirm the persistant circulation of BTV 
serotypes, BTV-1, BTV-2, BTV-4, BTV-5, BTV9, BTV-10 and BTV-12 in Southern India 
during the 2014-15 BT outbreaks. These data could be used to update and ensure the 
design and implementation of relevant vaccines (containing the most appropriate serotypes 
/ strains) as part of effective control measures for BT outbreaks. 
6.7 Seg-2 based phylogenetic analysis of 46 Indian BTV strains 
from Southern India, 2014-15 
Phylogenetic analysis of the full ORF of Seg-2 identified 7 BTV serotypes: BTV-1, BTV- 
2, BTV- 4, BTV-5, BTV-9, BTV-10 and BTV-12 in 46 Indian BTV isolates from BT 
suspected outbreaks in four Southern states of India: Telangana, Andhra Pradesh, 
Karnataka and Tamil Nadu, during 2014-2015. The majority of BTV isolates were 
confirmed as BTV-5 and BTV-12, 17 isolates each, while the remaining 12 BTV isolates 
were identified as: 3 BTV-1, 4 BTV-2, 2 BTV-4, 1 BTV-9 and 2 BTV-10. In each case, 
phylogenetic analysis revealed > 68.4 % nt sequence identity with reference strains of the 
corresponding serotypes. These relatively high levels of sequence variation may reflect the 
fact that most of the reference strains for individual BTV serotypes were originally derived 
from South Africa and consequently belong to western topotypes, while most Indian 
strains belong to the major eastern topotype. It also suggests that it would be helpful to 
indentify specific eastern strains of each serotype that could be used as reference strains for 
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eastern topotypes (such as the isolates identified here). However, in most cases these 
sequencing and phylogenetic analysis confirmed the results of serotype-specific Seg-2 
qRT-PCR used for serotype identification (Maan et al., 2016) except for isolates 
[IND2015/2017]547 tissue, [IND2015/]K13, [IND2015/271]7A and [IND2015/18]40, 
where the serotype detected by qPCR was different of that detected by NGS. The BTV 
isolate [IND2015/271]7A was typed by serotype-specific qRT-PCR as BTV-4, but 
detected as BTV-1 by sequencing. Similarly, [IND2015/] K13 and [IND2015/18] 40 were 
detected as BTV-1 by sequencing, although typed by serotype-specific qRT-PCR as BTV-
2. Similarly, BTV isolate [IND2015/2017]547 tissue typed as BTV-10 by qRT-PCR was 
confirmed BTV-12 by NGS. 
Seg-2 from the Indian isolates of BTV serotypes BTV-1, BTV-2, BTV-4 and BTV-9 all 
showed >87 % nucleotide and > 93 % amino acid identity with earlier defined eastern 
strains of the same serotype, identifying them as ‘eastern topotype’ and indicating their 
origin from Asia or Australasia. In contrast Seg-2 from Indian isolates of serotype, BTV-5, 
BTV-10 and BTV-12, all showed >89 % nt and > 92 % aa identity with previously defined 
western strains of the same serotype, identifying them as members of the ‘western 
topotype’ and indicating their common origin and possible introduction from from Africa 
or America.  
Seg-2 of 3 Indian BTV-1 isolates, 1 each from Telangana, Tamil Nadu and Andhra 
Pradesh States respectively, during the 2015 BT outbreak, share high nt/aa sequence 
identity (> 99 %) with BTV-1 strains isolated from Southern India in 2010 
(1/IND/2010_KP339145, 1/IND/2010_KP339135), indicating a close ancestral 
relationship and a recent common origin. Similarly, 4 Indian BTV-2 isolates during the 
2015 BT outbreaks (3 from Telangana and 1 from Andhra Pradesh, sequenced in this 
study) share > 99 % nt/aa identity to each other, reflecting their common origin and 
represented an extension of a single outbreak. They are also closely related (> 99 % nt and 
aa identity) to recent BTV-2 strains isolated in southern India during 2010 
(2/IND/2010_KP339165). This suggests the persistence of this virus or at least of this 
lineage of Seg-2 in the field for over 5 years. 
Two Indian isolates from sporadic outbreaks in Telangana State during 2015 share 
identical Seg-2 coding sequences indicating a common origin. These Indian BTV-4 strains 
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also share a high nucleotide identity of 98.33% to 99.69 % with previously sequenced 
BTV-4 strains circulating during sporadic BT outbreak in Andhra Pradesh and Telangana 
States in Southern India during 2007–2013, (Reddy et al., 2018) again reflecting the 
continuing circulation of the same BTV-4 Seg-2 lineage.  
Nucleotide sequences of BTV-5 isolates from Karnataka 2015, Tamil Nadu 2015 and 
Telangana 2014 generated during this study are almost identical, supporting the conclusion 
that they are derived from the same Seg-2 lineage and represent a single outbreak. 
Serological evidence for the presence of neutralizing antibodies to BTV-5 was previously 
reported from Tamil Nadu, Maharashtra and Gujarat state (Prasad et al., 2009). BTV-5 has 
recently also been reported from clinical cases of BT in sheep in Karnataka state during 
2010-2011 (Hemadri et al., 2016) as well as from Telangana state during 2013 (P.P.Rao 
unpublished data). These studies show the origin of Seg-2 of these BTV-5 strains from a 
single lineage. Seg-2 of the Indian and Chinese BTV-5 strains, is also relatively closely 
related to African BTV-5 strains, sharing average nt and aa identities of 94.96% and 
97.77% respectively, which indicates that they share of a recent common ancestry 
(belonging to the same topotype) and suggests the introduction of an African-lineage BTV-
5 into India (or possibly vice versa). 
BTV-9 was previously reported as responsible for BT outbreaks in Andhra Pradesh during 
2002-2006 (Rao et al., 2012b). The BTV-9 strain isolated during the 2015 BT outbreak in 
Tamil Nadu and analysed here, is most closely related and shares high nt sequence identity 
(> 99%) with other BTV-9 strains belonging to the eastern Seg-2 topotype / lineage of 
BTV-9 from Southern India, during 2002-2003. This suggests that this lineage of BTV-9 
Seg-2 has persisted for at least a decade in the region. However, the first time that BTV-9 
was isolated from Tamil Nadu, which shares borders with Telangana and Andhra Pradesh 
states, was in 2015. This may reflect the interstate migration of ruminants or wind- driven 
movement of Culicoides spp. vectors in this region of India. The Indian BTV-9 isolates 
show a close relationship to BTV-9 strains from the Mediterranean region (>97% nt 
identity), raising concerns over intercontinental livestock trade / wider-movements of adult 
Culicoides. 
The coding region of Seg-2 from the two Indian BTV-10 isolates, from the 2014 outbreak 
in  Thanjavur district of Tamil Nadu are identical to each other and to another Indian strain 
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of BTV-10 isolated in 2003 from the Khamman district, Andhra Pradesh 
(10/IND/2003_KP339245). This indicates the circulation and maintenance of the same 
BTV-10 Seg-2 lineage over time. Seg-2 of these viruses is most closely related to BTV-10 
strains from Southern India isolated during 2003-2004 which share > 99% nt identity, 
collectively grouping them within a American topotype of BTV-10. The clustering of Seg-
2 of Indian strains of BTV-10 with BTV-10 isolates from the USA showing >99% nt 
identity, strongly suggests that this lineage of BTV-10 was introduced to India from the 
United States.  
Animals have been imported to India from the USA for a breed improvement programmes 
and it is considered possible that they were carrying BTV, resulting in the introduction of 
this exotic BTV-10 topotype. Seg-2 of the Indian BTV-10 strains also share >99% 
nucleotide identity with the live attenuated vaccine strain of BTV-10 
(10/USA/1980_U06782) from the United States. This raises concerns that the western 
vaccine strain may have been introducted by illegal use of the vaccine in India, or by 
international trade of livestock that were (persistently) infected with the vaccine strain 
(Maan et al., 2015c, Maan et al., 2012e, Rao et al., 2012a). 
17 Indian BTV isolates from BTV outbreaks Karnataka and Tamil Nadu states during 
2015, were identified as BTV-12 in this study, with nearly identical Seg-2 sequences, 
indicating a common origin from a single epizootic. This is the first time that BTV 
serotype BTV-12 has been isolated in Tamil Nadu and Karnataka (Southern India). These 
Indian BTV-12 strains are also closely related to BTV-12 isolates from Haryana State in 
north India during 2015-2016  as well as recent isolates 12/IND/2011_KC662613 from the 
Adilabad district of Telangana State in 2013, with average nt/aa identities of 99.93% / 
100%, 99.89% / 99.8% and 99.4% / 99.6% respectively. This again reflects a common 
ancestry with a single Seg-2 lineage, suggesting the circulation and maintenance of the 
same endemic BTV-12 strain for several years. Phylogenetic analyses of Seg-2 showed 
that BTV-12 strains from India cluster together, as an Indian lineage that is closely related 
to BTV-12 strains from South Africa, Taiwan and Japan, with <3.58 % nt variation overall.  
This demonstrates that all of these BTV-12 strains belong to the same Seg-2 topotype and 
share a relatively recent common ancestry, suggesting that Seg-2 of the Indian strains may 
be derived from an African origin (with <2.84% nt variation) or vice versa. 
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This is the first time that BTV-5, BTV-9 and BTV-12 have been isolated from BTV 
outbreaks in Tamil Nadu during 2015. The data presented here represent the first coding 
region Seg-2 sequence comparison of the Indian field strains of BTV-5 isolated during 
2015, with other BTV-5 strains from around the world. No full Seg-2 ORF sequence data 
has previousaly been reported for BTV-5 from India.  
 In this study, the full ORF of Seg-2 from BTV serotypes BTV-1, BTV-2, BTV-4, BTV-5, 
BTV-9, BTV-10 and BTV-12 in 46 BTV field strains isolated during 2014-2015 from 
India, along with well documented isolation dates, geographical location of sample 
collection and passage histories have been analysed. This study substantially increases the 
number of well documented full ORF Seg-2 sequences in the database of BTV isolates 
from India. At the time of writing, forty five full length full genome sequences of BTV 
strains from India were available in Genbank. The data for forty six ORF of Seg-2 from 
different Indian BTV strains, from the 2014-2015 BTV outbreaks in Southern India, that 
were generated in this study, substantially increases the number of full length Seg-2 ORF 
in the sequence database for Indian BTV strains.  These data, aliong with the analyses of 
the remainder of the genomes of these viruses that is still ongoing in Glasgow will 
facilitate more robust molecular epidemiological studies of the evolution, reassortment, 
geographical lineages and spread of BTV in India. 
6.8 Future work 
 The full genome sequencing and analyses is still ongoing in Glasgow. Sequencing 
and phylogenetic analyses of the entire BTV genome has helped in understanding 
the origins, lineage/topotype of each genome-segment as well as the evolution and 
emergence of reassortant strains. The presence of multiple circulating BTV 
serotypes in India provides multiple opportunities for reassortment between  BTV 
strains that could have distinct properties in terms of their infectivity and 
pathogenicity (Maan et al., 2012d, Maan et al., 2015b, Shafiq et al., 2013). 
 Bluetongue virus evolution occurs through the a mechanism that involves 
circulation as a ‘quasispecies’ driven by accumulation of mutations (genetic drift), 
and reassortment (genetic shift), intra-segment recombination and 
concatermerisation (gene duplication), although the latter two mechanisms are 
thought to be relatively rare but significant outcomes (Carpi et al., 2010, Maan et 
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al., 2012c, He et al., 2010, Anthony et al., 2011, Coetzee et al., 2012b, Mohd Jaafar 
et al., 2014, Nomikou et al., 2015, Shafiq et al., 2013, Bonneau et al., 2001, Oberst 
et al., 1987, Stott et al., 1987, Shaw et al., 2013, Batten et al., 2008). 
 Significant sequence variations occurs in Seg-2 of BTV strains from different 
geographic origins (topotypes) that belong of the same serotype (Maan et al., 
2009). Therefore, close monitoring of circulating BTV strains and BTV typing by 
serotype-specific TaqMan based qRT-PCR assay is important to ensure that the 
assays used in regular virological surveillance and to assess the molecular 
epidemiology of BT in India, remain relevant to currently circulating strains. The 
full-length sequence-data of the VP2 genes from the 46 Indian BTV isolates 
sequenced in this study will be used for the design of better ‘matched’ primers and 
probes and will support the further evaluation of hese alternative primers and 
probes for use in  serotype-specific qRT-PCR assays to detect, identify and 
distinguish Indian BTV serotypes.  
 The ICAR-NIVEDI annual report 2010 mentioned that the incidence of bluetongue 
is positively associated with climatic factors such as temperature, humidity and 
particularly the pattern of monsoons (ICAR-NIVEDI, 2010). Rao and colleagues 
reported that in Southern India, there was a correlation between BT outbreaks and 
climatic conditions, with BT particularly following the pattern of monsoons (Rao et 
al., 2016a) which provide conducive breeding grounds for the local Culicoides 
population that is involved in BTV transmission. Studies based on ecological 
factors, extracting weather parameters from outbreak areas, statistical analysis 
involving digital maps of water bodies, rivers, soil type and land cover, together 
with meteorological factors such as temperature, rainfall and humidity, will further 
help in the development of predictive models for the disease, and in planning 
strategies to forecast BT outbreaks well in advance.  
 In the present study, the small sample size from vaccinated animals demands a 
future study on a larger scale to show the efficacy of vaccination against different 
BTV serotypes, not only in terms of protecting individual animals against infection 
and clinical disease, but also in terms of its effect on the incidence and spread of 
the vaccine serotypes and protection of the animal population as a whole.  
The currently circulating serotypes BTV-4, BTV-5, BTV-9 and BTV-12 detected in 
present study are not present in the pentavalent inactivated BT vaccine and could 
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be included to make it more currently relevant, replacing serotypes that were not 
commonly found in the most recent outbreaks (such as BTV-23 & BTV-16).  The 
current study suggests that the vaccine is effective in individual animals and if the 
results of virological surveillance could be linked to the composition of the vaccine 
(which serotypes it contains) and if it was increased in scale (possibly even 
including cattle), vaccination could become more effective and may even help to 
reduce the circulation of these serotypes in the animal population as a whole.  
 Routine virological surveillance is very important for identifying currently 
circulating BTV serotypes to ensure the use of available vaccines of the appropriate 
BTV serotype and strain composition in the BT control program.   
 Further extensive studies involving large numbers of clinical cases that are 
suspected BT are needed to fully understand the severity and clinical presentation 
of dual or multiple mixed BT infections. 
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 List of primers and probes for serotype-specific qRT-PCR Appendix 1
(Maan et al., 2016) 
£
Primer name Primer sequence 5’ to 3’ 
BTV-1/2575-2597Fw GTATTTCTGAYGGTATTGTYTGG 
BTV-1/1599-1623Fe GCYAAATTRCGAATCAARCATRGYG 
BTV-1/2653-2633Rw TCATCAGATACCTCGATCGCT 
BTV-1/1711-1689Re GTTARCCTCTGCAAYACAATAGG 
BTV-2/1401-1421Fw GATGAYRYAARTAYTCTGAG 
BTV-2/60-81Fe GAGCATTTGTTGAAARGTTATG 
BTV-2/1528-1503Rw GYATCYYTTTCGAARTCRATTGTRAG 
BTV-2/170-148Re GATATCRAAYGCGTACATYTCTG 
BTV-3/S2/619-640Fw GARCGGTTRTCRACGGAWGARG 
BTV-3/S2/718-694Rw TATCRTAAGCGTTATCTCCTARCYG 
BTV-4/S2/2470-2488F2 GAACACGAAGATATCGCAG 
BTV-4/S2/2557-2532R2 GCATARAGAAGCTARATGTATCTTCA 
BTV-5/S2/08-26Fw GCTTCTCAGGATGGATGAG 
BTV-5/S2/101-79Rw CARRTCRAYCTTAAYRTCRTAYC 
BTV-6/2001-2023F GTCGATGTYACACAGTTGATCGT 
BTV-6/2112-2090R TAGCACGTCTAATCGTTTCTATG 
BTV-7/S2/1608-1631Fw AGTATGTGAGACGTCAATCTCAGA 
BTV-7/S2/1704-1682Rw GTCTAATAGGTCCGCAGCTTTAG 
BTV-8/72-93Fw GATGGRTATGATTACATCATTG 
BTV-8/159-138Rw GAATTYCTGTYACATCGTGTCG 
BTV-9/1673-1694Fw GGTTATGCTTCAATTACGAACG 
BTV-9/1706-1724Fe GTATGATACCAGGCCAGCG 
BTV-9/1779-1756Rw GGGTCTTATGTAGGGATGTCTGTG 
BTV-9/1803-1783Re GTTCATTTTGAGGATCATCCA 
BTV-10/S2/1470-1488Fw TATTRACWACWGAACCAAACCT 
BTV-10/S2/1577-1557Rw GYGARTTRATCCRTTTGTCAT 
BTV-11/S2/1510-1530Fw GGATGCGYAYYTGAATATTAG 
BTV-11/S2/1617-1596Rw ATCTCTCCATGAGTTATTCGCA 
BTV-12/S2/999-1019Fw ATACAATTCAGGCTATCCRGA 
BTV-12/S2/1136-1116Rw CAATGATYGTTCCTCGTAAGC 
BTV-13/S2/1147-1169Fw GGTGACGTYTATTATAAATTGCG 
BTV-13/S2/1225-1207Rw GGCGATCCARATCYCGWGG 
BTV-14/S2/2616-2636Fw GCCATTGARTTTTCTGAYGAYAG 
BTV-14/S2/2758-2734Rw TCWGTATAYGCCTTAACYGCTCT 
BTV-15/S2/29-47Fw CCTGTGAGCGTGATCGAAC 
BTV-15/S2/177-156Rw CTTACACCTATGTTTCGCACTC 
BTV-16/1221-1243Fw GCGAGAGCAAGAGAAGTATATCG 
BTV-16/1193-1213Fe GACCTGAATATAAACCGCGAG 
BTV-16/1337-1319Rw GATGTTCGATACGTCTGGG 
BTV-16/1320-1297Re ATTAATCAATTCGTACTCCCAGTG 
BTV-17/S2/2178-2202Fw TGCTRAAAGAGATCAAATTTGTRCGG 
BTV-17/S2/2315-2295Rw ACTTGATCGTATCGTCAAACA 
BTV-18/S2/357-381Fw GATTATCAACCACTTAAGGTCGACG 
BTV-18/S2/451-425Rw GCTCTCTTTGCGTGTAACCTTACCGTG 
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BTV-19/S2/2313-2336Fw AGTGTTGRTATCRCATAAATTACG 
BTV-19/S2/2410-2379Rw GGAAAGTYAGATGCGAAATYARRGAAGTCAAT 
BTV-20/S2/1838-1856Fw GCAATATGTCCGCATGCTG 
BTV-20/S2/1928-1909Rw GCTCCGGGCTTAATTTTTCG 
BTV-21/S2/1584-1603F GCCAGATTAAAGATAACGCA 
BTV-21/S2/1686-1669R GTAAATCGATAGGGTCCG 
BTV-22/S2/1013-1032Fw ATCTCAAGCGGTCAAACAGA 
BTV-22/S2/1124-1148Rw CCATTTCACAYGCTATTATAGTTCC 
BTV-23/S2/60-81F GCGGARYTGTTAGATGGCTATG 
BTV-23/S2/148-126R GGAATTTGWGYRACRTCATGACG 
BTV-24/S2/1901-1919Fw GAACTAYGAGAAGCTTAYR 
BTV-24/S2/2016-1994Rw GCGAAAARTCYYTCATATCTA 
BTV-25/S2/2554-2571F TTATCGGACTCGCTCGTT 
BTV-25/S2/2644-2622R GTGGATTCAACTTATTATCTCCG 
BTV-26/S2/1752-1771F1 GTTATAGGCAGCAGCAATCT 
BTV-26/S2/1849-1831R1 GCATATATCCCTTTCACCT 
BTV-27/S2/1334-1354F GCAAATCACAAGAAAAAGAAG 
BTV-27/S2/1450-1423R GTAACTTCAAGCTTTCCTGGCG 
BTV-29/S2/1502-1522F GAAAAGAACATCTTCAACATG 
BTV-29/S2/1642-1615R GATCTCAGTCGTGGTTACTCT 
BTV-4/S2/1379-1400Fe TTGTGTAAAGTGGATGAGGAGA 
BTV-4/S2/1504-1477Re GAAGTCTATCGTCAAAAGGTTAGGGGCT 
  
  
Probe name Probe sequence 5’to 3’ 
BTV-1/2604-2627Pw CCGATCACACATCCGAACAAATGC 
BTV-1/1632-1662Pe CAACGACRGAAYGATGAYCCRATGGTGAAAC 
BTV-2/1455-1428Pw CATTCCATCCACCATCTATAATTTCCCC 
BTV-2/116-139Pe CCAAGATGGCCGACATGACGTATC 
BTV-3/S2/656-688Pw CYCCRCAGTTTCAYACAATACAGAGGAACCATC 
BTV-4/S2/2502-2529P2 TACCTGTTGTGACRTCCAAGTTGGACAC 
BTV-4/S2/1454-1430Pe CCGCTCTTGATCCCACCCACCTTGA 
BTV-5/S2/36-61Pw CCGATWTTKCGRTCGAGCCAAGTTCC 
BTV-6/2086-2061P CACCTTGAYTCATCCACACTACGAAC 
BTV-7/S2/1635-1660Pw CCACAATCTAGACCCGGCAATATCGC 
BTV-8/132-106Pw CGGGCTCATCACCTTCCTCTTCAACAC 
BTV-9/1703-1727Pw CTTATATGACACTCGCCCTGCCATC 
BTV-9/1735-1762Pe CAACCCTATCAATGAGACAACGCCAGAC 
BTV-10/S2/1519-1552Pw YCTTGGYNCGCGYTCTGAATTAGTATTYCCRCCY 
BTV-11/S2/1540-1573Pw YGTGCTCCCAAGTTATTTCGATCAATGGATCTAC 
BTV-12/S2/1101-1077Pw CTCCACCATATGCGCCAACGATAGC 
BTV-13/S2/1206-1175Pw CTTATATCCCTCACGTACGCTCCAYTCATACC 
BTV-14/S2/2663-2683Pw CCGGCTTCGCGCGAGRTTYCC 
BTV-15/S2/130-105Pw CCCTCCCGATAAAGCGACCATATTCC 
BTV-16/1291-1264Pw CCTTCGTTGCTGGCTCTCCCTCTAGATC 
BTV-16/1291-1264Pe CCTTCGTTGCRGGCTCTCCTTCTAAGTC 
BTV-17/S2/2224-2254Pw CCTCCCTCTGATGTTCCTTGTTCATGATAAC 
BTV-18/S2/387-414Pw CATGTACCATCACGGATAAGCCACGCCC 
BTV-19/S2/2378-2346Pw CCAAACCTATTATARTACGCACCRAGCTCAACC 
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BTV-20/S2/1876-1902Pw CCGTAAAACCGCTTTGATGCTGATGGC 
BTV-21/S2/1613-1636P CGCTCAACGTAAAGCAGATGACCC 
BTV-22/S2/1101-1077Pw CTCCACCAGATACGCCACCGATAAC 
BTV-23/S2/92-118P CGAYGTAAGCACACGYATCGATGAACC 
BTV-24/S2/1944-1973Pw CATCAGACTTACAYGCACCCGAARATAAAY 
BTV-25/S2/2576-2605P CCCTCCCAATAACACATCCAGAGAAGTGCC 
BTV-26/S2/1796-1827P1 CGAGAGGACTTCGCTATGCTAACACATTACGC 
BTV-27/S2/1392-1420P CAACGGCATGCGTGATGATATTATACGGC 
BTV-29/S2/1541-1572P CATCTCGATAACCGCAATCACCTAGTGATGCC 
£  
To detect serotypes BTV-1 to BTV-27 and BTV-29. 
Abbreviations: F, Forward primer; R, Reverse primer; P, Probe; w, Western; e, Eastern. 
 
 
 
 
 
 
 
.
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 Details of BTV isolates from Southern India, 2014-15. Appendix 2
S.No. Virus collection number 
*Ct 
value 
Vaccination 
status Place of sampling Isolation date 
Host 
spp Sample 
        
1. [IND2015/03]2 29 UV Kayathar,Thoothukudi, TN 20/04/2016 S B 
2. [IND2015/06]8 30 UV Kayathar,Thoothukudi, TN 20/04/2016 S B 
3. [IND2015/09]12 31 UV Kayathar,Thoothukudi, TN 20/04/2016 S B 
4. [IND2015/12]14 30 UV Kayathar,Thoothukudi, TN 20/04/2016 S B 
5. [IND2015/15]22 29 V Kayathar,Thoothukudi, TN 21/04/2016 S B 
6. [IND2015/18]40 30 UV Kayathar,Thoothukudi, TN 21/04/2016 G B 
7. [IND2015/21]36 36 UV Kayathar,Thoothukudi, TN 20/04/2016 S B 
8. [IND2015/23]34 30 UV Kayathar,Thoothukudi, TN 20/04/2016 S B 
9. [IND2015/26]42 23 V Kayathar,Thoothukudi, TN 21/04/2016 S B 
10. [IND2015/29]52 30 V Kayathar,Thoothukudi, TN 21/04/2016 S B 
11. [IND2015/33]54 26 V Kayathar,Thoothukudi, TN 21/04/2016 S B 
12. [IND2015/36]56 30 V Kayathar,Thoothukudi, TN 21/04/2016 S B 
13. [IND2015/40]62 28 V Kayathar,Thoothukudi, TN 21/04/2016 S B 
14. [IND2015/44]68 30 UV Kayathar,Thoothukudi, TN 21/04/2016 S B 
15. [IND2015/47]70 31 UV Kayathar,Thoothukudi, TN 20/04/2016 S B 
16. [IND2015/50]72 27 UV Kayathar,Thoothukudi, TN 21/04/2016 S B 
17. [IND2015/53]76 30 UV Kayathar,Thoothukudi, TN 21/04/2016 S B 
18. [IND2015/56]80 29 UV Kayathar,Thoothukudi, TN 21/04/2016 S B 
19. [IND2015/59]98 31 UV Kayathar,Thoothukudi, TN 21/04/2016 S B 
20. [IND2015/62]100 31 UV Kayathar,Thoothukudi, TN 20/04/2016 G B 
21. [IND2015/64]530 31 UV Ottadanpathi, Thoothukudi, TN 08/04/2016 C B 
22. [IND2015/67]531 32 UV Ottadanpathi, Thoothukudi, TN 08/04/2016 C B 
23. [IND2015/70]532 33 UV Ottadanpathi, Thoothukudi, TN 08/04/2016 C B 
24. [IND2015/73]533 32 UV Ottadanpathi, Thoothukudi, TN 20/04/2016 C B 
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25. [IND2015/76]534 33 UV Ottadanpathi, Thoothukudi, TN 21/04/2016 G B 
26. [IND2015/79]535 28 UV Ottadanpathi, Thoothukudi, TN 08/04/2016 G B 
27. [IND2015/82]536 29 UV Ottadanpathi, Thoothukudi, TN 08/04/2016 G B 
28. [IND2015/86]541 28 UV Ottadanpathi, Thoothukudi, TN 20/04/2016 G B 
29. [IND2015/89]543 31 UV Ottadanpathi, Thoothukudi, TN 21/04/2016 S B 
30. [IND2015/92]545 31 UV Ottadanpathi, Thoothukudi, TN 20/04/2016 S B 
31. [IND2015/95]548 32 UV Ottadanpathi, Thoothukudi, TN 20/04/2016 C B 
32. [IND2015/98]549 32 UV Ottadanpathi, Thoothukudi, TN 20/04/2016 C B 
33. [IND2015/101]550 29 UV Ottadanpathi, Thoothukudi, TN 20/04/2016 C B 
34. [IND2015/104]551 32 UV Ottadanpathi, Thoothukudi, TN 09/04/2016 C B 
35. [IND2015/107]552 32 UV Ottadanpathi, Thoothukudi, TN 21/04/2016 G B 
36. [IND2015/110]479 28 V Tirunelveli, TN 21/04/2016 G B 
37. [IND2015/113]482 32 V Tirunelveli, TN 20/04/2016 S B 
38. [IND2015/116]481 29 V Tirunelveli, TN 21/04/2016 S B 
39. [IND2015/118]V1 28 V Vemgal,Sidlaghattataluk, Chikballapur,K 30/04/2016 S B 
40. [IND2015/121]V2 28 V Vemgal, Sidlaghattataluk, Chikballapur,K 30/04/2016 S B 
41. [IND2015/124]V13 24 V Vemgal, Sidlaghattataluk, Chikballapur,K 30/04/2016 S B 
42. [IND2015/127]V43 26 V GenjigunteSidlaghattataluk, Chikballapur, K 30/04/2016 S B 
43. [IND2015/130]V40 26 V Genjigunte,  Sidlaghattataluk, Chikballapur  K 30/04/2016 S B 
44. [IND2015/133]V 14 V Lakkenahalli, Sidlaghattataluk,Chikballapur,K 30/04/2016 S B 
45. [IND2015/136]V41 21 V Genjigunte,  Sidlaghattataluk, Chikballapur,K 30/04/2016 S B 
46. [IND2015/139]V42 14 V Genjigunte,  Sidlaghattataluk, Chikballapur,K 30/04/2016 S B 
47. [IND2015/142]V44 28 V Lakkenahalli, Sidlaghattataluk, Chikballapur,K 30/04/2016 S B 
48. [IND2015/145]V44 16 V Lakkenahalli, Sidlaghattataluk, Chikballapur,K 30/04/2016 S B 
49. [IND2015/148]491 33 UV Kanchipuram, TN 01/05/2016 S B 
50. [IND2015/151]492 31 UV Kanchipuram, TN 01/05/2016 S B 
51. [IND2015/154]493 26 UV Kanchipuram, TN 01/05/2016 S B 
52. [IND2015/157]494 27 UV Kanchipuram, TN 30/04/2016 S B 
53. [IND2015/160]CS4 18 V Tirunehveli, TN 30/04/2016 S B 
54. [IND2015/163]CS6 14 V Tirunehveli, TN 30/04/2016 S B 
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55. [IND2015/166]CS9 33 V Tirunehveli, TN 30/04/2016 S B 
56. [IND2015/169]470 18 V Tirunehveli, TN 30/04/2016 S B 
57. [IND2015/172]471 33 UV Tirunehveli, TN 30/04/2016 C B 
58. [IND2015/175]472 15 UV Tirunehveli, TN 30/04/2016 S B 
59. [IND2015/178]473 14 V Tirunehveli, TN 30/04/2016 S B 
60. [IND2015/181]474 18 UV Tirunehveli, TN 30/04/2016 S B 
61. [IND2015/184]475 36 V Tirunehveli, TN 30/04/2016 S B 
62. [IND2015/187]476 24 V Tirunehveli, TN 30/04/2016 S B 
63. [IND2015/190]477 18 V Tirunehveli, TN 30/04/2016 S B 
64. [IND2015/193]478 31 V Tirunehveli, TN 30/04/2016 S B 
65. [IND2015/196]480 20 V Tirunehveli, TN 30/04/2016 S B 
66. [IND2015/199]483 19 V Tirunehveli, TN 30/04/2016 S B 
67. [IND2015/202]484 32 V Tirunehveli, TN 30/04/2016 S B 
68. [IND2015/205]486 30 V Tirunehveli, TN 30/04/2016 S B 
69. [IND2015/208]404 36 V Erode, TN 30/04/2016 S B 
70. [IND2015/211]406 13 UV Erode, TN 30/04/2016 S B 
71. [IND2015/214]408 27 UV Erode, TN 30/04/2016 S B 
72. [IND2015/2017]547 35 UV Thoothukudi, TN 30/04/2016 S Sp 
73. [IND2015/220]228 30 UV Tirunelveli, TN 30/04/2016 S Sp 
74. [IND2015/223]34 15 UV Thoothukudi,TN 30/04/2016 S Sp 
75. [IND2015/226]PPR S 28 UV Medak, T 30/04/2016 S Sp 
76. [IND2015/229]555 28 UV Thoothukudi, TN 30/04/2016 C Sa 
77. [IND2015/232]556 30 UV Thoothukudi, TN 30/04/2016 C Sa 
78. [IND2015/235]BTV14 27 UV Thoothukudi, TN 30/04/2016 S LN 
79. [IND2015/238]6PK 10 UV Jukal, Parkal, Warangal,T 02/05/2016 S B 
80. [IND2015/241]K3 10 UV Medaram, Dharmaram, Karimnagar,T 02/05/2016 S B 
81. [IND2015/244]K4 9 UV Mallesham, Khilavanaparthi ,  Karimnagar,T 02/05/2016 S B 
82. [IND2015/247]K8 27 UV Oongathurthi, Karimnagar,T 03/05/2016 S B 
83. [IND2015/250]K9 10 UV Oongathurthi, Karimnagar, T 03/05/2016 S B 
84. [IND2015/253]K10 21 UV Madhurampally,Pegadapally,  Karimnagar, T 03/05/2016 S B 
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85. [IND2015/256]K14 11 UV Madhurampally,Pegadapally Karimnagar,  T 03/05/2016 S B 
86. [IND2015/259]K15 26 UV Madhurampally,Pegadapally,  Karimnagar, T 03/05/2016 S B 
87. [IND2015/262]PPR2 27 UV Nalthur , Medak,  T 03/05/2016 G B 
88. [IND2015/265]PPR1 25 UV Rauiapalli,  Medak,T 03/05/2016 G B 
89. [IND2015/268] 6A 28 UV Open air jail,Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
90. [IND2015/271] 7A 17 UV Open air jail,  Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
91. [IND2015/274] 9A 27 UV Ammavarapalli,Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
92. [IND2015/277]11A 28 UV Ammavarapalli,Bukkarayasamundram, Anantpur,AP 03/05/2016 S B 
93. [IND2015/280]12A 31 UV Ammavarapalli,Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
94. [IND2015/283]25A 30 UV Ammavarapalli,Bukkarayasamundram, Anantpur,AP 03/05/2016 S B 
95. [IND2015/286]27A 28 UV Bomnalatapally, Bukkarayasamundram, Anantpur,AP 03/05/2016 S B 
96. [IND2015/289]28A 26 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
97. [IND2015/292]29A 23 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
98. [IND2015/295]30A 28 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
99. IND2015/298] 40A 27 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
100. [IND2015/301]12Karn 26 UV Gonimoradahalli,Sidlaghattataluk, Chikballapur,  K 03/05/2016 S B 
101. [IND2015/302]18Karn 28 UV G.Kuruboahalli, Sidlaghattataluk,Chikballapur,     K 03/05/2016 S B 
102. [IND2015/307]31Karn 26 UV VemgalSidlaghattataluk, Chikballapur,  K 03/05/2016 S B 
103. [IND2015/310]35Karn 29 UV Genjigunte, Sidlaghattataluk, Chikballapur,  K 03/05/2016 S B 
104. [IND2015/313]40Karn 29 UV Lakkenahalli,Sidlaghattataluk, Chikballapur, K 03/05/2016 S B 
105. [IND2015/316]K1-K 29 UV Vemgal,Sidlaghattataluk, Chikballapu, K 03/05/2016 S B 
106. [IND2015/319]K2-K 26 UV VemgalSidlaghattataluk, Chikballapur, K 03/05/2016 S B 
107. [IND2015/322]K3-K 23 UV Vemgal,Sidlaghattataluk, Chikballapur,  K 03/05/2016 S B 
108. [IND2015/325]K16-K 27 UV Burudugun, chintamani, Chikballapur, K 03/05/2016 S B 
109. [IND2015/328]K20-K 26 UV Gangireddypalya , chintamani, Chikballapur,  K 03/05/2016 S B 
110. [IND2015/]A14 31 UV Madhurampally,Pegadapally,Karimnagar,T 03/05/2016 S B 
111. [IND2015/]26A 31 UV Ammavarapalli,Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
112. IND2015/]31A 31 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
113. [IND2015/]32A 33 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
114. [IND2015/]33A 31 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
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115. [IND2015]/34A 33 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
116. [IND2015/]35A 30 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
117. [IND2015/]36A 30 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
118. [IND2015/]37A 28 UV Bomnalatapaly, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
119. [IND2015/]38A 28 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
120. [IND2015/]39A 32 UV Bomnalatapally, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
121. [IND2015/]07Karn 28 UV Gowdanahalli, Chikballapur, K 03/05/2016 S B 
122. [IND2015/]08Karn 33 UV Gowdanahalli , Chikballapur,  K 03/05/2016 S B 
123. [IND2015/]32Karn 30 UV VemgalSidlaghattataluk, Chikballapur, K 03/05/2016 S B 
124. [IND2015/]33Karn 31 UV VemgaSidlaghattataluk, Chikballapur, K 03/05/2016 S B 
125. [IND2015]K1 29 UV Medaram,Dharmaram,Karimnagar,T 03/05/2016 S B 
126. [IND2015/]K11 30 UV Madhurampally,Pegadapally,Karimnagar, T 03/05/2016 S B 
127. [IND2015/]K12 30 UV Madhurampally,Pegadapally,  Karimnagar, T 03/05/2016 S B 
128. [IND2015/]K13 28 UV Madhurampally,Pegadapally, Karimnagar ,T 03/05/2016 S B 
129. [IND2015/]PPR1 30 UV Nalthur, Medak, T 03/05/2016 G B 
130. [IND2015] 4A 30 UV Open air jail, Bukkarayasamundram, Anantpur, AP 03/05/2016 S B 
131. [IND2015]spleen K 28 UV Gowdanahalli, MandikalMandal, Chikballapur, K 03/05/2016 S Sp 
132. [IND2015]3 organ 30 UV Thoothukudi,TN 30/04/2016 S Sp 
133. [IND2015]19Karn 27 UV G.Kuruboahalli, Sidlaghattataluk, Chikballapurtaluk, K 03/05/2016 S B 
134. [IND2015]20Karn 26 UV Chokkanahalli,Sidlaghatta,Chikballapur, K 03/05/2016 S B 
135. [IND2015]21Karn 28 UV Chokkanahalli,Sidlaghatta,Chikballapur, K 03/05/2016 S B 
136. [IND2014]CHE2 28 UV Erode,TN 02/02/2015 S B 
137. [IND2014]CHE5 23 UV Tirupur,TN 02/02/2015 S B 
138. [IND2014]CHE12 30 UV Karur,TN 02/02/2015 S B 
139. [IND2014]CHE14 29 UV Karur, TN 02/02/2015 S B 
140. [IND2014]CHE3 28 UV Karur, TN 02/02/2015 S B 
141. [IND2014]WGL4 28 UV Warangal, TN 30/01/2015 S B 
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*based on BTV specific qRT-PCR targeting BTV Seg- 10 (Hofmann et al; 2008) for 2015 outbreak and BTV specific qRT-PCR targeting BTV Seg-9 for 2014 outbreaks (Maan et al., 
2015a) 
Abbreviations: TN, Tamil Nadu; T, Telangana; K, Karnataka; AP, Andhra Pradesh; V, Vaccinated; UV, Unvaccinated; S, Sheep; G, Goat; C, Cattle; B, Blood; Sp, Spleen; LN, 
Lymph node; Sa, Saliva 
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 Detail of Seg-2 sequences of BTV reference strains available from GenBank. Appendix 3
Seg-2 sequences of reference strains of BTV serotypes BTV-1 to BTV-27 available from GenBank 
Serotype Country code Year of sampling GenBank accession number 
BTV-1 AUS 1979 JN881986 
BTV-1 
BTV-2 
RSArrrr 
AUS 
- 
2008 
FJ969720 
JQ086242 
BTV-2 RSArrrr 1959 KP821030 
BTV-3 RSArrrr 1943 KP821039 
BTV-4 RSArrrr 1969 KP821066 
BTV-4 CHN 1997 JX560414 
BTV-5 RSArrrr 1953 KP821101 
BTV-6 RSArrrr - AJ585127 
BTV-7 RSArrrr - AJ585128 
BTV-8 RSArrrr 1937 KP821076 
BTV-9 AUS 1985 JQ086302 
BTV-9 RSArrrr 1942 KP821088 
BTV-10 RSArrrr - AJ585131 
BTV-11 RSArrrr - AJ585132 
BTV-12 RSArrrr 1941 KP821100 
BTV-13 RSArrrr - AJ585134 
BTV-14 RSArrrr 1959 KP820983 
BTV-15 RSArrrr 1960 KP820984 
BTV-16 RSArrrr - AJ585149 
BTV-17 RSArrrr - AJ585138 
BTV-18 RSArrrr - AJ585139 
BTV-19 RSArrrr - AJ585140 
BTV-20 RSArrrr - AJ585141 
BTV-21 RSArrrr - AJ585142 
BTV-22 RSArrrr - AJ585143 
BTV-23 RSArrrr - AJ585144 
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The country codes were Australia (AUS), Kuwait (KWT), Switzerland (CHE), France: Corsica (FRA), China (CHN) and India (IND). RSArrrr stood for 
a reference strain (rrrr) originated in Republic of South Africa (RSA). 
Seg-2 sequences of reference Indian strains of BTV serotypes available from GenBank 
Serotype Country Code State Year of sampling GenBank Accession no. 
BTV-1 IND 
Thoothukudi,  
Tamil Nadu 2003 KP696563 
BTV-1 IND Haryana 1999 AJ585114 
BTV-1 IND Chennai 2001 AJ585115 
BTV-1 IND Avikanagar, Rajasthan 1992 AJ585111 
BTV-1 IND - 1992 AJ585112 
BTV-1 IND - 1988 AJ585113 
BTV-1 IND 
Khammam,  
Andhra Pradesh 2008 JX399149 
BTV-1 IND Andhra Pradesh 2008 KF664124 
BTV-1 IND Karimnagar, Telangana 2010 KP339135 
BTV-1 IND - 1985 KP696508 
BTV-1 IND Coimbatore, Tamil Nadu 2003 KP696553 
BTV-1 IND Gujarat 2007 KF664114 
BTV-1 IND - 2003 KP696573 
BTV-1 IND - 2008 KU234258 
BTV-2 IND - 1982 AJ585152 
BTV-2 IND - 1994 KP268775 
BTV-2 IND Chittoor, Andhra Pradesh 1993 KP339155 
BTV-2 IND South India 1993 KP696563 
BTV-24 RSArrrr - AJ585145 
BTV-25 CHE 2007 EU839840 
BTV-26 KWT 2010 HM590642 
BTV-27 FRA - KM200718 
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BTV-3 IND - 2003 JQ771814 
BTV-4 IND Andhra Pradesh 2008 KF560418 
BTV-9 IND Andhra Pradesh 2006 JF443167 
BTV-9 IND Andhra Pradesh 2007 JX003688 
BTV-9 IND - 2003 KP339176 
BTV-9 IND 
Mahboobnagar, 
Andhra Pradesh 2003 KP339185 
BTV-9 IND Hyderabad 2005 KP696633 
BTV-9 IND Andhra Pradesh 2004 KP696613 
BTV-9 IND Hyderabad 2005 KP696633 
BTV-9 IND Hyderabad 2004 KP696623 
BTV-9 IND Hyderabad 2005 KP696642 
BTV-10 IND Khammam, Andhra Pradesh 2003 KP339245 
BTV-12 IND Andhra Pradesh 2011 KC662613 
BTV-12 IND Pataudi, Gurugram, Haryana 2016 MF615238 
BTV-16 IND Karur, Tamil Nadu 2014 KX302635 
BTV-16 IND Adilabad, Telangana 2011 KP339215 
BTV-16 
 
BTV-16 
IND 
 
IND 
Mahboobnagar, Telangana 
Mahboobnagar, Telangana 
2010 
2010 
KP339205 
KP339195 
BTV-16 IND Nellore, Andhra Pradesh 2010 KP339225 
BTV-16 IND Chennai 2010 JQ924821 
BTV-16 PAK West Pakistan 1960 JX272460 
BTV-16 IND Andhra Pradesh 2008 KF664104 
BTV-16 IND Gujarat 2011 KF664134 
BTV-21 IND South India 2006 KP339235 
BTV-23 IND Bangalore 1997 AJ585189 
BTV-23 IND Maharastra 1988 JQ771824 
The country code: India (IND) 
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Seg-2 sequences of reference Indian strains of BTV-1 available from GenBank 
Serotype Country code Year of 
sampling 
Genbank accession 
number 
 Serotype Country code Year of 
sampling 
GenBank accession 
number 
BTV-1 ZAF - X55800 BTV-1 AUS 2010 KM099538 
BTV-1 ZAF - JX272380 BTV-1 AUS 2010 KM099539 
BTV-1 RSAvvvv 1958 KP821017 BTV-1 AUS 1994 KM099528 
BTV-1 RSAvvvv - AJ585110 BTV-1 AUS 1993 KM099527 
BTV-1 SDN 1987 AJ585117 BTV-1 AUS 1997 KM099530 
BTV-1 SDN 1987 KP821022 BTV-1 AUS 1996 KM099529 
BTV-1 RSArrrr 1958 AJ585122 BTV-1 AUS 1999 KM099532 
BTV-1 CHN 1997 JN848760 BTV-1 AUS 1999 KM099531 
BTV-1 ZAF - FJ969720 BTV-1 AUS 2002 KM099533 
BTV-1 ZAF - JX680458 BTV-1 AUS 2004 KM099535 
BTV-1 NGA 1982 AJ585118 BTV-1 AUS 2005 KM099536 
BTV-1 CMR 1982 AJ585119 BTV-1 AUS 2002 KM099534 
BTV-1 CMR 1982 KP820998 BTV-1 AUS 2008 KM099537 
BTV-1 LBY 2007 KP821008 BTV-1 CHN 1979 KC879616 
BTV-1 MAR 2007 KP821011 BTV-1 MYS 1987 AJ585116 
BTV-1 TUN 2011 KJ577105 BTV-1 KOR 2010 KC153300 
BTV-1 ITA 2010 KJ577115 BTV-1 GRC 2001 KP821006 
BTV-1 DZA 2008 KP820997  BTV-1 GRC 2001 KP821007 
BTV-1 ITA 2013 KJ577125 BTV-1 GRC 2001 JN635334 
BTV-1 ITA 2013 KJ661730 BTV-1 GRC 2001 AJ585121 
BTV-1 ITA 2013 KJ019206 BTV-1 GRC 2001 KP821005 
BTV-1 ITA 2012 KJ577095 BTV-1 IND 1988 AJ585113 
BTV-1 DZA 2006 KP820996 BTV-1 IND 1992 AJ585112 
BTV-1 MAR 2006 EU625362  BTV-1 IND 2008 KF563945 
BTV-1 DZA 2006 EU625361 BTV-1 IND 2007 KF563935 
BTV-1 DZA 2006 KP820995 BTV-1 IND 2007 KF563933 
BTV-1 MAR 2006 KP821009 BTV-1 IND 2007 KF563934 
BTV-1 MAR 2009 KP821016 BTV-1 IND 2008 KF664124 
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BTV-1 MAR 2009 KP821014 BTV-1 IND 2008 JX399149 
BTV-1 MAR 2009 KP821015 BTV-1 IND - KC751420 
BTV-1 ITA 2006 KJ736002 BTV-1 IND 2010 KP339145 
BTV-1 TUN 2007 KP821023 BTV-1 IND - KC751421 
BTV-1 MAR 2007 KP821012 BTV-1 IND 2010 KP339135 
BTV-1 MAR 2007 KP821010  BTV-1 IND 1992 AJ585111 
BTV-1 MAR 2007 KP821013 BTV-1 IND 1994 KF563930 
BTV-1 ESP 2007 KP821018 BTV-1 IND 2003 KP696553 
BTV-1 GIB 2007 KP821004 BTV-1 IND 1985 KP696508 
BTV-1 PRT 2007 EU498674 BTV-1 IND 1985 KF563929 
BTV-1 ESP 2007 KP821019 BTV-1 IND 1999 AJ585114 
BTV-1 
BTV-1 
BTV-1 
BTV-1 
FRA 2008 KP821001 BTV-1 IND 2001 AJ585115 
FRA 2008 KP821000 BTV-1 IND 2003 KP696563 
FRA 
FRA 
2008 
2008 
KP820999 
KP821002 
BTV-1 
BTV-1 
IND 
IND 
2007 
2007 
KF563938 
JX101695 
BTV-1 FRA 2008 JX861499 
FJ437557 
BTV-1 
BTV-1 
IND 
IND 
2003 
2011 
KF563932 
KF563946 BTV-1 FRA 2007 
BTV-1 FRA 2007 JX861489 
KP821021 
BTV-1 
BTV-1 
IND 
IND 
2007 
2008 
JX101694 
KF563940 BTV-1 ESP 2009 
BTV-1 FRA 2008 KP821003 BTV-1 IND 2008 HM014236 
BTV-1 ESP 2008 KP821020  BTV-1 IND 2008 KF563939 
BTV-1 USA 2010 KX164020 BTV-1 IND 1999 KF563931 
BTV-1 GUF 2015 KY049854 BTV-1 IND 2003 KP696573 
BTV-1 GUF 2011 JQ436736 BTV-1 IND 2008 KF563941 
BTV-1 GUF 2011 KY049844 BTV-1 IND 2007 JN558348 
BTV-1 AUS 1981 KM099523 BTV-1 IND 2007 KF563936 
BTV-1 AUS 1986 KM099524 BTV-1 IND 2008 KU234258 
BTV-1 AUS 1988 KM099525 BTV-1 IND 2008 KF563944 
BTV-1 AUS 1979 M21844 BTV-1 IND 2008 KF563943 
BTV-1 AUS 1981 AJ585178 BTV-1 IND 2007 KF664114 
BTV-1 AUS 1979 JN881986 BTV-1 IND 2011 KP735614 
BTV-1 AUS - AJ585120 BTV-1 IND 2008 KF563942 
BTV-1 AUS - X06464 BTV-1 IND 2007 JN558349 
BTV-1 AUS 1989 KM099526 BTV-1 IND 2007 KF563937 
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The country codes were France:Corsica (FRA), South Africa (ZAF), China (CHN), Greece(GRC), Spain (ESP), Italy (ITA), Morroco (MAR), Portugal 
(PRT), Sudan (SDN),  India (IND), Nigeria (NGA), Cameroon (CMR), Libya (LBY), Tunisia (TUN), Algeria (DZA), Gibraltar (GIB), Malaysia 
(MYS), South Korea (KOR), Australia (AUS), Greece (GRC) , French-Guiana (GUF) and United States of America (USA). RSArrrr and RSAvvvv 
stood for a reference strain (rrrr) and vaccine strain (vvvv) originated in Republic of South Africa (RSA). 
Seg-2 sequences of reference Indian strains of BTV-2 available from GenBank 
Serotype Country code Year of sampling GenBank accession 
number 
 Serotype Country code Year of sampling GenBank accession 
number 
BTV-2 AUS 2008 JQ086242 BTV-2 USA 1982 AY855266 
BTV-2 AUS 2010 JQ240322 BTV-2 USA 1982 AY855265 
BTV-2 JPN 2007 AB686224 BTV-2 IND 2003 KP696603 
BTV-2 TWN 2003 AY493687 BTV-2 RSArrrr 1959 AJ585123 
BTV-2 IND 1982 AJ585152 BTV-2 RSArrrr 1959 KP821030 
BTV-2 IND 1993 KP696583 BTV-2 ZAF - JX272600 
BTV-2 IND 1993 KP339155 BTV-2 RSAvvvv - AJ585157 
BTV-2 IND 1994 KP268775 BTV-2 RSAvvvv 1958 KP821031 
BTV-2 IND - KC751422 BTV-2 ZAF - AF481096 
BTV-2 IND 2010 KP339165 BTV-2 ITA 2001 DQ191271 
BTV-2 MTQ 2006 HQ222820 BTV-2 ZAF - JN255933 
BTV-2 PAN 1989 KF986501 BTV-2 ESP 2005 AM773697 
BTV-2 USA 1999 AY855267 BTV-2 ESP 2005 KP821035 
BTV-2 USA 2006 KF986495 BTV-2 ITA 2001 DQ191270 
BTV-2 USA 2003 KF986499 BTV-2 ISR 2001 KP821027 
BTV-2 USA 2010 JQ822249 BTV-2 PRT 2005 EF434177 
BTV-2 GUF 2011 KC633279 BTV-2 TUN 2000 AJ585156 
BTV-2 REU 2009 HQ222824 BTV-2 ITA 2000 DQ191272 
BTV-2 CAD - KY471278 BTV-2 ITA 2001 DQ191263 
BTV-2 NGA 1982 AJ585153 BTV-2 FRA 2000 AF356601 
BTV-2 SDN 1985 AJ585155 BTV-2 ITA 2000 DQ191262 
BTV-2 SDN 1983 KP821036 BTV-2 FRA 2001 KP821024 
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BTV-2 ZAF 1959 AY855264 BTV-2 ITA 2000 DQ191273 
BTV-2 USA - M21946 BTV-2 ITA 2001 AJ585161 
BTV-2 IND 2008 JQ904072 BTV-2 ITA 2002 KP821034 
BTV-2 IND 2003 KP696593 BTV-2 FRA 2001 KP821026 
BTV-2 IND 2003 JQ681258 BTV-2 ITA 2002 DQ191275 
BTV-2 ITA 2001 AJ585162 BTV-2 FRA 2001 KP821025 
BTV-2 ITA 2001 KP821032 BTV-2 ITA 2001 DQ191261 
BTV-2 ITA 2002 AJ585158 BTV-2 FRA 2001 AJ585154 
BTV-2 ITA 2002 AJ585160 BTV-2 ITA 2001 DQ191268 
BTV-2 ITA 2002 AJ585159 BTV-2 ITA 2001 DQ191269 
BTV-2 ITA 2002 AM773698 BTV-2 ITA 2002 DQ191274 
BTV-2 ITA 2002 AM773708 BTV-2 ITA 2001 DQ191266 
BTV-2 ITA 2002 KP821028 BTV-2 ITA 2001 DQ191267 
BTV-2 ITA 2002 KP821029 BTV-2 ITA 2000 JN255863 
BTV-2 ITA 2001 DQ191264 BTV-2 ITA 2000 KM053269 
BTV-2 ITA 2001 DQ191265 BTV-2 ITA 2000 JN255873 
BTV-2 ITA 2001 KP821033 BTV-2 TUN 2000 KP821037 
The country codes are France : Corsica (FRA), South Africa (ZAF), China (CHN), Greece(GRC), Cyprus (CYP), Israel (ISR), Turkey (TUR), Spain 
(ESP), Argentina (ARG), Italy (ITA), Egypt (EGY), Morroco (MAR), Portugal (PRT), Sudan (SDN), Hungary (HUN) and India (IND). RSArrrr and 
RSAvvvv stood for a reference and vaccine strain respectively, originated in Republic of South Africa (RSA). 
Seg-2 sequences of reference Indian strains of BTV-4 available from GenBank 
Serotype Country code Year of sampling Gen Bank accession 
number 
 Serotype Country code Year of sampling GenBank accession 
number 
BTV-4 IND 2013 KY947349 BTV-4 RSArrrr 1969 KP821066 
BTV-4 IND 2013 KY947347 BTV-4 RSArrrr 1969 AJ585125 
BTV-4 IND 2013 KY947350 BTV-4 ARG 1999 JX024950 
BTV-4 IND 2013 KY947346 BTV-4 ARG 2002 AJ585169 
BTV-4 IND 2013 KY947351 BTV-4 ARG 1999 JX024945 
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BTV-4 IND 2013 KY947348 BTV-4 ARG 2009 JX024955 
BTV-4 IND 2013 KY947342 BTV-4 ARG 1999 JX024940 
BTV-4 IND 2007 KY947343 BTV-4 ARG 2010 JX024960 
BTV-4 CHN 1997 JX560414 BTV-4 ZAF 2004 AY839948 
BTV-4 IND 2012 KY974345 BTV-4 RSArrrr - AJ585163 
BTV-4 IND 2008 KF560418 BTV-4 ZAF 1900 JN255943 
BTV-4 IND 2008 KY947344 BTV-4 TUR - AJ585164 
BTV-4 GRC 2012 KP821058 BTV-4 ITA 2002 DQ191276 
BTV-4 CYP 2011 KP821044 BTV-4 EGY 1977 KP821047 
BTV-4 GRC 2012 KP821056 BTV-4 ZAF - KM233615 
BTV-4 GRC 2012 KP821057  BTV-4 ZAF - JX272580 
BTV-4 CYP 2011 KP821042 BTV-4 MAR 2004 KP821061 
BTV-4 CYP 2011 KP821046  BTV-4 ESP 2004 KP821068 
BTV-4 CYP 2011 KP821045 BTV-4 MAR 2009 KP821064 
BTV-4 
BTV-4 
ISR 
ISR 
2006 
2001 
KP821059 
DQ191278 
BTV-4 MAR 2009 KP821065 
BTV-4 MAR 2009 KP821063 
BTV-4 ISR 2001 DQ191279 BTV-4 ESP 2010 KP821070 
BTV-4 TUR 1978 AJ585165 BTV-4 PRT 2004 EF434176 
BTV-4 TUR 1999 DQ825670 BTV-4 ESP 2005 KP821069 
BTV-4 GRC 2000 AJ585167 BTV-4 ESP 2003 KP821067 
BTV-4 GRC 2000 KP821054 BTV-4 ITA 2003 JN255893 
BTV-4 CYP 2004 KP821041 BTV-4 ITA 2003 JN255883 
BTV-4 GRC 1999 AY839947 BTV-4 ITA 2003 DQ191280 
BTV-4 GRC 2000 AY839946 BTV-4 ITA 2003 DQ191281 
BTV-4 GRC 2000 KP821055 BTV-4 FRA 2003 KP821050 
BTV-4 GRC 1999 KP821053 BTV-4 FRA 2003 AY839945 
BTV-4 GRC 1999 DQ191277 BTV-4 FRA 2003 KP821048 
BTV-4 GRC 1999 KP821052 BTV-4 FRA 2003 KP821049 
BTV-4 GRC 1979 KP821051 BTV-4 SDN 1983 AJ585166 
BTV-4 CYP 1969 KP821040 BTV-4 SDN 1983 KP821071 
BTV-4 ESP 2003 KJ700442  BTV-4 ZAF 2011 KT317666 
BTV-4 CYP 1969 AJ585180 BTV-4 HUN 2014 KP268815 
 BTV-4 FRA 2016 KY654329 
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The country codes were France : Corsica (FRA), South Africa (ZAF), China (CHN), Greece(GRC), Cyprus (CYP), Israel (ISR), Turkey (TUR), Spain 
(ESP), Argentina (ARG), Italy (ITA), Egypt (EGY), Morroco (MAR), Portugal (PRT), Sudan (SDN), Hungary (HUN) and India (IND). RSArrrr stood 
for a reference strain (rrrr) originated in Republic of South Africa (RSA). 
Seg-2 sequences of reference Indian strains of BTV-5 available from GenBank 
Serotype Country code Year of sampling GenBank accession number 
BTV-5 NGA 1982 AJ585182 
BTV-5 GLP 2010 HQ241072 
BTV-5 USA 2003 KX164060 
BTV-5 RSArrrr 1953 AJ585126 
BTV-5 RSArrrr 1953 KP821101 
BTV-5 ZAF - JX272570 
BTV-5 CMR 1982 AJ585181 
BTV-5 CHN 2014 KT945043 
BTV-5 CHN 2012 KT945042 
BTV-5 CHN 2012 KT945044 
BTV-5 CHN 2012 KT945045 
 
The country codes were Nigeria (NGA), French Guadeloupe Island (GLP), United States of America (USA), South Africa (ZAF), Cameroon (CMR), 
China (CHN) and India (IND). RSArrrr stood for a reference strain (rrrr) originated in Republic of South Africa (RSA). 
Seg-2 sequences of reference Indian strains of BTV-9 available from GenBank 
Serotype Country code Year of sampling GenBank accession 
number 
 Serotype Country code Year of sampling GenBank accession 
number 
BTV-9 RSArrrr 1942 KP821088 BTV-9 ZAF 2014 KT885056 
BTV-9 RSArrrr 1942 AJ585130 BTV-9 RSAvvvv 1942 KP821089 
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BTV-9 ECU 2015 KX442583 BTV-9 RSAvvv - AJ585173 
BTV-9 USA 2008 KX164070 BTV-9 ITA 2003 KP821083 
BTV-9 ITA 2001 DQ191284 BTV-9 ZAF - JX272530 
BTV-9 ITA 2000 JN255913 BTV-9 ZAF 1942 JN255953 
BTV-9 ITA 2001 DQ191285 BTV-9 AUS 1985 JQ086302 
BTV-9 ITA 2003 JN255903 BTV-9 JPN 2003 AB686223 
BTV-9 BIH 2002 KP821078 BTV-9 IND 2004 KP696623 
BTV-9 BIH 2002 AJ585174 BTV-9 IND 2005 KP696652 
BTV-9 XKX 2001 KP821084 BTV-9 IND 2005 KP696642 
BTV-9 XKX 2001 KP821085 BTV-9 IND 2003 KP696633 
BTV-9 SRB 2001 KP821090 BTV-9 IND 2005 JQ414046 
BTV-9 SRB 2001 AJ585172 BTV-9 IND 2005 KJ679573 
BTV-9 GRC 1999 KP821081 BTV-9 IND 2003 JF443155 
BTV-9 GRC 2000 AJ585171 BTV-9 IND 2003 JF443157 
BTV-9 GRC 1999 KP821082 BTV-9 IND 2003 KP339185 
BTV-9 LBY 2008 KP821087 BTV-9 IND 2003 KP339175 
BTV-9 LBY 2008 KP821086 BTV-9 IND 2006 JN579710 
BTV-9 ZAF 1942 JN255963 BTV-9 IND 2006 JF443167 
BTV-9 ZAF 2014 KT885076 BTV-9 IND 2002 JF443156 
BTV-9 GRC 1998 DQ191283 BTV-9 IND 2007 JX003688 
BTV-9 GRC 1998 KP821080 BTV-9 IND 2004 KP696613 
BTV-9 TUR 1998 KP821091 BTV-9 TUR 2000 KP821092 
BTV-9 TUR 2000 AJ585176 BTV-9 BGR 1999 AJ585170 
BTV-9 TUR 2001 KP821093 BTV-9 BGR 1999 KP821079 
BTV-9 TUR 2000 AJ585177 BTV-9 TUR 2000 AJ585175 
The country codes were United States of America (USA), Euadore (ECU), South Africa (ZAF), Libya (LBY), Australia (AUS), Japan (JPN) ,India 
(IND), Greece (GRC), Turkey (TUR), Bulgaria (BGR), Serbia (SRB), Bosnia & Hezegovina (BIH) and Kosovo (XKX). RSArrrr and RSAvvvv stood 
for a reference and vaccine strain respectively from South Africa. 
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Seg-2 sequences of reference Indian strains of BTV-10 available from GenBank 
Serotype Country code Year of sampling GenBank accession number 
BTV-10 RSArrrr 1956 AJ585131 
BTV-10 ZAF 2011 KT317696 
BTV-10 - - KX247939 
BTV-10 ZAF - JX272520 
BTV-10 MTR 2006 HQ222821 
BTV-10 GUF 2011 JQ436735 
BTV-10 USA 1990 U06784 
BTV-10 USA 1990 U06781 
BTV-10 USA 1990 U06785 
BTV-10 USA 1980 U06783 
BTV-10 USA 1980 U06780 
BTV-10 USA 1980 U06782 
BTV-10 USA - U06786 
BTV-10 USA - L29027 
BTV-10 USA - L29026 
BTV-10 USA - M11787 
BTV-10 USA 1953 NC006013 
BTV-10 IND 2003 KP339245 
BTV-10 IND 2004 JQ740772 
BTV-10 IND 2004 JN704634 
BTV-10 IND 2003 JF727655 
The country codes as per ISO 3166-1 alpha-3 are France: Guyane (GUF), France: Martinique Island (MTQ), United States of America (USA), South 
Africa (ZAF) and India (IND). RSArrrr stands for a reference strain (rrrr) originated in Republic of South Africa (RSA). 
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Seg-2 sequences of reference Indian strains of BTV-12 available from GenBank 
Serotype Country code Year of sampling GenBank accession number 
BTV-12 USA 2008 KX164080 
BTV-12 GUF 2011 KC633278 
BTV-12 USA 2012 KX164090 
BTV-12 RSArrrr 1941 AJ585133 
BTV-12 JPN 1990 AB686216 
BTV-12 TWN 2003 GU390659 
BTV-12 ZAF - JX272500 
BTV-12 ZAF 1941 KP821100 
BTV-12 IND 2011 KC662613 
BTV-12 IND 2016 MF615238 
BTV-12 IND 2015 KX905151 
The country codes were France Guyane (GUF), United States of America (USA), South Africa (ZAF), Japan (JPN), Taiwan (TWN) and India (IND). 
RSArrrr stood for a reference strain (rrah) originated in Republic of South Africa (RSA).
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 Percentage of nucleotide identity in Seg-2 between BTV strains sequenced in this study and global reference Appendix 4
strains of BTV. 
Percentage of nucleotide identity in Seg-2 between Indian BTV-1 strains sequenced in this study and global reference eastern BTV-1 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1 1/AUS/1979_M21844 100 99.38 99.38 99.34 94.73 94.94 94.91 95.05 95.15 95.15 95.39 95.05 95.15 95.36 95.32 86.8 86.87 86.87 
2 1/AUS/1981_AJ585178 99.38 100 100 99.97 95.15 95.36 95.32 95.39 95.56 95.56 95.81 95.46 95.56 95.77 95.74 87.21 87.28 87.28 
3 1/AUS/1979_JN881986 99.38 100 100 99.97 95.15 95.36 95.32 95.39 95.56 95.56 95.81 95.46 95.56 95.77 95.74 87.21 87.28 87.28 
4 1/AUS_X06464 99.34 99.97 99.97 100 95.11 95.32 95.29 95.36 95.53 95.53 95.77 95.43 95.53 95.74 95.7 87.18 87.25 87.25 
5 1/AUS/2010_KM099538 94.73 95.15 95.15 95.11 100 98.54 98.51 98.72 98.75 98.75 98.93 98.65 98.82 99.03 99 86.66 86.8 86.8 
6 1/AUS/2010_KM099539 94.94 95.36 95.36 95.32 98.54 100 98.65 98.86 98.96 98.96 99.06 98.93 99.03 99.24 99.2 87.21 87.35 87.35 
7 1/AUS/2008_KM099537 94.91 95.32 95.32 95.29 98.51 98.65 100 99.38 99.55 99.48 98.96 99.31 99.34 99.41 99.38 87.01 87.14 87.14 
8 1/AUS/2005_KM099536 95.05 95.39 95.39 95.36 98.72 98.86 99.38 100 99.69 99.69 99.17 99.51 99.55 99.62 99.58 86.8 86.94 86.94 
9 1/AUS/2002_KM099534 95.15 95.56 95.56 95.53 98.75 98.96 99.55 99.69 100 99.79 99.27 99.62 99.65 99.72 99.69 87.04 87.18 87.18 
10 1/AUS/2004_KM099535 95.15 95.56 95.56 95.53 98.75 98.96 99.48 99.69 99.79 100 99.27 99.62 99.65 99.72 99.69 86.9 87.04 87.04 
11 1/AUS/1989_KM099526 95.39 95.81 95.81 95.77 98.93 99.06 98.96 99.17 99.27 99.27 100 99.17 99.34 99.55 99.51 87.08 87.21 87.21 
12 1/AUS/2002_KM099533 95.05 95.46 95.46 95.43 98.65 98.93 99.31 99.51 99.62 99.62 99.17 100 99.55 99.62 99.58 87.08 87.21 87.21 
13 1/AUS/1999_KM099531 95.15 95.56 95.56 95.53 98.82 99.03 99.34 99.55 99.65 99.65 99.34 99.55 100 99.79 99.76 87.04 87.18 87.18 
14 1/AUS/1996_KM099529 95.36 95.77 95.77 95.74 99.03 99.24 99.41 99.62 99.72 99.72 99.55 99.62 99.79 100 99.97 87.11 87.25 87.25 
15 1/AUS/1997_KM099530 95.32 95.74 95.74 95.7 99 99.2 99.38 99.58 99.69 99.69 99.51 99.58 99.76 99.97 100 87.14 87.28 87.28 
16 IND2015/7A_2015-11- 86.8 87.21 87.21 87.18 86.66 87.21 87.01 86.8 87.04 86.9 87.08 87.08 87.04 87.11 87.14 100 99.17 99.17 
17 IND2015/K13_2015-09 86.87 87.28 87.28 87.25 86.8 87.35 87.14 86.94 87.18 87.04 87.21 87.21 87.18 87.25 87.28 99.17 100 100 
18 IND2015/40_2015-12- 86.87 87.28 87.28 87.25 86.8 87.35 87.14 86.94 87.18 87.04 87.21 87.21 87.18 87.25 87.28 99.17 100 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-1 strains sequenced in this study and global reference eastern BTV-1 strains 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 
1/MYS/1987_AJ585116 100 93.94 92 90.51 90.51 90.82 90.92 90.92 91.2 90.58 90.89 90.89 91.03 91.03 91.09 91.09 90.96 90.82 90.89 91.06 91.23 91.65 91.37 92.07 91.82 91.89 92.03 
1/KOR/2010_KC153300 93.94 100 92.13 90.33 90.33 90.58 90.61 90.61 90.71 90.51 90.75 90.75 90.89 90.89 90.96 90.96 90.54 90.54 90.61 90.71 90.82 91.2 90.89 91.58 91.27 91.34 91.41 
1/CHN/1979_KC879616 92 92.13 100 91.16 91.16 91.41 91.58 91.58 91.41 91.09 91.09 91.09 91.3 91.3 91.37 91.37 91.16 91.23 91.23 91.48 91.51 91.93 91.65 92.38 92.07 92.2 92.27 
1/GRC/2001_AJ585121 90.51 90.33 91.16 100 100 99.48 99.58 99.58 94.91 94.42 94.32 94.32 94.53 94.53 94.53 94.53 94.28 94.32 94.42 94.59 94.87 95.29 95.25 95.5 95.46 95.53 95.67 
1/GRC/2001_KP821005 90.51 90.33 91.16 100 100 99.48 99.58 99.58 94.91 94.42 94.32 94.32 94.53 94.53 94.53 94.53 94.28 94.32 94.42 94.59 94.87 95.29 95.25 95.5 95.46 95.53 95.67 
1/GRC/2001_JN635334 90.82 90.58 91.41 99.48 99.48 100 99.83 99.83 95.15 94.66 94.56 94.56 94.77 94.77 94.77 94.77 94.53 94.56 94.66 94.84 95.08 95.5 95.39 95.74 95.7 95.77 95.91 
1/GRC/2001_KP821006 90.92 90.61 91.58 99.58 99.58 99.83 100 100 95.25 94.7 94.66 94.66 94.87 94.87 94.87 94.87 94.63 94.66 94.77 94.94 95.25 95.67 95.56 95.91 95.88 95.95 96.08 
1/GRC/2001_KP821007 90.92 90.61 91.58 99.58 99.58 99.83 100 100 95.25 94.7 94.66 94.66 94.87 94.87 94.87 94.87 94.63 94.66 94.77 94.94 95.25 95.67 95.56 95.91 95.88 95.95 96.08 
1/IND/2007_KF563935 91.2 90.71 91.41 94.91 94.91 95.15 95.25 95.25 100 98.13 98.48 98.48 98.61 98.61 98.68 98.68 98.68 98.72 98.68 99.06 97.54 97.96 98.37 98.16 98.27 98.27 98.41 
IND2015/7A_2015-11- 90.58 90.51 91.09 94.42 94.42 94.66 94.7 94.7 98.13 100 99.17 99.17 99.38 99.38 99.31 99.31 98.61 98.72 98.75 99 96.29 96.71 97.16 96.99 96.95 96.95 97.09 
IND2015/K13_2015-09 90.89 90.75 91.09 94.32 94.32 94.56 94.66 94.66 98.48 99.17 100 100 99.65 99.65 99.72 99.72 98.96 99.06 99.1 99.34 96.6 97.02 97.44 97.3 97.26 97.26 97.4 
IND2015/40_2015-12- 90.89 90.75 91.09 94.32 94.32 94.56 94.66 94.66 98.48 99.17 100 100 99.65 99.65 99.72 99.72 98.96 99.06 99.1 99.34 96.6 97.02 97.44 97.3 97.26 97.26 97.4 
1/IND_KC751420 91.03 90.89 91.3 94.53 94.53 94.77 94.87 94.87 98.61 99.38 99.65 99.65 100 100 99.79 99.79 99.1 99.2 99.24 99.48 96.74 97.16 97.57 97.44 97.4 97.4 97.54 
1/IND/2010_KP339145 91.03 90.89 91.3 94.53 94.53 94.77 94.87 94.87 98.61 99.38 99.65 99.65 100 100 99.79 99.79 99.1 99.2 99.24 99.48 96.74 97.16 97.57 97.44 97.4 97.4 97.54 
1/IND_KC751421 91.09 90.96 91.37 94.53 94.53 94.77 94.87 94.87 98.68 99.31 99.72 99.72 99.79 99.79 100 100 99.17 99.27 99.31 99.55 96.81 97.23 97.64 97.51 97.47 97.47 97.61 
1/IND/2010_KP339135 91.09 90.96 91.37 94.53 94.53 94.77 94.87 94.87 98.68 99.31 99.72 99.72 99.79 99.79 100 100 99.17 99.27 99.31 99.55 96.81 97.23 97.64 97.51 97.47 97.47 97.61 
1/IND/2007_KF563934 90.96 90.54 91.16 94.28 94.28 94.53 94.63 94.63 98.68 98.61 98.96 98.96 99.1 99.1 99.17 99.17 100 99.13 99.17 99.48 96.71 97.12 97.61 97.4 97.37 97.37 97.51 
1/IND/2007_KF563933 90.82 90.54 91.23 94.32 94.32 94.56 94.66 94.66 98.72 98.72 99.06 99.06 99.2 99.2 99.27 99.27 99.13 100 99.27 99.51 96.95 97.26 97.71 97.51 97.54 97.47 97.61 
1/IND/2008_JX399149 90.89 90.61 91.23 94.42 94.42 94.66 94.77 94.77 98.68 98.75 99.1 99.1 99.24 99.24 99.31 99.31 99.17 99.27 100 99.55 96.78 97.19 97.61 97.47 97.44 97.44 97.57 
1/IND/2008_KF664124 91.06 90.71 91.48 94.59 94.59 94.84 94.94 94.94 99.06 99 99.34 99.34 99.48 99.48 99.55 99.55 99.48 99.51 99.55 100 97.02 97.44 97.85 97.71 97.68 97.68 97.82 
1/IND/2007_JN558348 91.23 90.82 91.51 94.87 94.87 95.08 95.25 95.25 97.54 96.29 96.6 96.6 96.74 96.74 96.81 96.81 96.71 96.95 96.78 97.02 100 99.58 98.2 98.54 98.72 98.79 98.86 
1/IND/2007_KF563936 91.65 91.2 91.93 95.29 95.29 95.5 95.67 95.67 97.96 96.71 97.02 97.02 97.16 97.16 97.23 97.23 97.12 97.26 97.19 97.44 99.58 100 98.61 98.96 99.13 99.2 99.27 
1/IND/2008_KF563945 91.37 90.89 91.65 95.25 95.25 95.39 95.56 95.56 98.37 97.16 97.44 97.44 97.57 97.57 97.64 97.64 97.61 97.71 97.61 97.85 98.2 98.61 100 98.61 98.79 98.79 98.86 
1/IND/1992_AJ585112 92.07 91.58 92.38 95.5 95.5 95.74 95.91 95.91 98.16 96.99 97.3 97.3 97.44 97.44 97.51 97.51 97.4 97.51 97.47 97.71 98.54 98.96 98.61 100 99.13 99.2 99.34 
1/IND/1994_KF563930 91.82 91.27 92.07 95.46 95.46 95.7 95.88 95.88 98.27 96.95 97.26 97.26 97.4 97.4 97.47 97.47 97.37 97.54 97.44 97.68 98.72 99.13 98.79 99.13 100 99.38 99.51 
1/IND/1985_KF563929 91.89 91.34 92.2 95.53 95.53 95.77 95.95 95.95 98.27 96.95 97.26 97.26 97.4 97.4 97.47 97.47 97.37 97.47 97.44 97.68 98.79 99.2 98.79 99.2 99.38 100 99.58 
1/IND/1985_KP696508 92.03 91.41 92.27 95.67 95.67 95.91 96.08 96.08 98.41 97.09 97.4 97.4 97.54 97.54 97.61 97.61 97.51 97.61 97.57 97.82 98.86 99.27 98.86 99.34 99.51 99.58 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-1 strains sequenced in this study and global reference western BTV-1 strains 
  
1 2 3 4 5 6 7 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
1 IND2015/7A_2015-11- 100 99.17 99.17 74.64 74.81 74.91 74.74 74.98 74.95 74.95 75.02 74.88 74.98 74.98 74.98 74.91 74.91 74.81 74.98 74.88 75.02 74.57 74.95 75.36 74.5 74.71 74.74 73.7 73.6 
2 IND2015/K13_2015-09 99.17 100 100 74.67 74.64 74.74 74.57 74.81 74.77 74.77 74.84 74.71 74.81 74.81 74.81 74.74 74.74 74.57 74.81 74.71 74.84 74.53 75.05 75.26 74.53 74.67 74.71 73.8 73.56 
3 IND2015/40_2015-12- 99.17 100 100 74.67 74.64 74.74 74.57 74.81 74.77 74.77 74.84 74.71 74.81 74.81 74.81 74.74 74.74 74.57 74.81 74.71 74.84 74.53 75.05 75.26 74.53 74.67 74.71 73.8 73.56 
4 1/LBY/2007_KP821008 74.64 74.67 74.67 100 97.05 97.09 96.95 97.19 97.16 97.16 97.26 97.09 97.3 97.3 97.23 97.26 97.3 97.12 97.16 97.05 94.14 94.94 95.7 94.59 93.9 95.05 95.08 87.01 85.83 
5 1/MAR/2009_KP821014 74.81 74.64 74.64 97.05 100 99.41 99.27 99.51 99.48 99.48 99.51 99.55 99.62 99.62 99.62 99.72 99.69 99.38 99.48 99.38 94.18 94.98 95.7 94.7 93.97 95.05 95.08 87.04 86.14 
6 1/ITA/2010_KJ577115 74.91 74.74 74.74 97.09 99.41 100 99.45 99.69 99.65 99.72 99.62 99.45 99.72 99.65 99.58 99.62 99.65 99.55 99.72 99.62 94.21 95.01 95.77 94.7 94.04 95.08 95.11 87.25 86.14 
7 1/FRA/2008_KP821001 74.74 74.57 74.57 96.95 99.27 99.45 100 99.69 99.79 99.65 99.48 99.31 99.58 99.51 99.45 99.48 99.51 99.27 99.38 99.27 94.14 94.87 95.56 94.63 93.94 94.98 95.01 86.97 86 
9 1/ESP/2008_KP821020 74.98 74.81 74.81 97.19 99.51 99.69 99.69 100 99.9 99.9 99.72 99.55 99.83 99.76 99.69 99.72 99.76 99.51 99.62 99.51 94.32 95.11 95.81 94.87 94.14 95.18 95.22 87.14 86.17 
10 1/FRA/2008_JX861499 74.95 74.77 74.77 97.16 99.48 99.65 99.79 99.9 100 99.86 99.69 99.51 99.79 99.72 99.65 99.69 99.72 99.48 99.58 99.48 94.35 95.08 95.77 94.84 94.11 95.15 95.18 87.18 86.21 
11 1/FRA/2007_FJ437557 74.95 74.77 74.77 97.16 99.48 99.72 99.65 99.9 99.86 100 99.69 99.51 99.79 99.72 99.65 99.69 99.72 99.48 99.58 99.48 94.28 95.08 95.77 94.84 94.11 95.15 95.18 87.11 86.14 
12 1/GIB/2007_KP821004 75.02 74.84 74.84 97.26 99.51 99.62 99.48 99.72 99.69 99.69 100 99.55 99.83 99.76 99.69 99.72 99.76 99.51 99.62 99.51 94.39 95.18 95.88 94.94 94.21 95.25 95.29 87.14 86.11 
13 1/MAR/2006_EU625362 74.88 74.71 74.71 97.09 99.55 99.45 99.31 99.55 99.51 99.51 99.55 100 99.65 99.65 99.79 99.83 99.72 99.41 99.51 99.41 94.21 95.08 95.74 94.77 94.01 95.08 95.11 87.11 86.14 
14 1/PRT/2007_EU498674 74.98 74.81 74.81 97.3 99.62 99.72 99.58 99.83 99.79 99.79 99.83 99.65 100 99.86 99.79 99.83 99.86 99.62 99.72 99.62 94.42 95.22 95.91 94.91 94.25 95.29 95.32 87.25 86.21 
15 1/MAR/2007_KP821010 74.98 74.81 74.81 97.3 99.62 99.65 99.51 99.76 99.72 99.72 99.76 99.65 99.86 100 99.79 99.83 99.86 99.62 99.72 99.62 94.42 95.22 95.88 94.91 94.21 95.29 95.32 87.18 86.28 
16 1/DZA/2006_EU625361 74.98 74.81 74.81 97.23 99.62 99.58 99.45 99.69 99.65 99.65 99.69 99.79 99.79 99.79 100 99.83 99.86 99.55 99.65 99.55 94.42 95.15 95.81 94.98 94.21 95.29 95.32 87.18 86.21 
17 1/MAR/2006_KP821009 74.91 74.74 74.74 97.26 99.72 99.62 99.48 99.72 99.69 99.69 99.72 99.83 99.83 99.83 99.83 100 99.9 99.58 99.69 99.58 94.39 95.25 95.91 94.87 94.18 95.25 95.29 87.21 86.24 
18 1/ITA/2006_KJ736002 74.91 74.74 74.74 97.3 99.69 99.65 99.51 99.76 99.72 99.72 99.76 99.72 99.86 99.86 99.86 99.9 100 99.62 99.72 99.62 94.42 95.22 95.88 94.91 94.21 95.29 95.32 87.25 86.28 
19 1/TUN/2011_KJ577105 74.81 74.57 74.57 97.12 99.38 99.55 99.27 99.51 99.48 99.48 99.51 99.41 99.62 99.62 99.55 99.58 99.62 100 99.69 99.51 94.25 95.05 95.77 94.73 94.04 95.11 95.15 87.08 86.17 
20 1/DZA/2008_KP820997 74.98 74.81 74.81 97.16 99.48 99.72 99.38 99.62 99.58 99.58 99.62 99.51 99.72 99.72 99.65 99.69 99.72 99.69 100 99.76 94.28 95.08 95.74 94.77 94.07 95.15 95.18 87.25 86.14 
21 1/ITA/2013_KJ661730 74.88 74.71 74.71 97.05 99.38 99.62 99.27 99.51 99.48 99.48 99.51 99.41 99.62 99.62 99.55 99.58 99.62 99.51 99.76 100 94.25 95.05 95.7 94.73 94.04 95.11 95.15 87.21 86.11 
22 1/ZAF_JX272380 75.02 74.84 74.84 94.14 94.18 94.21 94.14 94.32 94.35 94.28 94.39 94.21 94.42 94.42 94.42 94.39 94.42 94.25 94.28 94.25 100 95.46 96.08 95.88 96.12 96.15 96.19 88.22 87.28 
23 1/NGA/1982_AJ585118 74.57 74.53 74.53 94.94 94.98 95.01 94.87 95.11 95.08 95.08 95.18 95.08 95.22 95.22 95.15 95.25 95.22 95.05 95.08 95.05 95.46 100 97.89 95.63 95.95 95.88 95.91 87.04 86.31 
24 1/CMR/1982_KP820998 74.95 75.05 75.05 95.7 95.7 95.77 95.56 95.81 95.77 95.77 95.88 95.74 95.91 95.88 95.81 95.91 95.88 95.77 95.74 95.7 96.08 97.89 100 96.22 95.77 96.5 96.53 87.6 86.87 
25 1/SDN/1987_KP821022 75.36 75.26 75.26 94.59 94.7 94.7 94.63 94.87 94.84 94.84 94.94 94.77 94.91 94.91 94.98 94.87 94.91 94.73 94.77 94.73 95.88 95.63 96.22 100 95.91 97.05 97.09 87.6 86.8 
26 1/RSArrrr/1958_AJ58 74.5 74.53 74.53 93.9 93.97 94.04 93.94 94.14 94.11 94.11 94.21 94.01 94.25 94.21 94.21 94.18 94.21 94.04 94.07 94.04 96.12 95.95 95.77 95.91 100 98.06 98.09 87.11 86.11 
27 1/ZAF_FJ969720 74.71 74.67 74.67 95.05 95.05 95.08 94.98 95.18 95.15 95.15 95.25 95.08 95.29 95.29 95.29 95.25 95.29 95.11 95.15 95.11 96.15 95.88 96.5 97.05 98.06 100 99.97 87.98 86.76 
28 1/CHN/1997_JN848760 74.74 74.71 74.71 95.08 95.08 95.11 95.01 95.22 95.18 95.18 95.29 95.11 95.32 95.32 95.32 95.29 95.32 95.15 95.18 95.15 96.19 95.91 96.53 97.09 98.09 99.97 100 88.01 86.8 
29 1/USA/2010_KX164020 73.7 73.8 73.8 87.01 87.04 87.25 86.97 87.14 87.18 87.11 87.14 87.11 87.25 87.18 87.18 87.21 87.25 87.08 87.25 87.21 88.22 87.04 87.6 87.6 87.11 87.98 88.01 100 90.75 
30 1/GUF/2011_JQ436736 73.6 73.56 73.56 85.83 86.14 86.14 86 86.17 86.21 86.14 86.11 86.14 86.21 86.28 86.21 86.24 86.28 86.17 86.14 86.11 87.28 86.31 86.87 86.8 86.11 86.76 86.8 90.75 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-2 strains sequenced in this study and global reference eastern BTV-2 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1 IND2015/K9_2015-09-10 100 100 99.07 99.07 99.24 99.45 97.27 97.61 98.06 98.1 88.85 88.89 89.03 88.82 
2 IND2015/K14_2015-09-12 100 100 99.07 99.07 99.24 99.45 97.27 97.61 98.06 98.1 88.85 88.89 89.03 88.82 
3 IND2015/K3_2015-09-10 99.07 99.07 100 100 99.27 99.48 97.44 97.72 98.17 98.2 88.85 88.89 88.99 88.72 
4 IND2015/14A_2015-11-08 99.07 99.07 100 100 99.27 99.48 97.44 97.72 98.17 98.2 88.85 88.89 88.99 88.72 
5 2/IND_KC751422 99.24 99.24 99.27 99.27 100 99.79 97.47 97.89 98.34 98.37 88.85 88.89 89.13 88.85 
6 2/IND/2010_KP339165 99.45 99.45 99.48 99.48 99.79 100 97.61 98.03 98.48 98.51 88.96 88.99 89.24 88.96 
7 2/IND/1982_AJ585152 97.27 97.27 97.44 97.44 97.47 97.61 100 97.72 98.17 98.2 90.03 90 90 89.65 
8 2/IND/1993_KP696583 97.61 97.61 97.72 97.72 97.89 98.03 97.72 100 99.41 99.45 88.82 88.85 88.82 88.54 
9 2/IND/1994_KP268775 98.06 98.06 98.17 98.17 98.34 98.48 98.17 99.41 100 99.97 89.24 89.27 89.24 88.96 
10 2/IND/1993_KP339155 98.1 98.1 98.2 98.2 98.37 98.51 98.2 99.45 99.97 100 89.27 89.3 89.27 88.99 
11 2/AUS/2008_JQ086242 88.85 88.85 88.85 88.85 88.85 88.96 90.03 88.82 89.24 89.27 100 99.69 95.22 94.77 
12 2/AUS/2010_JQ240322 88.89 88.89 88.89 88.89 88.89 88.99 90 88.85 89.27 89.3 99.69 100 95.12 94.67 
13 2/JPN/2007_AB686224 89.03 89.03 88.99 88.99 89.13 89.24 90 88.82 89.24 89.27 95.22 95.12 100 98.55 
14 2/TWN/2003_AY493687 88.82 88.82 88.72 88.72 88.85 88.96 89.65 88.54 88.96 88.99 94.77 94.67 98.55 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-2 strains sequenced in this study and global reference western BTV-2 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
1 IND2015/K9_2015-09-10 100 100 99.07 99.07 71.89 71.75 72 72.07 72 71.1 71.17 71.48 71.37 71.37 71.51 71.48 71.55 71.58 71.55 71.55 71.55 71.55 71.55 
2 IND2015/K14_2015-09-12 100 100 99.07 99.07 71.89 71.75 72 72.07 72 71.1 71.17 71.48 71.37 71.37 71.51 71.48 71.55 71.58 71.55 71.55 71.55 71.55 71.55 
3 IND2015/K3_2015-09-10 99.07 99.07 100 100 71.96 71.86 72.1 72.17 72.1 71.34 71.41 71.55 71.44 71.44 71.41 71.37 71.44 71.48 71.44 71.44 71.44 71.44 71.44 
4 IND2015/14A_2015-11-08 99.07 99.07 100 100 71.96 71.86 72.1 72.17 72.1 71.34 71.41 71.55 71.44 71.44 71.41 71.37 71.44 71.48 71.44 71.44 71.44 71.44 71.44 
5 2/MTQ/2006_HQ222820 71.89 71.89 71.96 71.96 100 91.03 91.03 90.9 91 91.93 91.03 81.9 82.04 82.04 81.59 81.52 81.55 81.62 81.55 81.59 81.59 81.59 81.59 
6 2/PAN/1989_KF986501 71.75 71.75 71.86 71.86 91.03 100 92.94 92.7 92.73 93.35 92.18 82.62 82.69 82.69 82.31 82.24 82.28 82.35 82.28 82.31 82.31 82.31 82.31 
7 2/USA/1999_AY855267 72 72 72.1 72.1 91.03 92.94 100 99.03 99.07 94.39 93.18 82.76 83 83 82.73 82.73 82.76 82.83 82.76 82.8 82.8 82.8 82.8 
8 2/USA/2006_KF986495 72.07 72.07 72.17 72.17 90.9 92.7 99.03 100 99.83 94.36 93.22 82.52 82.76 82.76 82.76 82.76 82.8 82.87 82.8 82.83 82.83 82.83 82.83 
9 2/USA/2003_KF986499 72 72 72.1 72.1 91 92.73 99.07 99.83 100 94.25 93.04 82.42 82.66 82.66 82.66 82.66 82.69 82.76 82.69 82.73 82.73 82.73 82.73 
10 2/USA/2010_JQ822249 71.1 71.1 71.34 71.34 91.93 93.35 94.39 94.36 94.25 100 97.68 82.76 82.94 82.94 82.55 82.49 82.52 82.59 82.52 82.55 82.55 82.55 82.55 
11 2/GUF/2011_KC633279 71.17 71.17 71.41 71.41 91.03 92.18 93.18 93.22 93.04 97.68 100 83.07 83.25 83.25 82.69 82.62 82.66 82.73 82.66 82.69 82.69 82.69 82.69 
12 2/NGA/1982_AJ585153 71.48 71.48 71.55 71.55 81.9 82.62 82.76 82.52 82.42 82.76 83.07 100 99.34 99.34 95.43 95.4 95.43 95.43 95.43 95.47 95.47 95.47 95.47 
13 2/SDN/1985_AJ585155 71.37 71.37 71.44 71.44 82.04 82.69 83 82.76 82.66 82.94 83.25 99.34 100 100 95.19 95.15 95.19 95.19 95.19 95.22 95.22 95.22 95.22 
14 2/SDN/1983_KP821036 71.37 71.37 71.44 71.44 82.04 82.69 83 82.76 82.66 82.94 83.25 99.34 100 100 95.19 95.15 95.19 95.19 95.19 95.22 95.22 95.22 95.22 
15 2/TUN/2000_AJ585156 71.51 71.51 71.41 71.41 81.59 82.31 82.73 82.76 82.66 82.55 82.69 95.43 95.19 95.19 100 99.83 99.86 99.86 99.86 99.9 99.9 99.9 99.9 
16 2/ITA/2000_JN255873 71.48 71.48 71.37 71.37 81.52 82.24 82.73 82.76 82.66 82.49 82.62 95.4 95.15 95.15 99.83 100 99.9 99.9 99.9 99.93 99.93 99.93 99.93 
17 2/ITA/2001_DQ191263 71.55 71.55 71.44 71.44 81.55 82.28 82.76 82.8 82.69 82.52 82.66 95.43 95.19 95.19 99.86 99.9 100 99.93 99.93 99.97 99.97 99.97 99.97 
18 2/ITA/2000_DQ191262 71.58 71.58 71.48 71.48 81.62 82.35 82.83 82.87 82.76 82.59 82.73 95.43 95.19 95.19 99.86 99.9 99.93 100 99.93 99.97 99.97 99.97 99.97 
19 2/FRA/2001_KP821024 71.55 71.55 71.44 71.44 81.55 82.28 82.76 82.8 82.69 82.52 82.66 95.43 95.19 95.19 99.86 99.9 99.93 99.93 100 99.97 99.97 99.97 99.97 
20 2/FRA/2000_AF356601 71.55 71.55 71.44 71.44 81.59 82.31 82.8 82.83 82.73 82.55 82.69 95.47 95.22 95.22 99.9 99.93 99.97 99.97 99.97 100 100 100 100 
21 2/ITA/2000_JN255863 71.55 71.55 71.44 71.44 81.59 82.31 82.8 82.83 82.73 82.55 82.69 95.47 95.22 95.22 99.9 99.93 99.97 99.97 99.97 100 100 100 100 
22 2/ITA/2000_KM053269 71.55 71.55 71.44 71.44 81.59 82.31 82.8 82.83 82.73 82.55 82.69 95.47 95.22 95.22 99.9 99.93 99.97 99.97 99.97 100 100 100 100 
23 2/TUN/2000_KP821037 71.55 71.55 71.44 71.44 81.59 82.31 82.8 82.83 82.73 82.55 82.69 95.47 95.22 95.22 99.9 99.93 99.97 99.97 99.97 100 100 100 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-2 strains sequenced in this study and global reference western BTV-2 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1 IND2015/K9_2015-09-10 100 100 99.07 99.07 71.44 71.48 71.48 71.48 71.48 71.34 71.62 71.62 71.55 71.69 71.72 71.82 71.79 71.82 
2 IND2015/K14_2015-09-12 100 100 99.07 99.07 71.44 71.48 71.48 71.48 71.48 71.34 71.62 71.62 71.55 71.69 71.72 71.82 71.79 71.82 
3 IND2015/K3_2015-09-10 99.07 99.07 100 100 71.34 71.37 71.37 71.37 71.37 71.24 71.51 71.51 71.44 71.58 71.62 71.72 71.69 71.72 
4 IND2015/14A_2015-11-08 99.07 99.07 100 100 71.34 71.37 71.37 71.37 71.37 71.24 71.51 71.51 71.44 71.58 71.62 71.72 71.69 71.72 
5 2/ITA/2001_AJ585161 71.44 71.44 71.34 71.34 100 99.83 99.83 99.83 99.83 95.74 96.16 96.16 96.09 96.23 96.26 96.37 96.37 96.4 
6 2/ITA/2001_DQ191261 71.48 71.48 71.37 71.37 99.83 100 100 100 100 95.64 96.05 96.05 95.98 96.12 96.16 96.26 96.26 96.3 
7 2/FRA/2001_KP821025 71.48 71.48 71.37 71.37 99.83 100 100 100 100 95.64 96.05 96.05 95.98 96.12 96.16 96.26 96.26 96.3 
8 2/FRA/2001_KP821026 71.48 71.48 71.37 71.37 99.83 100 100 100 100 95.64 96.05 96.05 95.98 96.12 96.16 96.26 96.26 96.3 
9 2/ITA/2002_KP821034 71.48 71.48 71.37 71.37 99.83 100 100 100 100 95.64 96.05 96.05 95.98 96.12 96.16 96.26 96.26 96.3 
10 2/PRT/2005_EF434177 71.34 71.34 71.24 71.24 95.74 95.64 95.64 95.64 95.64 100 99 99 98.89 99.03 99.1 99.17 99.17 99.2 
11 2/RSArrrr/1959_AJ585123 71.62 71.62 71.51 71.51 96.16 96.05 96.05 96.05 96.05 99 100 100 99.79 99.52 99.69 99.65 99.65 99.69 
12 2/RSArrrr/1959_KP821030 71.62 71.62 71.51 71.51 96.16 96.05 96.05 96.05 96.05 99 100 100 99.79 99.52 99.69 99.65 99.65 99.69 
13 2/IND/2003_KP696603 71.55 71.55 71.44 71.44 96.09 95.98 95.98 95.98 95.98 98.89 99.79 99.79 100 99.58 99.62 99.65 99.65 99.69 
14 2/USA_M21946 71.69 71.69 71.58 71.58 96.23 96.12 96.12 96.12 96.12 99.03 99.52 99.52 99.58 100 99.76 99.79 99.79 99.83 
15 2/IND/2003_KP696593 71.72 71.72 71.62 71.62 96.26 96.16 96.16 96.16 96.16 99.1 99.69 99.69 99.62 99.76 100 99.83 99.83 99.86 
16 2/USA/1982_AY855266 71.82 71.82 71.72 71.72 96.37 96.26 96.26 96.26 96.26 99.17 99.65 99.65 99.65 99.79 99.83 100 99.93 99.97 
17 2/USA/1982_AY855265 71.79 71.79 71.69 71.69 96.37 96.26 96.26 96.26 96.26 99.17 99.65 99.65 99.65 99.79 99.83 99.93 100 99.97 
18 2/ZAF/1959_AY855264 71.82 71.82 71.72 71.72 96.4 96.3 96.3 96.3 96.3 99.2 99.69 99.69 99.69 99.83 99.86 99.97 99.97 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-2 strains sequenced in this study and global reference western BTV-2 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1 IND2015/K9_2015-09-10 100 100 99.07 99.07 71.86 71.82 71.75 71.79 71.72 71.82 71.75 71.82 71.79 71.79 72.79 72.17 
2 IND2015/K14_2015-09-12 100 100 99.07 99.07 71.86 71.82 71.75 71.79 71.72 71.82 71.75 71.82 71.79 71.79 72.79 72.17 
3 IND2015/K3_2015-09-10 99.07 99.07 100 100 71.75 71.72 71.65 71.69 71.62 71.72 71.65 71.72 71.69 71.69 72.86 72.1 
4 IND2015/14A_2015-11-08 99.07 99.07 100 100 71.75 71.72 71.65 71.69 71.62 71.72 71.65 71.72 71.69 71.69 72.86 72.1 
5 2/ZAF_JX272600 71.86 71.86 71.75 71.75 100 99.97 99.9 99.93 99.58 99.76 99.79 99.79 99.83 99.83 88.72 89.27 
6 2/ZAF_JN255923 71.82 71.82 71.72 71.72 99.97 100 99.93 99.97 99.55 99.72 99.76 99.76 99.79 99.79 88.68 89.24 
7 2/IND/2003_JQ681258 71.75 71.75 71.65 71.65 99.9 99.93 100 99.97 99.48 99.65 99.69 99.69 99.72 99.72 88.61 89.17 
8 2/IND/2008_JQ904072 71.79 71.79 71.69 71.69 99.93 99.97 99.97 100 99.52 99.69 99.72 99.72 99.76 99.76 88.65 89.2 
9 2/ZAF_AF481096 71.72 71.72 71.62 71.62 99.58 99.55 99.48 99.52 100 99.69 99.72 99.72 99.76 99.76 88.58 89.2 
10 2/ESP/2005_KP821035 71.82 71.82 71.72 71.72 99.76 99.72 99.65 99.69 99.69 100 99.9 99.9 99.93 99.93 88.68 89.24 
11 2/ITA/2001_DQ191271 71.75 71.75 71.65 71.65 99.79 99.76 99.69 99.72 99.72 99.9 100 99.93 99.97 99.97 88.72 89.27 
12 2/ITA/2001_DQ191270 71.82 71.82 71.72 71.72 99.79 99.76 99.69 99.72 99.72 99.9 99.93 100 99.97 99.97 88.72 89.27 
13 2/ZAF_JN255933 71.79 71.79 71.69 71.69 99.83 99.79 99.72 99.76 99.76 99.93 99.97 99.97 100 100 88.75 89.3 
14 2/ISR/2001_KP821027 71.79 71.79 71.69 71.69 99.83 99.79 99.72 99.76 99.76 99.93 99.97 99.97 100 100 88.75 89.3 
15 2/REU/2009_HQ222824 72.79 72.79 72.86 72.86 88.72 88.68 88.61 88.65 88.58 88.68 88.72 88.72 88.75 88.75 100 96.16 
16 2/CAD_KY471278 72.17 72.17 72.1 72.1 89.27 89.24 89.17 89.2 89.2 89.24 89.27 89.27 89.3 89.3 96.16 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-4 strains sequenced in this study and global reference eastern BTV-4 strains. 
 
 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1 4/CHN/1997_JX560414 100 91.4 91.36 91.19 91.19 91.29 91.15 91.43 91.33 91.33 91.36 91.47 91.57 91.54 
2 4/IND/2013_KY947347 91.4 100 99.83 99.3 99.3 99.37 99.34 99.41 99.44 99.44 99.55 98.85 98.47 98.64 
3 4/IND/2013_KY947349 91.36 99.83 100 99.27 99.27 99.34 99.3 99.37 99.41 99.41 99.51 98.75 98.43 98.61 
4 IND2015/K4_2015-09-10 91.19 99.3 99.27 100 100 99.51 99.48 99.55 99.58 99.58 99.69 98.64 98.33 98.5 
5 IND2015/6PK_2015-09-07 91.19 99.3 99.27 100 100 99.51 99.48 99.55 99.58 99.58 99.69 98.64 98.33 98.5 
6 4/IND/2013_KY947350 91.29 99.37 99.34 99.51 99.51 100 99.55 99.62 99.65 99.65 99.76 98.71 98.4 98.57 
7 4/IND/2007_KY947343 91.15 99.34 99.3 99.48 99.48 99.55 100 99.58 99.62 99.76 99.72 98.68 98.43 98.61 
8 4/IND/2013_KY947348 91.43 99.41 99.37 99.55 99.55 99.62 99.58 100 99.69 99.76 99.79 98.75 98.43 98.61 
9 4/IND/2013_KY947351 91.33 99.44 99.41 99.58 99.58 99.65 99.62 99.69 100 99.72 99.83 98.78 98.47 98.64 
10 4/IND/2013_KY947342 91.33 99.44 99.41 99.58 99.58 99.65 99.76 99.76 99.72 100 99.83 98.78 98.54 98.71 
11 4/IND/2013_KY947346 91.36 99.55 99.51 99.69 99.69 99.76 99.72 99.79 99.83 99.83 100 98.89 98.57 98.75 
12 4/IND/2012_KY947345 91.47 98.85 98.75 98.64 98.64 98.71 98.68 98.75 98.78 98.78 98.89 100 98.92 99.09 
13 4/IND/2008_KF560418 91.57 98.47 98.43 98.33 98.33 98.4 98.43 98.43 98.47 98.54 98.57 98.92 100 99.83 
14 4/IND/2008_KY947344 91.54 98.64 98.61 98.5 98.5 98.57 98.61 98.61 98.64 98.71 98.75 99.09 99.83 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-4 strains sequenced in this study and global reference western BTV-4 strains. 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
IND2015/K4_2015-09-10 100 100 99.51 99.48 99.55 99.58 99.58 99.69 98.64 98.33 98.5 71.4 71.82 71.68 71.79 71.79 71.89 72.41 72.48 72.52 72.38 72.45 72.48 72.48 72.45 
IND2015/6PK_2015-09-07 100 100 99.51 99.48 99.55 99.58 99.58 99.69 98.64 98.33 98.5 71.4 71.82 71.68 71.79 71.79 71.89 72.41 72.48 72.52 72.38 72.45 72.48 72.48 72.45 
4/ARG/1999_JX024950 71.4 71.4 71.44 71.44 71.44 71.37 71.44 71.44 71.72 71.47 71.58 100 94.5 94.98 94.81 94.85 94.81 90.28 90.04 90.11 89.9 89.93 90 90 89.97 
4/ARG/2002_AJ585169 71.82 71.82 71.86 71.79 71.93 71.79 71.86 71.86 72 71.47 71.58 94.5 100 98.78 98.89 98.85 98.89 89.69 89.52 89.59 89.38 89.41 89.48 89.48 89.45 
4/ARG/1999_JX024940 71.68 71.68 71.72 71.65 71.79 71.65 71.72 71.72 71.86 71.33 71.44 94.98 98.78 100 99.69 99.65 99.62 89.45 89.24 89.31 89.1 89.13 89.2 89.2 89.17 
4/ARG/2010_JX024960 71.79 71.79 71.82 71.75 71.89 71.75 71.82 71.82 71.96 71.44 71.54 94.81 98.89 99.69 100 99.76 99.79 89.52 89.31 89.38 89.17 89.2 89.27 89.27 89.24 
4/ARG/1999_JX024945 71.79 71.79 71.82 71.75 71.89 71.75 71.82 71.82 71.96 71.44 71.54 94.85 98.85 99.65 99.76 100 99.83 89.48 89.24 89.31 89.1 89.13 89.2 89.2 89.17 
4/ARG/2009_JX024955 71.89 71.89 71.93 71.86 72 71.86 71.93 71.93 72.07 71.54 71.65 94.81 98.89 99.62 99.79 99.83 100 89.48 89.27 89.34 89.13 89.17 89.24 89.24 89.2 
4/ZAF/2004_AY839948 72.41 72.41 72.45 72.34 72.45 72.34 72.38 72.38 72.52 72.1 72.27 90.28 89.69 89.45 89.52 89.48 89.48 100 98.47 98.68 98.68 98.71 98.78 98.78 98.75 
4/ZAF_KM233615 72.48 72.48 72.45 72.41 72.52 72.38 72.45 72.45 72.52 72.17 72.34 90.04 89.52 89.24 89.31 89.24 89.27 98.47 100 99.79 99.58 99.65 99.69 99.69 99.65 
4/ZAF_JX272580 72.52 72.52 72.48 72.45 72.55 72.41 72.48 72.48 72.55 72.2 72.38 90.11 89.59 89.31 89.38 89.31 89.34 98.68 99.79 100 99.79 99.83 99.9 99.9 99.86 
4/EGY/1977_KP821047 72.38 72.38 72.34 72.31 72.41 72.27 72.34 72.34 72.41 72.07 72.24 89.9 89.38 89.1 89.17 89.1 89.13 98.68 99.58 99.79 100 99.83 99.9 99.9 99.86 
4/TUR_AJ585164 72.45 72.45 72.41 72.38 72.48 72.34 72.41 72.41 72.48 72.14 72.31 89.93 89.41 89.13 89.2 89.13 89.17 98.71 99.65 99.83 99.83 100 99.93 99.93 99.9 
4/RSAvvvv_AJ585163 72.48 72.48 72.45 72.41 72.52 72.38 72.45 72.45 72.52 72.17 72.34 90 89.48 89.2 89.27 89.2 89.24 98.78 99.69 99.9 99.9 99.93 100 100 99.97 
4/ZAF/1900_JN255943 72.48 72.48 72.45 72.41 72.52 72.38 72.45 72.45 72.52 72.17 72.34 90 89.48 89.2 89.27 89.2 89.24 98.78 99.69 99.9 99.9 99.93 100 100 99.97 
4/ITA/2002_DQ191276 72.45 72.45 72.41 72.38 72.48 72.41 72.41 72.41 72.48 72.14 72.31 89.97 89.45 89.17 89.24 89.17 89.2 98.75 99.65 99.86 99.86 99.9 99.97 99.97 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-4 strains sequenced in this study and global reference western BTV-4 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
1 IND2015/K4_2015-09-10 100 100 71.6 71.7 71.7 71.7 71.7 71.7 71.7 71.7 72.1 72.0 71.9 71.7 71.7 71.4 71.5 71.5 71.5 71.5 71.5 71.5 71.5 71.5 71.4 71.4 71.5 71.5 71.5 
2 IND2015/6PK_2015-09-07 100 100 71.6 71.7 71.7 71.7 71.7 71.7 71.7 71.7 72.1 72.0 71.9 71.7 71.7 71.4 71.5 71.5 71.5 71.5 71.5 71.5 71.5 71.5 71.4 71.4 71.5 71.5 71.5 
3 4/CYP/2011_KP821042 71.6 71.6 100 99.9 99.9 99.9 99.9 99.9 99.9 99.9 95.0 95.3 95.3 96.1 96.1 96.1 96.3 96.3 96.3 96.3 96.3 96.2 96.2 96.2 96.2 96.2 96.2 96.2 96.2 
4 4/GRC/2012_KP821056 71.7 71.7 99.9 100 100 99.9 99.9 99.9 99.9 100 95.1 95.3 95.3 96.1 96.1 96.1 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.2 96.2 96.2 96.2 96.3 
5 4/GRC/2012_KP821057 71.7 71.7 99.9 100 100 99.9 99.9 99.9 99.9 100 95.1 95.3 95.3 96.1 96.1 96.1 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.2 96.2 96.2 96.2 96.3 
6 4/CYP/2011_KP821043 71.7 71.7 99.9 99.9 99.9 100 100 100 99.9 100 95.1 95.3 95.3 96.1 96.1 96.1 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.2 96.2 96.2 96.2 96.3 
7 4/CYP/2011_KP821045 71.7 71.7 99.9 99.9 99.9 100 100 100 99.9 100 95.1 95.3 95.3 96.1 96.1 96.1 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.2 96.2 96.2 96.2 96.3 
8 4/CYP/2011_KP821046 71.7 71.7 99.9 99.9 99.9 100 100 100 99.9 100 95.1 95.3 95.3 96.1 96.1 96.1 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.2 96.2 96.2 96.2 96.3 
9 4/GRC/2012_KP821058 71.7 71.7 99.9 99.9 99.9 99.9 99.9 99.9 100 100 95.1 95.3 95.4 96.1 96.1 96.2 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.2 96.2 96.3 96.3 96.3 
10 4/CYP/2011_KP821044 71.7 71.7 99.9 100 100 100 100 100 100 100 95.1 95.3 95.4 96.1 96.1 96.2 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.2 96.2 96.3 96.3 96.3 
11 4/ISR/2006_KP821059 72.1 72.1 95.0 95.1 95.1 95.1 95.1 95.1 95.1 95.1 100 99.6 99.7 98.4 98.4 98.0 98.3 98.3 98.3 98.3 98.3 98.2 98.2 98.2 98.2 98.2 98.3 98.2 98.2 
12 4/ISR/2001_DQ191278 72.0 72.0 95.3 95.3 95.3 95.3 95.3 95.3 95.3 95.3 99.6 100 99.8 98.6 98.6 98.2 98.4 98.4 98.4 98.4 98.4 98.4 98.4 98.3 98.3 98.3 98.4 98.4 98.4 
13 4/ISR/2001_DQ191279 71.9 71.9 95.3 95.3 95.3 95.3 95.3 95.3 95.4 95.4 99.7 99.8 100 98.6 98.6 98.2 98.5 98.5 98.5 98.5 98.5 98.4 98.4 98.4 98.4 98.4 98.5 98.4 98.4 
14 4/TUR/1978_AJ585165 71.7 71.7 96.1 96.1 96.1 96.1 96.1 96.1 96.1 96.1 98.4 98.6 98.6 100 100 99.3 99.5 99.5 99.5 99.5 99.5 99.5 99.5 99.4 99.5 99.4 99.4 99.4 99.5 
15 4/TUR/1999_DQ825670 71.7 71.7 96.1 96.1 96.1 96.1 96.1 96.1 96.1 96.1 98.4 98.6 98.6 100 100 99.3 99.5 99.5 99.5 99.5 99.5 99.5 99.5 99.4 99.5 99.4 99.4 99.4 99.5 
16 4/ESP/2003_KJ700442 71.4 71.4 96.1 96.1 96.1 96.1 96.1 96.1 96.2 96.2 98.0 98.2 98.2 99.3 99.3 100 99.8 99.8 99.8 99.8 99.8 99.7 99.7 99.7 99.7 99.7 99.7 99.7 99.7 
17 4/RSArrrr/1969_AJ58512 71.5 71.5 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.3 98.4 98.5 99.5 99.5 99.8 100 100 100 100 100 100 100 99.9 99.9 99.9 99.9 99.9 100 
18 4/CYP/1969_AJ585180 71.5 71.5 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.3 98.4 98.5 99.5 99.5 99.8 100 100 100 100 100 100 100 99.9 99.9 99.9 99.9 99.9 100 
19 4/CYP/1969_KP821040 71.5 71.5 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.3 98.4 98.5 99.5 99.5 99.8 100 100 100 100 100 100 100 99.9 99.9 99.9 99.9 99.9 100 
20 4/GRC/1979_KP821051 71.5 71.5 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.3 98.4 98.5 99.5 99.5 99.8 100 100 100 100 100 100 100 99.9 99.9 99.9 99.9 99.9 100 
21 4/RSArrrr/1969_KP82106 71.5 71.5 96.3 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.3 98.4 98.5 99.5 99.5 99.8 100 100 100 100 100 100 100 99.9 99.9 99.9 99.9 99.9 100 
22 4/GRC/1999_DQ191277 71.5 71.5 96.2 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.2 98.4 98.4 99.5 99.5 99.7 100 100 100 100 100 100 100 99.9 99.9 99.9 99.9 99.9 99.9 
23 4/GRC/1999_KP821052 71.5 71.5 96.2 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.2 98.4 98.4 99.5 99.5 99.7 100 100 100 100 100 100 100 99.9 99.9 99.9 99.9 99.9 99.9 
24 4/GRC/2000_KP821055 71.5 71.5 96.2 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.2 98.3 98.4 99.4 99.4 99.7 99.9 99.9 99.9 99.9 99.9 99.9 99.9 100 99.9 99.9 99.9 99.9 99.9 
25 4/GRC/2000_AJ585167 71.4 71.4 96.2 96.2 96.2 96.2 96.2 96.2 96.2 96.2 98.2 98.3 98.4 99.5 99.5 99.7 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 100 99.9 99.9 99.9 99.9 
26 4/GRC/1999_KP821053 71.4 71.4 96.2 96.2 96.2 96.2 96.2 96.2 96.2 96.2 98.2 98.3 98.4 99.4 99.4 99.7 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 100 99.9 99.9 99.9 
27 4/CYP/2004_KP821041 71.5 71.5 96.2 96.2 96.2 96.2 96.2 96.2 96.3 96.3 98.3 98.4 98.5 99.4 99.4 99.7 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 100 99.9 100 
28 4/GRC/2000_KP821054 71.5 71.5 96.2 96.2 96.2 96.2 96.2 96.2 96.3 96.3 98.2 98.4 98.4 99.4 99.4 99.7 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 100 100 
29 4/GRC/2000_AY839946 71.5 71.5 96.2 96.3 96.3 96.3 96.3 96.3 96.3 96.3 98.2 98.4 98.4 99.5 99.5 99.7 100.0 100.0 100.0 100.0 100.0 99.9 99.9 99.9 99.9 99.9 100 100 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-4 strains sequenced in this study and global reference western BTV-4 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
1 IND2015/K4_2015-09-10 100 100 72.3 72.2 72.3 72.3 72.3 72.3 72.3 72.2 72.3 72.3 72.3 72.2 72.3 72.2 72.2 72.2 72.1 72.3 72.2 72.2 72.3 72.3 72.5 
2 IND2015/6PK_2015-09-07 100 100 72.3 72.2 72.3 72.3 72.3 72.3 72.3 72.2 72.3 72.3 72.3 72.2 72.3 72.2 72.2 72.2 72.1 72.3 72.2 72.2 72.3 72.3 72.5 
3 4/HUN/2014_KP268815 72.3 72.3 100 99.8 94.0 94.2 94.3 94.3 94.3 94.3 94.3 94.4 94.4 94.5 94.5 94.5 94.4 94.4 94.5 94.6 94.5 94.6 95.7 95.7 95.6 
4 4/FRA-COR/2016_KY65432 72.2 72.2 99.8 100 94.0 94.2 94.3 94.3 94.3 94.3 94.3 94.4 94.4 94.5 94.5 94.5 94.4 94.4 94.5 94.6 94.5 94.6 95.7 95.7 95.7 
5 4/MAR/2009_KP821065 72.3 72.3 94.0 94.0 100 99.6 99.8 99.8 99.7 98.8 99.0 99.2 99.2 99.4 99.3 99.4 99.4 99.2 99.1 99.3 99.3 99.2 95.9 95.9 95.0 
6 4/ESP/2010_KP821070 72.3 72.3 94.2 94.2 99.6 100 99.9 99.9 99.9 98.9 99.2 99.3 99.3 99.5 99.5 99.5 99.5 99.3 99.3 99.4 99.4 99.4 96.0 96.0 95.1 
7 4/MAR/2009_KP821062 72.3 72.3 94.3 94.3 99.8 99.9 100 100 100 99.0 99.3 99.4 99.4 99.6 99.6 99.6 99.6 99.4 99.4 99.6 99.5 99.5 96.1 96.1 95.2 
8 4/MAR/2009_KP821063 72.3 72.3 94.3 94.3 99.8 99.9 100 100 100 99.0 99.3 99.4 99.4 99.6 99.6 99.6 99.6 99.4 99.4 99.6 99.5 99.5 96.1 96.1 95.2 
9 4/MAR/2009_KP821064 72.3 72.3 94.3 94.3 99.7 99.9 100 100 100 99.0 99.3 99.4 99.4 99.6 99.6 99.6 99.6 99.4 99.4 99.6 99.5 99.5 96.1 96.1 95.2 
10 4/FRA-COR/2003_AY83994 72.2 72.2 94.3 94.3 98.8 98.9 99.0 99.0 99.0 100 99.1 99.3 99.3 99.2 99.2 99.3 99.3 99.6 99.5 99.4 99.5 99.5 96.1 96.1 95.2 
11 4/ITA/2003_JN255893 72.3 72.3 94.3 94.3 99.0 99.2 99.3 99.3 99.3 99.1 100 99.9 99.9 99.4 99.4 99.5 99.5 99.5 99.5 99.7 99.6 99.6 96.1 96.1 95.2 
12 4/ITA/2003_DQ191280 72.3 72.3 94.4 94.4 99.2 99.3 99.4 99.4 99.4 99.3 99.9 100 100 99.6 99.6 99.7 99.7 99.7 99.6 99.9 99.8 99.7 96.2 96.2 95.3 
13 4/ITA/2003_JN255883 72.3 72.3 94.4 94.4 99.2 99.3 99.4 99.4 99.4 99.3 99.9 100 100 99.6 99.6 99.7 99.7 99.7 99.6 99.9 99.8 99.7 96.2 96.2 95.3 
14 4/PRT/2004_EF434176 72.2 72.2 94.5 94.5 99.4 99.5 99.6 99.6 99.6 99.2 99.4 99.6 99.6 100 100 99.8 99.8 99.6 99.6 99.7 99.7 99.7 96.2 96.2 95.3 
15 4/ESP/2005_KP821069 72.3 72.3 94.5 94.5 99.3 99.5 99.6 99.6 99.6 99.2 99.4 99.6 99.6 100 100 99.8 99.8 99.6 99.5 99.7 99.7 99.6 96.2 96.2 95.3 
16 4/MAR/2004_KP821061 72.2 72.2 94.5 94.5 99.4 99.5 99.6 99.6 99.6 99.3 99.5 99.7 99.7 99.8 99.8 100 99.9 99.7 99.6 99.8 99.8 99.7 96.2 96.2 95.4 
17 4/ESP/2004_KP821068 72.2 72.2 94.4 94.4 99.4 99.5 99.6 99.6 99.6 99.3 99.5 99.7 99.7 99.8 99.8 99.9 100 99.7 99.6 99.8 99.8 99.7 96.2 96.2 95.3 
18 4/FRA-COR/2003_KP82104 72.2 72.2 94.4 94.4 99.2 99.3 99.4 99.4 99.4 99.6 99.5 99.7 99.7 99.6 99.6 99.7 99.7 100 100 99.8 99.9 99.9 96.3 96.3 95.3 
19 4/FRA-COR/2003_KP82104 72.1 72.1 94.5 94.5 99.1 99.3 99.4 99.4 99.4 99.5 99.5 99.6 99.6 99.6 99.5 99.6 99.6 100 100 99.8 99.9 99.8 96.3 96.3 95.3 
20 4/ESP/2003_KP821067 72.3 72.3 94.6 94.6 99.3 99.4 99.6 99.6 99.6 99.4 99.7 99.9 99.9 99.7 99.7 99.8 99.8 99.8 99.8 100 99.9 99.9 96.4 96.4 95.5 
21 4/ITA/2003_DQ191281 72.2 72.2 94.5 94.5 99.3 99.4 99.5 99.5 99.5 99.5 99.6 99.8 99.8 99.7 99.7 99.8 99.8 99.9 99.9 99.9 100 100 96.4 96.4 95.4 
22 4/FRA-COR/2003_KP82105 72.2 72.2 94.6 94.6 99.2 99.4 99.5 99.5 99.5 99.5 99.6 99.7 99.7 99.7 99.6 99.7 99.7 99.9 99.8 99.9 100 100 96.4 96.4 95.4 
23 4/SDN/1983_AJ585166 72.3 72.3 95.7 95.7 95.9 96.0 96.1 96.1 96.1 96.1 96.1 96.2 96.2 96.2 96.2 96.2 96.2 96.3 96.3 96.4 96.4 96.4 100 100 96.7 
24 4/SDN/1983_KP821071 72.3 72.3 95.7 95.7 95.9 96.0 96.1 96.1 96.1 96.1 96.1 96.2 96.2 96.2 96.2 96.2 96.2 96.3 96.3 96.4 96.4 96.4 100 100 96.7 
25 4/ZAF/2011_KT317666 72.5 72.5 95.6 95.7 95.0 95.1 95.2 95.2 95.2 95.2 95.2 95.3 95.3 95.3 95.3 95.4 95.3 95.3 95.3 95.5 95.4 95.4 96.7 96.7 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-5 strains sequenced in this study and global reference western BTV-5 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 
1 IND2015/404_2015-12-25 100 99.93 99.93 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 98.43 98.74 98.78 98.78 95.68 94.87 94.94 94.94 77.44 76.99 77.55 
2 IND2015/475_2015-12-25 99.93 100 99.93 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 98.43 98.74 98.78 98.78 95.68 94.87 94.94 94.94 77.44 76.99 77.55 
3 IND2015/CS9_2015-12-25 99.93 99.93 100 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 98.43 98.74 98.78 98.78 95.68 94.87 94.94 94.94 77.44 77.02 77.55 
4 IND2015/491_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
5 IND2015/492_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
6 IND2015/408_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
7 IND2015/471_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
8 IND2015/476_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
9 IND2015/478_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
10 IND2015/486_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
11 IND2015/534_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
12 IND2015/547_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
13 IND2015/228_2015-12-25 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
14 IND2015/V1_2015-11-26 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
15 IND2015/V2_2015-11-26 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
16 IND2015/V44_2015-11-26 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
17 IND2014/10NLG_2014- 99.97 99.97 99.97 100 100 100 100 100 100 100 100 100 100 100 100 100 100 98.47 98.78 98.81 98.81 95.71 94.91 94.98 94.98 77.48 77.02 77.58 
18 5/CHN/2014_KT945043 98.43 98.43 98.43 98.47 98.47 98.47 98.47 98.47 98.47 98.47 98.47 98.47 98.47 98.47 98.47 98.47 98.47 100 98.99 99.02 99.02 95.85 95.05 95.12 95.12 77.34 76.85 77.86 
19 5/CHN/2012_KT945045 98.74 98.74 98.74 98.78 98.78 98.78 98.78 98.78 98.78 98.78 98.78 98.78 98.78 98.78 98.78 98.78 98.78 98.99 100 99.86 99.9 96.16 95.5 95.57 95.57 77.27 76.85 77.75 
20 5/CHN/2012_KT945042 98.78 98.78 98.78 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 99.02 99.86 100 99.9 96.13 95.4 95.47 95.47 77.23 76.74 77.72 
21 5/CHN/2012_KT945044 98.78 98.78 98.78 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 98.81 99.02 99.9 99.9 100 96.13 95.4 95.47 95.47 77.23 76.74 77.72 
22 5/CMR/1982_AJ585181 95.68 95.68 95.68 95.71 95.71 95.71 95.71 95.71 95.71 95.71 95.71 95.71 95.71 95.71 95.71 95.71 95.71 95.85 96.16 96.13 96.13 100 96.69 96.76 96.76 77.55 77.16 78.31 
23 5/RSArrrr/1953_AJ585126 94.87 94.87 94.87 94.91 94.91 94.91 94.91 94.91 94.91 94.91 94.91 94.91 94.91 94.91 94.91 94.91 94.91 95.05 95.5 95.4 95.4 96.69 100 99.93 99.93 77.65 77.16 78.17 
24 5/ZAF_JX272570 94.94 94.94 94.94 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 95.12 95.57 95.47 95.47 96.76 99.93 100 100 77.68 77.2 78.21 
25 5/RSArrrr/1953_KP821101 94.94 94.94 94.94 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 94.98 95.12 95.57 95.47 95.47 96.76 99.93 100 100 77.68 77.2 78.21 
26 5/NGA/1982_AJ585182 77.44 77.44 77.44 77.48 77.48 77.48 77.48 77.48 77.48 77.48 77.48 77.48 77.48 77.48 77.48 77.48 77.48 77.34 77.27 77.23 77.23 77.55 77.65 77.68 77.68 100 85.22 85.77 
27 5/GLP/2010_HQ241072 76.99 76.99 77.02 77.02 77.02 77.02 77.02 77.02 77.02 77.02 77.02 77.02 77.02 77.02 77.02 77.02 77.02 76.85 76.85 76.74 76.74 77.16 77.16 77.2 77.2 85.22 100 86.72 
28 5/USA/2003_KX164060 77.55 77.55 77.55 77.58 77.58 77.58 77.58 77.58 77.58 77.58 77.58 77.58 77.58 77.58 77.58 77.58 77.58 77.86 77.75 77.72 77.72 78.31 78.17 78.21 78.21 85.77 86.72 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-9 strains sequenced in this study and global reference eastern BTV-9 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
1 9/AUS/1985_JQ086302 100 90.7 89.4 89.6 89.7 89.7 89.6 89.6 89.8 89.8 89.8 89.8 89.8 89.8 89.5 89.6 89.6 89.5 89.5 89.6 89.7 89.8 89.6 89.6 89.6 89.6 89.6 89.6 89.6 89.6 89.8 
2 9/JPN/2003_AB686223 90.7 100 91.0 91.4 91.5 91.5 91.4 91.5 91.6 91.6 91.6 91.6 91.6 91.6 91.0 91.1 91.1 91.1 91.1 91.1 91.3 91.3 91.2 91.1 91.1 91.2 91.2 91.3 91.3 91.3 91.4 
3 IND2015/477_2015-12 89.4 91.0 100 99.0 99.1 98.9 98.8 98.9 99.0 99.0 99.0 99.1 99.1 99.1 97.0 97.1 97.1 97.0 97.0 97.1 97.2 97.3 97.1 97.1 97.1 97.1 97.1 97.2 97.2 97.2 97.3 
4 9/IND/2006_JN579710 89.6 91.4 99.0 100 100 99.4 99.3 99.4 100 100 100 100 100 100 97.6 97.7 97.7 97.6 97.6 97.7 97.8 97.8 97.7 97.7 97.7 97.7 97.7 97.8 97.8 97.8 97.9 
5 9/IND/2006_JF443167 89.7 91.5 99.1 100 100 100 99.4 100 100 100 100 100 100 100 97.7 97.8 97.8 97.7 97.7 97.8 97.9 97.9 97.8 97.8 97.8 97.8 97.8 97.9 97.9 97.9 98.0 
6 9/IND/2004_KP696613 89.7 91.5 98.9 99.4 100 100 100 100 100 100 100 100 100 100 97.8 97.9 97.9 97.9 97.9 97.9 98.0 98.1 97.9 97.9 97.9 97.9 98.0 98.0 98.0 98.0 98.1 
7 9/IND/2005_JQ414046 89.6 91.4 98.8 99.3 99.4 100 100 100 100 100 100 100 100 100 97.8 97.9 97.9 97.9 97.9 97.9 98.1 98.1 97.9 98.0 98.0 98.0 98.1 98.1 98.1 98.1 98.2 
8 9/IND/2005_KJ679573 89.6 91.5 98.9 99.4 100 100 100 100 100 100 100 100 100 100 97.7 97.8 97.8 97.9 97.9 97.8 98.0 98.0 97.9 97.9 97.9 97.9 98.0 98.0 98.0 98.0 98.1 
9 9/IND/2003_KP696633 89.8 91.6 99.0 100 100 100 100 100 100 100 100 100 100 100 97.8 97.9 97.9 98.0 98.0 97.9 98.1 98.1 98.0 98.0 98.0 98.1 98.1 98.1 98.1 98.1 98.2 
10 9/IND/2003_JF443155 89.8 91.6 99.0 100 100 100 100 100 100 100 100 100 100 100 97.9 98.0 98.0 97.9 97.9 98.0 98.1 98.2 98.0 98.0 98.0 98.0 98.1 98.1 98.1 98.1 98.2 
11 9/IND/2003_JF443157 89.8 91.6 99.0 100 100 100 100 100 100 100 100 100 100 100 97.9 98.0 98.0 97.9 97.9 98.0 98.1 98.2 98.0 98.0 98.0 98.0 98.1 98.1 98.1 98.1 98.2 
12 9/IND/2002_JF443156 89.8 91.6 99.1 100 100 100 100 100 100 100 100 100 100 100 97.9 98.0 98.0 98.0 98.0 98.0 98.2 98.2 98.1 98.0 98.0 98.1 98.1 98.2 98.2 98.2 98.3 
13 9/IND/2003_KP339175 89.8 91.6 99.1 100 100 100 100 100 100 100 100 100 100 100 97.9 98.0 98.0 98.0 98.0 98.0 98.2 98.2 98.1 98.0 98.0 98.1 98.1 98.2 98.2 98.2 98.3 
14 9/IND/2003_KP339185 89.8 91.6 99.1 100 100 100 100 100 100 100 100 100 100 100 97.9 98.0 98.0 98.0 98.0 98.0 98.2 98.2 98.1 98.0 98.0 98.1 98.1 98.2 98.2 98.2 98.3 
15 9/GRC/2000_AJ585171 89.5 91.0 97.0 97.6 97.7 97.8 97.8 97.7 97.8 97.9 97.9 97.9 97.9 97.9 100 100 100 100 100 100 100 100 100 100 100 100 100 99.3 99.3 99.4 100 
16 9/BGR/1999_AJ585170 89.6 91.1 97.1 97.7 97.8 97.9 97.9 97.8 97.9 98.0 98.0 98.0 98.0 98.0 100 100 100 100 100 100 100 100 100 100 100 100 100 99.4 99.4 100 100 
17 9/BGR/1999_KP821079 89.6 91.1 97.1 97.7 97.8 97.9 97.9 97.8 97.9 98.0 98.0 98.0 98.0 98.0 100 100 100 100 100 100 100 100 100 100 100 100 100 99.4 99.4 100 100 
18 9/SRB/2001_AJ585172 89.5 91.1 97.0 97.6 97.7 97.9 97.9 97.9 98.0 97.9 97.9 98.0 98.0 98.0 100 100 100 100 100 100 100 100 100 100 100 100 100 99.3 99.3 100 100 
19 9/SRB/2001_KP821090 89.5 91.1 97.0 97.6 97.7 97.9 97.9 97.9 98.0 97.9 97.9 98.0 98.0 98.0 100 100 100 100 100 100 100 100 100 100 100 100 100 99.3 99.3 100 100 
20 9/ITA/2000_JN255913 89.6 91.1 97.1 97.7 97.8 97.9 97.9 97.8 97.9 98.0 98.0 98.0 98.0 98.0 100 100 100 100 100 100 100 100 100 100 100 100 100 99.4 99.4 100 100 
21 9/GRC/1999_KP821081 89.7 91.3 97.2 97.8 97.9 98.0 98.1 98.0 98.1 98.1 98.1 98.2 98.2 98.2 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
22 9/GRC/1999_KP821082 89.8 91.3 97.3 97.8 97.9 98.1 98.1 98.0 98.1 98.2 98.2 98.2 98.2 98.2 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
23 9/ITA/2001_DQ191285 89.6 91.2 97.1 97.7 97.8 97.9 97.9 97.9 98.0 98.0 98.0 98.1 98.1 98.1 100 100 100 100 100 100 100 100 100 100 100 100 100 99.4 99.4 100 100 
24 9/BIH/2002_AJ585174 89.6 91.1 97.1 97.7 97.8 97.9 98.0 97.9 98.0 98.0 98.0 98.0 98.0 98.0 100 100 100 100 100 100 100 100 100 100 100 100 100 99.4 99.4 100 100 
25 9/BIH/2002_KP821078 89.6 91.1 97.1 97.7 97.8 97.9 98.0 97.9 98.0 98.0 98.0 98.0 98.0 98.0 100 100 100 100 100 100 100 100 100 100 100 100 100 99.4 99.4 100 100 
26 9/XKX/2001_KP821085 89.6 91.2 97.1 97.7 97.8 97.9 98.0 97.9 98.1 98.0 98.0 98.1 98.1 98.1 100 100 100 100 100 100 100 100 100 100 100 100 100 99.4 99.4 100 100 
27 9/XKX/2001_KP821084 89.6 91.2 97.1 97.7 97.8 98.0 98.1 98.0 98.1 98.1 98.1 98.1 98.1 98.1 100 100 100 100 100 100 100 100 100 100 100 100 100 99.4 99.4 100 100 
28 9/GRC/1998_DQ191283 89.6 91.3 97.2 97.8 97.9 98.0 98.1 98.0 98.1 98.1 98.1 98.2 98.2 98.2 99.3 99.4 99.4 99.3 99.3 99.4 100 100 99.4 99.4 99.4 99.4 99.4 100 100 100 100 
29 9/GRC/1998_KP821080 89.6 91.3 97.2 97.8 97.9 98.0 98.1 98.0 98.1 98.1 98.1 98.2 98.2 98.2 99.3 99.4 99.4 99.3 99.3 99.4 100 100 99.4 99.4 99.4 99.4 99.4 100 100 100 100 
30 9/TUR/2000_AJ585176 89.6 91.3 97.2 97.8 97.9 98.0 98.1 98.0 98.1 98.1 98.1 98.2 98.2 98.2 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
31 9/TUR/1998_KP821091 89.8 91.4 97.3 97.9 98.0 98.1 98.2 98.1 98.2 98.2 98.2 98.3 98.3 98.3 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-9 strains sequenced in this study and global reference western BTV-9 strains 
 
1 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
IND2015/477_2015-12-25 100 69.04 69 68.62 68.65 68.65 68.83 68.83 68.83 68.76 68.69 68.69 68.69 68.79 69.32 
9/LBY/2008_KP821086 69.04 100 99.86 95.19 95.15 95.15 95.36 95.36 95.43 95.33 95.26 95.26 95.26 85.77 85.91 
9/LBY/2008_KP821087 69 99.86 100 95.12 95.08 95.08 95.29 95.29 95.36 95.26 95.19 95.19 95.19 85.77 85.84 
9/ITA/2003_KP821083 68.62 95.19 95.12 100 99.9 99.9 99.65 99.65 99.72 99.83 99.9 99.9 99.9 86.26 87.03 
9/RSAvvv_AJ585173 68.65 95.15 95.08 99.9 100 100 99.62 99.62 99.69 99.79 99.86 99.86 99.86 86.23 87.03 
9/RSAvvvv/1942_KP82108 68.65 95.15 95.08 99.9 100 100 99.62 99.62 99.69 99.79 99.86 99.86 99.86 86.23 87.03 
9/RSArrrr/1942_AJ58513 68.83 95.36 95.29 99.65 99.62 99.62 100 100 99.93 99.83 99.76 99.76 99.76 86.47 87.24 
9/RSArrrr/1942_KP82108 68.83 95.36 95.29 99.65 99.62 99.62 100 100 99.93 99.83 99.76 99.76 99.76 86.47 87.24 
9/ZAF/1942_JN255953 68.83 95.43 95.36 99.72 99.69 99.69 99.93 99.93 100 99.9 99.83 99.83 99.83 86.54 87.31 
9/ZAF_JX272530 68.76 95.33 95.26 99.83 99.79 99.79 99.83 99.83 99.9 100 99.93 99.93 99.93 86.44 87.2 
9/ZAF/1942_JN255963 68.69 95.26 95.19 99.9 99.86 99.86 99.76 99.76 99.83 99.93 100 100 100 86.37 87.13 
9/ZAF/2014_KT885056 68.69 95.26 95.19 99.9 99.86 99.86 99.76 99.76 99.83 99.93 100 100 100 86.37 87.13 
9/ZAF/2014_KT885076 68.69 95.26 95.19 99.9 99.86 99.86 99.76 99.76 99.83 99.93 100 100 100 86.37 87.13 
9/USA/2008_KX164070 68.79 85.77 85.77 86.26 86.23 86.23 86.47 86.47 86.54 86.44 86.37 86.37 86.37 100 93.2 
9/ECU/2015_KX442583 69.32 85.91 85.84 87.03 87.03 87.03 87.24 87.24 87.31 87.2 87.13 87.13 87.13 93.2 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-10 strains sequenced in this study and global reference western BTV-10 strains 
 
BTV-10 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
1 10/RSArrrr/1956_AJ585131 100 99 99.3 99.3 87.4 87.5 89.2 89.3 89.4 89.2 89.2 89.3 89.3 89.3 89.3 89.3 89.3 89.3 89.3 89.4 87.7 87.8 87.7 
2 10_KX247939 99 100 99.7 99.6 87.6 87.5 88.9 89 89.1 88.7 88.7 88.9 88.9 89 89 89 89 89 89 89.1 87.4 87.5 87.5 
3 10/ZAF_JX272520 99.3 99.7 100 99.9 87.6 87.5 88.9 89 89.1 88.8 88.8 88.9 88.9 89 89 89 89 89 89 89.1 87.5 87.6 87.6 
4 10/ZAF/2011_KT317696 99.3 99.6 99.9 100 87.5 87.5 88.9 89 89 88.8 88.8 88.9 89 89 89 89 89 89 89 89 87.5 87.6 87.5 
5 10/FRA/2006_HQ222821 87.4 87.6 87.6 87.5 100 96.3 89.5 89.4 89.5 89.2 89.2 89.5 89.5 89.5 89.5 89.5 89.5 89.5 89.5 89.6 88.3 88.6 88.4 
6 10/GUF/2011_JQ436735 87.5 87.5 87.5 87.5 96.3 100 89.3 89.2 89.3 89.1 89.1 89.3 89.3 89.3 89.3 89.3 89.3 89.3 89.3 89.4 88.3 88.5 88.3 
7 10/USA/1980_U06780 89.2 88.9 88.9 88.9 89.5 89.3 100 99.8 99.8 99.2 99.2 99.5 99.4 99.5 99.5 99.5 99.5 99.5 99.5 99.6 95.3 95.2 95.1 
8 10/USA/1980_U06782 89.3 89 89 89 89.4 89.2 99.8 100 99.9 99.2 99.2 99.5 99.4 99.5 99.5 99.5 99.5 99.5 99.5 99.6 95.2 95.1 95.1 
9 10/USA/1980_U06783 89.4 89.1 89.1 89 89.5 89.3 99.8 99.9 100 99.2 99.3 99.6 99.5 99.6 99.6 99.6 99.6 99.6 99.6 99.7 95.3 95.3 95.1 
10 10/IND/2004_JN704634 89.2 88.7 88.8 88.8 89.2 89.1 99.2 99.2 99.2 100 99.5 99.4 99.7 99.7 99.7 99.7 99.5 99.5 99.5 99.6 95.2 95.2 95.1 
11 10/IND/2003_JF727655 89.2 88.7 88.8 88.8 89.2 89.1 99.2 99.2 99.3 99.5 100 99.4 99.7 99.7 99.7 99.7 99.6 99.6 99.6 99.6 95.3 95.2 95.2 
12 10/USA_U06786 89.3 88.9 88.9 88.9 89.5 89.3 99.5 99.5 99.6 99.4 99.4 100 99.7 99.7 99.7 99.7 99.7 99.7 99.7 99.8 95.3 95.3 95.2 
13 10/IND/2004_JQ740772 89.3 88.9 88.9 89 89.5 89.3 99.4 99.4 99.5 99.7 99.7 99.7 100 100 100 100 99.8 99.8 99.8 99.9 95.3 95.3 95.3 
14 10/IND/2003_KP339245 89.3 89 89 89 89.5 89.3 99.5 99.5 99.6 99.7 99.7 99.7 100 100 100 100 99.8 99.8 99.8 99.9 95.3 95.3 95.2 
15 IND2014/BTV1_2014-12-06 89.3 89 89 89 89.5 89.3 99.5 99.5 99.6 99.7 99.7 99.7 100 100 100 100 99.8 99.8 99.8 99.9 95.3 95.3 95.2 
16 IND2014/BTV2_2014-12-06 89.3 89 89 89 89.5 89.3 99.5 99.5 99.6 99.7 99.7 99.7 100 100 100 100 99.8 99.8 99.8 99.9 95.3 95.3 95.2 
17 10/USA_L29026 89.3 89 89 89 89.5 89.3 99.5 99.5 99.6 99.5 99.6 99.7 99.8 99.8 99.8 99.8 100 99.9 99.9 99.9 95.4 95.3 95.3 
18 10/USA_M11787 89.3 89 89 89 89.5 89.3 99.5 99.5 99.6 99.5 99.6 99.7 99.8 99.8 99.8 99.8 99.9 100 100 99.9 95.4 95.3 95.3 
19 10/USA/1953_NC_006013 89.3 89 89 89 89.5 89.3 99.5 99.5 99.6 99.5 99.6 99.7 99.8 99.8 99.8 99.8 99.9 100 100 99.9 95.4 95.3 95.3 
20 10/USA_L29027 89.4 89.1 89.1 89 89.6 89.4 99.6 99.6 99.7 99.6 99.6 99.8 99.9 99.9 99.9 99.9 99.9 99.9 99.9 100 95.4 95.4 95.3 
21 10/USA/1990_U06784 87.7 87.4 87.5 87.5 88.3 88.3 95.3 95.2 95.3 95.2 95.3 95.3 95.3 95.3 95.3 95.3 95.4 95.4 95.4 95.4 100 98.3 98.1 
22 10/USA/1990_U06781 87.8 87.5 87.6 87.6 88.6 88.5 95.2 95.1 95.3 95.2 95.2 95.3 95.3 95.3 95.3 95.3 95.3 95.3 95.3 95.4 98.3 100 99.7 
23 10/USA/1990_U06785 87.7 87.5 87.6 87.5 88.4 88.3 95.1 95.1 95.1 95.1 95.2 95.2 95.3 95.2 95.2 95.2 95.3 95.3 95.3 95.3 98.1 99.7 100 
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Percentage of nucleotide identity in Seg-2 between Indian BTV-12 strains sequenced in this study and global reference western BTV-12 strains 
  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 
1 12/IND/2011_KC662613 100 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 99.4 97.4 97.6 97.5 96.8 96.1 87.9 87.6 88.6 
2 IND2015/22_2015-12-18 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
3 IND2015/494_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
4 IND2015/406_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
5 IND2015/470_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
6 IND2015/472_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
7 IND2015/473_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
8 IND2015/474_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
9 IND2015/480_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
10 IND2015/483_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
11 IND2015/484_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
12 IND2015/CS4_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
13 IND2015/CS6_2015-12-25 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
14 IND2015/34_tissue_2015-12- 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
15 IND2015/556_saliva_2015-12- 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
16 IND2015/V41_2015-11-26 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
17 IND2015/V44_lamb_2015-11- 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
18 IND2015/V44Severe_2015-11- 99.4 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 99.9 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.4 
19 12/IND/2016_MF615238 99.4 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 100 99.9 97.1 97.2 97.1 96.4 95.7 87.9 87.5 88.3 
20 12/IND/2015_KX905151 99.4 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 100 97.1 97.2 97.2 96.5 95.8 87.9 87.6 88.4 
21 12/RSArrrr/1941_AJ585133 97.4 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 100 99.8 99.8 99.0 98.1 88.9 88.5 89.6 
22 12/ZAF_JX272500 97.6 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2 99.8 100 100 98.9 98.0 89.0 88.6 89.7 
23 12/RSArrrr/1941_KP821100 97.5 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.1 97.2 99.8 100 100 98.9 98.0 89.0 88.5 89.6 
24 12/JPN/1990_AB686216 96.8 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.4 96.5 99.0 98.9 98.9 100 99.0 88.6 88.0 88.9 
25 12/TWN/2003_GU390659 96.1 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.7 95.8 98.1 98.0 98.0 99.0 100 88.1 87.7 88.5 
26 12/USA/2008_KX164080 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 87.9 88.9 89.0 89.0 88.6 88.1 100 88.1 89.1 
27 12/GUF/2011_KC633278 87.6 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.5 87.6 88.5 88.6 88.5 88.0 87.7 88.1 100 90.6 
28 12/USA/2012_KX164090 88.6 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.4 88.3 88.4 89.6 89.7 89.6 88.9 88.5 89.1 90.6 100 
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